
<html lang="en"     class="pb-page"  data-request-id="fa7a67ed-934f-4a65-9bc8-a84930922817"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-11;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm5017544;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future" /></meta><meta name="dc.Creator" content="Manuela  Ariza" /></meta><meta name="dc.Creator" content="Hartmuth C.  Kolb" /></meta><meta name="dc.Creator" content="Dieder  Moechars" /></meta><meta name="dc.Creator" content="Frederik  Rombouts" /></meta><meta name="dc.Creator" content="José Ignacio  Andrés" /></meta><meta name="dc.Description" content="Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population. The good correlation of the density and neocortical spread of ne..." /></meta><meta name="Description" content="Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population. The good correlation of the density and neocortical spread of ne..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 25, 2015" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5017544" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5017544" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5017544" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5017544" /></link>
        
    
    

<title>Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5017544" /></meta><meta property="og:title" content="Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0013.jpeg" /></meta><meta property="og:description" content="Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population. The good correlation of the density and neocortical spread of neurofibrillary tangles (NFTs) with clinical AD disease progression offers an opportunity for the early diagnosis and staging using a noninvasive imaging technique such as positron emission tomography (PET). Thus, PET imaging of NFTs not only holds promise as a diagnostic tool but also may enable the development of disease modifying therapeutics for AD. In this review, we focus on the structural diversity of tau PET tracers, the challenges related to the identification of high affinity and highly selective NFT ligands, and recent progress in the clinical development of tau PET radioligands." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5017544"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5017544">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5017544&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5017544&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5017544&amp;href=/doi/10.1021/jm5017544" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4365-4382</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm501853m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manuela++Ariza">Manuela Ariza</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hartmuth+C.++Kolb">Hartmuth C. Kolb</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dieder++Moechars">Dieder Moechars</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederik++Rombouts">Frederik Rombouts</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9+Ignacio++Andr%C3%A9s">José Ignacio Andrés</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Neuroscience Medicinal Chemistry, Janssen Research and Development, a Division of Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Neuroscience Biomarkers, Janssen Research and Development, 3210 Merryfield Row, San Diego, California 92121, United States</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Neuroscience Discovery Biology, Janssen Research and Development, a Division of Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Discovery Sciences, Janssen Research and Development, a Division of Janssen-Cilag, Jarama 75, 45007 Toledo, Spain</span></div><div class="corresp-info"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#e089818e84928593a0899493ce8a8e8ace838f8d"><span class="__cf_email__" data-cfemail="ff969e919b8d9a8cbf968b8cd1959195d19c9092">[email protected]</span></a>. Phone: 0034 925 24 57 80.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5017544&amp;href=/doi/10.1021%2Fjm5017544" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4365–4382</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 11, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 November 2014</li><li><span class="item_label"><b>Published</b> online</span>25 February 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 June 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5017544" title="DOI URL">https://doi.org/10.1021/jm5017544</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4365%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DManuela%2BAriza%252C%2BHartmuth%2BC.%2BKolb%252C%2BDieder%2BMoechars%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D11%26contentID%3Djm5017544%26title%3DTau%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BImaging%253A%2BPast%252C%2BPresent%252C%2Band%2BFuture%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4382%26publicationDate%3DJune%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5017544"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4295</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">68</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5017544" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Manuela&quot;,&quot;last_name&quot;:&quot;Ariza&quot;},{&quot;first_name&quot;:&quot;Hartmuth&quot;,&quot;last_name&quot;:&quot;C. Kolb&quot;},{&quot;first_name&quot;:&quot;Dieder&quot;,&quot;last_name&quot;:&quot;Moechars&quot;},{&quot;first_name&quot;:&quot;Frederik&quot;,&quot;last_name&quot;:&quot;Rombouts&quot;},{&quot;first_name&quot;:&quot;José&quot;,&quot;last_name&quot;:&quot;Ignacio Andrés&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;25&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;4365-4382&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5017544&quot;},&quot;abstract&quot;:&quot;Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population. The good correlation of the density and neocortical spread of neurofibrillary tangles (NFTs) with clinical AD disease progression offers an opportunity for the early diagnosis and staging using a noninvasive imaging technique such as positron emission tomography (PET). Thus, PET imaging of NFTs not only holds promise as a diagnostic tool but also may enable the development of disease modifying therapeutics for AD. In this review, we focus on the structural diversity of tau PET tracers, the challenges related to the identification of high affinity and highly selective NFT ligands, and recent progress in the clinical development of tau PET radioligands.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017544&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017544" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017544&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017544" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5017544&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017544" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5017544&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5017544&amp;href=/doi/10.1021/jm5017544" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5017544" /></input><a href="/doi/pdf/10.1021/jm5017544" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5017544%26sid%3Dliteratum%253Aachs%26pmid%3D25671691%26genre%3Darticle%26aulast%3DAriza%26date%3D2015%26atitle%3DTau%2BPositron%2BEmission%2BTomography%2B%2528PET%2529%2BImaging%253A%2BPast%252C%2BPresent%252C%2Band%2BFuture%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D11%26spage%3D4365%26epage%3D4382%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292366" title="Ligands">Ligands</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291663" title="Positron emission tomography">Positron emission tomography</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jmcmar.2015.58.issue-11/20150611/jmcmar.2015.58.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population. The good correlation of the density and neocortical spread of neurofibrillary tangles (NFTs) with clinical AD disease progression offers an opportunity for the early diagnosis and staging using a noninvasive imaging technique such as positron emission tomography (PET). Thus, PET imaging of NFTs not only holds promise as a diagnostic tool but also may enable the development of disease modifying therapeutics for AD. In this review, we focus on the structural diversity of tau PET tracers, the challenges related to the identification of high affinity and highly selective NFT ligands, and recent progress in the clinical development of tau PET radioligands.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">1 Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26743" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26743" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a chronic neurodegenerative disorder and the most common cause of dementia among the elderly population, which is characterized by memory loss, spatial disorientation, and cognitive impairment.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> In a constantly growing aging population, AD has become a major public health burden.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Thus far, only symptomatic treatments have been developed, which are able to slow the progression of cognitive decline only temporarily. Considerable progress has been made by numerous groups and organizations to understand the pathogenic mechanisms underlying AD, resulting in a number of promising disease modifying therapeutic approaches that are currently under development and clinical evaluation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">Multiple factors are considered to be involved in the pathogenic mechanism leading to AD, such as age, genetic makeup, environmental factors, head trauma, depression, diabetes mellitus, hyperlipidemia, and vascular factors.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Apart from the intrinsic complexity of AD, the development of a cure for AD has been hampered by the lack of reliable tools for early diagnosis, staging, and accurately monitoring disease progression. According to the new reviewed criteria and guidelines for diagnosing AD proposed by the National Institute on Aging (NIA) and the Alzheimer’s Association in 2011, three different stages have been accepted:<a onclick="showRef(event, 'ref6 ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref6 ref7 ref8 ref9">(6-9)</a> (1) Preclinical Alzheimer’s disease, characterized by early brain changes without noticeable physical or clinical symptoms; (2) mild cognitive impairment (MCI) due to Alzheimer’s disease, outlined by very mild symptoms without affecting activities of daily living; (3) dementia due to Alzheimer’s disease, described by important memory and behavioral symptoms that hamper regular life.</div><div class="NLM_p">The initial neuropathological changes in the brain are thought to begin 20 years or more before symptoms appear in AD, which is in accordance to Braak and Braak stages,<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10, 11)</a> and during this period, individuals are able to function normally. The long duration of this presymptomatic phase offers an opportunity to elucidate the link between the pathophysiological process of AD and the emergence of the clinical disorder, which could allow both the early diagnosis and early intervention with a disease-modifying therapy.</div><div class="NLM_p">To date, the diagnosis of AD can only be confirmed by post-mortem histological analysis of human brain samples.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Post-mortem studies of AD brains reveal two pathological hallmarks of AD: (1) senile plaques (SPs), composed by amyloid (Aβ) peptides, and (2) neurofibrillary tangles (NFT) that are composed of paired helical filaments (PHF) of hyperphosphorylated aggregated tau protein.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Aβ peptide deposits are commonly found outside neurons in the brain, while the tau protein tangles are formed inside the neurons but eventually end up in the intercellular space after neuronal death.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Currently, the clinical diagnosis of AD is based largely on history and statistical memory testing such as DSM-IV-TR<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (the Diagnostic and Statistical Manual of Mental Disorders) and NINCDS-ADRDA<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> (the National Institute of Neurological Disorders and Stroke–Alzheimer Disease and Related Disorders). However, these examinations require clear evidence of impairment or dementia and are often inaccurate or insensitive because of the difficulty in distinguishing AD from age-related cognitive decline.</div><div class="NLM_p">Measurement of Aβ peptides and total tau protein levels in cerebrospinal fluid (CSF) has been presented as a complementary useful tool in the diagnosis and monitoring of AD by the European Medicines Agency (EMA).<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> However, CSF sample collection by lumbar puncture is invasive and may lead to adverse events.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div><div class="NLM_p">Modern imaging techniques are noninvasive and may be used to identify patients at risk of developing AD and/or monitor disease progression.<a onclick="showRef(event, 'ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21">(19-21)</a> Specifically, positron emission tomography (PET) is a sensitive molecular imaging technique that enables in vivo and in situ noninvasive visualization, characterization, and quantification of physiological processes at the cellular or molecular levels.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> As such, PET has become an extremely powerful diagnostic tool that is increasingly used in the drug discovery and development process to demonstrate target engagement and monitor disease progression.<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23, 24)</a></div><div class="NLM_p">Since the deposition of neuritic plaques is one of the pathological hallmarks of AD, a significant effort has been devoted to developing PET imaging probes that visualize Aβ-plaques in vivo in human brain (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref25 ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref25 ref26 ref27 ref28 ref29">(25-29)</a> Pittsburgh compound B, 2-[4-([<sup>11</sup>C]methylamino)phenyl]benzothiazol-6-ol (<b>1</b>, [<sup>11</sup>C]-PiB), a thioflavin-T (ThT) derivative, was the first successful Aβ-selective PET radioligand<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and is currently among the most widely used agents for the delineation of Aβ-plaques in the brain.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> However, the short half-life of carbon-11 (<sup>11</sup>C, <i>t</i><sub>1/2</sub> = 20.3 min) limits the use of <b>1</b> to centers that have a cyclotron on site. For a wider use, tracers with a longer half-life, i.e., fluorine-18 (<sup>18</sup>F, <i>t</i><sub>1/2</sub> = 109.8 min), have been developed. Significant examples include <i>N</i>-[4-[2(<i>E</i>)-[4-[2-[2-(2-[<sup>18</sup>F]fluoroethoxy)ethoxy]ethoxy]phenyl]vinyl]phenyl]-<i>N</i>-methylamine (<b>2</b>, [<sup>18</sup>F]florbetaben, [<sup>18</sup>F]AV-1, Neuroceq),<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a><i>N</i>-[4-[2(<i>E</i>)-[6-[2-[2-(2-[<sup>18</sup>F]fluoroethoxy)ethoxy]ethoxy]pyridin-3-yl]vinyl]pheny]-<i>N</i>-methylamine (<b>3</b>, [<sup>18</sup>F]-florbetapir, [<sup>18</sup>F]AV-45, Amyvid),<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> 2-[3-[<sup>18</sup>F]fluoro-4-(methylamino)phenyl]benzothiazol-6-ol (<b>4</b>, [<sup>18</sup>F]flutemetamol, Vizamyl),<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> and 2-[2-[<sup>18</sup>F]fluoro-6-(methylamino)pyridin-3-yl]-1-benzofuran-5-ol (<b>5</b>, [<sup>18</sup>F]AZD4694, NAV4694).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Several articles and reviews have been published in recent years discussing the status and advances of this class of PET imaging agents.<a onclick="showRef(event, 'ref36 ref37 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38 ref39">(36-39)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Aβ PET probes for AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Generally, the density of amyloid plaques in brain tissue does not correlate well with neurodegeneration and cognitive impairment in AD.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> However, amyloid deposits have been shown to accumulate in the brain of individuals at risk of developing AD.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> As a result, amyloid imaging has not been approved for the diagnosis of AD or the measurement of the extent of cognitive impairment but rather as a diagnostic method for the <i>exclusion</i> of AD in subjects that are cognitively impaired and amyloid PET-negative.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Currently, it is being evaluated as a diagnostic tool for defining the preclinical stages of AD.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_p">In contrast to Aβ-plaques, the density and neocortical spread of NFTs correlate with progressive neuronal degeneration and cognitive impairment,<a onclick="showRef(event, 'ref40 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref40 ref43 ref44">(40, 43, 44)</a> thus making PET imaging of NFTs a desirable biomarker for AD. Recent findings provide additional support for the central role of tau in the pathogenesis of AD,<a onclick="showRef(event, 'ref43 ref45'); return false;" href="javascript:void(0);" class="ref ref43 ref45">(43, 45)</a> supporting this protein as both a diagnostic and a therapeutic target.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> For instance, imaging NFTs may allow the early detection of disease, possibly even before the onset of cognitive symptoms, as well as presymptomatic staging. PET imaging of NFTs, especially when done in conjunction with amyloid diagnosis, may also provide a means for distinguishing between AD and non-AD dementias: the absence of NFTs and amyloid would provide support for the latter diagnosis, while the presence of NFTs and amyloid would support for the former. For the research audience, NFT imaging provides insights into the relationships between tau aggregate accumulation and spread as a function of time, cognition, and brain structure, across the continuum from normal aging to AD, and to investigate the effect of disease-modifying therapies on tau aggregation. Consequently, the development of radiotracers for tau aggregates has been pursued by numerous academic and industrial groups.<a onclick="showRef(event, 'ref47 ref48 ref49 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50 ref51 ref52">(47-52)</a></div><div class="NLM_p last">The aim of this article is to chronologically review the progress that has been made in the field of tau aggregate imaging, from a medicinal chemistry perspective, as well as the recent evolution in the development of selective tau PET radioligands currently undergoing clinical evaluation, starting with an overview of the structural characteristics of tau aggregates and requirements that a suitable tau PET ligand must fulfill.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">2 Structure of Aggregated Tau</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75308" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75308" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The protein tau belongs to a large family of microtubule-associated proteins (MAPs) and is mainly localized in the neuronal axons. The best described biological function of tau protein is the binding to tubulin to stabilize and control the polymerization of microtubules, which is critical to maintain cell shape, axonal transport, and the neurotransmission machinery.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Knowledge of the molecular structure and composition of tau protein is essential for the understanding of the protein self-assembly leading to the pathological tau aggregates and could allow for the rational design of NFT radiotracers.</div><div class="NLM_p">In human brain, six tau isoforms have been identified that arise from alternative mRNA splicing of a single gene composed of 16 exons located on the chromosome 17q21.31.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54, 55)</a> The presence or absence of exon 2, exon 3, and exon 10 manifested in the protein constitutes the main differences in these six isoforms. Exons 2 and 3 encode the insertion of 29 amino acids in the N-terminus (called N); thus, tau isoforms may have 2N (both exons inserted), 1N (only exon 2) or 0N (neither). Likewise, exon 10 encodes a 31 amino acid stretch in the C-terminus, which is commonly known as the microtubule-binding repeat/domain (R). Hence, tau isoforms may comprise four repeated microtubule-binding domains called four repeat tau (4R, exon 10 included) or three repeated microtubule-binding domains called three repeat tau (3R, exon 10 excluded). Accordingly, the six tau isoforms are [4R 2N], [4R 1N], [4R 0N], [3R 2N], [3R 1N], and [3R 0N], of which the isoform [3R 0N] is expressed in fetal brains (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Adult human 4R isoforms have been shown to be better at promoting microtubule assembly than the fetal 3R isoforms. In healthy human brains, there is an equal 4R/3R ratio and the alteration of this equilibrium is the underlying pathogenic mechanism of a certain clinical mutation in tau associated with FTLD-17.<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a></div><div class="NLM_p">It is important to note that tau is a natively unfolded protein lacking a well-defined 3D structure. However, X-ray, Fourier transform infrared (FTIR), and circular dichroism (CD) studies suggest that the N- and C-terminal domains are folded to form a “paper clip” conformation (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Additionally, nuclear magnetic resonance (NMR) measurements revealed regions with transient secondary structure (α-helix, β-strand, and polyproline II).<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Further studies have demonstrated that tau protein contains isolated short peptide motifs localized at the beginning of repeat domains R2-R4. Indeed, two of such motifs, called PHF6* (VQIINK) and PHF6 (VQIVYK), have a high tendency for β-structure formation and they play a crucial role in microtubule interactions but also in the tau aggregation process,<a onclick="showRef(event, 'ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref60 ref61">(60, 61)</a> which clearly illustrates the close relationship between physiological and pathological functions of tau. A protective effect against tau aggregation of the paper clip conformation has been postulated by shielding the hexapeptide motifs.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of the human tau protein: (A) six human tau isoforms (reproduced from  <cite>Neurochemistry International</cite>, Vol. <em>58</em>, <contrib-group>Martin, L.; Latypova, X.; Terro, F.</contrib-group>, Post-translational modifications of tau protein: implications for Alzheimer’s disease, pp 458–471, Copyright <span class="NLM_year">2011</span>,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> with permission from Elsevier); (B) paper clip conformation (illustration based on ref <a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">58</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Apart from the primary structure diversity, tau protein is subject to several post-translational modifications such as glycosylation, phosphorylation, nitration, acetylation, or ubiquitination, of which phosphorylation is considered the most common and important modification. Whereas phosphorylation is essential for the normal protein function under physiological conditions, abnormalities in tau phosphorylation have been proposed to play a crucial role in tau aggregation.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> In fact, under pathological conditions in AD, higher concentrations of tau protein appear dissociated from microtubules, becoming more prone to hyperphosphorylation. This abnormally hyperphosphorylated tau is able to bind to normal tau protein disrupting the usual microtubule network and promoting self-assembly into filaments and NFTs.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a></div><div class="NLM_p">Aggregation of tau is characteristic of different neurodegenerative diseases known as “tauopathies”.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> Although the most prevalent is AD, they additionally include tangle-only dementia (TD), argyrophilic grain disease (AGD), progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Pick disease (PiD), and frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). The heterogeneity of these disorders is closely related to the wide range of human tau isoforms and post-translational modifications. Indeed, tau aggregates may appear ultrastructurally as paired helical filaments (PHF), straight filaments (SF), randomly coiled filaments (RCF), or twisted filaments (TF). This variability translates into polymorphism, whereby either the same tau isoform adopts different conformations and tau aggregate ultrastructure or different isoforms appear with the same ultrastructure. For example, in AD and TD tau inclusions appear as both 4R and 3R isoforms in the shape of NFTs, whereas 3R isoforms predominate in PiD as Pick’s bodies in the shape of RCFs and SFs. In CBD, tau deposits are found as astrocytic plaques composed of 4R tau isoform in the form of SFs and TFs.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a></div><div class="NLM_p">Recent studies of the ultrastructure of the tau fibrils in AD brains showed that the core of NFTs is composed of hyperphosphorylated tau filaments in the form of PHF which were found to be a twisted double-helical fibril with a crossover repeat of ∼80 nm and a width varying between 8 and 20 nm.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> The region around the hexapeptide motifs exhibits three major β-strands in a cross-β conformation, which constitutes the rigid core of the fibril. In addition, the tau fibril core is stabilized by the formation of distinct salt bridges as well as by hydrophobic and π-stacking interactions.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Even though structure determination of PHF cannot be achieved with present techniques, the structure of the amino acid 386–391 core of the C-terminal tail has been elucidated by using conformation-dependent monoclonal antibodies.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> This <sup>386</sup>TDHGAE<sup>391</sup> fragment was isolated and crystallized from PHFs in a complex with the antibody MN423 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">03</a>).<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 3D structure of the <sup>386</sup>TDHGAE<sup>391</sup> core of the PHF C-terminus.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">It is also noteworthy that the occurrence of each of the six tau isoforms is highly variable along different species. For instance, both rats and mice are characterized by the complete absence of tau isoforms with three tubulin binding regions, while both 4R and 3R tau isoforms are expressed in pigs, although only four out of the six possible isoforms are found.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Tau research benefits from the availability of preclinical in vivo models, such as transgenic tauopathy mouse models,<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> most of which are based on the overexpression of the known MAPT mutations discovered in FTDP-17 patients or expression of the six isoforms of wild type tau.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> More recently, tauopathies have been induced by injection of tau aggregates into the brains of experimental animals, providing support for a prion-like seeding mechanism.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">3 Properties of a Tau PET Ligand</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The ideal PET radioligand for brain imaging is almost exclusively a small molecule (MW < 500), which must fulfill a wide range of requirements that have been reviewed on multiple occasions.<a onclick="showRef(event, 'ref24 ref75 ref76 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref24 ref75 ref76 ref77 ref78">(24, 75-78)</a> First of all, a suitable CNS PET ligand must show high affinity and selectivity toward its biological target, and this binding needs to be reversible to ensure that equilibrium is reached quickly enough to image the subject. The density of the target in the brain region of interest is an important factor for consideration, and in this respect the maximum concentration of target binding sites (<i>B</i><sub>max</sub>) is key, as it has a direct impact on the level of affinity (<i>K</i><sub>d</sub>) required for a successful radiotracer, most usually in the low nanomolar range. It is generally accepted that the ratio <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> should be ≥10.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Importantly, a CNS PET radiotracer should be able to cross the blood–brain barrier (BBB) and hence should not be a substrate for efflux transporters. At the same time it should exhibit low nonspecific binding in order to avoid attenuation of the signal-to-noise ratio due to undesired binding to brain tissue. An adequate balance between lipophilicity and fraction of radiotracer that is freely available in plasma is required, and in general a free fraction of the tracer in plasma of >5% and log <i>D</i> values ranging from 2 to 3.5 are considered optimal.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> However, there may exist exceptions to these two general rules, provided that the dissociation from plasma proteins occurs fast enough to ensure that sufficient concentration of radiotracer is available for an adequate brain uptake.<a onclick="showRef(event, 'ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref80 ref81">(80, 81)</a></div><div class="NLM_p">Ideally, a CNS PET ligand does not form BBB permeable radioactive metabolites, which would complicate the efficient quantification of the PET imaging data because of signals stemming from the parent radiotracer and the radiometabolite(s). In the case of <sup>18</sup>F radiolabeled PET ligands, extensive defluorination should be prevented, as it would lead to high signals from bones and skull, which would thwart accurate measurement of cortical uptake. A suitable brain pharmacokinetic profile, i.e., observable brain uptake and washout kinetics, is also a must for a successful CNS PET tracer.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Finally, PET ligand candidates must be synthetically accessible using quick (within 3 half-lives) and efficient (enough radiochemical yield and specific activity) processes, because of the short half-lives of the two most widely used positron emission radionuclides, <sup>11</sup>C (half-life of 20.4 min) and <sup>18</sup>F (half-life of 109.7 min).</div><div class="NLM_p last">PET imaging of NFTs in human brain presents a number of specific challenges.<a onclick="showRef(event, 'ref40 ref51'); return false;" href="javascript:void(0);" class="ref ref40 ref51">(40, 51)</a> First of all, the tracer needs to discriminate PHF-tau from the other β-sheet-structured aggregates present in Alzheimer’s brain, i.e., amyloid plaques. Structural similarity aside, amyloid aggregates different from tau aggregates are also in the order of 5- to 20-fold more abundant in brain than tau aggregates<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> and are colocalized in certain brain regions. Furthermore, recently it has been reported that α-synuclein-containing aggregates are abundant in AD; hence, tau PET tracers should be selective over these protein aggregates as well.<a onclick="showRef(event, 'ref82 ref83'); return false;" href="javascript:void(0);" class="ref ref82 ref83">(82, 83)</a> In addition, given the intracellular localization of tau, the radiotracer must be able to cross not just the BBB but also the cell membrane. Furthermore, since tau aggregates are present also in white matter, a tau PET ligand should be devoid of nonspecific binding in this brain area. Finally, although the structural variability displayed by tau protein might be an advantage for the differential diagnosis of tauopathies, selective discrimination among different forms of aggregated tau offers an additional challenge for a PET ligand due to similarities in isoform composition, post-translational modifications, and β-sheet structure.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">4 Tau PET Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21011" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21011" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nonselective β-sheet binders such as thioflavin T (ThT) have been instrumental to the discovery of specific tau aggregate binders. Since Aβ-plaques and other amyloid aggregates and NFTs share a similar β-sheet structure, it is not surprising that structural similarities exist between imaging agents for both species.</div><div class="NLM_p">The structural diversity of tau protein and its aggregates as well as their post-translational modification has thwarted the systematic evaluation of potential binding sites for a PET ligand using crystal structure or bioinformatical methods. For this reason, compound screening approaches were utilized for ligand discovery, guided by the hypothesis that fused aromatic systems are more likely to interact with the β-sheet fibrillar aggregates present in PHF-tau. These efforts led to the discovery of leads based on benzothiazoles, benzimidazoles, benzoxazoles, naphthalenes, and quinolines.</div><div class="NLM_p">Compound screening is generally based on competitive in vitro assays using either synthetic heparin-induced tau polymers (HITP) or post-mortem AD human brain homogenates (AD-PHFs) or sections. HITP are composed only of 3R and/or 4R tau and are unlikely to have similar hyperphosphorylation or glycated or ubiquitinated residues as the native AD-PHFs. Furthermore, HITPs and AD-PHFs differ with respect to the structure and variability in twist in the observed tau filaments.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> Such differences could be the reason why screening campaigns based on synthetic HITP have not been very successful for identifying ligands for native AD-PHF tau.<a onclick="showRef(event, 'ref67 ref70'); return false;" href="javascript:void(0);" class="ref ref67 ref70">(67, 70)</a> Assays based on native protein, as found in brain homogenates or brain slices from AD patients, have yielded the most promising tau ligands.<a onclick="showRef(event, 'ref47 ref48 ref49 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref47 ref48 ref49 ref50 ref51">(47-51)</a></div><div class="NLM_p">To our knowledge there are no reports providing a systematic SAR analysis on the features that are required to achieve tau selectivity over amyloid aggregates. Only a few of the papers describing tau ligands discuss briefly the SAR around the respective chemical series<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> but do not provide any robust conclusions.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">4.1 Lead Compounds</h3><div class="NLM_p">One of the earliest ligand screening campaigns targeting tau aggregates for PET tracer discovery was performed by Okamura et al. in 2005.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> In this study, more than 2000 small molecules were tested, which resulted in the discovery of quinolines and benzimidazoles leads, such as <b>6</b> (BF-126), <b>7</b> (BF-158), and <b>8</b> (BF-170) (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> Structurally, compound <b>6</b> resembles <b>1</b>, with the benzothiazole core being replaced by benzimidazole and a carbon–carbon double bond spacer being inserted between the planar aromatic ring and the aniline-like substituent at position 2. Compounds <b>7</b> and <b>8</b> also carry an aniline moiety, which is directly attached to a quinoline ring at the 2-position. In vitro fluorescence binding affinity assay data as well as neuropathological staining results suggested quinolines <b>7</b> and <b>8</b> to be better tau ligands than the benzimidazole <b>6</b>; yet all compounds showed a relatively low selectivity over amyloid plaques (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Additionally, compounds <b>6</b>, <b>7</b>, and <b>8</b> were unable to bind to tau present in non-AD tauopathies such as PiD and PSP. Compound <b>7</b> was radiolabeled with <sup>11</sup>C for in vitro autoradiographic studies, which confirmed the accumulation of this tracer in tangle-rich brain regions. Biodistribution studies of <sup>11</sup>C-<b>7</b> in mice showed good brain uptake (11.3% ID/g at 2 min postinjection) but rather slow clearance from the brain (3.1% ID/g at 30 min postinjection). Despite their low affinity (EC<sub>50</sub> > 200 nM) and high nonspecific binding, these compounds first highlighted the potential utility of quinolines and benzimidazoles as tau PET radioligands in AD.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p">A subsequent screening campaign of 72 455 compounds with the aim of distinguishing tau aggregates from Aβ plaques was performed by Kuret et al. in 2007.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> This effort identified phenyldiazenylbenzothiazole (PDB) derivative <b>9</b> with only 2-fold selectivity for tau tangles over amyloid. Compound <b>9</b> is structurally very similar to <b>6</b>, and a benzothiazole replaces the benzimidazole and a diazo group the carbon–carbon double bond. On the basis of these structures, Matsumura et al. developed two novel PDB agents by substituting the methoxy group with iodine-125 (<b>10</b>, <sup>125</sup>I-PDB-3)<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> and by replacing it with a fluoropolyethylene glycol (FPEG) chain, respectively (<b>11</b>, <sup>18</sup>F-FPPDB)<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Compound <b>10</b> showed a clear improvement in binding affinity to synthetic tau aggregates (<i>K</i><sub>i</sub> = 0.48 nM) and selectivity over amyloid plaques. However, unfavorable pharmacokinetics made this compound unsuitable for imaging NFTs in vivo, probably because of the high lipophilicity (log <i>P</i> = 3.84, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). The fluoro-PDB analogue <b>11</b> with a lower log <i>P</i> of 2.05 demonstrated improved pharmacokinetics, increased initial brain uptake, and accelerated clearance versus <b>10</b>; however, affinity and selectivity were compromised (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of benzimidazoles <b>6</b>, <b>12</b>–<b>18</b>; quinolines <b>7</b> and <b>8</b>; benzothiazoles <b>9</b>–<b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The substitution of the benzothiazole scaffold by a benzimidazole ring proved an effective strategy to reduce lipophilicity, as expected from the lower calculated log <i>P</i> for an unsubstituted benzimidazole ring than for an unsubstituted benzothiazole ring (Clog <i>P</i> = 1.57 versus 2.08, using Daylight software and Biobyte). Thus, radioiodinated styrylbenzimidazole derivatives similar to compound <b>10</b> were synthesized with the goal of reducing the nonspecific binding.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Although clearance was improved (0.33% ID/g at 60 min postinjection), the best candidate, <b>12</b> (<sup>125</sup>I-ISBIM-3)<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), did not display sufficient potency or Aβ/tau selectivity (2.73-fold), which may not be surprising, given the close structural similarity with the previously reported compound <b>6</b>.</div><div class="NLM_p">More recently, the butadienylbenzimidazole derivative <b>13</b><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> was identified as a modestly tau selective multispectral fluorescent imaging (MSFI) probe, which gives different fluorescent spectra when bound to tau or Aβ fibrils (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Although <b>13</b> was specifically developed for fluorescence-based imaging, it is an equally promising lead for the development of new tau PET probes.</div><div class="NLM_p">Besides the planar aromatic bicycle, compounds <b>6</b>–<b>13</b> are characterized by the presence of an aniline terminus either directly linked to the aromatic ring or via a sp<sup>2</sup> hybridized two- or four-atom spacer. Interestingly, the aniline moiety is also present in previously reported Aβ ligands, which may explain the low selectivity achieved with those compounds and illustrates the challenge in differentiating between both fibrillar proteins.</div><div class="NLM_p">The binding characteristics of the benzimidazole drugs astemizole (<b>14</b>) and lansoprazole (<b>15</b>) to aggregated tau were recently reported by Rojo et. al (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> Compound <b>14</b> appears to have high affinity for both HITP and AD-PHF tau, although no selectivity over Aβ plaques and only minor brain uptake and clearance were observed. The latter is likely due to the fact that <b>14</b> is a substrate of the ATP-dependent efflux transporter p-glycoprotein (P-gP) in rats, which may limit its utility as a human PET tracer as well.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. The log <i>P</i>, Affinity for Tau, Selectivity Aβ/Tau, and Brain Uptake for Compounds <b>6</b>–<b>15</b> and <b>17</b>–<b>20</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">tau affinity (nM)</th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">brain uptake (% ID/g)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">log <i>P</i></th><th class="colsep0 rowsep0" align="center">HITP</th><th class="colsep0 rowsep0" align="center">AD-PHF</th><th class="colsep0 rowsep0" align="center">selectivity, tau/Aβ</th><th class="colsep0 rowsep0" align="center">2 min</th><th class="colsep0 rowsep0" align="center">30 min</th><th class="colsep0 rowsep0" align="center">60 min</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">1.09</td><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> = 583</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">2.20<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">7.2</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>11</sup>C-<b>7</b></td><td class="colsep0 rowsep0" align="left">1.67</td><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> = 399</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.60<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">11.3</td><td class="colsep0 rowsep0" align="left">3.1</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">1.85</td><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> = 221</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">3.50<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">9.1</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">EC<sub>50</sub> = 83</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.70<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>125</sup>I-<b>10</b></td><td class="colsep0 rowsep0" align="left">3.84</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> = 0.48</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">17.20<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.94</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">2.89</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>18</sup>F-<b>11</b></td><td class="colsep0 rowsep0" align="left">2.05</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> = 13.0</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.54<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">4.28</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">2.53</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>125</sup>I-<b>12</b></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>d</sub> = 300</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">2.73<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">3.28</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> = 3.9</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">1.60<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">4.8</td><td class="colsep0 rowsep0" align="left">0.12</td><td class="colsep0 rowsep0" align="left">N/A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>11</sup>C-<b>14</b></td><td class="colsep0 rowsep0" align="left">5.57</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>d</sub> = 1.86</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>d</sub> = 13.4</td><td class="colsep0 rowsep0" align="left">1.13<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">∼6 × 10<sup>–3</sup></td><td class="colsep0 rowsep0" align="left">∼8 × 10<sup>–3</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">1.47</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> = 2.5</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> = 833.3</td><td class="colsep0 rowsep0" align="left">N/A<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">∼3 × 10<sup>–3</sup></td><td class="colsep0 rowsep0" align="left">∼2.7 × 10<sup>–3</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>11</sup>C-<b>17</b></td><td class="colsep0 rowsep0" align="left">2.18</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>d</sub> = 0.7</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">11.7<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">∼0.1</td><td class="colsep0 rowsep0" align="left">∼0.05</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>125</sup>I-<b>19</b></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left"><i>K</i><sub>i</sub> = 64</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">7.33<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.54</td><td class="colsep0 rowsep0" align="left">0.70</td><td class="colsep0 rowsep0" align="left">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><sup>18</sup>F-<b>20</b></td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">N/A</td><td class="colsep0 rowsep0" align="left">6.50</td><td class="colsep0 rowsep0" align="left">2.83</td><td class="colsep0 rowsep0" align="left">2.35</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">The log <i>P</i> values are the partition coefficient (octanol/water) measured for each compound as reported in the respective references. Selectivity tau vs Aβ:</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">EC<sub>50</sub>(Aβ)/EC<sub>50</sub> (tau).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last"><i>K</i><sub>i</sub>(Aβ)/<i>K</i><sub>i</sub>(tau).</p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last"><i>K</i><sub>d</sub>(Aβ)/<i>K</i><sub>d</sub>(tau).</p></div></div></div><div class="NLM_p">Nevertheless, several radioactive derivatives were synthesized by <sup>11</sup>C-methylation or <sup>18</sup>F-alkylation of the <i>p</i>-hydroxyphenyl position (<b>16</b>), but it proved impossible to overcome the pharmacokinetics and permeability issues.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> Unlike <b>14</b>, compound <b>15</b> displayed higher affinity for HITP than for AD-PHF tau protein, probably due to differences in the structure of induced tau fibrils and human isolated tau aggregates. Despite the low AD-PHF tau affinity, the low permeability, and lack of selectivity, several radioactive derivatives of <b>15</b> were prepared, e.g. <sup>11</sup>C-<b>17</b><a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> and <sup>18</sup>F-<b>18</b>.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Both tracers display excellent affinity to HITP, and preliminary studies with transgenic mice expressing human AD and PSP tau revealed their promise as tau PET probes.<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93, 94)</a> Additionally, autoradiography staining with human AD brain sections colocalized with tau immunostaining, but not with amyloid plaques, yet white-matter nonspecific binding was observed as well. In vivo metabolic studies of <sup>11</sup>C<b>-17</b> in rodents and non-human primates showed the presence of a single polar radioactive metabolite that is likely the hydroxyl or sulfone derivative, in accordance with the known metabolism of lansoprazole. It is important to note that both radiotracers are substrates for the rodent P-gP transporter but not for the corresponding primate P-gP transporter. This suggests a potential utility of these compounds in humans, although additional studies are clearly needed.</div><div class="NLM_p">The growing interest for imaging tau aggregates in human brain and the need to find a more potent and selective ligand have spurred a quest for structurally different compounds from the ones originally reported. For example, compounds <b>19</b><a onclick="showRef(event, 'ref95 ref96'); return false;" href="javascript:void(0);" class="ref ref95 ref96">(95, 96)</a> and <b>20</b><a onclick="showRef(event, 'ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref97 ref98">(97, 98)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) were considered as tau PET tracers when studying the effect and properties of similar compounds as potential tau aggregation inhibitors.<a onclick="showRef(event, 'ref99 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref99 ref100 ref101">(99-101)</a> Compound <b>19</b> is a thiohydantoin derivative linked via rigid <i>Z</i>-methylidene to a 5-phenylfuryl group at the 5-position, and a flexible 2-(1<i>H</i>-imidazol-4-yl)ethyl chain at the 1-position. Even though the affinity and selectivity of compound <b>19</b> were moderate (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), autoradiography and immunohistochemical studies in sections of human AD brain show that this tracer binds to tangle-rich brain regions.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><div class="NLM_p">Brain section staining experiments suggest that 7-aminothieno[3,4-<i>d</i>]pyridazin-1(2<i>H</i>)-one (<b>20</b>) is able to discriminate NFTs from Aβ plaques. A biodistribution evaluation of <b>20</b> in normal mice revealed relatively rapid brain uptake and clearance (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). However, additional studies are needed to test the utility of <b>20</b> as a tau PET ligand, such as the determination of the binding affinity for NFTs and tau/Aβ selectivity.</div><div class="NLM_p">A recent Hoffman-La Roche patent application claims imidazo[2,1]thiazol-3-one derivatives<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> (<b>21</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>) as potent (<i>K</i><sub>i</sub>(HITP tau) ≈ 0.010 nM) and exceptionally selective tau aggregate binders (tau/Aβ of approximately 100- to 1000-fold), suggesting that they have potential as tau PET tracers. Structurally, these derivatives are similar to the thiohydantoin compound <b>19</b>, and it is interesting to note the highly polar phenolic terminus on one side and a lipophilic aromatic terminus on the opposite side. Previous studies with amphiphilic molecules had suggested that it may be possible to increase potency and selectivity by incorporating lipophilic and hydrophilic features in the same compound.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> However, the true potential of this chemical class has yet to be shown, since the affinity and selectivity in human AD brain have not yet been disclosed. These compounds might be the subject of a recently registered clinical phase 1 study, “Evaluation of [<sup>11</sup>C]RO6924963, [<sup>11</sup>C]RO6931643, and [<sup>18</sup>F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer’s Disease Participants”,<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> which does not disclose the exact chemical nature of the test compounds.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Diverse tau PET ligands: structures of compounds <b>19</b>–<b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several additional scaffolds have been proposed in recent years as potential tau imaging agents, such as bis(aryl)urea azaindole <b>22</b>, developed by Merck,<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> or SKT04-137 (<b>23</b>) by Wista Laboratories LTD,<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> bearing an urea or an amide moiety, respectively, as linkers between two aromatic partners. Bis(arylvinyl)pyrimidines such as <b>24</b><a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> are characterized by a linear π-conjugated symmetric structure having two styryl moieties bound to a pyrimidine central core. This compound displayed good affinity (IC<sub>50</sub>(HITP tau) = 2 nM) and selectivity (26-fold), although no pharmacokinetic studies assessing brain penetration have been reported.</div><div class="NLM_p last">Finally, the naphthalene derivative 2-[1-[6-[<i>N</i>-(2[<sup>18</sup>F]-fluoroethyl)-<i>N</i>-methylamino]naphthalen-2-yl]ethylidene]malononitrile (<b>25</b>, <sup>18</sup>F-FDDNP) is an older radioligand, first described as a potential PET tracer for Aβ and NFTs by Barrio et al. in 1999.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> Although the authors have touted the potential efficacy of <b>25</b>,<a onclick="showRef(event, 'ref109 ref110 ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref109 ref110 ref111 ref112">(109-112)</a> the apparently low affinity for amyloid structures<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> and the low Aβ/tau selectivity of <b>25</b> are likely to limit its utility as a PET tracer. Different studies reported with this radioligand have been covered in several recent review articles.<a onclick="showRef(event, 'ref40 ref47 ref50 ref51'); return false;" href="javascript:void(0);" class="ref ref40 ref47 ref50 ref51">(40, 47, 50, 51)</a></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">4.2 Selective Tau Binders Evaluated in Human Subjects</h3><div class="NLM_p">Recently, considerable progress in the development of high-affinity, tau-selective ligands has been made independently by three groups: the Tohoku University/Austin Hospital group, led by N. Okamura, has described a series of <sup>18</sup>F-labeled THK compounds; the Chiba group, led by M. Maruyama and H. Shimada, has described a new series of <sup>11</sup>C-labeled PBB compounds; and the Siemens group, led by H. Kolb, has reported two <sup>18</sup>F-labeled compounds, which are now being developed by Avid/Lilly.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i8" class="anchor-spacer"></div><h4 class="article-section__title" id="_i8">4.2.1 THK Compounds</h4><div class="NLM_p">The THK tau imaging probes comprise a family of arylquinolines first reported by Okamura et al. after structural optimization of lead compounds <b>7</b> and <b>8</b>.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> 4-[6-(2-[<sup>18</sup>F]Fluoroethoxy)quinolin-2-yl]phenylamine (<b>26</b>, THK-523)<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> was the first candidate described with good affinity for synthetic tau fibrils and reasonable selectivity over amyloid plaques (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The introduction of an alkyl ether at the 6-position of the arylquinoline not only allowed introduction of <sup>18</sup>F but was also accompanied by an improvement in affinity and selectivity compared to the initial hits <b>7</b> and <b>8</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Binding Affinities and Pharmacokinetics of Compounds <b>26</b>–<b>28</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0011.gif" alt="" id="fx1" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">The log <i>P</i> values are the partition coefficient (octanol/water) measured for each compound as reported in the respective references. Selectivity tau vs Aβ:</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last"><i>K</i><sub>d</sub>(Aβ)/<i>K</i><sub>d</sub>(tau).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last"><i>K</i><sub>i</sub>(Aβ)/<i>K</i><sub>i</sub>(tau), and the asterisk (∗) indicates unpublished data, AAIC Meeting, Copenhagen. 2014.</p></div></div><div></div></div><div class="NLM_p">Initial in vitro saturation binding studies with <b>26</b> suggested two different binding sites,<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> and further competition studies revealed the affinity for recombinant tau fibrils to be relatively low (<i>K</i><sub>i</sub> = 59.30 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Unfortunately, the binding affinity for AD-PHF, present in AD brain homogenates, was even lower (<i>K</i><sub>d</sub> = 86.50 nM) than for synthetic HITP, which again demonstrated the shortcomings of synthetic tau preparations. Even though the tau/Aβ selectivity was initially reported to be 10-fold, based on the synthetic tau affinity data (<i>K</i><sub>d1</sub> = 1.67 nM), <b>26</b> is actually nonselective, based on the other tau binding data.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a></div><div class="NLM_p">Interestingly, in vivo retention of <b>26</b> in tau transgenic mice (rTg4510) was significantly higher compared to the analogue model for Aβ plaques (APP/PS1 mice),<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> suggesting that <b>26</b> may be selective for tau pathology in vivo, with a favorable brain uptake and washout.</div><div class="NLM_p">In vivo PET imaging with <b>26</b> showed higher cortical retention in AD patients compared to healthy controls (HC), and the tracer distribution was in agreement with the reported histopathological brain distribution of PHF in AD.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> However, the high white matter retention of <b>26</b> hampers a clear visualization of PET scans and consequently precluded its further development.</div><div class="NLM_p">The optimization of the alkyl chain at the quinoline 6-position provided two novel arylquinolines, 1-([2-[4-(dimethylamino)phenyl]quinolin-6-yl]oxy)-3-[<sup>18</sup>F]fluoropropan-2-ol (<b>27</b>, THK-5105) and 1-([2-[4-(methylamino)phenyl]quinolin-6-yl]oxy)-3-[<sup>18</sup>F]fluoropropan-2-ol (<b>28</b>, THK-5117).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Both compounds showed higher in vitro tau affinities than <b>26</b> for synthetic HITP tau fibrils as well as for human AD-PHF tau aggregates (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) with <i>K</i><sub>d</sub> values of 2.6 nM (<b>27</b>) and 5.2 nM (<b>28</b>) for the latter. Additionally, <b>27</b> and <b>28</b> show higher in vitro Aβ/tau selectivity. In vitro autoradiography staining of human AD brain sections showed that the distribution of <b>27</b> and <b>28</b> in the mesial temporal sections coincided with Gallyas–Braak staining and tau immunostaining but not with the distribution of <b>1</b>. Compared to <b>26</b>, both compounds <b>27</b> and <b>28</b> showed higher contrast of tau pathology, mostly due to their higher affinity and selectivity.</div><div class="NLM_p">The presence of the secondary alcohol again introduces a polar terminus which might explain the higher selectivity observed for <b>27</b> and <b>28</b> compared to <b>26</b>. Additionally, in view of the structural similarities of these compounds, mono and dimethylation of the aniline moiety appears to be the reason for the enhanced tau affinity and improved pharmacokinetic profile, with <b>27</b> and <b>28</b> showing a better brain uptake and washout than <b>26</b>.</div><div class="NLM_p">First-in-human PET studies of <b>27</b> revealed this radiotracer’s ability to differentiate between AD patients and healthy controls.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> Furthermore, the pattern distribution in mesial and lateral lobes of AD patients agrees with the reported NFT distribution in AD brain<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and did not correlate with <sup>11</sup>C-<b>1</b> retention. These results suggest that <b>27</b> is selective for NFT over Aβ plaques, although nonspecific binding to brainstem, thalamus and subcortical white matter hamper data interpretation.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> The relatively slow kinetics and clearance displayed by this ligand compared to other known PET ligands has limited its further use.</div><div class="NLM_p">First-in-human PET studies with <b>28</b> are currently underway (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>)<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and preliminary results show faster kinetics and better signal-to-noise ratio than observed for <b>27</b>, as expected from its higher hydrophilicity and the preclinical pharmacokinetic studies. The <i>S</i>-enantiomer has been selected as the clinical candidate based on the faster kinetics and better signal-to-noise ratio than the <i>R</i>-enantiomer (Villemagne et al., unpublished data, AAIC Meeting, Copenhagen, July 2014).</div><div class="NLM_p">Autoradiography studies with the tritiated ligand <sup>3</sup>H-<b>28</b> in human brain slices exhibited a good correlation with AT8 immunostaining, and the <i>B</i><sub>max</sub> was calculated to be 704 fmol/mg (Lemoine et al., unpublished data, AAIC Meeting, Copenhagen, July 2014). Additionally, tracer retentions were associated with severity of dementia and human brain atrophy (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div><div class="NLM_p">In order to further improve the pharmacokinetic properties of arylquinolines, further structural modifications are currently underway.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Very recently another analogue was reported: <sup>18</sup>F-THK-5351, which is the 4-methylaminopyridyl analogue of <b>28</b>. The authors claim that this new tau PET tracer shows faster kinetics, lower white matter retention, and higher signal-to-noise ratio than <b>27</b> and <b>28</b>.<a onclick="showRef(event, 'ref51 ref120'); return false;" href="javascript:void(0);" class="ref ref51 ref120">(51, 120)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. [<sup>18</sup>F]<b>28</b> PET images in mild, moderate, and severe AD patients. In the mild AD case, specific <b>28</b> binding is confined to the medial, anterior, and inferior temporal cortex. The moderate AD case shows additional <b>28</b> retention in association areas. The severe AD case shows more extensive and higher <b>28</b> retention in the neocortex.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Reproduced from  <cite>Current Neurology and Neuroscience Reports</cite>, Vol. <em>14</em>, <contrib-group>Okamura, N.; Harada, R.; Furumoto, S.; Arai, H.; Yanai, K.; Kudo, Y.</contrib-group>, Tau PET imaging in Alzheimer’s disease, p 500, Copyright <span class="NLM_year">2014</span>,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> with permission from Springer Science and Business Media.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10">4.2.2 Phenylbutadienylbenzothiazole (PBB) Compounds</h4><div class="NLM_p">A class of phenyl- and pyridylbutadienylbenzothiazoles (PBBs) has been identified as potential tau imaging probes by the National Institute of Radiological Sciences (NIRS) in Chiba, Japan (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">07</a>).<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> These scaffolds are characterized by a π-electron conjugated backbone with a specific extent ranging from 13 to 19 Å, which the authors deem essential for getting selectivity for AD and non-AD tau aggregates. Structurally, the PBB series can be seen as analogues of fluorescent amyloid dye (ThT) in which the two aromatic moieties are spaced with an all-<i>trans</i> butadiene bridge.</div><div class="NLM_p">Taking advantage of the fluorescent properties of PBBs, NFT-like pathology in the brain stem and spinal cord of transgenic mouse models could be visualized ex vivo in both PS19 and rTg4510 strains. Among five different PBB compounds, 2-[(1<i>E</i>,3<i>E</i>)-4-[6-(<sup>11</sup>C-methylamino)pyridin-3-yl]buta-1,3-dien-1-yl]-1,3-benzothiazol-6-ol (<b>29</b>, PBB3)<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> was found to be the best candidate with a good tau affinity in the nanomolar range (<i>K</i><sub>d</sub>(HITP) = 2.55 nM) and selectivity for tau over Aβ (50-fold). This compound exhibited reasonable biostability (unmetabolized compound ∼20% at 3 min postinjection) and sufficient uptake and clearance from mouse brain.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><div class="NLM_p">Radiolabeling of <b>29</b> with <sup>11</sup>C afforded the PET tracer <sup>11</sup>C-<b>29</b> that yielded superior signals with less nonspecific binding in the brain stem of PS19 mice compared to other tracers. However, micro-PET studies seemed to show that Tg4510 mice are better for visualizing tau aggregates with <sup>11</sup>C-<b>29</b> (Higuchi et al., unpublished data, AAIC Meeting, Copenhagen, July 2014).</div><div class="NLM_p">On the basis of these preclinical findings in mice, compound <sup>11</sup>C<b>-29</b> was selected as a candidate for further evaluation in humans. Despite its relatively fast metabolism in humans, accumulation of <sup>11</sup>C-<b>29</b> in the medial temporal region of AD patients as compared to controls was demonstrated. Furthermore, these preliminary results suggested the possibility of capturing the temporospatial spreading of neurofibrillary tau pathologies from the limbic system (Braak stage III/IV) to neocortical areas (Braak stage V/VI). Distribution of <sup>11</sup>C-<b>29</b> in AD human brains was different from that of amyloid tracer <sup>11</sup>C-<b>1</b> showing minimal nonspecific binding to white matter, although <sup>11</sup>C-<b>29</b> is accumulated in dural venous sinuses in both control and AD brains. Additional PET scans using <sup>11</sup>C-<b>29</b> with a CBD patient exhibited tracer retention in the basal ganglia, suggesting it could be useful for imaging non-AD tauopathies as well.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a></div><div class="NLM_p">Accordingly, compound <b>29</b> appeared to be a promising candidate for in vivo imaging of tau pathology. However, this compound exhibits stability issues, largely due to the rapid interconversion of <i>E</i>/<i>Z</i> isomers in the presence of light (photoisomerization),<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> which is a well-known phenomenon in stilbenes.<a onclick="showRef(event, 'ref123 ref124'); return false;" href="javascript:void(0);" class="ref ref123 ref124">(123, 124)</a> This photoisomerization can be largely suppressed by shielding the compound from light during chemical synthesis, radiosynthesis, and purification.</div><div class="NLM_p">Metabolite analysis in mouse and human plasma of <sup>11</sup>C-<b>29</b> revealed a polar radioactive metabolite.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> The percentage of unchanged <b>29</b> was less than 2% as early as 1 min after injection in mice, although relatively slower in human (<b>29</b>, <8% at 3 min postinjection). This may explain the lower brain uptake of <b>29</b> (1.92% ID/g at 1 min postinjection) when compared to other radiotracers. One of the key disadvantages of <b>29</b> stems from the presence of this undesirable radioactive metabolite in mouse which confounds image analysis. Consequently, determination of the metabolic pathway for <b>29</b> as well as identification of the metabolite chemical structure is required in order to improve biostability. These additional studies would support the consistency of properties and data previously displayed by <b>29</b>.</div><div class="NLM_p">As <sup>18</sup>F is a more preferred radionuclide than <sup>11</sup>C, new fluorinated PBB compounds are currently under investigation, such as <b>30</b>, which apparently exhibited promising preliminary results. (Higuchi et al., unpublished data, AAIC Meeting, Copenhagen, July 2014).</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of <sup>11</sup>C-PBB3 (<b>29</b>) and a novel fluorinated <sup>18</sup>F-PBB3 derivative (<b>30</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">4.2.3 Siemens–Avid/Lilly Compounds</h4><div class="NLM_p">An in vitro autoradiography screening campaign of human AD brain sections of over 800 compounds at Siemens MI Biomarker Research revealed two lead series, carbazoles and benzimidazoles. Compound optimization eventually provided two novel promising tracers: 7-[6-[<sup>18</sup>F]fluoropyridin-3-yl]-5<i>H</i>-pyrido[4,3-<i>b</i>]indole (<b>31</b>, AV-1451, <sup>18</sup>F-T807)<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> and 2-[4-(2-[<sup>18</sup>F]fluoroethyl)piperidin-1-yl]pyrimido[1,2-<i>a</i>]benzimidazole (<b>32</b>, AV-680, <sup>18</sup>F-T808).<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> As PET imaging probes, <b>31</b> and <b>32</b> satisfy all criteria for quantitative imaging of tau pathology, which include high affinity for tau in the nanomolar range, more than 25-fold selectivity for AD-PHF over Aβ, lack of white matter binding, and a favorable pharmacokinetic profile (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).<a onclick="showRef(event, 'ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref127 ref128">(127, 128)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Binding Affinities and Pharmacokinetics of Compounds <b>31</b> and <b>32</b><a class="ref internalNav" href="#t3fn2" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn2"><div class="footnote" id="t3fn2"><sup>Table a</sup><p class="last">The log <i>P</i> values are the partition coefficient (octanol/water) measured for each compound as reported in the respective references.</p></div><div class="footnote" id="t3fn1"><sup>Table b</sup><p class="last">Selectivity tau vs Aβ: <i>K</i><sub>d</sub>(Aβ)/<i>K</i><sub>d</sub>(tau). The asterisk (∗) indicates that the data are based on Scatchard plot analysis of autoradiography staining of human AD brain slices, containing PHF-tau.</p></div></div><div></div></div><div class="NLM_p"><b>31</b> brain section autoradiography comparison with immunostaining demonstrates good agreement with the tau staining pattern but not with the β-amyloid pattern (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>), suggesting that <b>31</b> binding colocalizes with tau but not β-amyloid. Additionally, a linear correlation was observed between immunostaining-based NFT loads of brain sections from 26 human donors and the <b>31</b>-based autoradiography staining intensity. Such a correlation did not exist between <b>31</b> and β-amyloid immunostaining.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. [<sup>18</sup>F]<b>31</b> autoradiography on brain sections from different groups and its comparison with PHF-tau and Aβ double IHC.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> [<sup>18</sup>F]<b>31</b> colocalized with PHF-tau but not with Aβ plaques: (top) low magnification; (bottom) high magnification from the framed areas. Shown are images of PHF-tau (left) and Aβ (right) IHC double immunostaining and autoradiogram image (middle) from two adjacent sections (10 μm) from a PHF-tau rich AD brain (frontal lobe). Fluorescent and autoradiographic images were obtained using a Fuji Film FLA-7000 imaging instrument. Scale bars = 2 mm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Interestingly, preclinical in vivo studies with <b>31</b> and <b>32</b> using β-amyloid plaque bearing APP<sub>SWE</sub>-PS19 transgenic mice<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> showed no noticeable differences in retention between tau transgenic mice and wild-type animals, suggesting that these compounds are specific binders for human aggregated tau but not the aggregated β-amyloid PHF-tau present in these mouse models.</div><div class="NLM_p">The initial clinical PET scans of <b>31</b> with AD and MCI patients and healthy controls showed a radiotracer accumulation in line with the known distribution of PHF in brain according to Braak,<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> where increasing neocortical spread was clearly associated with severity of dementia (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. [<sup>18</sup>F]<b>31</b> PET images in a healthy subject (left), mild MCI, and mild and severe AD patients. SUVR means the target-to-cerebellum standardized uptake value. The PET data show increasing tau spread with increasing disease severity. The sensory motor cortex and the primary visual cortex (not visible in this projection) are largely spared even in the severe case, in agreement with Braak staging.<a onclick="showRef(event, 'ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref131 ref132">(131, 132)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The radiotracer displays favorable kinetics with rapid brain uptake and clearance and minimal nonspecific binding to white matter as well as cortical gray matter of healthy control subjects.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. [<sup>18</sup>F]<b>31</b> target-to-cerebellum SUV ratio. Images of SUVR measured from 80 to 100 min after injection showed the highest cortical tracer retention by the severe AD subject. The increasing neocortical spread detected in the PET scans with increasing dementia severity agrees with the pathology-derived Braak staging system.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">First-in-human PET studies of <b>32</b> showed faster kinetics than <b>31</b>, matching earlier preclinical rodent PET studies. The cortical retention of <b>31</b><a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) and <b>32</b><a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> was correlated with increasing disease severity. Additionally, post-mortem human brain analysis by fluorescence tau staining of one subject who died after undergoing a PET scan with <b>32</b> was consistent with the observed pattern of regional in vivo uptake.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> However, substantial accumulation of <sup>18</sup>F in the skull, due to metabolic defluorination of <b>32</b>, was observed in some cases, which may hamper PET images and the use of this radiotracer in vivo. For this reason, the more stable <b>31</b> was selected for further clinical development.</div><div class="NLM_p last">Further in vivo studies of <b>31</b> in large groups of AD and non-AD tauopathy patients are currently underway.</div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">5 Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08825" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08825" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The development of tau PET radioligands complements earlier work on Aβ imaging, since it is now possible to detect both pathological hallmarks of AD in living patients. Together, both types of tracer may enable earlier diagnosis of AD, possibly even before cognitive symptoms arise, as well as more accurate staging of this neurodegenerative disease and differentiation from non-AD dementia. This may pave the way for early intervention with a disease-modifying therapy, which may have a better chance of halting the irreversible neurodegenerative processes. The well-established correlation of the density and neocortical spread of NFTs with memory decline in AD may provide the basis for tau PET imaging as a means for monitoring disease progression or success of therapy. This may be applicable not only to therapies that target amyloid and concomitant tau pathology in AD but, importantly, also to tau-centric therapies.</div><div class="NLM_p last">Considerable progress has been made in the development of high-affinity, tau-selective ligands, and three series of tracers, <b>28</b> and analogues, <b>29</b> and fluorinated derivatives, and <b>31</b>, are currently undergoing clinical evaluation. The heterogeneity of tau protein aggregates and the fact that the binding site to these is probably ill-defined<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> complicate the interpretation of binding data and classification of ligands. For instance, saturation binding studies with <sup>18</sup>F-<b>26</b> suggested the presence of two different binding sites.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Competition binding studies performed at Janssen R&D also suggest that there is an overlap between <b>29</b> and <b>31</b> binding sites (unpublished results). The reason for this differential binding is still poorly understood. One possibility is that ligands show varying affinity for different forms of aggregated tau, due to differences in primary structure and/or post-translational modifications. Second, the lack of a well-defined binding site across the fiber axis opens the possibility that multiple binding modes exist to one particular form of aggregated tau.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Studying further the structure and binding characteristics of tau aggregates isolated from preclinical models and human tauopathies at various disease stages could be instrumental to gain more understanding in the binding characteristics of tau ligands. It will be important to investigate longitudinal imaging in the context of disease progression and to compare the in vivo PET results with ex vivo pathology. Additionally, the dynamic range of the tracers needs to be evaluated, as well as their test/retest reproducibility. These tracers are currently being studied across various tauopathies, and resulting insights will guide the development of disease modifying therapies, enable early intervention, and hopefully improve outcomes.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm5017544" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77621" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77621" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">José Ignacio Andrés</span> - <span class="hlFld-Affiliation affiliation">Discovery
Sciences, Janssen Research and Development,
a Division of Janssen-Cilag, Jarama 75, 45007 Toledo, Spain</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6009010e04120513200914134e0a0e0a4e030f0d"><span class="__cf_email__" data-cfemail="771e161913051204371e0304591d191d5914181a">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuela Ariza</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research and
Development, a Division of Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hartmuth C. Kolb</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Biomarkers, Janssen Research and Development, 3210 Merryfield Row, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dieder Moechars</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Discovery Biology, Janssen Research and
Development, a Division of Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederik Rombouts</span> - <span class="hlFld-Affiliation affiliation">Neuroscience
Medicinal Chemistry, Janssen Research and
Development, a Division of Janssen Pharmaceutica NV, Turnhoutseweg 30, B-2340 Beerse, Belgium</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>All authors have contributed equally to the preparation of this Review and have read and accepted the final revised version prior to submission.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04230" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04230" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Manuela Ariza</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=BIO-d899e2593-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Manuela Ariza</b> had her academic training at the University of Malaga, Spain, where she obtained her Ph.D. in Organic Chemistry in 2011 in the group of Prof. Dr. Rafael Suau. During this period, she spent 3 months as a visiting researcher at the École Supérieure de Physique et Chemie Industrielles (ESPCI ParisTech), Paris, France, under the supervision of Prof. Dr. Janine Cossy. In 2011 she obtained a 1-year research internship from the Company-University Foundation of the Autonomous University of Madrid to collaborate with the neuroscience team at Janssen Pharmaceutica in Toledo. In 2013 she became a Postdoctoral Scientist at the Neuroscience Department of Janssen Pharmaceutica in Belgium, where she has been focused on the design and synthesis of novel potential tau PET ligands.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Hartmuth C. Kolb</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=BIO-d899e2598-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hartmuth C. Kolb</b> received his Ph.D. in Organic Chemistry in 1991 at Imperial College of Science, Technology and Medicine, London. Following postdoctoral work with Barry Sharpless, he joined Ciba-Geigy in 1993. In 1997, Dr. Kolb became the Head of Chemistry at Coelacanth Corporation. In this role, he and Dr. Sharpless developed the click chemistry approach to drug discovery. In 2002, he joined The Scripps Research Institute as an Associate Professor. From 2004 to 2013, he was the Head of Siemens Biomarker Research, where his team developed novel oncology and neurodegenerative disease PET tracers, a key highlight being the PHF-tau tracer [<sup>18</sup>F]T807. Dr. Kolb joined Johnson & Johnson in January 2014 as the Head of Neuroscience Biomarkers. He is an author on over 75 peer-reviewed publications.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Dieder Moechars</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=BIO-d899e2606-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dieder Moechars</b> obtained his doctorate in Biomedical Sciences at the Katholieke Universiteit Leuven (Belgium) in 1996. Next he became a postdoctoral researcher at the Centre for Human and Experimental Genetics, K. U. Leuven, under the supervision of Prof. F. Van Leuven. In 1999 he joined Janssen Pharmaceutica, Belgium, where he currently holds the position of Scientific Director. He is a preclinical biologist with over 20 years of experience in AD research, internationally recognized for work in basic neurobiology and pharmaceutical R&D with more than 70 peer reviewed articles and several patents. His research interests include a multitude of drug discovery projects from TI-TV to NME delivery, and currently he is actively involved in the development of β-amyloid and tau based therapies for disease modification in AD.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Frederik Rombouts</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=BIO-d899e2611-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Frederik Rombouts</b> obtained his doctorate in Organic Chemistry at the Katholieke Universiteit Leuven (Belgium) in 2002 in the group of Prof. Georges Hoornaert. Next he became a postdoctoral researcher at the Université de Montreal (Canada) under supervision of Prof. William D. Lubell. In 2003 he joined Janssen Pharmaceutica, Belgium, where he currently holds the position of Principal Scientist. In 2008, Dr. Rombouts joined the Neuroscience Medicinal Chemistry department, focused on developing therapies and imaging agents for Alzheimer’s disease. Since then he has led the Hit Generation Team, which supports all pre-HTL, HTL, and LO projects with novel chemical starting points. His research interests include especially the creative aspects of drug design and synthesis, structure- and fragment-based drug discovery, novel synthetic methodologies, and target identification.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="15" class="article__inlineFigure"><h2 class="fig-label">José Ignacio Andrés</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=BIO-d899e2616-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>José Ignacio Andrés</b> obtained his doctorate in Organic Chemistry in 1985 at the Complutense University of Madrid, Spain. That year he joined Janssen Research & Development to start up the Medicinal Chemistry Department in Toledo (Spain), and he currently holds the position of Scientific Director & Fellow. In 2001 he was appointed Medicinal Chemistry Associate for CNS—Psychiatry Discovery, and in 2007 he was appointed Head of the newly created PET Ligand Discovery Team in Toledo. During his scientific career he has been directly involved in a large number of discovery programs, several of which have successfully brought compounds into the clinic including two new PET radioligands. He is coauthor of around 50 peer-reviewed publications and co-inventor of around 50 patent applications.</p></figure></div><div class="ack" id="ACK-d899e2621-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Katleen Fierens, Ph.D., Discovery Sciences, Janssen R&D, for her key contribution to the progress of our tau PET discovery program. This work was supported in part by the Institute for the Promotion of Innovation by Science and Technology (IWT120492) in Flanders.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i21" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i21"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i22" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i22"> Abbreviations Used</h2><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">AGD</td><td class="NLM_def"><p class="first last">argyrophilic grain disease</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">CBD</td><td class="NLM_def"><p class="first last">corticobasal degeneration</p></td></tr><tr><td class="NLM_term">CD</td><td class="NLM_def"><p class="first last">circular dichroism</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">DSM-IV-TR</td><td class="NLM_def"><p class="first last">Diagnostic and Statistical Manual of Mental Disorders</p></td></tr><tr><td class="NLM_term">EMA</td><td class="NLM_def"><p class="first last">European Medicines Agency</p></td></tr><tr><td class="NLM_term">FPEG</td><td class="NLM_def"><p class="first last">fluoropolyethylen glycol</p></td></tr><tr><td class="NLM_term">FTDP-17</td><td class="NLM_def"><p class="first last">frontotemporal dementia and parkinsonism linked to chromosome 17</p></td></tr><tr><td class="NLM_term">FTIR</td><td class="NLM_def"><p class="first last">Fourier transform infrared</p></td></tr><tr><td class="NLM_term">HC</td><td class="NLM_def"><p class="first last">healthy control</p></td></tr><tr><td class="NLM_term">MAP</td><td class="NLM_def"><p class="first last">microtubule-associated protein</p></td></tr><tr><td class="NLM_term">MCI</td><td class="NLM_def"><p class="first last">mild cognitive impairment</p></td></tr><tr><td class="NLM_term">MSFI</td><td class="NLM_def"><p class="first last">selective multispectral fluorescent imaging</p></td></tr><tr><td class="NLM_term">NIA</td><td class="NLM_def"><p class="first last">National Institute on Aging</p></td></tr><tr><td class="NLM_term">NFT</td><td class="NLM_def"><p class="first last">neurofibrillary tangles</p></td></tr><tr><td class="NLM_term">NINCDS-ADRDA</td><td class="NLM_def"><p class="first last">National Institute of Neurological Disorders and Stroke–Alzheimer Disease and Related Disorders</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">phenyldiazenylbenzothiazole</p></td></tr><tr><td class="NLM_term">PiD</td><td class="NLM_def"><p class="first last">Pick disease</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">PiB</td><td class="NLM_def"><p class="first last">Pittsburgh compound B</p></td></tr><tr><td class="NLM_term">P-gP</td><td class="NLM_def"><p class="first last">p-glycoprotein</p></td></tr><tr><td class="NLM_term">PHF</td><td class="NLM_def"><p class="first last">paired helical filament</p></td></tr><tr><td class="NLM_term">PSP</td><td class="NLM_def"><p class="first last">progressive supranuclear palsy</p></td></tr><tr><td class="NLM_term">RCF</td><td class="NLM_def"><p class="first last">randomly coiled filament</p></td></tr><tr><td class="NLM_term">SF</td><td class="NLM_def"><p class="first last">straight filament</p></td></tr><tr><td class="NLM_term">SP</td><td class="NLM_def"><p class="first last">senile plaque</p></td></tr><tr><td class="NLM_term">SUV</td><td class="NLM_def"><p class="first last">standardized uptake value</p></td></tr><tr><td class="NLM_term">SUVR</td><td class="NLM_def"><p class="first last">target-to-cerebellum standardized uptake value</p></td></tr><tr><td class="NLM_term">TD</td><td class="NLM_def"><p class="first last">tangle-only dementia</p></td></tr><tr><td class="NLM_term">TF</td><td class="NLM_def"><p class="first last">twisted filament</p></td></tr><tr><td class="NLM_term">ThT</td><td class="NLM_def"><p class="first last">thioflavin T</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 135 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Khachaturian, Z. S.</span><span> </span><span class="NLM_article-title">Diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1001%2Farchneur.1985.04060100083029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=2864910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADyaL28%252FisV2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1985&pages=1097-1105&author=Z.+S.+Khachaturian&title=Diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Khachaturian Z S</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1097-105</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTc9SvEChaSAWGmni0r9GoKfW6udTcc2eaFRpP_ATYmKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL28%252FisV2kug%253D%253D&md5=a47cb19684c6e17f83431a1aadd57cde</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchneur.1985.04060100083029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.1985.04060100083029%26sid%3Dliteratum%253Aachs%26aulast%3DKhachaturian%26aufirst%3DZ.%2BS.%26atitle%3DDiagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1985%26volume%3D42%26spage%3D1097%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span>Alzheimer’s Association. <a href="http://www.alz.org" class="extLink">www.alz.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Association.+www.alz.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Anand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dip Gill, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali Mahdi, A.</span><span> </span><span class="NLM_article-title">Therapeutics of Alzheimer’s disease: past, present and future</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=27-50&author=R.+Anandauthor=K.+Dip+Gillauthor=A.+Ali+Mahdi&title=Therapeutics+of+Alzheimer%E2%80%99s+disease%3A+past%2C+present+and+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DDip%2BGill%26aufirst%3DK.%26aulast%3DAli%2BMahdi%26aufirst%3DA.%26atitle%3DTherapeutics%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D76%26spage%3D27%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Fargo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleiler, L.</span><span> </span><span class="NLM_article-title">Alzheimer’s Association report</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e47</span><span class="NLM_x">–</span> <span class="NLM_lpage">e92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e47-e92&author=K.+Fargoauthor=L.+Bleiler&title=Alzheimer%E2%80%99s+Association+report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFargo%26aufirst%3DK.%26aulast%3DBleiler%26aufirst%3DL.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Association%2520report%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2014%26volume%3D10%26spage%3De47%26epage%3De92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Jack, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKhann, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=257-262&author=C.+R.+Jackauthor=M.+S.+Albertauthor=D.+S.+Knopmanauthor=G.+M.+McKhannauthor=R.+A.+Sperlingauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=C.+H.+Phelps&title=Introduction+to+the+recommendations+from+the+National+Institute+on+Aging-Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Jack Clifford R Jr; Albert Marilyn S; Knopman David S; McKhann Guy M; Sperling Reisa A; Carrillo Maria C; Thies Bill; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Criteria for the clinical diagnosis of Alzheimer's disease (AD) were established in 1984.  A broad consensus now exists that these criteria should be revised to incorporate state-of-the-art scientific knowledge.  METHODS:  The National Institute on Aging (NIA) and the Alzheimer's Association sponsored a series of advisory round table meetings in 2009 whose purpose was to establish a process for revising diagnostic and research criteria for AD.  The recommendation from these advisory meetings was that three separate work groups should be formed with each assigned the task of formulating diagnostic criteria for one phase of the disease: the dementia phase; the symptomatic, pre-dementia phase; and the asymptomatic, preclinical phase of AD.  RESULTS:  Two notable differences from the AD criteria published in 1984 are incorporation of biomarkers of the underlying disease state and formalization of different stages of disease in the diagnostic criteria.  There was a broad consensus within all three workgroups that much additional work is needed to validate the application of biomarkers for diagnostic purposes.  In the revised NIA-Alzheimer's Association criteria, a semantic and conceptual distinction is made between AD pathophysiological processes and clinically observable syndromes that result, whereas this distinction was blurred in the 1984 criteria.  CONCLUSIONS:  The new criteria for AD are presented in three documents.  The core clinical criteria of the recommendations regarding AD dementia and MCI due to AD are intended to guide diagnosis in the clinical setting.  However, the recommendations of the preclinical AD workgroup are intended purely for research purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSC-bLEOO4dYpfW6udTcc2eYU7oUCmdGn-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktg%253D%253D&md5=348e60537bf1bed543d5572130fc2f3e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DAlbert%26aufirst%3DM.%2BS.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DMcKhann%26aufirst%3DG.%2BM.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DIntroduction%2520to%2520the%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging-Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D257%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">McKhann, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chertkow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawash, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koroshetz, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manly, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossor, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=263-269&author=G.+M.+McKhannauthor=D.+S.+Knopmanauthor=H.+Chertkowauthor=B.+T.+Hymanauthor=C.+R.+Jackauthor=C.+H.+Kawashauthor=W.+E.+Klunkauthor=W.+J.+Koroshetzauthor=J.+J.+Manlyauthor=R.+Mayeuxauthor=R.+C.+Mohsauthor=J.+C.+Morrisauthor=M.+N.+Rossorauthor=P.+Scheltensauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=S.+Weintraubauthor=C.+H.+Phelps&title=The+diagnosis+of+dementia+due+to+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+National+Institute+on+Aging-Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">McKhann Guy M; Knopman David S; Chertkow Howard; Hyman Bradley T; Jack Clifford R Jr; Kawas Claudia H; Klunk William E; Koroshetz Walter J; Manly Jennifer J; Mayeux Richard; Mohs Richard C; Morris John C; Rossor Martin N; Scheltens Philip; Carrillo Maria C; Thies Bill; Weintraub Sandra; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia.  The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available.  We present criteria for all-cause dementia and for AD dementia.  We retained the general framework of probable AD dementia from the 1984 criteria.  On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis.  We also retained the term possible AD dementia, but redefined it in a manner more focused than before.  Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings.  The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dementia.  Much work lies ahead for validating the biomarker diagnosis of AD dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSIJKJbLTgsvCfW6udTcc2eYU7oUCmdGn-7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktQ%253D%253D&md5=866f02e65270dc427366138022cc1feb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DMcKhann%26aufirst%3DG.%2BM.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DChertkow%26aufirst%3DH.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKawash%26aufirst%3DC.%2BH.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DKoroshetz%26aufirst%3DW.%2BJ.%26aulast%3DManly%26aufirst%3DJ.%2BJ.%26aulast%3DMayeux%26aufirst%3DR.%26aulast%3DMohs%26aufirst%3DR.%2BC.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DRossor%26aufirst%3DM.%2BN.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DWeintraub%26aufirst%3DS.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DThe%2520diagnosis%2520of%2520dementia%2520due%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging-Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia.%26date%3D2011%26volume%3D7%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Albert, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=270-279&author=M.+S.+Albertauthor=S.+T.+DeKoskyauthor=D.+Dicksonauthor=B.+Duboisauthor=H.+H.+Feldmanauthor=N.+C.+Foxauthor=A.+Gamstauthor=D.+M.+Holtzmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=P.+J.+Snyderauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=C.+H.+Phelps&title=The+diagnosis+of+mild+cognitive+impairment+due+to+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+National+Institute+on+Aging-Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Albert Marilyn S; DeKosky Steven T; Dickson Dennis; Dubois Bruno; Feldman Howard H; Fox Nick C; Gamst Anthony; Holtzman David M; Jagust William J; Petersen Ronald C; Snyder Peter J; Carrillo Maria C; Thies Bill; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">270-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's disease (AD), referred to in this article as mild cognitive impairment due to AD.  The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal fluid analysis, and (2) research criteria that could be used in clinical research settings, including clinical trials.  The second set of criteria incorporate the use of biomarkers based on imaging and cerebrospinal fluid measures.  The final set of criteria for mild cognitive impairment due to AD has four levels of certainty, depending on the presence and nature of the biomarker findings.  Considerable work is needed to validate the criteria that use biomarkers and to standardize biomarker analysis for use in community settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSOqrn-c4Of3KfW6udTcc2eYP58bWFiD5Wrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktA%253D%253D&md5=609df181936d75a42ae8db4826713f85</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DM.%2BS.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DDickson%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DGamst%26aufirst%3DA.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DSnyder%26aufirst%3DP.%2BJ.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DThe%2520diagnosis%2520of%2520mild%2520cognitive%2520impairment%2520due%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging-Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D270%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Sperling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckett, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison-Bogorad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagster, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=280-292&author=R.+A.+Sperlingauthor=P.+S.+Aisenauthor=L.+A.+Beckettauthor=D.+A.+Bennettauthor=S.+Craftauthor=A.+M.+Faganauthor=T.+Iwatsuboauthor=C.+R.+Jackauthor=J.+Kayeauthor=T.+J.+Montineauthor=D.+C.+Parkauthor=E.+M.+Reimanauthor=C.+C.+Roweauthor=E.+Siemersauthor=Y.+Sternauthor=K.+Yaffeauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=M.+Morrison-Bogoradauthor=M.+V.+Wagsterauthor=C.+H.+Phelps&title=Toward+defining+the+preclinical+stages+of+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+National+Institute+on+Aging-Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Sperling Reisa A; Aisen Paul S; Beckett Laurel A; Bennett David A; Craft Suzanne; Fagan Anne M; Iwatsubo Takeshi; Jack Clifford R Jr; Kaye Jeffrey; Montine Thomas J; Park Denise C; Reiman Eric M; Rowe Christopher C; Siemers Eric; Stern Yaakov; Yaffe Kristine; Carrillo Maria C; Thies Bill; Morrison-Bogorad Marcelle; Wagster Molly V; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia.  This long "preclinical" phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the link between the pathological cascade of AD and the emergence of clinical symptoms.  The National Institute on Aging and the Alzheimer's Association convened an international workgroup to review the biomarker, epidemiological, and neuropsychological evidence, and to develop recommendations to determine the factors which best predict the risk of progression from "normal" cognition to mild cognitive impairment and AD dementia.  We propose a conceptual framework and operational research criteria, based on the prevailing scientific evidence to date, to test and refine these models with longitudinal clinical research studies.  These recommendations are solely intended for research purposes and do not have any clinical implications at this time.  It is hoped that these recommendations will provide a common rubric to advance the study of preclinical AD, and ultimately, aid the field in moving toward earlier intervention at a stage of AD when some disease-modifying therapies may be most efficacious.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSLt7lRqEFUJVfW6udTcc2ebD8fEkE7gmbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktw%253D%253D&md5=116797e3769a70f38cac89730a967b4d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DBeckett%26aufirst%3DL.%2BA.%26aulast%3DBennett%26aufirst%3DD.%2BA.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DStern%26aufirst%3DY.%26aulast%3DYaffe%26aufirst%3DK.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DMorrison-Bogorad%26aufirst%3DM.%26aulast%3DWagster%26aufirst%3DM.%2BV.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DToward%2520defining%2520the%2520preclinical%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging-Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D280%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2ebD8fEkE7gmbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Frequency of stages of Alzheimer-related lesions in different age categories</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS0197-4580%2897%2900056-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=9330961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADyaK2svnt1Sgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=351-357&author=H.+Braakauthor=E.+Braak&title=Frequency+of+stages+of+Alzheimer-related+lesions+in+different+age+categories"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Frequency of stages of Alzheimer-related lesions in different age categories</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-7</span>
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">Alzheimer's disease is a relentlessly progressing dementing disorder.  Major pathological hallmarks include extracellular deposits of amyloid protein and intraneuronal neurofibrillary changes.  No remissions occur in the course of the disease.  Initial amyloid deposits develop in poorly myelinated areas of the basal neocortex.  From there, they spread into adjoining areas and the hippocampus.  Deposits eventually infiltrate all cortical areas, including densely myelinated primary fields of the neocortex (stages A-C).  Intraneuronal lesions develop initially in the transentorhinal region, then spread in a predictable manner across other areas (stages I-VI).  At stages I-II, neurofibrillary changes develop preferentially in the absence of amyloid deposits.  A proportion of cases shows early development of amyloid deposits and/or intraneuronal changes.  Advanced age is thus not a prerequisite for the evolution of the lesions.  Alzheimer's disease is an age-related, not an age-dependent disease.  The degree of brain destruction at stages III-IV frequently leads to the appearance of initial clinical symptoms.  The stages V-VI representing fully developed Alzheimer's disease are increasingly prevalent with increasing age.  The arithmetic means of the stages of both the amyloid-depositing and the neurofibrillary pathology increase with age.  Age is a risk factor for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOL3vvMAZc7kwlCcfExbvbfW6udTcc2ebD8fEkE7gmbrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svnt1Sgug%253D%253D&md5=8ec456cdc5b4a34af45d92871144eeda</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2897%2900056-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252897%252900056-0%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DFrequency%2520of%2520stages%2520of%2520Alzheimer-related%2520lesions%2520in%2520different%2520age%2520categories%26jtitle%3DNeurobiol.%2520Aging%26date%3D1997%26volume%3D18%26spage%3D351%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Delacourte, A.</span><span> </span><span class="NLM_article-title">Diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Ann. Biol. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=9754238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADyaK1cvis1yntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=133-142&author=A.+Delacourte&title=Diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Delacourte A</div><div class="citationInfo"><span class="NLM_cas:title">Annales de biologie clinique</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-42</span>
        ISSN:<span class="NLM_cas:issn">0003-3898</span>.
    </div><div class="casAbstract">Alzheimer's disease is a neurodegenerative disorder leading to cognitive impairment (amnesia, aphasia, apraxia and agnosia).  The prevalence of this age related disabling illness is increasing.  During the course of the disease, the clinical diagnosis will be that of "possible Alzheimer's disease", then "probable Alzheimer's disease".  But the diagnosis of "definite Alzheimer's disease" requires a post-mortem brain examination and the demonstration of numerous senile plaques and neurofibrillary tangles in hippocampal and association cortical areas.  The neuropathological examination confirms probable Alzheimer's disease clinical diagnosis in 85% of the cases examined in medical schools.  However, with much more than 15% errors, the early diagnosis of Alzheimer's disease must be improved since it is a key factor for the therapeutic approach, and more especially for the efficiency of drug trials.  At the present time, there are new leads for a biological diagnosis in the blood or the CSF.  However, the natural (and molecular) history of Alzheimer's disease points out that all biochemical dysfunctions remain in the CNS, and more particularly in association brain areas.  This is demonstrated using reliable biochemical markers such as A beta and pathological Tau proteins, which are the basic components of amyloid deposits and neurofibrillary tangles, respectively.  Also, a genetic diagnosis can be performed in half of familial autosomic dominant Alzheimer's disease, which represents less than 1% of all Alzheimer's disease cases.  Together, this shows that there is a lack of reliable Alzheimer's disease markers.  The search for new specific markers (clinical, epidemiological, genetic, biochemical, biological) must go on.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1f1PBUrz3XdyzdcP07UmufW6udTcc2ea_JVYGJQQFh7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvis1yntA%253D%253D&md5=3c95236af3100e692fad9515b72cfbdd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelacourte%26aufirst%3DA.%26atitle%3DDiagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Biol.%2520Clin.%26date%3D1998%26volume%3D56%26spage%3D133%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Strategies for improving the postmortem neuropathological diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">S75</span><span class="NLM_x">–</span> <span class="NLM_lpage">S79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=S75-S79&author=J.+Q.+Trojanowskiauthor=C.+M.+Clarkauthor=M.+L.+Schmidtauthor=S.+E.+Arnoldauthor=V.+M.+Lee&title=Strategies+for+improving+the+postmortem+neuropathological+diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DSchmidt%26aufirst%3DM.%2BL.%26aulast%3DArnold%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DStrategies%2520for%2520improving%2520the%2520postmortem%2520neuropathological%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1997%26volume%3D18%26spage%3DS75%26epage%3DS79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&issue=9&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D9%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacova, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberger-Gateau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delacourte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galasko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jicha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span> </span><span class="NLM_article-title">Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS1474-4422%2807%2970178-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=17616482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BD2svhslKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=734-746&author=B.+Duboisauthor=H.+H.+Feldmanauthor=C.+Jacovaauthor=S.+T.+DeKoskyauthor=P.+Barberger-Gateauauthor=J.+Cummingsauthor=A.+Delacourteauthor=D.+Galaskoauthor=S.+Gauthierauthor=G.+Jichaauthor=K.+Meguroauthor=J.+O%E2%80%99Brienauthor=F.+Pasquierauthor=P.+Robertauthor=M.+Rossorauthor=S.+Sallowayauthor=Y.+Sternauthor=P.+J.+Visserauthor=P.+Scheltens&title=Research+criteria+for+the+diagnosis+of+Alzheimer%E2%80%99s+disease%3A+revising+the+NINCDS-ADRDA+criteria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria</span></div><div class="casAuthors">Dubois Bruno; Feldman Howard H; Jacova Claudia; Dekosky Steven T; Barberger-Gateau Pascale; Cummings Jeffrey; Delacourte Andre; Galasko Douglas; Gauthier Serge; Jicha Gregory; Meguro Kenichi; O'brien John; Pasquier Florence; Robert Philippe; Rossor Martin; Salloway Steven; Stern Yaakov; Visser Pieter J; Scheltens Philip</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">734-46</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">The NINCDS-ADRDA and the DSM-IV-TR criteria for Alzheimer's disease (AD) are the prevailing diagnostic standards in research; however, they have now fallen behind the unprecedented growth of scientific knowledge.  Distinctive and reliable biomarkers of AD are now available through structural MRI, molecular neuroimaging with PET, and cerebrospinal fluid analyses.  This progress provides the impetus for our proposal of revised diagnostic criteria for AD.  Our framework was developed to capture both the earliest stages, before full-blown dementia, as well as the full spectrum of the illness.  These new criteria are centred on a clinical core of early and significant episodic memory impairment.  They stipulate that there must also be at least one or more abnormal biomarkers among structural neuroimaging with MRI, molecular neuroimaging with PET, and cerebrospinal fluid analysis of amyloid beta or tau proteins.  The timeliness of these criteria is highlighted by the many drugs in development that are directed at changing pathogenesis, particularly at the production and clearance of amyloid beta as well as at the hyperphosphorylation state of tau.  Validation studies in existing and prospective cohorts are needed to advance these criteria and optimise their sensitivity, specificity, and accuracy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSI_NH_wEZ5GZ6KlWarZTAzfW6udTcc2ebBQNnh6VvPV7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhslKitQ%253D%253D&md5=cfbed7fc82fae795e4739464f937c2c1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2807%2970178-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252807%252970178-3%26sid%3Dliteratum%253Aachs%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DJacova%26aufirst%3DC.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DBarberger-Gateau%26aufirst%3DP.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DGalasko%26aufirst%3DD.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DJicha%26aufirst%3DG.%26aulast%3DMeguro%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%26aulast%3DPasquier%26aufirst%3DF.%26aulast%3DRobert%26aufirst%3DP.%26aulast%3DRossor%26aufirst%3DM.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DStern%26aufirst%3DY.%26aulast%3DVisser%26aufirst%3DP.%2BJ.%26aulast%3DScheltens%26aufirst%3DP.%26atitle%3DResearch%2520criteria%2520for%2520the%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520revising%2520the%2520NINCDS-ADRDA%2520criteria%26jtitle%3DLancet%2520Neurol.%26date%3D2007%26volume%3D6%26spage%3D734%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Isaac, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vamvakas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abadie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gispen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pani, L.</span><span> </span><span class="NLM_article-title">Qualification opinion of novel methodologies in the predementia stage of Alzheimer’s disease: cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden—regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.euroneuro.2011.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21903360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GrtLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=781-788&author=M.+Isaacauthor=S.+Vamvakasauthor=E.+Abadieauthor=B.+Jonssonauthor=C.+Gispenauthor=L.+Pani&title=Qualification+opinion+of+novel+methodologies+in+the+predementia+stage+of+Alzheimer%E2%80%99s+disease%3A+cerebro-spinal-fluid+related+biomarkers+for+drugs+affecting+amyloid+burden%E2%80%94regulatory+considerations+by+European+Medicines+Agency+focusing+in+improving+benefit%2Frisk+in+regulatory+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden - Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials</span></div><div class="casAuthors">Isaac, Maria; Vamvakas, Spiros; Abadie, Eric; Jonsson, Bertil; Gispen, Christine; Pani, Luca</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">781-788</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The European Medicines Agency (EMA) in London is responsible for the Regulatory review of new medicinal products for Marketing Authorisation, through which pharmaceutical companies may obtain first Marketing Authorisation and subsequent Variations valid throughout the EU and EFTA.  The qualification opinion of novel methodologies is a new procedure where applicants can obtain scientific advice on new methodologies for regulatory clin. trials of efficacy of new compds.  It will help benefit/risk assessment of the CHMP.  The definition of prodromal AD is acceptable.  The "Dubois Criteria" as criteria to define the population must be validated in full at the time of the submission of the dossiers.  Including a pos. CSF biomarker profile is considered predictive for the evaluation of the AD-dementia type.  However, although high CSF tau and low CSF Aβ42 are predictive of Alzheimer's disease, the criterion "pos. CSF tau/Aβ42 ratio" is not well defined.  The qualification of biomarkers in the pre-dementia stage of Alzheimer's disease will allow better inclusion criteria of patients in pre-dementia trials in which the benefit/risk is higher for treatment with these novel compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR89C6L4ik77Vg90H21EOLACvtfcHk0lhOg1rZU0ptbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GrtLzE&md5=c0f8433dfde0cdae9af86f0975478da9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2011.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2011.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DIsaac%26aufirst%3DM.%26aulast%3DVamvakas%26aufirst%3DS.%26aulast%3DAbadie%26aufirst%3DE.%26aulast%3DJonsson%26aufirst%3DB.%26aulast%3DGispen%26aufirst%3DC.%26aulast%3DPani%26aufirst%3DL.%26atitle%3DQualification%2520opinion%2520of%2520novel%2520methodologies%2520in%2520the%2520predementia%2520stage%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520cerebro-spinal-fluid%2520related%2520biomarkers%2520for%2520drugs%2520affecting%2520amyloid%2520burden%25E2%2580%2594regulatory%2520considerations%2520by%2520European%2520Medicines%2520Agency%2520focusing%2520in%2520improving%2520benefit%252Frisk%2520in%2520regulatory%2520trials%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D21%26spage%3D781%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Biomarkers in amyloid-β immunotherapy trials in Alzheimer’s disease</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=189-201&author=K.+Blennowauthor=H.+Hampelauthor=H.+Zetterberg&title=Biomarkers+in+amyloid-%CE%B2+immunotherapy+trials+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DBiomarkers%2520in%2520amyloid-%25CE%25B2%2520immunotherapy%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D189%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tullhög, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Londos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span> </span><span class="NLM_article-title">Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients</span> <span class="citation_source-journal">Eur. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1159%2F000311703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20516693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3cnmsV2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2010&pages=326-330&author=H.+Zetterbergauthor=K.+Tullh%C3%B6gauthor=O.+Hanssonauthor=L.+Minthonauthor=E.+Londosauthor=K.+Blennow&title=Low+incidence+of+post-lumbar+puncture+headache+in+1%2C089+consecutive+memory+clinic+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients</span></div><div class="casAuthors">Zetterberg Henrik; Tullhog Kristian; Hansson Oskar; Minthon Lennart; Londos Elisabet; Blennow Kaj</div><div class="citationInfo"><span class="NLM_cas:title">European neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">326-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM:  To examine the incidence of post-lumbar puncture headache (PLPH) in patients admitted for cognitive disturbances.  METHODS:  The incidence of PLPH and other general (subdural hematoma, meningitis, encephalitis) or local (local pain, spinal hematoma, local infection) complications was evaluated in 1,089 consecutive patients (aged 23-89 years) who underwent lumbar puncture as a part of the routine diagnostic evaluation between February 2001 and March 2007 at a specialized memory clinic.  RESULTS:  28 (2.6%) of the patients reported PLPH of mild severity.  No other local or general complications occurred.  CONCLUSIONS:  The incidence of PLPH in patients with cognitive disturbances is low and CSF analyses can thus be part of the diagnostic work-up at memory clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWW9h57PWlOtK0qsdY6Nc1fW6udTcc2ebiCJclgyIQ8Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnmsV2msA%253D%253D&md5=63d693a5c91fbcce3e41f423f62df042</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1159%2F000311703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000311703%26sid%3Dliteratum%253Aachs%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DTullh%25C3%25B6g%26aufirst%3DK.%26aulast%3DHansson%26aufirst%3DO.%26aulast%3DMinthon%26aufirst%3DL.%26aulast%3DLondos%26aufirst%3DE.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DLow%2520incidence%2520of%2520post-lumbar%2520puncture%2520headache%2520in%25201%252C089%2520consecutive%2520memory%2520clinic%2520patients%26jtitle%3DEur.%2520Neurol.%26date%3D2010%26volume%3D63%26spage%3D326%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, K.</span><span> </span><span class="NLM_article-title">Looking backward to move forward: early detection of neurodegenerative disorders</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">830</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=830-834&author=S.+T.+DeKoskyauthor=K.+Marek&title=Looking+backward+to+move+forward%3A+early+detection+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DMarek%26aufirst%3DK.%26atitle%3DLooking%2520backward%2520to%2520move%2520forward%253A%2520early%2520detection%2520of%2520neurodegenerative%2520disorders%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D830%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span> </span><span class="NLM_article-title">Brain imaging in the study of Alzheimer’s disease</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=505-516&author=E.+M.+Reimanauthor=W.+J.+Jagust&title=Brain+imaging+in+the+study+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DBrain%2520imaging%2520in%2520the%2520study%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuroImage%26date%3D2012%26volume%3D61%26spage%3D505%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, W.</span><span> </span><span class="NLM_article-title">Advances of molecular imaging probes for the diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.2174%2F1567205011666140131121259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24484277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1eru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=221-231&author=M.+Zhouauthor=X.+Wangauthor=Z.+Liuauthor=L.+Yuauthor=S.+Huauthor=L.+Chenauthor=W.+Zeng&title=Advances+of+molecular+imaging+probes+for+the+diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease</span></div><div class="casAuthors">Zhou, Ming; Wang, Xiaobo; Liu, Zhiguo; Yu, Lun; Hu, Shuo; Chen, Lizhang; Zeng, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive decline in multiple cognitive domains and it becomes the most common cause of dementia in the elderly.  There is an urgent need for the early diagnosis and treatment of AD to ease caregiver burden and medical costs, as well as improve patients' living activities assocd. with the dramatic increasing no. of affected individuals.  Mol. imaging with target-specific probes is contributing to identify the underlying biol. in AD, which benefits to the early diagnosis of AD and the evaluation of anti-AD therapy.  Mol. imaging probes, such as 11C-PIB, 11C-MP4A, 18F-AV-45, and 18F-FDG, can selectively bind to special bimol. of AD or accurately accumulate at the location of damage areas, thus become an edge tool for a better management of the diseases in the clin. practice and new drug development.  In the past decades, a large variety of probes is being developed and tested to be useful for the early and accurate diagnosis of Alzheimer's disease, patient selection for disease-modifying therapeutic trials and monitoring the effect of anti-amyloid therapy.  Since imaging probes may also help to guide physicians to identify those patients that could best benefit from a given therapeutic regimen, dose, or duration of drug, this paper is to present a perspective of the available imaging probes for AD, classified on different modalities.  Meanwhile, recent advances of those probes that have been selected for clin. trials and are at the different stages of the US Food and Drugs Administration (FDA) approval are outlined.  Addnl., future directions and specific application of imaging strategies designed for both diagnosis and treatment for AD are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLa6ITw42ws7Vg90H21EOLACvtfcHk0ljAatysL9TFBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1eru7k%253D&md5=d919e86d68e5ba2243d1715db76c3d4d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1567205011666140131121259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205011666140131121259%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DW.%26atitle%3DAdvances%2520of%2520molecular%2520imaging%2520probes%2520for%2520the%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2014%26volume%3D11%26spage%3D221%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Valk, P. E.; Bailey, D. L.; Townsend, D. W.; Maisey, M. N.</span> <span class="citation_source-book">Positron Emission Tomography: Basic Science</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=P.+E.+Valk&author=D.+L.+Bailey&author=D.+W.+Townsend&author=M.+N.+Maisey&title=Positron+Emission+Tomography%3A+Basic+Science"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DValk%26aufirst%3DP.%2BE.%26btitle%3DPositron%2520Emission%2520Tomography%253A%2520Basic%2520Science%26pub%3DSpringer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Matthews, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">Positron emission tomography molecular imaging for drug development</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1111%2Fj.1365-2125.2011.04085.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2011&pages=175-186&author=P.+M.+Matthewsauthor=E.+A.+Rabinerauthor=J.+Passchierauthor=R.+N.+Gunn&title=Positron+emission+tomography+molecular+imaging+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.04085.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.04085.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DP.%2BM.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DPositron%2520emission%2520tomography%2520molecular%2520imaging%2520for%2520drug%2520development%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D73%26spage%3D175%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Piel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösch, F.</span><span> </span><span class="NLM_article-title">Positron emission tomography in CNS drug discovery and drug monitoring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9232</span><span class="NLM_x">–</span> <span class="NLM_lpage">9258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5001858" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSns77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9232-9258&author=M.+Pielauthor=I.+Vernalekenauthor=F.+R%C3%B6sch&title=Positron+emission+tomography+in+CNS+drug+discovery+and+drug+monitoring"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring</span></div><div class="casAuthors">Piel, Markus; Vernaleken, Ingo; Roesch, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9232-9258</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Mol. imaging methods such as positron emission tomog. (PET) are increasingly involved in the development of new drugs.  Using radioactive tracers as imaging probes, PET allows the detn. of the pharmacokinetic and pharmacodynamic properties of a drug candidate, via recording target engagement, the pattern of distribution, and metab.  Because of the noninvasive nature and quant. end point obtainable by mol. imaging, it seems inherently suited for the examn. of a pharmaceutical's behavior in the brain.  Mol. imaging, most esp. PET, can therefore be a valuable tool in CNS drug research.  In this Perspective, we present the basic principles of PET, the importance of appropriate tracer selection, the impact of improved radiopharmaceutical chem. in radiotracer development, and the different roles that PET can fulfill in CNS drug research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGTZn1_mOVTLVg90H21EOLACvtfcHk0lgIUFdMQe1pJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSns77E&md5=4b8af654ccd92d927b9b938afccd978e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm5001858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5001858%26sid%3Dliteratum%253Aachs%26aulast%3DPiel%26aufirst%3DM.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26atitle%3DPositron%2520emission%2520tomography%2520in%2520CNS%2520drug%2520discovery%2520and%2520drug%2520monitoring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9232%26epage%3D9258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">The β-amyloid hypothesis in Alzheimer’s disease: seeing is believing</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300058m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=265-267&author=H.+F.+Kung&title=The+%CE%B2-amyloid+hypothesis+in+Alzheimer%E2%80%99s+disease%3A+seeing+is+believing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fml300058m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300058m%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DThe%2520%25CE%25B2-amyloid%2520hypothesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520seeing%2520is%2520believing%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D265%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fjlcr.2989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24285314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=89-95&author=N.+S.+Masonauthor=C.+A.+Mathisauthor=W.+E.+Klunk&title=Positron+emission+tomography+radioligands+for+in+vivo+imaging+of+A%CE%B2+plaques"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span></div><div class="casAuthors">Mason, N. Scott; Mathis, Chester A.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">89-95</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of positron emission tomog. (PET) radioligands for the non-invasive imaging of amyloid-β plaque burden has been the focus of intense research efforts over the last decade.  A variety of structural backbones have been investigated and several radiolabeled mols. have been evaluated in phase I (and later) clin. studies.  These efforts have been driven by the desire not only to develop a suitable diagnostic imaging agent but also to develop a means to evaluate potential therapies for Alzheimer's disease.  This review focuses on the development of these ligands, as well as the radiochem. and current regulatory status of these PET radioligands.  Particular attention is given to those ligands that have progressed to the later stages of drug development (phase II/III clin. trial studies) or approved New Drug Application status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhPmau7iHILVg90H21EOLACvtfcHk0lg5vnalL75WRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D&md5=423e02bcc2709e718d7a32adb552f81f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.2989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.2989%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DPositron%2520emission%2520tomography%2520radioligands%2520for%2520in%2520vivo%2520imaging%2520of%2520A%25CE%25B2%2520plaques%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D89%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Noël, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hureau, C.</span><span> </span><span class="NLM_article-title">The benzazole scaffold: a SWAT to combat Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">7747</span><span class="NLM_x">–</span> <span class="NLM_lpage">7762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=7747-7762&author=S.+No%C3%ABlauthor=S.+Cadetauthor=E.+Grasauthor=C.+Hureau&title=The+benzazole+scaffold%3A+a+SWAT+to+combat+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNo%25C3%25ABl%26aufirst%3DS.%26aulast%3DCadet%26aufirst%3DS.%26aulast%3DGras%26aufirst%3DE.%26aulast%3DHureau%26aufirst%3DC.%26atitle%3DThe%2520benzazole%2520scaffold%253A%2520a%2520SWAT%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26spage%3D7747%26epage%3D7762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Amyloid imaging with PET in early Alzheimer disease diagnosis</span> <span class="citation_source-journal">Med. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.mcna.2012.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23642577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3sngvFCrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2013&pages=377-398&author=C.+C.+Roweauthor=V.+L.+Villemagne&title=Amyloid+imaging+with+PET+in+early+Alzheimer+disease+diagnosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid imaging with PET in early Alzheimer disease diagnosis</span></div><div class="casAuthors">Rowe Christopher C; Villemagne Victor L</div><div class="citationInfo"><span class="NLM_cas:title">The Medical clinics of North America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In vivo imaging of amyloid-β (Aβ) with positron emission tomography has moved from the research arena into clinical practice.  Clinicians working with cognitive decline and dementia must become familiar with its benefits and limitations.  Amyloid imaging allows earlier diagnosis of Alzheimer disease and better differential diagnosis of dementia and provides prognostic information for mild cognitive impairment.  It also has an increasingly important role in therapeutic trial recruitment and for evaluation of anti-Aβ treatments.  Longitudinal observations are required to elucidate the role of Aβ deposition in the course of Alzheimer disease and provide information needed to fully use the prognostic power of this investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6G2K_LCaW1QHqQV89nF-2fW6udTcc2ebeNYT6rGscqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sngvFCrug%253D%253D&md5=46ec97a002c90bbd2b1f14303b243fa3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.mcna.2012.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcna.2012.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DAmyloid%2520imaging%2520with%2520PET%2520in%2520early%2520Alzheimer%2520disease%2520diagnosis%26jtitle%3DMed.%2520Clin.%2520North%2520Am.%26date%3D2013%26volume%3D97%26spage%3D377%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Holland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotstein, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greguric, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span> </span><span class="NLM_article-title">Alternative approaches for PET radiotracer development in Alzheimers disease: imaging beyond plaque</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fjlcr.3158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24327420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFakur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=323-331&author=J.+P.+Hollandauthor=S.+H.+Liangauthor=B.+H.+Rotsteinauthor=T.+L.+Collierauthor=N.+A.+Stephensonauthor=I.+Greguricauthor=N.+Vasdev&title=Alternative+approaches+for+PET+radiotracer+development+in+Alzheimers+disease%3A+imaging+beyond+plaque"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative approaches for PET radiotracer development in Alzheimers disease: imaging beyond plaque</span></div><div class="casAuthors">Holland, Jason P.; Liang, Steven H.; Rotstein, Benjamin H.; Collier, Thomas L.; Stephenson, Nickeisha A.; Greguric, Ivan; Vasdev, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) and related dementias show increasing clin. prevalence, yet our understanding of the etiol. and pathobiol. of disease-related neurodegeneration remains limited.  In this regard, noninvasive imaging with radiotracers for positron emission tomog. (PET) presents a unique tool for quantifying spatial and temporal changes in characteristic biol. markers of brain disease and for assessing potential drug efficacy.  PET radiotracers targeting different protein markers are being developed to address questions pertaining to the mol. and/or genetic heterogeneity of AD and related dementias.  For example, radiotracers including [11C]-PiB and [18F]-AV-45 (Florbetapir) are being used to measure the d. of Aβ-plaques in AD patients and to interrogate the biol. mechanisms of disease initiation and progression.  Our focus is on the development of novel PET imaging agents, targeting proteins beyond Aβ-plaques, which can be used to investigate the broader mechanism of AD pathogenesis.  Here, we present the chem. basis of various radiotracers which show promise in preclin. or clin. studies for use in evaluating the phenotypic or biochem. characteristics of AD.  Radiotracers for PET imaging neuroinflammation, metal ion assocn. with Aβ-plaques, tau protein, cholinergic and cannabinoid receptors, and enzymes including glycogen-synthase kinase-3β and monoamine oxidase B amongst others, and their connection to AD are highlighted.  Copyright © 2013 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGqOOrpGlyrVg90H21EOLACvtfcHk0ljOgPy_k4GFEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFakur%252FL&md5=d908d7a016b475367ebe86cb8693f01f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3158%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DJ.%2BP.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26aulast%3DRotstein%26aufirst%3DB.%2BH.%26aulast%3DCollier%26aufirst%3DT.%2BL.%26aulast%3DStephenson%26aufirst%3DN.%2BA.%26aulast%3DGreguric%26aufirst%3DI.%26aulast%3DVasdev%26aufirst%3DN.%26atitle%3DAlternative%2520approaches%2520for%2520PET%2520radiotracer%2520development%2520in%2520Alzheimers%2520disease%253A%2520imaging%2520beyond%2520plaque%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2014%26volume%3D57%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomqvist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitcheva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ausén, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koivisto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Långström, B.</span><span> </span><span class="NLM_article-title">Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fana.20009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=14991808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFKntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=306-319&author=W.+E.+Klunkauthor=H.+Englerauthor=A.+Nordbergauthor=Y.+Wangauthor=G.+Blomqvistauthor=D.+P.+Holtauthor=M.+Bergstr%C3%B6mauthor=I.+Savitchevaauthor=G.+F.+Huangauthor=S.+Estradaauthor=B.+Aus%C3%A9nauthor=M.+L.+Debnathauthor=J.+Barlettaauthor=J.+C.+Priceauthor=J.+Sandellauthor=B.+J.+Loprestiauthor=A.+Wallauthor=P.+Koivistoauthor=G.+Antoniauthor=C.+A.+Mathisauthor=B.+L%C3%A5ngstr%C3%B6m&title=Imaging+brain+amyloid+in+Alzheimer%E2%80%99s+disease+with+Pittsburgh+compound-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B</span></div><div class="casAuthors">Klunk, William E.; Engler, Henry; Nordberg, Agneta; Wang, Yanming; Blomqvist, Gunnar; Holt, Daniel P.; Bergstrom, Mats; Savitcheva, Irina; Huang, Guo-feng; Estrada, Sergio; Ausen, Birgitta; Debnath, Manik L.; Barletta, Julien; Price, Julie C.; Sandell, Johan; Lopresti, Brian J.; Wall, Anders; Koivisto, Pernilla; Antoni, Gunnar; Mathis, Chester A.; Langstrom, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-319</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">This report describes the first human study of a novel amyloid-imaging positron emission tomog. (PET) tracer, termed Pittsburgh Compd.-B (PIB), in 16 patients with diagnosed mild AD and 9 controls.  Compared with controls, AD patients typically showed marked retention of PIB in areas of assocn. cortex known to contain large amts. of amyloid deposits in AD.  In the AD patient group, PIB retention was increased most prominently in frontal cortex (1.94-fold, p = 0.0001).  Large increases also were obsd. in parietal (1.71-fold, p = 0.0002), temporal (1.52-fold, p = 0.002), and occipital (1.54-fold, p = 0.002) cortex and the striatum (1.76-fold, p = 0.0001).  PIB retention was equiv. in AD patients and controls in areas known to be relatively unaffected by amyloid deposition (such as subcortical white matter, pons, and cerebellum).  Studies in three young (21 yr) and six older healthy controls (69.5±11 yr) showed low PIB retention in cortical areas and no significant group differences between young and older controls.  In cortical areas, PIB retention correlated inversely with cerebral glucose metab. detd. with 18F-fluorodeoxyglucose.  This relationship was most robust in the parietal cortex (r = -0.72; p = 0.0001).  The results suggest that PET imaging with the novel tracer, PIB, can provide quant. information on amyloid deposits in living subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXxBSvpITSxLVg90H21EOLACvtfcHk0ljOgPy_k4GFEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFKntb8%253D&md5=3e036dca56dcb81e0cf131a5b100f95f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fana.20009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20009%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DEngler%26aufirst%3DH.%26aulast%3DNordberg%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBlomqvist%26aufirst%3DG.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSavitcheva%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DEstrada%26aufirst%3DS.%26aulast%3DAus%25C3%25A9n%26aufirst%3DB.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DBarletta%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DSandell%26aufirst%3DJ.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DKoivisto%26aufirst%3DP.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DL%25C3%25A5ngstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DImaging%2520brain%2520amyloid%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520Pittsburgh%2520compound-B%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D306%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Cohen, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinovici, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikonomovic, M. D.</span><span> </span><span class="NLM_article-title">Using Pittsburgh compound B for in vivo PET imaging of fibrillar amyloid-beta</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=27-81&author=A.+D.+Cohenauthor=G.+D.+Rabinoviciauthor=C.+A.+Mathisauthor=W.+J.+Jagustauthor=W.+E.+Klunkauthor=M.+D.+Ikonomovic&title=Using+Pittsburgh+compound+B+for+in+vivo+PET+imaging+of+fibrillar+amyloid-beta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DA.%2BD.%26aulast%3DRabinovici%26aufirst%3DG.%2BD.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DIkonomovic%26aufirst%3DM.%2BD.%26atitle%3DUsing%2520Pittsburgh%2520compound%2520B%2520for%2520in%2520vivo%2520PET%2520imaging%2520of%2520fibrillar%2520amyloid-beta%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2012%26volume%3D64%26spage%3D27%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">F-18 polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.nucmedbio.2005.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=16253804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=799-809&author=W.+Zhangauthor=S.+Oyaauthor=M.-P.+Kungauthor=C.+Houauthor=D.+L.+Maierauthor=H.+F.+Kung&title=F-18+polyethyleneglycol+stilbenes+as+PET+imaging+agents+targeting+A%CE%B2+aggregates+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain</span></div><div class="casAuthors">Zhang, Wei; Oya, Shunichi; Kung, Mei-Ping; Hou, Catherine; Maier, Donna L.; Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">799-809</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This paper describes a novel series of 18F-labeled polyethyleneglycol (PEG)-stilbene derivs. as potential β-amyloid (Aβ) plaque-specific imaging agents for positron emission tomog. (PET).  In these series of compds., 18F is linked to the stilbene through a PEG chain, of which the no. of ethoxy groups ranges from 2 to 5.  The purpose of adding PEG groups is to lower the lipophilicity and improve bioavailability.  The syntheses of the "cold" compds. and the 18F-labeled PEG stilbene derivs. are successfully achieved.  All of the fluorinated stilbenes displayed high binding affinities in an assay using postmortem AD brain homogenates (Ki=2.9-6.7 nM).  Labeling was successfully performed by a substitution of the mesylate group of 10a-d by [18F]fluoride giving the target compds. [18F]12a-d (EOS, specific activity, 900-1500 Ci/mmol; radiochem. purity >99%).  In vivo biodistribution of these novel 18F ligands in normal mice exhibited excellent brain penetrations and rapid washouts after an i.v. injection (6.6-8.1 and 1.2-2.6 %dose/g at 2 and 60 min, resp.).  Autoradiog. of postmortem AD brain sections of [18F]12a-d confirmed the specific binding related to the presence of Aβ plaques.  In addn., in vivo plaque labeling can be clearly demonstrated with these 18F-labeled agents in transgenic mice (Tg2576), a useful animal model for Alzheimer's disease.  In conclusion, the preliminary results strongly suggest these fluorinated PEG stilbene derivs. are suitable candidates as Aβ plaque imaging agents for studying patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLVZvNjp7mrVg90H21EOLACvtfcHk0lj89KCPkYekLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb%252FN&md5=059e56c983730296968273991e30f0b8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DOya%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DM.-P.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DMaier%26aufirst%3DD.%2BL.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DF-18%2520polyethyleneglycol%2520stilbenes%2520as%2520PET%2520imaging%2520agents%2520targeting%2520A%25CE%25B2%2520aggregates%2520in%2520the%2520brain%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D799%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Dollé, F.</span><span> </span><span class="NLM_article-title">Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fjlcr.3037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24285311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlaqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=65-67&author=F.+Doll%C3%A9&title=Carbon-11+and+fluorine-18+chemistry+devoted+to+molecular+probes+for+imaging+the+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography11C/18F chemistry devoted to molecular probes for imaging the brain with PETF. DolleCarbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography</span></div><div class="casAuthors">Dolle, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">65-67</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Exploration of the living human brain in real-time and in a noninvasive way was for centuries only a dream, made, however, possible today with the remarkable development during the four last decades of powerful mol. imaging techniques, and esp. positron emission tomog. (PET).  Mol. PET imaging relies, from a chem. point of view, on the use and prepn. of a positron-emitting radiolabeled probe or radiotracer, notably compds. incorporating one of two short-lived radionuclides fluorine-18 (T1/2: 109.8 min) and carbon-11 (T1/2: 20.38 min).  The growing availability and interest for the radiohalogen fluorine-18 in radiopharmaceutical chem. undoubtedly results from its convenient half-life and the successful use in clin. oncol. of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG).  The special interest of carbon-11 is not only that carbon is present in virtually all biomols. and drugs allowing therefore for isotopic labeling of their chem. structures but also that a given mol. could be radiolabeled at different functions or sites, permitting to explore (or to take advantage of) in vivo metabolic pathways.  PET chem. includes prodn. of these short-lived radioactive isotopes via nuclear transmutation reactions using a cyclotron, and is directed towards the development of rapid synthetic methods, at the trace level, for the introduction of these nuclides into a mol., as well as the use of fast purifn., anal. and formulation techniques.  PET chem. is the driving force in mol. PET imaging, and this special issue of the Journal of Labeled Compds. and Radiopharmaceuticals, which is strongly chem. and radiochem.-oriented, aims at illustrating, be it in part only, the state-of-the-art arsenal of reactions currently available and its potential for the research and development of specific mol. probes labeled with the positron emitters carbon-11 and fluorine-18, with optimal imaging properties for PET exploration of the brain.  Copyright © 2013 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4MdO4LHXnqLVg90H21EOLACvtfcHk0lgiynH3Eil3fQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlaqtb8%253D&md5=731e38e4015a139fa653b30e48a10879</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3037%26sid%3Dliteratum%253Aachs%26aulast%3DDoll%25C3%25A9%26aufirst%3DF.%26atitle%3DCarbon-11%2520and%2520fluorine-18%2520chemistry%2520devoted%2520to%2520molecular%2520probes%2520for%2520imaging%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D65%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Serdons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verduyckt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderghinste, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleynhens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghgraef, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermaelen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwinghe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span> </span><span class="NLM_article-title">Synthesis of <sup>18</sup>F-labeled 2-(4'-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [<sup>11</sup>C]-PIB</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=602-605&author=K.+Serdonsauthor=T.+Verduycktauthor=D.+Vanderghinsteauthor=J.+Cleynhensauthor=P.+Borghgraefauthor=P.+Vermaelenauthor=C.+Terwingheauthor=F.+Van+Leuvenauthor=K.+Van+Laereauthor=H.+Kungauthor=G.+Bormansauthor=A.+Verbruggen&title=Synthesis+of+18F-labeled+2-%284%27-fluorophenyl%29-1%2C3-benzothiazole+and+evaluation+as+amyloid+imaging+agent+in+comparison+with+%5B11C%5D-PIB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerdons%26aufirst%3DK.%26aulast%3DVerduyckt%26aufirst%3DT.%26aulast%3DVanderghinste%26aufirst%3DD.%26aulast%3DCleynhens%26aufirst%3DJ.%26aulast%3DBorghgraef%26aufirst%3DP.%26aulast%3DVermaelen%26aufirst%3DP.%26aulast%3DTerwinghe%26aufirst%3DC.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DH.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVerbruggen%26aufirst%3DA.%26atitle%3DSynthesis%2520of%252018F-labeled%25202-%25284%2527-fluorophenyl%2529-1%252C3-benzothiazole%2520and%2520evaluation%2520as%2520amyloid%2520imaging%2520agent%2520in%2520comparison%2520with%2520%255B11C%255D-PIB%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D602%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Jureus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstroem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunnemark, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S. P. S.</span><span> </span><span class="NLM_article-title">Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1111%2Fj.1471-4159.2010.06812.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20477945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslygtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2010&pages=784-794&author=A.+Jureusauthor=B.-M.+Swahnauthor=J.+Sandellauthor=F.+Jeppssonauthor=A.+E.+Johnsonauthor=P.+Johnstroemauthor=J.+A.+M.+Neelissenauthor=D.+Sunnemarkauthor=L.+Fardeauthor=S.+P.+S.+Svensson&title=Characterization+of+AZD4694%2C+a+novel+fluorinated+A%CE%B2+plaque+neuroimaging+PET+radioligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand</span></div><div class="casAuthors">Jureus, Anders; Swahn, Britt-Marie; Sandell, Johan; Jeppsson, Fredrik; Johnson, Allan E.; Johnstroem, Peter; Neelissen, Jan A. M.; Sunnemark, Dan; Farde, Lars; Svensson, Samuel P. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">784-794</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) radioligands that bind selectively to β-amyloid plaques (Aβ) are promising imaging tools aimed at supporting the diagnosis of Alzheimer's disease and the evaluation of new drugs aiming to modify amyloid plaque load.  For extended clin. use, there is a particular need for PET tracers labeled with fluorine-18, a radionuclide with 110 min half-life allowing for central synthesis followed by wide distribution.  The development of fluorinated radioligands is, however, challenging because of the lipophilic nature of arom. fluorine, rendering fluorinated ligands more prone to have high non-specific white matter binding.  We have here developed the new benzofuran-derived radioligand contg. fluorine, AZD4694 that shows high affinity for β-amyloid fibrils in vitro (Kd = 2.3 ± 0.3 nM).  In cortical sections from human Alzheimer's disease brain [3H]AZD4694 selectively labeled β-amyloid deposits in gray matter, whereas there was a lower level of non-displaceable binding in plaque devoid white matter.  Administration of unlabeled AZD4694 to rat showed that it has a pharmacokinetic profile consistent with good PET radioligands, i.e., it quickly entered and rapidly cleared from normal rat brain tissue.  Ex vivo binding data in aged Tg2576 mice after i.v. administration of [3H]AZD4694 showed selective binding to β-amyloid deposits in a reversible manner.  In Tg2576 mice, plaque bound [3H]AZD4694 could still be detected 80 min after i.v. administration.  Taken together, the preclin. profile of AZD4694 suggests that fluorine-18 labeled AZD4694 may have potential for PET-visualization of cerebral β-amyloid deposits in the living human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyIbO8Tjk5-rVg90H21EOLACvtfcHk0lifZ-3dS9Vkow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslygtbY%253D&md5=2631a6a6ccf17cfc9041dfba4e4febe2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.06812.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.06812.x%26sid%3Dliteratum%253Aachs%26aulast%3DJureus%26aufirst%3DA.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DSandell%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DA.%2BE.%26aulast%3DJohnstroem%26aufirst%3DP.%26aulast%3DNeelissen%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DSunnemark%26aufirst%3DD.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DSvensson%26aufirst%3DS.%2BP.%2BS.%26atitle%3DCharacterization%2520of%2520AZD4694%252C%2520a%2520novel%2520fluorinated%2520A%25CE%25B2%2520plaque%2520neuroimaging%2520PET%2520radioligand%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D114%26spage%3D784%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Landau, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurfjell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span> </span><span class="NLM_article-title">Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs00259-014-2753-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24647577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslSqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=1398-1407&author=S.+M.+Landauauthor=B.+A.+Thomasauthor=L.+Thurfjellauthor=M.+Schmidtauthor=R.+Margolinauthor=M.+Mintunauthor=M.+Pontecorvoauthor=S.+L.+Bakerauthor=W.+J.+Jagust&title=Amyloid+PET+imaging+in+Alzheimer%E2%80%99s+disease%3A+a+comparison+of+three+radiotracers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers</span></div><div class="casAuthors">Landau, S. M.; Thomas, B. A.; Thurfjell, L.; Schmidt, M.; Margolin, R.; Mintun, M.; Pontecorvo, M.; Baker, S. L.; Jagust, W. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1398-1407</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The increasing use of amyloid PET in Alzheimer's disease research and clin. trials has motivated efforts to standardize methodol.  We compared retention of the 11C radiotracer Pittsburgh Compd. B (PiB) and that of two 18F amyloid radiotracers (florbetapir and flutemetamol) using two study populations.  We also examd. the feasibility of converting between tracer-specific measures, using PiB as the common link between the two 18F tracers.  Methods: One group of 40 subjects underwent PiB and flutemetamol imaging sessions and a sep. group of 32 subjects underwent PiB and florbetapir imaging sessions.  We compared cortical and white matter retention for each 18F tracer relative to that of PiB, as well as retention in several ref. regions and image anal. methods.  Correlations between tracer pairs were used to convert tracer-specific threshold values for amyloid positivity between tracers.  Results: Cortical retention for each pair of tracers was strongly correlated regardless of ref. region (PiB-flutemetamol, ρ = 0.84-0.99; PiB-florbetapir, ρ = 0.83-0.97) and anal. method (ρ = 0.90-0.99).  Compared to PiB, flutemetamol had higher white matter retention, while florbetapir had lower cortical retention.  Two previously established independent thresholds for amyloid positivity were highly consistent when values were converted between tracer pairs.  Conclusion: Despite differing white and gray matter retention characteristics, cortical retention for each 18F tracer was highly correlated with that of PiB, enabling conversion of thresholds across tracer measurement scales with a high level of internal consistency.  Standardization of anal. methods and measurement scales may facilitate the comparison of amyloid PET data obtained using different tracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78zTuzp6drVg90H21EOLACvtfcHk0lifZ-3dS9Vkow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslSqu7o%253D&md5=dec3dc2c6e9eed9370697afa921ea999</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00259-014-2753-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-014-2753-3%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DB.%2BA.%26aulast%3DThurfjell%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DMargolin%26aufirst%3DR.%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DPontecorvo%26aufirst%3DM.%26aulast%3DBaker%26aufirst%3DS.%2BL.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DAmyloid%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520comparison%2520of%2520three%2520radiotracers%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D1398%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cselényi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=880-886&author=C.+C.+Roweauthor=S.+Pejoskaauthor=R.+S.+Mulliganauthor=G.+Jonesauthor=J.+G.+Chanauthor=S.+Svenssonauthor=Z.+Csel%C3%A9nyiauthor=C.+L.+Mastersauthor=V.+L.+Villemagne&title=Head-to-head+comparison+of+11C-PiB+and+18F-AZD4694+%28NAV4694%29+for+%CE%B2-amyloid+imaging+in+aging+and+dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DChan%26aufirst%3DJ.%2BG.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DCsel%25C3%25A9nyi%26aufirst%3DZ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DHead-to-head%2520comparison%2520of%252011C-PiB%2520and%252018F-AZD4694%2520%2528NAV4694%2529%2520for%2520%25CE%25B2-amyloid%2520imaging%2520in%2520aging%2520and%2520dementia%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D880%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghbel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langström, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudeet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoilund-Carlsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">Amyloid-β positron emission tomography imaging probes: a critical review</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">631</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23648516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Srt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=613-631&author=V.+Kepeauthor=M.+C.+Moghbelauthor=B.+Langstr%C3%B6mauthor=H.+Zaidiauthor=H.+V.+Vintersauthor=S.-C.+Huangauthor=N.+Satyamurthyauthor=D.+Doudeetauthor=E.+Mishaniauthor=R.+M.+Cohenauthor=P.+F.+Hoilund-Carlsenauthor=A.+Alaviauthor=J.+R.+Barrio&title=Amyloid-%CE%B2+positron+emission+tomography+imaging+probes%3A+a+critical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review</span></div><div class="casAuthors">Kepe, Vladimir; Moghbel, Mateen C.; Langstroem, Bengt; Zaidi, Habib; Vinters, Harry V.; Huang, Sung-Cheng; Satyamurthy, Nagichettiar; Doudet, Doris; Mishani, Eyal; Cohen, Robert M.; Hoilund-Carlsen, Poul F.; Alavi, Abass; Barrio, Jorge R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-631</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The rapidly rising prevalence and cost of Alzheimer's disease in recent decades has made the imaging of amyloid-β deposits the focus of intense research.  Several amyloid imaging probes with purported specificity for amyloid-β plaques are currently at various stages of FDA approval.  However, a no. of factors appear to preclude these probes from clin. utilization.  As the available "amyloid specific" positron emission tomog. imaging probes have failed to demonstrate diagnostic value and have shown limited utility for monitoring therapeutic interventions in humans, a debate on their significance has emerged.  The aim of this review is to identify and discuss critically the scientific issues contributing to the extensive inconsistencies reported in the literature on their purported in vivo amyloid specificity and potential utilization in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDVE_xuB1karVg90H21EOLACvtfcHk0li6Boqhbuck5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Srt7zI&md5=deefdf403451d2621afdbc31ae9cc4a9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DMoghbel%26aufirst%3DM.%2BC.%26aulast%3DLangstr%25C3%25B6m%26aufirst%3DB.%26aulast%3DZaidi%26aufirst%3DH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DHuang%26aufirst%3DS.-C.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DDoudeet%26aufirst%3DD.%26aulast%3DMishani%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DR.%2BM.%26aulast%3DHoilund-Carlsen%26aufirst%3DP.%2BF.%26aulast%3DAlavi%26aufirst%3DA.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DAmyloid-%25CE%25B2%2520positron%2520emission%2520tomography%2520imaging%2520probes%253A%2520a%2520critical%2520review%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D36%26spage%3D613%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Eckroat, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhoub, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau-Tsodikova, S.</span><span> </span><span class="NLM_article-title">Amyloid-β probes: review of structure-activity and brain-kinetics relationships</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.3762%2Fbjoc.9.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23766818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFemtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1012-1044&author=T.+J.+Eckroatauthor=A.+S.+Mayhoubauthor=S.+Garneau-Tsodikova&title=Amyloid-%CE%B2+probes%3A+review+of+structure-activity+and+brain-kinetics+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β probes: review of structure-activity and brain-kinetics relationships</span></div><div class="casAuthors">Eckroat, Todd J.; Mayhoub, Abdelrahman S.; Garneau-Tsodikova, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1012-1044, No. 116</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A review.  The no. of people suffering from Alzheimer's disease (AD) is expected to increase dramatically in the coming years, placing a huge burden on society.  Current treatments for AD leave much to be desired, and numerous research efforts around the globe are focused on developing improved therapeutics.  In addn., current diagnostic tools for AD rely largely on subjective cognitive assessment rather than on identification of pathophysiol. changes assocd. with disease onset and progression.  These facts have led to numerous efforts to develop chem. probes to detect pathophysiol. hallmarks of AD, such as amyloid-β plaques, for diagnosis and monitoring of therapeutic efficacy.  This review provides a survey of chem. probes developed to date for AD with emphasis on synthetic methodologies and structure-activity relationships with regards to affinity for target and brain kinetics.  Several probes discussed herein show particularly promising results and will be of immense value moving forward in the fight against AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJR5Z0CHX_e7Vg90H21EOLACvtfcHk0li6Boqhbuck5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFemtbw%253D&md5=07672376d3d0eba52e3627d0b8cfff81</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.9.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.9.116%26sid%3Dliteratum%253Aachs%26aulast%3DEckroat%26aufirst%3DT.%2BJ.%26aulast%3DMayhoub%26aufirst%3DA.%2BS.%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26atitle%3DAmyloid-%25CE%25B2%2520probes%253A%2520review%2520of%2520structure-activity%2520and%2520brain-kinetics%2520relationships%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2013%26volume%3D9%26spage%3D1012%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">The challenges of tau imaging</span> <span class="citation_source-journal">Future Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.2217%2Ffnl.12.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSgs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=409-421&author=V.+L.+Villemagneauthor=S.+Furumotoauthor=M.+Fodero-Tavolettiauthor=R.+Haradaauthor=R.+S.+Mulliganauthor=Y.+Kudoauthor=C.+L.+Mastersauthor=K.+Yanaiauthor=C.+C.+Roweauthor=N.+Okamura&title=The+challenges+of+tau+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The challenges of tau imaging</span></div><div class="casAuthors">Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle; Harada, Ryuichi; Mulligan, Rachel S.; Kudo, Yukitsuka; Masters, Colin L.; Yanai, Kazuhiko; Rowe, Chistopher C.; Okamura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Future Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-421</span>CODEN:
                <span class="NLM_cas:coden">FNUEAM</span>;
        ISSN:<span class="NLM_cas:issn">1479-6708</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  In vivo imaging of tau pathol. will provide new insights into tau deposition in the human brain, thus facilitating research into causes, diagnosis and treatment of major dementias, such as Alzheimer's disease, or some variants of frontotemporal lobar degeneration, in which tau plays a role.  Tau imaging poses several challenges, some related to the singularities of tau aggregation, and others related to radiotracer design.  Several groups around the world are working on the development of imaging agents that will allow the in vivo assessment of tau deposition in aging and in neurodegeneration.  Development of a tau imaging tracer will enable researchers to noninvasively examine the degree and extent of tau pathol. in the brain, quantify changes in tau deposition over time, evaluate its relation to cognition and assess the efficacy of anti-tau therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfIVpSOSew27Vg90H21EOLACvtfcHk0lie1nSN01aoMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSgs7nE&md5=bc3d8d6579bc07a7ab7065948bdfaa73</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2217%2Ffnl.12.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffnl.12.34%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DThe%2520challenges%2520of%2520tau%2520imaging%26jtitle%3DFuture%2520Neurol.%26date%3D2012%26volume%3D7%26spage%3D409%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Sperling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckett, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison-Bogorad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagster, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=280-292&author=R.+A.+Sperlingauthor=P.+S.+Aisenauthor=L.+A.+Beckettauthor=D.+A.+Bennettauthor=S.+Craftauthor=A.+M.+Faganauthor=T.+Iwatsuboauthor=C.+R.+Jackauthor=J.+Kayeauthor=T.+J.+Montineauthor=D.+C.+Parkauthor=E.+M.+Reimanauthor=C.+C.+Roweauthor=E.+Siemersauthor=Y.+Sternauthor=K.+Yaffeauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=M.+Morrison-Bogoradauthor=M.+V.+Wagsterauthor=C.+H.+Phelps&title=Toward+defining+the+preclinical+stages+of+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+National+Institute+on+Aging+and+the+Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Sperling Reisa A; Aisen Paul S; Beckett Laurel A; Bennett David A; Craft Suzanne; Fagan Anne M; Iwatsubo Takeshi; Jack Clifford R Jr; Kaye Jeffrey; Montine Thomas J; Park Denise C; Reiman Eric M; Rowe Christopher C; Siemers Eric; Stern Yaakov; Yaffe Kristine; Carrillo Maria C; Thies Bill; Morrison-Bogorad Marcelle; Wagster Molly V; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia.  This long "preclinical" phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the link between the pathological cascade of AD and the emergence of clinical symptoms.  The National Institute on Aging and the Alzheimer's Association convened an international workgroup to review the biomarker, epidemiological, and neuropsychological evidence, and to develop recommendations to determine the factors which best predict the risk of progression from "normal" cognition to mild cognitive impairment and AD dementia.  We propose a conceptual framework and operational research criteria, based on the prevailing scientific evidence to date, to test and refine these models with longitudinal clinical research studies.  These recommendations are solely intended for research purposes and do not have any clinical implications at this time.  It is hoped that these recommendations will provide a common rubric to advance the study of preclinical AD, and ultimately, aid the field in moving toward earlier intervention at a stage of AD when some disease-modifying therapies may be most efficacious.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSLt7lRqEFUJVfW6udTcc2eYq4Y73wY0gJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktw%253D%253D&md5=116797e3769a70f38cac89730a967b4d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DBeckett%26aufirst%3DL.%2BA.%26aulast%3DBennett%26aufirst%3DD.%2BA.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DStern%26aufirst%3DY.%26aulast%3DYaffe%26aufirst%3DK.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DMorrison-Bogorad%26aufirst%3DM.%26aulast%3DWagster%26aufirst%3DM.%2BV.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DToward%2520defining%2520the%2520preclinical%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging%2520and%2520the%2520Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D280%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span>U.S. Food and Drug Administration. <a href="http://www.fda.gov" class="extLink">www.fda.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+Food+and+Drug+Administration.+www.fda.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Maccioni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farías, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarrete, L.</span><span> </span><span class="NLM_article-title">The revitalized tau hypothesis on Alzheimer’s disease</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.arcmed.2010.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20682182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVemt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2010&pages=226-231&author=R.+B.+Maccioniauthor=G.+Far%C3%ADasauthor=I.+Moralesauthor=L.+Navarrete&title=The+revitalized+tau+hypothesis+on+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Revitalized Tau Hypothesis on Alzheimer's Disease</span></div><div class="casAuthors">Maccioni, Ricardo B.; Farias, Gonzalo; Morales, Inelia; Navarrete, Leonardo</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">226-231</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Many hypotheses have been raised regarding the pathophysiol. of Alzheimer's disease (AD).  Because amyloid beta peptide (Aβ) deposition in senile plaques appears as a late, nonspecific event, recent evidence points to tau phosphorylation and aggregation as the final common pathway in this multifactorial disease.  Current approaches that provide evidence in favor of neuroimmunomodulation in AD and the roles of tau pathol. modifications and aggregation into oligomers and filamentous forms are presented.  We propose an integrative model on the pathogenesis of AD that includes several damage signals such as Aβ oligomers, oxygen free radicals, iron overload, homocysteine, cholesterol and LDL species.  These activate microglia cells, releasing proinflammatory cytokines and producing neuronal degeneration and tau pathol. modifications.  Altered and aggregated forms of tau appear to act as a toxic stimuli contributing to neurodegeneration.  Recent findings provide further support to the central role of tau in the pathogenesis of AD, so this protein has turned into a diagnostic and therapeutic target for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos_mQZP6_GRrVg90H21EOLACvtfcHk0ljauO-UVYeLWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVemt7o%253D&md5=b8d948914ce470f13a3e8b36f0bb563d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2010.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2010.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26aulast%3DFar%25C3%25ADas%26aufirst%3DG.%26aulast%3DMorales%26aufirst%3DI.%26aulast%3DNavarrete%26aufirst%3DL.%26atitle%3DThe%2520revitalized%2520tau%2520hypothesis%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2010%26volume%3D41%26spage%3D226%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Arriagada, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley-Whyte, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=631-639&author=P.+V.+Arriagadaauthor=J.+H.+Growdonauthor=E.+T.+Hedley-Whyteauthor=B.+T.+Hyman&title=Neurofibrillary+tangles+but+not+senile+plaques+parallel+duration+and+severity+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArriagada%26aufirst%3DP.%2BV.%26aulast%3DGrowdon%26aufirst%3DJ.%2BH.%26aulast%3DHedley-Whyte%26aufirst%3DE.%2BT.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DNeurofibrillary%2520tangles%2520but%2520not%2520senile%2520plaques%2520parallel%2520duration%2520and%2520severity%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1992%26volume%3D42%26spage%3D631%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Ke, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchowerska, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Hoven, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Silva, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eersel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittner, L. M.</span><span> </span><span class="NLM_article-title">Lessons from tau-deficient mice</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">873270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=22720190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC38jjslCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=873270&author=Y.+D.+Keauthor=A.+K.+Suchowerskaauthor=J.+van+der+Hovenauthor=D.+M.+De+Silvaauthor=C.+W.+Wuauthor=J.+van+Eerselauthor=A.+Ittnerauthor=L.+M.+Ittner&title=Lessons+from+tau-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from tau-deficient mice</span></div><div class="casAuthors">Ke Yazi D; Suchowerska Alexandra K; van der Hoven Julia; De Silva Dineeka M; Wu Christopher W; van Eersel Janet; Ittner Arne; Ittner Lars M</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">873270</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Both Alzheimer's disease (AD) and frontotemporal dementia (FTD) are characterized by the deposition of hyperphosphorylated forms of the microtubule-associated protein tau in neurons and/or glia.  This unifying pathology led to the umbrella term "tauopathies" for these conditions, also emphasizing the central role of tau in AD and FTD.  Generation of transgenic mouse models expressing human tau in the brain has contributed to the understanding of the pathomechanistic role of tau in disease.  To reveal the physiological functions of tau in vivo, several knockout mouse strains with deletion of the tau-encoding MAPT gene have been established over the past decade, using different gene targeting constructs.  Surprisingly, when initially introduced tau knockout mice presented with no overt phenotype or malformations.  The number of publications using tau knockout mice has recently markedly increased, and both behavioural changes and motor deficits have been identified in aged mice of certain strains.  Moreover, tau knockout mice have been instrumental in identifying novel functions of tau, both in cultured neurons and in vivo.  Importantly, tau knockout mice have significantly contributed to the understanding of the pathophysiological interplay between Aβ and tau in AD.  Here, we review the literature that involves tau knockout mice to summarize what we have learned so far from depleting tau in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAKliQebel62gRQsDqrjW_fW6udTcc2eZRtji3gIn0mbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jjslCjtw%253D%253D&md5=6cfa2953007f4967778e8bf7d100ec16</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DY.%2BD.%26aulast%3DSuchowerska%26aufirst%3DA.%2BK.%26aulast%3Dvan%2Bder%2BHoven%26aufirst%3DJ.%26aulast%3DDe%2BSilva%26aufirst%3DD.%2BM.%26aulast%3DWu%26aufirst%3DC.%2BW.%26aulast%3Dvan%2BEersel%26aufirst%3DJ.%26aulast%3DIttner%26aufirst%3DA.%26aulast%3DIttner%26aufirst%3DL.%2BM.%26atitle%3DLessons%2520from%2520tau-deficient%2520mice%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D873270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Medeiros, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baglietto-Vargas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">The role of tau in Alzheimer’s disease and related disorders</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1111%2Fj.1755-5949.2010.00177.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20553310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOntL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=514-524&author=R.+Medeirosauthor=D.+Baglietto-Vargasauthor=F.+M.+LaFerla&title=The+role+of+tau+in+Alzheimer%E2%80%99s+disease+and+related+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Tau in Alzheimer's disease and related disorders</span></div><div class="casAuthors">Medeiros, Rodrigo; Baglietto-Vargas, David; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">514-524</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Tau, the microtubule-assocd. protein, forms insol. filaments that accumulate as neurofibrillary tangles in Alzheimer's disease (AD) and related tauopathies.  Under physiol. conditions, tau regulates the assembly and maintenance of the structural stability of microtubules.  In the diseased brain, however, tau becomes abnormally hyperphosphorylated, which ultimately causes the microtubules to disassemble, and the free tau mols. aggregate into paired helical filaments.  A large body of evidence suggests that tau hyperphosphorylation results from perturbation of cellular signaling, mainly through imbalance in the activities of different protein kinases and phosphatases.  In AD, it appears that β-amyloid peptide (Aβ) plays a pivotal role in triggering this imbalance.  In this review, we summarize our current understanding of the role of tau in AD and other tauopathies, and highlight key issues that need to be addressed to improve the success of developing novel therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPWguaVVJhw7Vg90H21EOLACvtfcHk0li1BN_zMe_G0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOntL%252FF&md5=b354d941e7e61c1c148a98dbe0b91aba</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2010.00177.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2010.00177.x%26sid%3Dliteratum%253Aachs%26aulast%3DMedeiros%26aufirst%3DR.%26aulast%3DBaglietto-Vargas%26aufirst%3DD.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DThe%2520role%2520of%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520disorders%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2011%26volume%3D17%26spage%3D514%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">In vivo tau imaging: obstacles and progress</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">S254</span><span class="NLM_x">–</span> <span class="NLM_lpage">S264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=S254-S264&author=V.+L.+Villemagneauthor=N.+Okamura&title=In+vivo+tau+imaging%3A+obstacles+and+progress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520tau%2520imaging%253A%2520obstacles%2520and%2520progress%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2014%26volume%3D10%26spage%3DS254%26epage%3DS264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catafau, A. M.</span><span> </span><span class="NLM_article-title">Molecular imaging insights into neurodegeneration: focus on tau PET radiotracers</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=871-874&author=M.+Shahauthor=A.+M.+Catafau&title=Molecular+imaging+insights+into+neurodegeneration%3A+focus+on+tau+PET+radiotracers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26atitle%3DMolecular%2520imaging%2520insights%2520into%2520neurodegeneration%253A%2520focus%2520on%2520tau%2520PET%2520radiotracers%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D871%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1221-1224&author=R.+H.+Mach&title=New+targets+for+the+development+of+PET+tracers+for+imaging+neurodegeneration+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DNew%2520targets%2520for%2520the%2520development%2520of%2520PET%2520tracers%2520for%2520imaging%2520neurodegeneration%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1221%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Zimmer, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuzy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa-Neto, P.</span><span> </span><span class="NLM_article-title">Developments in tau PET imaging</span> <span class="citation_source-journal">Can. J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1017%2Fcjn.2014.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25424608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC2MzgvFKltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=547-553&author=E.+R.+Zimmerauthor=A.+Leuzyauthor=S.+Gauthierauthor=P.+Rosa-Neto&title=Developments+in+tau+PET+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Developments in Tau PET Imaging</span></div><div class="casAuthors">Zimmer Eduardo Rigon; Leuzy Antoine; Rosa-Neto Pedro; Gauthier Serge</div><div class="citationInfo"><span class="NLM_cas:title">The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">547-53</span>
        ISSN:<span class="NLM_cas:issn">0317-1671</span>.
    </div><div class="casAbstract">ABSTRACT The presence of neurofibrillary tangles in the brain is a hallmark feature of several neurodegenerative diseases termed "tauopathies," including Alzheimer's disease (AD) and the tau molecular subgroup of frontotemporal lobar degeneration (FTLD-tau).  Recently, several positron emission tomography (PET) radiopharmaceuticals targeting abnormal conformations of the tau protein have been developed.  To date, six novel tau imaging agents-[18F]THK523, [18F]THK5105, [18F]THK5117, [18F]T807, [18F]T808, and [11C]PBB3-have been described and are considered promising as potential tau radioligands.  Tau imaging agents offer the opportunity of in vivo topographical mapping and quantification of tau aggregates in parallel with clinical and cognitive assessments.  As such, tau imaging is considered of key importance for progress toward earlier and more accurate diagnosis of tauopathies as well as for the monitoring of therapeutic interventions and drug development.  Here, we shed light on the most important developments in tau radiopharmaceuticals, highlighting challenges, possibilities and future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPHrSw-HxLgeIHSmpohpd0fW6udTcc2eb4J2huc3vGTrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzgvFKltQ%253D%253D&md5=bf5b7d4ed0578fd1fe55dfde23d38544</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1017%2Fcjn.2014.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252Fcjn.2014.15%26sid%3Dliteratum%253Aachs%26aulast%3DZimmer%26aufirst%3DE.%2BR.%26aulast%3DLeuzy%26aufirst%3DA.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DRosa-Neto%26aufirst%3DP.%26atitle%3DDevelopments%2520in%2520tau%2520PET%2520imaging%26jtitle%3DCan.%2520J.%2520Neurol.%2520Sci.%26date%3D2014%26volume%3D41%26spage%3D547%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span> </span><span class="NLM_article-title">Tau imaging: early progress and future directions</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS1474-4422%2814%2970252-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25496902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=114-124&author=V.+L.+Villemagneauthor=M.+T.+Fodero-Tavolettiauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Tau+imaging%3A+early+progress+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging: early progress and future directions</span></div><div class="casAuthors">Villemagne Victor L; Fodero-Tavoletti Michelle T; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration.  Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes.  Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time.  Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers.  Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIuS1EFOTTc50d-O_J5C0AfW6udTcc2eaawQyUr2Culrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D&md5=95eb0f9b98711e30caaf4a7c67bd46e0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970252-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970252-2%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DTau%2520imaging%253A%2520early%2520progress%2520and%2520future%2520directions%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D114%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Tau PET imaging in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs11910-014-0500-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25239654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=500&author=N.+Okamuraauthor=R.+Haradaauthor=S.+Furumotoauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Tau+PET+imaging+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Tau PET imaging in Alzheimer's disease</span></div><div class="casAuthors">Okamura Nobuyuki; Harada Ryuichi; Furumoto Shozo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Current neurology and neuroscience reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">500</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment.  Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression.  Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo.  For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits.  PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration.  This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy6LVoglwXzIqdXsLcGTEUfW6udTcc2eaawQyUr2Culrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D&md5=343715c63553be883942f9829da91648</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs11910-014-0500-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-014-0500-6%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DTau%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2014%26volume%3D14%26spage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Weingarten, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockwood, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwo, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, M. W.</span><span> </span><span class="NLM_article-title">A protein factor essential for microtubule assembly</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1858</span><span class="NLM_x">–</span> <span class="NLM_lpage">1862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1073%2Fpnas.72.5.1858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=1057175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADyaE2MXkt1ersbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1975&pages=1858-1862&author=M.+D.+Weingartenauthor=A.+H.+Lockwoodauthor=S.-Y.+Hwoauthor=M.+W.+Kirschner&title=A+protein+factor+essential+for+microtubule+assembly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Protein factor essential for microtubule assembly</span></div><div class="casAuthors">Weingarten, Murray D.; Lockwood, Arthur H.; Hwo, Shu-Ying; Kirschner, Marc W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1858-62</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A heat stable protein essential for microtubule assembly was isolated.  This protein, designated tau (τ), was present in assocn. with tubulin purified from porcine brain by repeated cycles of polymerization.  Tau was sepd. from tubulin by ion exchange chromatog. on phosphocellulose.  In the absence of tau, tubulin existed entirely as a 6 S dimer of 2 polypeptide chains (α and β tubulin) with a mol. wt. of 120,000, which will not assemble into microtubules in vitro.  Addn. of tau completely restored tubule-forming capacity.  Under nonpolymerizing conditions, tau converted 6 S dimers to 36 S rings-structures implicated as intermediates in tubule formation.  Hence, tau appears to act on the 6 S tubulin dimer, activating it for polymerization.  The unique ability of tau to restore the normal features of in vitro microtubule assembly makes it likely that tau is a major regulator of microtubule formation in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF1DLd-GTWGLVg90H21EOLACvtfcHk0litK35wsQsbaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXkt1ersbw%253D&md5=fb14f3b19fbd890adc61846ef868a943</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1073%2Fpnas.72.5.1858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.72.5.1858%26sid%3Dliteratum%253Aachs%26aulast%3DWeingarten%26aufirst%3DM.%2BD.%26aulast%3DLockwood%26aufirst%3DA.%2BH.%26aulast%3DHwo%26aufirst%3DS.-Y.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26atitle%3DA%2520protein%2520factor%2520essential%2520for%2520microtubule%2520assembly%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1975%26volume%3D72%26spage%3D1858%26epage%3D1862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Andreadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosik, K. S.</span><span> </span><span class="NLM_article-title">Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3585</span><span class="NLM_x">–</span> <span class="NLM_lpage">3593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=3585-3593&author=A.+Andreadisauthor=J.+A.+Broderickauthor=K.+S.+Kosik&title=Relative+exon+affinities+and+suboptimal+splice+site+signals+lead+to+non-equivalence+of+two+cassette+exons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreadis%26aufirst%3DA.%26aulast%3DBroderick%26aufirst%3DJ.%2BA.%26aulast%3DKosik%26aufirst%3DK.%2BS.%26atitle%3DRelative%2520exon%2520affinities%2520and%2520suboptimal%2520splice%2520site%2520signals%2520lead%2520to%2520non-equivalence%2520of%2520two%2520cassette%2520exons%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1995%26volume%3D23%26spage%3D3585%26epage%3D3593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Andreadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosik, K. S.</span><span> </span><span class="NLM_article-title">Structure and novel exons of the human tau gene</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">10626</span><span class="NLM_x">–</span> <span class="NLM_lpage">10633</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00158a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1992&pages=10626-10633&author=A.+Andreadisauthor=W.+M.+Brownauthor=K.+S.+Kosik&title=Structure+and+novel+exons+of+the+human+tau+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fbi00158a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00158a027%26sid%3Dliteratum%253Aachs%26aulast%3DAndreadis%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DW.%2BM.%26aulast%3DKosik%26aufirst%3DK.%2BS.%26atitle%3DStructure%2520and%2520novel%2520exons%2520of%2520the%2520human%2520tau%2520gene%26jtitle%3DBiochemistry%26date%3D1992%26volume%3D31%26spage%3D10626%26epage%3D10633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Buée, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussière, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buée-Scherrerb, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delacourte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span> </span><span class="NLM_article-title">Tau protein isoforms, phosphorylation and role in neurodegenerative disorders</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS0165-0173%2800%2900019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=10967355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVCrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=95-130&author=L.+Bu%C3%A9eauthor=T.+Bussi%C3%A8reauthor=V.+Bu%C3%A9e-Scherrerbauthor=A.+Delacourteauthor=P.+R.+Hof&title=Tau+protein+isoforms%2C+phosphorylation+and+role+in+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Tau protein isoforms, phosphorylation and role in neurodegenerative disorders</span></div><div class="casAuthors">Buee, L.; Bussiere, T.; Buee-Scherrer, V.; Delacourte, A.; Hof, P. R.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-130</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with 425 refs.  Tau proteins belong to the family of microtubule-assocd. proteins.  They are mainly expressed in neurons where they play an important role in the assembly of tubulin monomers into microtubules to constitute the neuronal microtubules network.  Microtubules are involved in maintaining the cell shape and serve as tracks for axonal transport.  Tau proteins also establish some links between microtubules and other cytoskeletal elements or proteins.  Tau proteins are translated from a single gene located on chromosome 17.  Their expression is developmentally regulated by an alternative splicing mechanism and six different isoforms exist in the human adult brain.  Tau proteins are the major constituents of intra-neuronal and glial fibrillar lesions described in Alzheimer's disease and numerous neurodegenerative disorders referred to as 'tauopathies'.  Mol. anal. has revealed that an abnormal phosphorylation might be one of the important events in the process leading to their aggregation.  Moreover, a specific set of pathol. tau proteins exhibiting a typical biochem. pattern, and a different regional and laminar distribution could characterize each of these disorders.  Finally, a direct correlation has been established between the progressive involvement of the neocortical areas and the increasing severity of dementia, suggesting that pathol. tau proteins are reliable marker of the neurodegenerative process.  The recent discovery of tau gene mutations in frontotemporal dementia with parkinsonism linked to chromosome 17 has reinforced the predominant role attributed to tau proteins in the pathogenesis of neurodegenerative disorders, and underlined the fact that distinct sets of tau isoforms expressed in different neuronal populations could lead to different pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KNCSKfZ8_7Vg90H21EOLACvtfcHk0litK35wsQsbaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVCrtbY%253D&md5=d51d14c9e8b56e9661db4ae4afc2c943</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0165-0173%2800%2900019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0173%252800%252900019-9%26sid%3Dliteratum%253Aachs%26aulast%3DBu%25C3%25A9e%26aufirst%3DL.%26aulast%3DBussi%25C3%25A8re%26aufirst%3DT.%26aulast%3DBu%25C3%25A9e-Scherrerb%26aufirst%3DV.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DHof%26aufirst%3DP.%2BR.%26atitle%3DTau%2520protein%2520isoforms%252C%2520phosphorylation%2520and%2520role%2520in%2520neurodegenerative%2520disorders%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2000%26volume%3D33%26spage%3D95%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Levy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leboeuf, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, S. C.</span><span> </span><span class="NLM_article-title">Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegeneration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13520</span><span class="NLM_x">–</span> <span class="NLM_lpage">13528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13520-13528&author=S.+F.+Levyauthor=A.+C.+Leboeufauthor=M.+R.+Massieauthor=M.+A.+Jordanauthor=L.+Wilsonauthor=S.+C.+Feinstein&title=Three-+and+four-repeat+tau+regulate+the+dynamic+instability+of+two+distinct+microtubule+subpopulations+in+qualitatively+different+manners.+Implications+for+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DS.%2BF.%26aulast%3DLeboeuf%26aufirst%3DA.%2BC.%26aulast%3DMassie%26aufirst%3DM.%2BR.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DFeinstein%26aufirst%3DS.%2BC.%26atitle%3DThree-%2520and%2520four-repeat%2520tau%2520regulate%2520the%2520dynamic%2520instability%2520of%2520two%2520distinct%2520microtubule%2520subpopulations%2520in%2520qualitatively%2520different%2520manners.%2520Implications%2520for%2520neurodegeneration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13520%26epage%3D13528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Proline-directed pseudophosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of tau and generates a pathological (MC-1) conformation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32066</span><span class="NLM_x">–</span> <span class="NLM_lpage">32076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32066-32076&author=S.+Jeganathanauthor=A.+Hascherauthor=S.+Chinnathambiauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Proline-directed+pseudophosphorylation+at+AT8+and+PHF1+epitopes+induces+a+compaction+of+the+paperclip+folding+of+tau+and+generates+a+pathological+%28MC-1%29+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3DHascher%26aufirst%3DA.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DProline-directed%2520pseudophosphorylation%2520at%2520AT8%2520and%2520PHF1%2520epitopes%2520induces%2520a%2520compaction%2520of%2520the%2520paperclip%2520folding%2520of%2520tau%2520and%2520generates%2520a%2520pathological%2520%2528MC-1%2529%2520conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32066%26epage%3D32076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Mukrasch, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korukottu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">Structural polymorphism of 441-residue tau at single residue resolution</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=e34&author=M.+D.+Mukraschauthor=S.+Bibowauthor=J.+Korukottuauthor=S.+Jeganathanauthor=J.+Biernatauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=Structural+polymorphism+of+441-residue+tau+at+single+residue+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukrasch%26aufirst%3DM.%2BD.%26aulast%3DBibow%26aufirst%3DS.%26aulast%3DKorukottu%26aufirst%3DJ.%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DStructural%2520polymorphism%2520of%2520441-residue%2520tau%2520at%2520single%2520residue%2520resolution%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3De34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedhoff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heberle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming β structure</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">5129</span><span class="NLM_x">–</span> <span class="NLM_lpage">5134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5129-5134&author=M.+von+Bergenauthor=P.+Friedhoffauthor=J.+Biernatauthor=J.+Heberleauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Assembly+of+tau+protein+into+Alzheimer+paired+helical+filaments+depends+on+a+local+sequence+motif+%28%28306%29VQIVYK%28311%29%29+forming+%CE%B2+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DFriedhoff%26aufirst%3DP.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DHeberle%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DAssembly%2520of%2520tau%2520protein%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%2520depends%2520on%2520a%2520local%2520sequence%2520motif%2520%2528%2528306%2529VQIVYK%2528311%2529%2529%2520forming%2520%25CE%25B2%2520structure%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D5129%26epage%3D5134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">48165</span><span class="NLM_x">–</span> <span class="NLM_lpage">48174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1074%2Fjbc.M105196200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=11606569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVWq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=48165-48174&author=M.+Von+Bergenauthor=S.+Barghornauthor=L.+Liauthor=A.+Marxauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Mutations+of+tau+protein+in+frontotemporal+dementia+promote+aggregation+of+paired+helical+filaments+by+enhancing+local+%CE%B2-structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure</span></div><div class="casAuthors">Von Bergen, Martin; Barghorn, Stefan; Li, Li; Marx, Alexander; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">48165-48174</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The microtubule-assocd. protein tau is a natively unfolded protein in soln., yet it is able to polymerize into the ordered paired helical filaments (PHF) of Alzheimer's disease.  In the splice isoforms lacking exon 10, this process is facilitated by the formation of β-structure around the hexapeptide motif PHF6 (306VQIVYK311) encoded by exon 11.  We have investigated the structural requirements for PHF polymn. in the context of adult tau isoforms contg. four repeats (including exon 10).  In addn. to the PHF6 motif there exists a related PHF6* motif (275VQIINK280) in the repeat encoded by the alternatively spliced exon 10.  We show that this PHF6* motif also promotes aggregation by the formation of β-structure and that there is a cross-talk between the two hexapeptide motifs during PHF aggregation.  We also show that two of the tau mutations found in hereditary frontotemporal dementias, ΔK280 and P301L, have a much stronger tendency for PHF aggregation which correlates with their high propensity for β-structure around the hexapeptide motifs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio6uZlbctuLVg90H21EOLACvtfcHk0lgCC1sZz34mbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVWq&md5=570cd75c036557ade8d4539ff2e2b054</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M105196200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M105196200%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BBergen%26aufirst%3DM.%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMarx%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DMutations%2520of%2520tau%2520protein%2520in%2520frontotemporal%2520dementia%2520promote%2520aggregation%2520of%2520paired%2520helical%2520filaments%2520by%2520enhancing%2520local%2520%25CE%25B2-structure%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D48165%26epage%3D48174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latypova, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terro, F.</span><span> </span><span class="NLM_article-title">Post-translational modifications of tau protein: implications for Alzheimer’s disease</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.neuint.2010.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21215781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFGnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2011&pages=458-471&author=L.+Martinauthor=X.+Latypovaauthor=F.+Terro&title=Post-translational+modifications+of+tau+protein%3A+implications+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational modifications of tau protein: Implications for Alzheimer's disease</span></div><div class="casAuthors">Martin, Ludovic; Latypova, Xenia; Terro, Faraj</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-471</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) belongs to a group of neurodegenerative diseases collectively designated as "tauopathies", because they are characterized by the aggregation of abnormally phosphorylated tau protein.  The mechanisms responsible for tau aggregation and its contribution to neurodegeneration are still unknown.  Thereby, understanding the modes of regulation of tau is of high interest in the detn. of the possible causes at the origin of the formation of tau aggregates and to elaborate protection strategies to cope with these pathol. lesions.  The regulation of tau takes place predominantly through post-translational modifications.  Extensive reports have been published about tau phosphorylation; however, the other tau post-translational modifications have received much less attention.  Here, we review the different types of post-translational modifications of tau including phosphorylation, glycosylation, glycation, prolyl-isomerization, cleavage or truncation, nitration, polyamination, ubiquitination, sumoylation, oxidn. and aggregation, with a particular interest towards their relevance in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsG774y8lsNrVg90H21EOLACvtfcHk0ljaNvzoElVdvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFGnsLo%253D&md5=dde6742c84b61e90575c394bbe05c55a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLatypova%26aufirst%3DX.%26aulast%3DTerro%26aufirst%3DF.%26atitle%3DPost-translational%2520modifications%2520of%2520tau%2520protein%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Int.%26date%3D2011%26volume%3D58%26spage%3D458%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span> </span><span class="NLM_article-title">Microtubule-associated protein tau as a therapeutic target in Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1517%2F14728222.2014.870156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24387228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=307-318&author=K.+Iqbalauthor=C.-X.+Gongauthor=F.+Liu&title=Microtubule-associated+protein+tau+as+a+therapeutic+target+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease</span></div><div class="casAuthors">Iqbal, Khalid; Gong, Cheng-Xin; Liu, Fei</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-318</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease (AD) is a major public health problem in modern society and as yet, other than a few symptomatic drugs, there is no disease-modifying treatment for this disease available.  Areas covered: Neurofibrillary pathol., which is made up from abnormally hyperphosphorylated microtubule-assocd. protein tau, is both a hallmark and key lesion of AD and related tauopathies.  The d. of neurofibrillary pathol. in the cerebral cortex correlates with the degree of dementia.  Both exptl. and transgenic animal studies have consistently shown that abnormal hyperphosphorylation of tau causes cognitive impairment.  Abnormal hyperphosphorylation of tau converts it from a microtubule assembly-promoting to a microtubule-disrupting protein and promotes its self-assembly into paired helical filaments.  To date, the bulk of studies have shown that abnormal hyperphosphorylation is the key gain of toxic function step though some cell culture and transgenic mouse studies have also reported that aggregated tau can lead to neurodegeneration.  In this article, we have reviewed data from our lab and that from PubMed search on the mol. mechanism of tau pathol. and the potential of tau as a therapeutic target for AD and related disorders.  Expert opinion: In our opinion, inhibition of abnormal hyperphosphorylation of tau is the most rational therapeutic target.  Therapeutic approaches include restoration of the activity of protein phosphatase-2A, which is the major regulator of tau phosphorylation and the activity of which is compromised in AD brain, inhibition of one or more tau protein kinases which include GSK-3β, cyclin-dependent protein kinase-5, dual-specificity tyrosine phosphorylated-regulated kinase 1A, Ca2+/calmodulin-activated protein kinase II and casein kinase I, enhancement of O-GlcNAcylation of tau, and tau immunization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUf6R7H9W1MLVg90H21EOLACvtfcHk0ljaNvzoElVdvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cjtb4%253D&md5=67bb858f39c97e2a9312805d42187727</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.870156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.870156%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGong%26aufirst%3DC.-X.%26aulast%3DLiu%26aufirst%3DF.%26atitle%3DMicrotubule-associated%2520protein%2520tau%2520as%2520a%2520therapeutic%2520target%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D307%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span> </span><span class="NLM_article-title">Tau pathology and neurodegeneration</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS1474-4422%2813%2970090-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23684085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=609-622&author=M.+G.+Spillantiniauthor=M.+Goedert&title=Tau+pathology+and+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Tau pathology and neurodegeneration</span></div><div class="casAuthors">Spillantini, Maria Grazia; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-622</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathway leading from sol. and monomeric to hyperphosphorylated, insol. and filamentous tau protein is at the center of many human neurodegenerative diseases, collectively referred to as tauopathies.  Dominantly inherited mutations in MAPT, the gene that encodes tau, cause forms of frontotemporal dementia and parkinsonism, proving that dysfunction of tau is sufficient to cause neurodegeneration and dementia.  However, most cases of tauopathy are not inherited in a dominant manner.  The first tau aggregates form in a few nerve cells in discrete brain areas.  These become self propagating and spread to distant brain regions in a prion-like manner.  The prevention of tau aggregation and propagation is the focus of attempts to develop mechanism-based treatments for tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-Mr15hi3grVg90H21EOLACvtfcHk0ljIj8HXq7uPVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D&md5=532220e2bfffdb228277e80868bdde65</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970090-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970090-5%26sid%3Dliteratum%253Aachs%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DTau%2520pathology%2520and%2520neurodegeneration%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D609%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Clavaguera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grueninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolnay, M.</span><span> </span><span class="NLM_article-title">Intercellular transfer of tau aggregates and spreading of tau pathology: implications for therapeutic strategies</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=9-15&author=F.+Clavagueraauthor=F.+Grueningerauthor=M.+Tolnay&title=Intercellular+transfer+of+tau+aggregates+and+spreading+of+tau+pathology%3A+implications+for+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClavaguera%26aufirst%3DF.%26aulast%3DGrueninger%26aufirst%3DF.%26aulast%3DTolnay%26aufirst%3DM.%26atitle%3DIntercellular%2520transfer%2520of%2520tau%2520aggregates%2520and%2520spreading%2520of%2520tau%2520pathology%253A%2520implications%2520for%2520therapeutic%2520strategies%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D76%26spage%3D9%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Progress and developments in tau aggregation inhibitors for Alzheimer disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4155</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3017317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4135-4155&author=B.+Bulicauthor=M.+Pickhardtauthor=E.+Mandelkow&title=Progress+and+developments+in+tau+aggregation+inhibitors+for+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm3017317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3017317%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DProgress%2520and%2520developments%2520in%2520tau%2520aggregation%2520inhibitors%2520for%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4135%26epage%3D4155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Ramachandran, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udgaonkar, J. B.</span><span> </span><span class="NLM_article-title">Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer’s disease and the tauopathies</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4107</span><span class="NLM_x">–</span> <span class="NLM_lpage">4126</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi400209z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=4107-4126&author=G.+Ramachandranauthor=J.+B.+Udgaonkar&title=Mechanistic+studies+unravel+the+complexity+inherent+in+tau+aggregation+leading+to+Alzheimer%E2%80%99s+disease+and+the+tauopathies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fbi400209z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400209z%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DG.%26aulast%3DUdgaonkar%26aufirst%3DJ.%2BB.%26atitle%3DMechanistic%2520studies%2520unravel%2520the%2520complexity%2520inherent%2520in%2520tau%2520aggregation%2520leading%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520the%2520tauopathies%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D4107%26epage%3D4126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Sevcik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrabana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csokova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, M.</span><span> </span><span class="NLM_article-title">X-ray structure of the PHF core C terminus: insight into the folding of the intrinsically disordered protein tau in Alzheimer’s disease</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">–</span> <span class="NLM_lpage">5878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=5872-5878&author=J.+Sevcikauthor=R.+Skrabanaauthor=R.+Dvorskyauthor=N.+Csokovaauthor=K.+Iqbalauthor=M.+Novak&title=X-ray+structure+of+the+PHF+core+C+terminus%3A+insight+into+the+folding+of+the+intrinsically+disordered+protein+tau+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSevcik%26aufirst%3DJ.%26aulast%3DSkrabana%26aufirst%3DR.%26aulast%3DDvorsky%26aufirst%3DR.%26aulast%3DCsokova%26aufirst%3DN.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DNovak%26aufirst%3DM.%26atitle%3DX-ray%2520structure%2520of%2520the%2520PHF%2520core%2520C%2520terminus%253A%2520insight%2520into%2520the%2520folding%2520of%2520the%2520intrinsically%2520disordered%2520protein%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D5872%26epage%3D5878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Skrabana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevcik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, M.</span><span> </span><span class="NLM_article-title">Monoclonal antibody MN423 as a stable mold facilitates structure determination of disordered tau protein</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2010&pages=74-81&author=R.+Skrabanaauthor=R.+Dvorskyauthor=J.+Sevcikauthor=M.+Novak&title=Monoclonal+antibody+MN423+as+a+stable+mold+facilitates+structure+determination+of+disordered+tau+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkrabana%26aufirst%3DR.%26aulast%3DDvorsky%26aufirst%3DR.%26aulast%3DSevcik%26aufirst%3DJ.%26aulast%3DNovak%26aufirst%3DM.%26atitle%3DMonoclonal%2520antibody%2520MN423%2520as%2520a%2520stable%2520mold%2520facilitates%2520structure%2520determination%2520of%2520disordered%2520tau%2520protein%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2010%26volume%3D171%26spage%3D74%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Janke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendt, T.</span><span> </span><span class="NLM_article-title">Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS0169-328X%2899%2900079-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=10320789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1eiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1999&pages=119-128&author=C.+Jankeauthor=M.+Beckauthor=T.+Stahlauthor=M.+Holzerauthor=K.+Brauerauthor=V.+Biglauthor=T.+Arendt&title=Phylogenetic+diversity+of+the+expression+of+the+microtubule-associated+protein+tau%3A+implications+for+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders</span></div><div class="casAuthors">Janke, Carsten; Beck, Mike; Stahl, Tobias; Holzer, Max; Brauer, Kurt; Bigl, Volker; Arendt, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The microtubule-assocd. protein tau regulates the dynamic stability of the neuronal cytoskeleton by interacting with microtubules.  It is encoded by a single gene, but expressed in a variety of isoforms due to differential RNA splicing.  Six isoforms can be found in the human central nervous system.  These isoforms differ in their ability to promote the assembly of microtubules as well as in their capacity to stabilize existing microtubule structures.  Furthermore, some of the isoforms of tau are specifically involved in the pathogenesis of neurodegenerative disorders.  Thus, splicing of tau might critically influence the physiol. functions of tau protein as well as the pathogenesis of neurodegenerative diseases with tauopathy.  The present study addresses the differential expression of the six isoforms of tau in the central nervous system of 12 mammalian species including Homo sapiens.  The occurrence of each of the six tau isoforms was highly variable.  However, species that were phylogenetically related expressed a similar pattern of tau isoforms.  These results suggest a phylogenetic descent of splicing paradigms, which can be matched with known phylogenetic concepts based on morphol. and mol. genetical studies.  Esp., the unique expression pattern of tau isoforms in the human central nervous system implicates a possible link to the particular vulnerability of humans to neurodegenerative disorders with tauopathy, namely Alzheimer's disease, frontotemporal dementia and Pick's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdW04gm0vFAbVg90H21EOLACvtfcHk0lhE9r22lqCa9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1eiurs%253D&md5=a6c7c9bbde0c6831967e976ee0f9d6d0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2899%2900079-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252899%252900079-0%26sid%3Dliteratum%253Aachs%26aulast%3DJanke%26aufirst%3DC.%26aulast%3DBeck%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DT.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DBrauer%26aufirst%3DK.%26aulast%3DBigl%26aufirst%3DV.%26aulast%3DArendt%26aufirst%3DT.%26atitle%3DPhylogenetic%2520diversity%2520of%2520the%2520expression%2520of%2520the%2520microtubule-associated%2520protein%2520tau%253A%2520implications%2520for%2520neurodegenerative%2520disorders%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1999%26volume%3D68%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Noble, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J.-M.</span><span> </span><span class="NLM_article-title">Transgenic mouse models of tauopathy in drug discovery</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.2174%2F187152710791556131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20522014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOlsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=403-428&author=W.+Nobleauthor=D.+P.+Hangerauthor=J.-M.+Gallo&title=Transgenic+mouse+models+of+tauopathy+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic mouse models of tauopathy in drug discovery</span></div><div class="casAuthors">Noble, W.; Hanger, D. P.; Gallo, J.-M.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-428</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tauopathies, including Alzheimer's disease, are neurodegenerative diseases characterized by the deposition of hyperphosphorylated tau protein in the central nervous system, and are the major cause of dementia in later life.  Considerable advances have been made in developing mouse models that recapitulate, to varying extents, the development of human tau pathol., and the learning and memory deficits characteristic of some tauopathies.  Furthermore, such models have been used to show promising disease-modifying effects in pre-clin. testing of new therapeutics.  Various strategies have been utilized to generate mouse models of tauopathies.  Some of the most enlightening models developed to date either constitutively or inducibly express pathogenic tau mutations.  These animals have been instrumental in defining crit. disease-related mechanisms, including the observation that tangles are not the toxic form of tau in disease.  Here, we discuss the strengths and weaknesses of well characterized transgenic models that emulate human tauopathy, and include a comprehensive listing of the main phenotypic characteristics of all reported tau transgenic rodents.  We summarize the use of tau mice for the development and evaluation of new therapeutic approaches, and their utility in identifying novel drug targets.  In addn., we review the parameters to be considered in the development of the next generation of rodent models of tauopathy, aimed at further increasing our understanding of disease etiol. and in evaluating novel treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphmm6yFcZBKLVg90H21EOLACvtfcHk0lhE9r22lqCa9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOlsLfN&md5=6c04ce9b630a690cb7397905e8576024</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2174%2F187152710791556131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152710791556131%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DW.%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DGallo%26aufirst%3DJ.-M.%26atitle%3DTransgenic%2520mouse%2520models%2520of%2520tauopathy%2520in%2520drug%2520discovery%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2010%26volume%3D9%26spage%3D403%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Denk, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade-Martins, R.</span><span> </span><span class="NLM_article-title">Knock-out and transgenic mouse models of tauopathies</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.neurobiolaging.2007.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=17590238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWmsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1-13&author=F.+Denkauthor=R.+Wade-Martins&title=Knock-out+and+transgenic+mouse+models+of+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Knock-out and transgenic mouse models of tauopathies</span></div><div class="casAuthors">Denk, Franziska; Wade-Martins, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Tauopathies, characterized by the dysfunction and aggregation of the microtubule-assocd. protein tau (MAPT), represent some of the most devastating neurodegenerative disorders afflicting the elderly, including Alzheimer's disease and progressive supranuclear palsy.  Here we review the range of Mapt knock-out and MAPT transgenic mouse models which have proven successful at providing insights into the mol. mechanisms of neurodegenerative disease.  In this overview we highlight several themes, including the insights such models provide into the cellular and mol. mechanisms of tauopathy, the direct relationship between neuropathol. and behavior, and the use of mouse models to help provide a platform for testing novel therapies.  Mouse models have helped clarify the relationship between pathol. forms of tau, cell death, and the emergence of disease, as well as the interaction between tau and other disease-assocd. mols., such as the Aβ peptide.  Finally, we discuss potential future MAPT genomic DNA models to investigate the importance of alternative splicing of the MAPT locus and its role in sporadic tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLvPtTI3HK7rVg90H21EOLACvtfcHk0lhFOn4BpaXstg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWmsbzM&md5=b6facdcdd4bb4eca805f5658165c4771</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2007.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2007.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DDenk%26aufirst%3DF.%26aulast%3DWade-Martins%26aufirst%3DR.%26atitle%3DKnock-out%2520and%2520transgenic%2520mouse%2520models%2520of%2520tauopathies%26jtitle%3DNeurobiol.%2520Aging%26date%3D2009%26volume%3D30%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Roberson, E. D.</span><span> </span><span class="NLM_article-title">Mouse models of frontotemporal dementia</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fana.23722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23280835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjs1ygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=837-849&author=E.+D.+Roberson&title=Mouse+models+of+frontotemporal+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse models of frontotemporal dementia</span></div><div class="casAuthors">Roberson, Erik D.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-849</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The pace of discovery in frontotemporal dementia (FTD) has accelerated dramatically with the discovery of new genetic causes and pathol. substrates of the disease.  MAPT/tau, GRN/progranulin, and C9ORF72 have emerged as common FTD genes, and TARDBP/TDP-43, VCP, FUS, and CHMP2B have been identified as less common genetic causes.  TDP-43 and FUS have joined tau as common neuropathol. substrates of the disease.  Mouse models provide an important tool for understanding the role of these mols. in FTD pathogenesis.  Here, we review recent progress with mouse models based on tau, TDP-43, progranulin, VCP, and CHMP2B.  We also consider future prospects for FTD models, including developing new models to address unanswered questions.  There are also opportunities for capitalizing on conservation of the salience network, which is selectively vulnerable in FTD, and the availability of FTD-related behavioral paradigms to analyze mouse models of the disease.  Ann Neurol ANN NEUROL 2012;72:837-849.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6NAkoupeW_rVg90H21EOLACvtfcHk0lhFOn4BpaXstg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjs1ygsw%253D%253D&md5=55b7c71e48dbdfc6a04404d661af802c</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fana.23722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.23722%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26atitle%3DMouse%2520models%2520of%2520frontotemporal%2520dementia%26jtitle%3DAnn.%2520Neurol.%26date%3D2012%26volume%3D72%26spage%3D837%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Peeraer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottelbergs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Kolen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stancu, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasconcelos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duytschaever, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ver Donck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torremans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluydts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Acker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span> </span><span class="NLM_article-title">Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.nbd.2014.08.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25220759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGltL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2015&pages=83-95&author=E.+Peeraerauthor=A.+Bottelbergsauthor=K.+Van+Kolenauthor=I.+C.+Stancuauthor=B.+Vasconcelosauthor=M.+Mahieuauthor=H.+Duytschaeverauthor=L.+Ver+Donckauthor=A.+Torremansauthor=E.+Sluydtsauthor=N.+Van+Ackerauthor=J.+A.+Kempauthor=M.+Merckenauthor=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=I.+Dewachterauthor=V.+M.+Leeauthor=D.+Moechars&title=Intracerebral+injection+of+preformed+synthetic+tau+fibrils+initiates+widespread+tauopathy+and+neuronal+loss+in+the+brains+of+tau+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice</span></div><div class="casAuthors">Peeraer, Eve; Bottelbergs, Astrid; Van Kolen, Kristof; Stancu, Ilie-Cosmin; Vasconcelos, Bruno; Mahieu, Michel; Duytschaever, Hilde; Ver Donck, Luc; Torremans, An; Sluydts, Ellen; Van Acker, Nathalie; Kemp, John A.; Mercken, Marc; Brunden, Kurt R.; Trojanowski, John Q.; Dewachter, Ilse; Lee, Virginia M. Y.; Moechars, Diederik</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-95</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Neurofibrillary tangles composed of hyperphosphorylated fibrillized tau are found in numerous tauopathies including Alzheimer's disease.  Increasing evidence suggests that tau pathol. can be transmitted from cell-to-cell; however the mechanisms involved in the initiation of tau fibrillization and spreading of disease linked to progression of tau pathol. are poorly understood.  We show here that intracerebral injections of preformed synthetic tau fibrils into the hippocampus or frontal cortex of young tau transgenic mice expressing mutant human P301L tau induces tau hyperphosphorylation and aggregation around the site of injection, as well as a time-dependent propagation of tau pathol. to interconnected brain areas distant from the injection site.  Furthermore, we show that the tau pathol. as a consequence of injection of tau preformed fibrils into the hippocampus induces selective loss of CA1 neurons.  Together, our data confirm previous studies on the seeded induction and the spreading of tau pathol. in a different tau transgenic mouse model and reveals neuronal loss assocd. with seeded tau pathol. in tau transgenic mouse brain.  These results further validate the utility of the tau seeding model in studying disease transmission, and provide a more complete in vivo tauopathy model with assocd. neurodegeneration which can be used to investigate the mechanisms involved in tau aggregation and spreading, as well as aid in the search for disease modifying treatments for Alzheimer's disease and related tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKWwdTyPoIEbVg90H21EOLACvtfcHk0lhFOn4BpaXstg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGltL3P&md5=56c876e8ab01a9607d84e5a5c3732b27</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2014.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2014.08.032%26sid%3Dliteratum%253Aachs%26aulast%3DPeeraer%26aufirst%3DE.%26aulast%3DBottelbergs%26aufirst%3DA.%26aulast%3DVan%2BKolen%26aufirst%3DK.%26aulast%3DStancu%26aufirst%3DI.%2BC.%26aulast%3DVasconcelos%26aufirst%3DB.%26aulast%3DMahieu%26aufirst%3DM.%26aulast%3DDuytschaever%26aufirst%3DH.%26aulast%3DVer%2BDonck%26aufirst%3DL.%26aulast%3DTorremans%26aufirst%3DA.%26aulast%3DSluydts%26aufirst%3DE.%26aulast%3DVan%2BAcker%26aufirst%3DN.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DMoechars%26aufirst%3DD.%26atitle%3DIntracerebral%2520injection%2520of%2520preformed%2520synthetic%2520tau%2520fibrils%2520initiates%2520widespread%2520tauopathy%2520and%2520neuronal%2520loss%2520in%2520the%2520brains%2520of%2520tau%2520transgenic%2520mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2015%26volume%3D73%26spage%3D83%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.tips.2009.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=19616318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+radiotracers%3A+crossing+the+blood-brain+barrier+and+surviving+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">431-440</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Radiotracers for imaging protein targets in the living human brain with positron emission tomog. (PET) are increasingly useful in clin. research and in drug development.  Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the d. of a target protein (e.g. neuroreceptor, transporter, enzyme or plaque).  Candidate radiotracers can fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metab.  These issues are reviewed.  Emerging PET radiotracers for measuring efflux transporter function and new strategies for ameliorating radiotracer metab. are discussed.  A growing understanding of the mol. features affecting the brain penetration, metab. and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ftMCpkOSmrVg90H21EOLACvtfcHk0lg0iYGVhEzqhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D&md5=97704995fecd968baf1e0892bf70324e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520radiotracers%253A%2520crossing%2520the%2520blood-brain%2520barrier%2520and%2520surviving%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-375&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+between+radiotracer+properties+and+image+quality+in+molecular+imaging+of+the+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eZ7KSJAn_MsHbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520between%2520radiotracer%2520properties%2520and%2520image%2520quality%2520in%2520molecular%2520imaging%2520of%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hech, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasadny, K.</span><span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Hechauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lhOXyZ0u1JwbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHech%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martarello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comley, R. A.</span><span> </span><span class="NLM_article-title">Radioligand development for molecular imaging of the central nervous system with positron emission tomography</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.drudis.2014.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25173703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1936-1944&author=M.+Honerauthor=L.+Gobbiauthor=L.+Martarelloauthor=R.+A.+Comley&title=Radioligand+development+for+molecular+imaging+of+the+central+nervous+system+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Radioligand development for molecular imaging of the central nervous system with positron emission tomography</span></div><div class="casAuthors">Honer, Michael; Gobbi, Luca; Martarello, Laurent; Comley, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1936-1944</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Positron emission tomog. (PET) is routinely used to support the development of drugs to treat neurol. and psychiatric disorders.  PET radioligands must not only be selective for the target of interest but must also possess a range of physicochem. and pharmacol. characteristics that allow them to be radiolabeled with short-lived positron-emitting isotopes, safely administered to humans, and for the degree of target binding to be quantified in vivo.  We review the ligand development process, including target selection, radioligand discovery (in vitro and preclin. evaluation), radiochem. and evaluation in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOrjEdZ64wLVg90H21EOLACvtfcHk0lhOXyZ0u1JwbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtrbE&md5=9ae3bb3030cdc3a701be1df568190371</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DL.%26aulast%3DMartarello%26aufirst%3DL.%26aulast%3DComley%26aufirst%3DR.%2BA.%26atitle%3DRadioligand%2520development%2520for%2520molecular%2520imaging%2520of%2520the%2520central%2520nervous%2520system%2520with%2520positron%2520emission%2520tomography%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1936%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R.</span><span> </span><span class="NLM_article-title">In vivo site-directed radiotracers: a minireview</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+vivo+site-directed+radiotracers%3A+a+minireview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0ljke4ENAXEA1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520site-directed%2520radiotracers%253A%2520a%2520minireview%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitneni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeurwaerdere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1584-1591&author=S.+Celenauthor=M.+Kooleauthor=M.+De+Angelisauthor=I.+Sannenauthor=S.+K.+Chitneniauthor=J.+Alcazarauthor=S.+Dedeurwaerdereauthor=D.+Moecharsauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andr%C3%A9sauthor=G.+Bormans&title=Preclinical+evaluation+of+18F-JNJ41510417+as+a+radioligand+for+PET+imaging+of+phosphodiesterase-10A+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DChitneni%26aufirst%3DS.%2BK.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ41510417%2520as%2520a%2520radioligand%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase-10A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D1584%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcázar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Synthesis, evaluation and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8685</span><span class="NLM_x">–</span> <span class="NLM_lpage">8699</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300912k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8685-8699&author=J.+I.+Andr%C3%A9sauthor=J.+Alc%C3%A1zarauthor=J.+M.+Cidauthor=M.+De+Angelisauthor=L.+Iturrinoauthor=X.+Langloisauthor=H.+Lavreysenauthor=A.+A.+Trabancoauthor=S.+Celenauthor=G.+Bormans&title=Synthesis%2C+evaluation+and+radiolabeling+of+new+potent+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+as+potential+tracers+for+positron+emission+tomography+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm300912k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300912k%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DJ.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DIturrino%26aufirst%3DL.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520evaluation%2520and%2520radiolabeling%2520of%2520new%2520potent%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520as%2520potential%2520tracers%2520for%2520positron%2520emission%2520tomography%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8685%26epage%3D8699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Clinton, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blurton-Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Ferla, F. M.</span><span> </span><span class="NLM_article-title">Synergistic interactions between Aβ, tau, and α-synuclein: acceleration of neuropathology and cognitive decline</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">7281</span><span class="NLM_x">–</span> <span class="NLM_lpage">7289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1523%2FJNEUROSCI.0490-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20505094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVOisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=7281-7289&author=L.+K.+Clintonauthor=M.+Blurton-Jonesauthor=K.+Myczekauthor=J.+Q.+Trojanowskiauthor=F.+M.+La+Ferla&title=Synergistic+interactions+between+A%CE%B2%2C+tau%2C+and+%CE%B1-synuclein%3A+acceleration+of+neuropathology+and+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic interactions between Aβ, Tau, and α-synuclein: acceleration of neuropathology and cognitive decline</span></div><div class="casAuthors">Clinton, Lani K.; Blurton-Jones, Mathew; Myczek, Kristoffer; Trojanowski, John Q.; La Ferla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7281-7289</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), the most prevalent age-related neurodegenerative disorder, is characterized pathol. by the accumulation of β-amyloid (Aβ) plaques and tau-laden neurofibrillary tangles.  Interestingly, up to 50% of AD cases exhibit a third prevalent neuropathol.: the aggregation of α-synuclein into Lewy bodies.  Importantly, the presence of Lewy body pathol. in AD is assocd. with a more aggressive disease course and accelerated cognitive dysfunction.  Thus, Aβ, tau, and α-synuclein may interact synergistically to promote the accumulation of each other.  In this study, we used a genetic approach to generate a model that exhibits the combined pathologies of AD and dementia with Lewy bodies (DLB).  To achieve this goal, we introduced a mutant human α-synuclein transgene into 3×Tg-AD mice.  As occurs in human disease, transgenic mice that develop both DLB and AD pathologies (DLB-AD mice) exhibit accelerated cognitive decline assocd. with a dramatic enhancement of Aβ, tau, and α-synuclein pathologies.  These findings also provide addnl. evidence that the accumulation of α-synuclein alone can significantly disrupt cognition.  Together,these data support the notion that Aβ, tau, and α-synuclein interact in vivo to promote the aggregation and accumulation of each other and accelerate cognitive dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLHhbVKUf-KbVg90H21EOLACvtfcHk0ljke4ENAXEA1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVOisLw%253D&md5=b3580778e574ff9c53123d02a21f4290</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0490-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0490-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DClinton%26aufirst%3DL.%2BK.%26aulast%3DBlurton-Jones%26aufirst%3DM.%26aulast%3DMyczek%26aufirst%3DK.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLa%2BFerla%26aufirst%3DF.%2BM.%26atitle%3DSynergistic%2520interactions%2520between%2520A%25CE%25B2%252C%2520tau%252C%2520and%2520%25CE%25B1-synuclein%253A%2520acceleration%2520of%2520neuropathology%2520and%2520cognitive%2520decline%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D7281%26epage%3D7289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Irwin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Parkinson’s disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1038%2Fnrn3549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23900411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=626-636&author=D.+J.+Irwinauthor=V.+M.-Y.+Leeauthor=J.+Q.+Trojanowski&title=Parkinson%E2%80%99s+disease+dementia%3A+convergence+of+%CE%B1-synuclein%2C+tau+and+amyloid-%CE%B2+pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies</span></div><div class="casAuthors">Irwin, David J.; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">626-636</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized in cases of Parkinson's disease (PD); such cases are termed PD dementia (PDD).  The spread of fibrillar α-synuclein (α-syn) pathol. from the brainstem to limbic and neocortical structures seems to be the strongest neuropathol. correlate of emerging dementia in PD.  In addn., up to 50% of patients with PDD also develop sufficient nos. of amyloid-β plaques and tau-contg. neurofibrillary tangles for a secondary diagnosis of Alzheimer's disease, and these pathologies may act synergistically with α-syn pathol. to confer a worse prognosis.  An understanding of the relationships between these three distinct pathologies and their resultant clin. phenotypes is crucial for the development of effective disease-modifying treatments for PD and PDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHKxvVpPusLVg90H21EOLACvtfcHk0lgOsXhAOCGPzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7bN&md5=e8de266b3d41136269251f1857ec72db</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fnrn3549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3549%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DD.%2BJ.%26aulast%3DLee%26aufirst%3DV.%2BM.-Y.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520dementia%253A%2520convergence%2520of%2520%25CE%25B1-synuclein%252C%2520tau%2520and%2520amyloid-%25CE%25B2%2520pathologies%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D626%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Wegmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, D. J.</span><span> </span><span class="NLM_article-title">Human tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">27302</span><span class="NLM_x">–</span> <span class="NLM_lpage">27313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=27302-27313&author=S.+Wegmannauthor=Y.-J.+Jungauthor=S.+Chinnathambiauthor=E.-M.+Mandelkowauthor=E.+Mandelkowauthor=D.+J.+Muller&title=Human+tau+isoforms+assemble+into+ribbon-like+fibrils+that+display+polymorphic+structure+and+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWegmann%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DY.-J.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DD.%2BJ.%26atitle%3DHuman%2520tau%2520isoforms%2520assemble%2520into%2520ribbon-like%2520fibrils%2520that%2520display%2520polymorphic%2520structure%2520and%2520stability%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D27302%26epage%3D27313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10857</span><span class="NLM_x">–</span> <span class="NLM_lpage">10862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1523%2FJNEUROSCI.1738-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=16306398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yks77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10857-10862&author=N.+Okamuraauthor=T.+Suemotoauthor=S.+Furumotoauthor=M.+Suzukiauthor=H.+Shimadzuauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Fujiwaraauthor=M.+Nemotoauthor=M.+Maruyamaauthor=H.+Araiauthor=K.+Yanaiauthor=T.+Sawadaauthor=Y.+Kudo&title=Quinoline+and+benzimidazole+derivatives%3A+candidate+probes+for+in+vivo+imaging+of+tau+pathology+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline and benzimidazole derivatives: Candidate probes for in vivo imaging of tau pathology in Alzheimer's disease</span></div><div class="casAuthors">Okamura, Nobuyuki; Suemoto, Takahiro; Furumoto, Shozo; Suzuki, Masako; Shimadzu, Hiroshi; Akatsu, Hiroyasu; Yamamoto, Takayuki; Fujiwara, Hironori; Nemoto, Miyako; Maruyama, Masahiro; Arai, Hiroyuki; Yanai, Kazuhiko; Sawada, Tohru; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">10857-10862</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs), neuropil threads, and neuritic elements of senile plaques predominantly comprise hyperphosphorylated tau protein and represent pathol. characteristics of Alzheimer's disease (AD).  These lesions occur before the presentation of clin. symptoms and correlate with the severity of dementia.  In vivo detection of these lesions would thus prove useful for preclin. diagnosis of AD and for tracking disease progression.  The present study introduces three novel compds., 4-[2-(2-benzoimidazolyl)ethenyl]-N,N-diethylbenzenamine (BF-126), 2-[(4-methylamino)phenyl]quinoline (BF-158), and 2-(4-aminophenyl)quinoline (BF-170), as candidate probes for in vivo imaging of tau pathol. in the AD brain.  When solns. of these compds. are injected i.v. into normal mice, these agents exhibit excellent brain uptake and rapid clearance from normal brain tissue.  These compds. display relatively lower binding affinity to β-amyloid fibrils and higher binding affinity to tau fibrils, compared with previously reported probe BF-168.  In neuropathol. examn. using AD brain sections, BF-126, BF-158, and BF-170 clearly visualize NFTs, neuropil threads, and paired helical filament-type neuritis.  Autoradiog. using 11C-labeled BF-158 further demonstrated labeling of NFTs in AD brain sections.  These findings suggest the potential usefulness of quinoline and benzimidazole derivs. for in vivo imaging of tau pathol. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1dHoJmFJtNLVg90H21EOLACvtfcHk0lgOsXhAOCGPzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yks77K&md5=4b0bc18420a2429789d47bcb91eeb11c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1738-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1738-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DSuemoto%26aufirst%3DT.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DNemoto%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DSawada%26aufirst%3DT.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DQuinoline%2520and%2520benzimidazole%2520derivatives%253A%2520candidate%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10857%26epage%3D10862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Honson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Differentiating Alzheimer disease-associated aggregates with small molecules</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.nbd.2007.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=17761424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGgsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=251-260&author=N.+S.+Honsonauthor=R.+L.+Johnsonauthor=W.+Huangauthor=J.+Ingleseauthor=C.+P.+Austinauthor=J.+Kuret&title=Differentiating+Alzheimer+disease-associated+aggregates+with+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiating Alzheimer disease-associated aggregates with small molecules</span></div><div class="casAuthors">Honson, Nicolette S.; Johnson, Ronald L.; Huang, Wenwei; Inglese, James; Austin, Christopher P.; Kuret, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer disease is diagnosed postmortem by the d. and spatial distribution of β-amyloid plaques and tau-bearing neurofibrillary tangles.  The major protein component of each lesion adopts cross-β-sheet conformation capable of binding small mols. with submicromolar affinity.  In many cases, however, Alzheimer pathol. overlaps with Lewy body disease, characterized by the accumulation of a third cross-β-sheet forming protein, α-synuclein.  To det. the feasibility of distinguishing tau aggregates from β-amyloid and α-synuclein aggregates with small mol. probes, a library contg. 72,455 small mols. was screened for antagonists of tau-aggregate-mediated changes in Thioflavin S fluorescence, followed by secondary screens to distinguish the relative affinity for each substrate protein.  Results showed that > 10-fold binding selectivity among substrates could be achieved, with mols. selective for tau aggregates contg. at least three arom. or rigid moieties connected by two rotatable bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9wia16OfSrVg90H21EOLACvtfcHk0lhGhU3kpQ1ZXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGgsrzO&md5=70434cbb21ca7e4380e06bf5113ee868</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2007.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2007.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DHonson%26aufirst%3DN.%2BS.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DDifferentiating%2520Alzheimer%2520disease-associated%2520aggregates%2520with%2520small%2520molecules%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2007%26volume%3D28%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moric, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Phenyldiazenyl benzothiazole derivatives as probes for in vivo imaging of neurofibrillary tangles in Alzheimer’s disease brains</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1039%2Fc1md00034a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=596-600&author=K.+Matsumuraauthor=M.+Onoauthor=S.+Hayashiauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Moricauthor=H.+Saji&title=Phenyldiazenyl+benzothiazole+derivatives+as+probes+for+in+vivo+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease+brains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1039%2Fc1md00034a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00034a%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMoric%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DPhenyldiazenyl%2520benzothiazole%2520derivatives%2520as%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D596%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-Labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer’s disease brains</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200230e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=58-62&author=K.+Matsumuraauthor=M.+Onoauthor=H.+Kimuraauthor=M.+Uedaauthor=Y.+Nakamotoauthor=K.+Togashiauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=18F-Labeled+phenyldiazenyl+benzothiazole+for+in+vivo+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease+brains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fml200230e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200230e%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DM.%26aulast%3DNakamoto%26aufirst%3DY.%26aulast%3DTogashi%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3D18F-Labeled%2520phenyldiazenyl%2520benzothiazole%2520for%2520in%2520vivo%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D58%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3356</span><span class="NLM_x">–</span> <span class="NLM_lpage">3362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3356-3362&author=K.+Matsumuraauthor=M.+Onoauthor=M.+Yoshimuraauthor=H.+Kimuraauthor=H.+Watanabeauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=Synthesis+and+biological+evaluation+of+novel+styryl+benzimidazole+derivatives+as+probes+for+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520styryl%2520benzimidazole%2520derivatives%2520as%2520probes%2520for%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3356%26epage%3D3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer’s disease brain</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs11307-013-0667-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23868612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=19-27&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=T.+Yoshikawaauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Use+of+a+benzimidazole+derivative+BF-188+in+fluorescence+multispectral+imaging+for+selective+visualization+of+tau+protein+fibrils+in+the+Alzheimer%E2%80%99s+disease+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain</span></div><div class="casAuthors">Harada Ryuichi; Okamura Nobuyuki; Furumoto Shozo; Yoshikawa Takeo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Selective visualization of amyloid-β and tau protein deposits will help to understand the pathophysiology of Alzheimer's disease (AD).  Here, we introduce a novel fluorescent probe that can distinguish between these two deposits by multispectral fluorescence imaging technique.  PROCEDURES:  Fluorescence spectral analysis was performed using AD brain sections stained with novel fluorescence compounds.  Competitive binding assay using [(3)H]-PiB was performed to evaluate the binding affinity of BF-188 for synthetic amyloid-β (Aβ) and tau fibrils.  RESULTS:  In AD brain sections, BF-188 clearly stained Aβ and tau protein deposits with different fluorescence spectra.  In vitro binding assays indicated that BF-188 bound to both amyloid-β and tau fibrils with high affinity (K i  < 10 nM).  In addition, BF-188 showed an excellent blood-brain barrier permeability in mice.  CONCLUSION:  Multispectral imaging with BF-188 could potentially be used for selective in vivo imaging of tau deposits as well as amyloid-β in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkJCOOHC_nB-3MPKNEWB5RfW6udTcc2ean1_eNx6cw0rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitFWhuw%253D%253D&md5=2b4d4aa9b23c8430946fc594d392a108</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1007%2Fs11307-013-0667-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-013-0667-2%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DUse%2520of%2520a%2520benzimidazole%2520derivative%2520BF-188%2520in%2520fluorescence%2520multispectral%2520imaging%2520for%2520selective%2520visualization%2520of%2520tau%2520protein%2520fibrils%2520in%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D19%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Rojo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzate-Morales, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedraa, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccioni, R. B.</span><span> </span><span class="NLM_article-title">Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20110603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Slt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=573-589&author=L.+E.+Rojoauthor=J.+Alzate-Moralesauthor=I.+N.+Saavedraaauthor=P.+Daviesauthor=R.+B.+Maccioni&title=Selective+interaction+of+lansoprazole+and+astemizole+with+tau+polymers%3A+potential+new+clinical+use+in+diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease</span></div><div class="casAuthors">Rojo, Leonel E.; Alzate-Morales, Jans; Saavedra, Ivan N.; Davies, Peter; Maccioni, Ricardo B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-589</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">We describe the interactions of two benzimidazole derivs., astemizole (AST) and lansoprazole (LNS), with anomalous aggregates of tau protein (neurofibrillary tangles).  Interestingly, these compds., with important medical applications in the treatment of allergies and gastrointestinal disorders resp., specifically bind to aggregated variants of tau protein and to paired helical filaments isolated from brains of Alzheimer's disease (AD) patients.  These ligands appear to be a powerful tool to tag brain-isolated tau-aggregates and heparin-induced polymers of recombinant tau.  The interactions of AST and LNS with tau aggregates were assessed by classical radioligand assays, surface plasmon resonance, and bioinformatic approaches.  The affinity of AST and LNS for tau aggregates was comparatively higher than that for amyloid-β polymers according to our data.  This is relevant since senile plaques are also abundant but are not pathognomonic in AD patients.  Immunochem. studies on paired helical filaments from brains of AD patients and surface plasmon resonance studies confirm these findings.  The capacity of these drugs to penetrate the blood-brain barrier was evaluated: (i) in vitro by parallel artificial membrane permeability assay followed by exptl. Log P detns.; and (ii) in vivo by pharmacokinetic studies comparing distribution profiles in blood and brain of mice using HPLC/UV.  Importantly, our studies indicate that the brain/blood concn. ratios for these compds. were suitable for their use as PET radiotracers.  Since neurofibrillary tangles are pos. correlated with cognitive impairment, we concluded that LNS and AST have a great potential in PET neuroimaing for in vivo early detection of AD and in reducing the formation of neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJZHJBdFsZE7Vg90H21EOLACvtfcHk0liChqx4TkhR1w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Slt7s%253D&md5=db44a10a6d6cf5665e71e10537aaf12f</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%26aufirst%3DL.%2BE.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSaavedraa%26aufirst%3DI.%2BN.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520interaction%2520of%2520lansoprazole%2520and%2520astemizole%2520with%2520tau%2520polymers%253A%2520potential%2520new%2520clinical%2520use%2520in%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D19%26spage%3D573%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brichard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F. I.</span><span> </span><span class="NLM_article-title">Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1039%2Fc3md00017f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=852-855&author=P.+J.+Rissauthor=L.+Brichardauthor=V.+Ferrariauthor=D.+J.+Williamsonauthor=T.+D.+Fryerauthor=Y.+T.+Hongauthor=J.-C.+Baronauthor=F.+I.+Aigbirhio&title=Radiosynthesis+and+characterization+of+astemizole+derivatives+as+lead+compounds+toward+PET+imaging+of+%CF%84-pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1039%2Fc3md00017f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00017f%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DBrichard%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DV.%26aulast%3DWilliamson%26aufirst%3DD.%2BJ.%26aulast%3DFryer%26aufirst%3DT.%2BD.%26aulast%3DHong%26aufirst%3DY.%2BT.%26aulast%3DBaron%26aufirst%3DJ.-C.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26atitle%3DRadiosynthesis%2520and%2520characterization%2520of%2520astemizole%2520derivatives%2520as%2520lead%2520compounds%2520toward%2520PET%2520imaging%2520of%2520%25CF%2584-pathology%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D852%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J. H.</span><span> </span><span class="NLM_article-title">Evaluation of [<sup>11</sup>C]N-methyl lansoprazole as a radiopharmaceutical for PET imaging of tau neurofibrillary tangles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300216t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=936-941&author=X.+Shaoauthor=G.+M.+Carpenterauthor=T.+J.+Desmondauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=M.+Fawazauthor=A.+F.+Brooksauthor=M.+R.+Kilbournauthor=R.+L.+Albinauthor=K.+A.+Freyauthor=P.+J.+H.+Scott&title=Evaluation+of+%5B11C%5DN-methyl+lansoprazole+as+a+radiopharmaceutical+for+PET+imaging+of+tau+neurofibrillary+tangles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of [11C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles</span></div><div class="casAuthors">Shao, Xia; Carpenter, Garrett M.; Desmond, Timothy J.; Sherman, Phillip; Quesada, Carole A.; Fawaz, Maria; Brooks, Allen F.; Kilbourn, Michael R.; Albin, Roger L.; Frey, Kirk A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">936-941</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">[11C]N-Me lansoprazole ([11C]NML, 3) was synthesized and evaluated as a radiopharmaceutical for quantifying tau neurofibrillary tangle (NFT) burden using positron emission tomog. (PET) imaging. [11C]NML was synthesized from com. available lansoprazole in 4.6% radiochem. yield (noncorrected RCY, based upon [11C]MeI), 99% radiochem. purity, and 16095 Ci/mmol specific activity (n = 5).  Log P was detd. to be 2.18.  A lack of brain uptake in rodent microPET imaging revealed [11C]NML to be a substrate for the rodent permeability-glycoprotein 1 (PGP) transporter, but this could be overcome by pretreating with cyclosporin A to block the PGP.  Contrastingly, [11C]NML was not found to be a substrate for the primate PGP, and microPET imaging in rhesus revealed [11C]NML uptake in the healthy primate brain of ∼1600 nCi/cc max. at 3 min followed by rapid egress to 500 nCi/cc.  Comparative autoradiog. between wild-type rats and transgenic rats expressing human tau (hTau +/+) revealed 12% higher uptake of [11C]NML in the cortex of brains expressing human tau.  Further autoradiog. with tau pos. brain samples from progressive supranuclear palsy (PSP) patients revealed colocalization of [11C]NML with tau NFTs identified using modified Bielschowsky staining.  Finally, satn. binding expts. with heparin-induced tau confirmed Kd and Bmax values of [11C]NML as 700 pM and 0.214 fmol/μg, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjXJkNjeWv4rVg90H21EOLACvtfcHk0lhrSZ5So8b1vg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr%252FI&md5=a1fd3561aca6b2d9366271582e9bf60f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fml300216t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300216t%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DX.%26aulast%3DCarpenter%26aufirst%3DG.%2BM.%26aulast%3DDesmond%26aufirst%3DT.%2BJ.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DFawaz%26aufirst%3DM.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DAlbin%26aufirst%3DR.%2BL.%26aulast%3DFrey%26aufirst%3DK.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26atitle%3DEvaluation%2520of%2520%255B11C%255DN-methyl%2520lansoprazole%2520as%2520a%2520radiopharmaceutical%2520for%2520PET%2520imaging%2520of%2520tau%2520neurofibrillary%2520tangles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D936%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Fawaz, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodnick, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockley, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J. H.</span><span> </span><span class="NLM_article-title">High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer’s disease and progressive supranuclear palsy: synthesis, pre-clinical evaluation and lead selection</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn500103u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Sqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=718-730&author=M.+V.+Fawazauthor=A.+F.+Brooksauthor=M.+E.+Rodnickauthor=G.+M.+Carpenterauthor=X.+Shaoauthor=T.+J.+Desmondauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=B.+G.+Hockleyauthor=M.+R.+Kilbournauthor=R.+L.+Albinauthor=K.+A.+Freyauthor=P.+J.+H.+Scott&title=High+affinity+radiopharmaceuticals+based+upon+lansoprazole+for+PET+imaging+of+aggregated+tau+in+Alzheimer%E2%80%99s+disease+and+progressive+supranuclear+palsy%3A+synthesis%2C+pre-clinical+evaluation+and+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer's Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection</span></div><div class="casAuthors">Fawaz, Maria V.; Brooks, Allen F.; Rodnick, Melissa E.; Carpenter, Garrett M.; Shao, Xia; Desmond, Timothy J.; Sherman, Phillip; Quesada, Carole A.; Hockley, Brian G.; Kilbourn, Michael R.; Albin, Roger L.; Frey, Kirk A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">718-730</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abnormally aggregated tau is the hallmark pathol. of tauopathy neurodegenerative disorders and is a target for development of both diagnostic tools and therapeutic strategies across the tauopathy disease spectrum.  Development of carbon-11- or fluorine-18-labeled radiotracers with appropriate affinity and specificity for tau would allow noninvasive quantification of tau burden using positron emission tomog. (PET) imaging.  We have synthesized [18F]lansoprazole, [11C]N-Me lansoprazole, and [18F]N-Me lansoprazole and identified them as high affinity radiotracers for tau with low to subnanomolar binding affinities.  Herein, we report radiosyntheses and extensive preclin. evaluation with the aim of selecting a lead radiotracer for translation into human PET imaging trials.  We demonstrate that [18F]N-Me lansoprazole, on account of the favorable half-life of fluorine-18 and its rapid brain entry in nonhuman primates, favorable kinetics, low white matter binding, and selectivity for binding to tau over amyloid, is the lead compd. for progression into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpII8L0rzeJ2LVg90H21EOLACvtfcHk0lifMQvRTrlm6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Sqs7o%253D&md5=2b2c7c0e014296ec6865430167067066</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fcn500103u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500103u%26sid%3Dliteratum%253Aachs%26aulast%3DFawaz%26aufirst%3DM.%2BV.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DRodnick%26aufirst%3DM.%2BE.%26aulast%3DCarpenter%26aufirst%3DG.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DDesmond%26aufirst%3DT.%2BJ.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DHockley%26aufirst%3DB.%2BG.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DAlbin%26aufirst%3DR.%2BL.%26aulast%3DFrey%26aufirst%3DK.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26atitle%3DHigh%2520affinity%2520radiopharmaceuticals%2520based%2520upon%2520lansoprazole%2520for%2520PET%2520imaging%2520of%2520aggregated%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520progressive%2520supranuclear%2520palsy%253A%2520synthesis%252C%2520pre-clinical%2520evaluation%2520and%2520lead%2520selection%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D718%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer’s brains</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200002t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=269-275&author=M.+Onoauthor=S.+Hayashiauthor=K.+Matsumuraauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Moriauthor=H.+Saji&title=Rhodanine+and+thiohydantoin+derivatives+for+detecting+tau+pathology+in+Alzheimer%E2%80%99s+brains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer's Brains</span></div><div class="casAuthors">Ono, Masahiro; Hayashi, Shun; Matsumura, Kenji; Kimura, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Mori, Hiroshi; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of rhodanine (RH) and thiohydantoin (TH) derivs. were designed and synthesized for detecting tau pathol. in the brains of patients with Alzheimer's disease (AD).  In expts. in vitro using tau and β-amyloid (Aβ) aggregates, the TH deriv., TH2, showed high specific binding to tau aggregates.  In hippocampal sections obtained from AD patients, TH2 intensely stained neurofibrillary tangles.  In expts. using normal mice, [125I]TH2 showed good uptake (1.54%ID/g, 2 min postinjection) into and a rapid washout (0.25%ID/g, 60 min postinjection) from the brain. [123I]TH2 should be further investigated as a potential imaging agent for detecting tau pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvU2DzEOu6ubVg90H21EOLACvtfcHk0lifMQvRTrlm6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D&md5=6f4924eaa828e075a59d9ead25ed3c36</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fcn200002t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200002t%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRhodanine%2520and%2520thiohydantoin%2520derivatives%2520for%2520detecting%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520brains%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Saji, H.; Ono, M.; Seki, I.</span><span> </span><span class="NLM_article-title">Radioactive iodine labeled organic compound or salt thereof</span>. International Patent WO2011/108236 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=H.+Saji&author=M.+Ono&author=I.+Seki&title=Radioactive+iodine+labeled+organic+compound+or+salt+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRadioactive%2520iodine%2520labeled%2520organic%2520compound%2520or%2520salt%2520thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Ballatore, C.; Smith, A. B.,  III; Lee, V. M.-Y.; Trojanowski, J. Q.; Brunden, K. R.</span><span> </span><span class="NLM_article-title">Aminothienopyridazines as imaging probes of tau pathology</span>: a patent evaluation of WO2013090497,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Ballatore&author=A.+B.+Smith&author=V.+M.-Y.+Lee&author=J.+Q.+Trojanowski&author=K.+R.+Brunden&title=Aminothienopyridazines+as+imaging+probes+of+tau+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DAminothienopyridazines%2520as%2520imaging%2520probes%2520of%2520tau%2520pathology%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="ref97_2"><span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/ref97_2&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1517%2F13543776.2014.871526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/ref97_2&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24387030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/ref97_2&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisF2gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Expert+Opin.+Ther.+Pat.+2014%2C+24%2C+355%E2%80%93360."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_ref97_2R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Aminothienopyridazines as imaging probes of tau pathology: a patent evaluation of WO2013090497</span></div><div class="casAuthors">Ballatore, Carlo; Smith, Amos B., III; Lee, Virginia M.-Y.; Trojanowski, John Q.; Brunden, Kurt R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-360</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Small-mol. ligands, amenable to positron emission tomog. (PET) imaging of different types of neurodegenerative disease-assocd. amyloid deposits in the CNS of living patients, hold considerable promise for diagnostic purposes, as well as for monitoring disease progression and the effectiveness of treatments.  The patent entitled 'Heterocyclic Compds. as Imaging Probes of Tau Pathol.' (WO2013090497) discloses the identification of a novel class of tau imaging agents, the aminothienopyridazines.  Selected compds. from this class are described that can stain selectively tau pathol. in brain tissue sections.  Moreover, examples of this class of compds. exhibit absorption, distribution, metab., excretion and pharmacokinetics (ADME-PK) properties that are appropriate for CNS PET ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFRrV4O-pbXLVg90H21EOLACvtfcHk0lhB1-RTd_2cdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisF2gsb8%253D&md5=4665c60b9d2534819012a472964cf034</span></div><a href="/servlet/linkout?suffix=ref97_2&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.871526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.871526%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Jones, C.; Glaser, M. E.; Wynn, D.; Nairne, J.; Mokkapati, U. P.; Newington, I. M.; Rangaswamy, C.; Jose, J.; Johansson, S.</span><span> </span><span class="NLM_article-title">Heterocyclic compounds as imaging probes of tau pathology</span>. International Patent WO2013/090497,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Jones&author=M.+E.+Glaser&author=D.+Wynn&author=J.+Nairne&author=U.+P.+Mokkapati&author=I.+M.+Newington&author=C.+Rangaswamy&author=J.+Jose&author=S.+Johansson&title=Heterocyclic+compounds+as+imaging+probes+of+tau+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%26atitle%3DHeterocyclic%2520compounds%2520as%2520imaging%2520probes%2520of%2520tau%2520pathology%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Rhodanine-based tau aggregation inhibitors in cell models of tauopathy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9215</span><span class="NLM_x">–</span> <span class="NLM_lpage">9219</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9215-9219&author=B.+Bulicauthor=M.+Pickhardtauthor=I.+Khlistunovaauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkowauthor=H.+Waldmann&title=Rhodanine-based+tau+aggregation+inhibitors+in+cell+models+of+tauopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DRhodanine-based%2520tau%2520aggregation%2520inhibitors%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D9215%26epage%3D9219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  III.</span><span> </span><span class="NLM_article-title">Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3739</span><span class="NLM_x">–</span> <span class="NLM_lpage">3747</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100138f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3739-3747&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=F.+Piscitelliauthor=M.+J.+Jamesauthor=A.+Croweauthor=Y.+Yaoauthor=E.+Hydeauthor=J.+Q.+Trojanowskiauthor=V.+M.-Y.+Leeauthor=A.+B.+Smith&title=Discovery+of+brain-penetrant%2C+orally+bioavailable+aminothienopyridazine+inhibitors+of+tau+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm100138f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100138f%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DHyde%26aufirst%3DE.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.-Y.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520of%2520brain-penetrant%252C%2520orally%2520bioavailable%2520aminothienopyridazine%2520inhibitors%2520of%2520tau%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3739%26epage%3D3747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span> </span><span class="NLM_article-title">Aminothienopyridazines and methylene blue affect tau fibrillization via cysteine oxidation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">11024</span><span class="NLM_x">–</span> <span class="NLM_lpage">11037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=11024-11037&author=A.+Croweauthor=M.+J.+Jamesauthor=V.+M.-Y.+Leeauthor=A.+B.+Smithauthor=J.+Q.+Trojanowskiauthor=C.+Ballatoreauthor=K.+R.+Brunden&title=Aminothienopyridazines+and+methylene+blue+affect+tau+fibrillization+via+cysteine+oxidation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DV.%2BM.-Y.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26atitle%3DAminothienopyridazines%2520and%2520methylene%2520blue%2520affect%2520tau%2520fibrillization%2520via%2520cysteine%2520oxidation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D11024%26epage%3D11037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Gobbi, L.; Knust, H.; Koblet, A.</span><span> </span><span class="NLM_article-title">Imidazo[2,1]thiazol-3-one derivatives useful as diagnostic agents for Alzheimer’s disease</span>. International Patent WO2014/026881 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Gobbi&author=H.+Knust&author=A.+Koblet&title=Imidazo%5B2%2C1%5Dthiazol-3-one+derivatives+useful+as+diagnostic+agents+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DL.%26atitle%3DImidazo%255B2%252C1%255Dthiazol-3-one%2520derivatives%2520useful%2520as%2520diagnostic%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Taghavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyny-von Hauβen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title"><i>N</i>-Benzylidene-benzohydrazides as novel and selective tau-PHF ligands</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21891864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sls7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=835-843&author=A.+Taghaviauthor=S.+Nasirauthor=M.+Pickhardtauthor=R.+Heyny-von+Hau%CE%B2enauthor=G.+Mallauthor=E.+Mandelkowauthor=E.-M.+Mandelkowauthor=B.+Schmidt&title=N-Benzylidene-benzohydrazides+as+novel+and+selective+tau-PHF+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">N'-Benzylidene-Benzohydrazides as Novel and Selective Tau-PHF Ligands</span></div><div class="casAuthors">Taghavi, Ali; Nasir, Samir; Pickhardt, Marcus; Heyny-von Haussen, Roland; Mall, Gerhard; Mandelkow, Eckhard; Mandelkow, Eva-Maria; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">835-843</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The structure activity relationship of N'-benzylidene-benzohydrazide (NBB) binding to tau and paired helical filament (PHF) proteins as well as amyloid-β1-42 fibrils indicate differential selectivity for these protein aggregates.  The ability of the compds. to stain neurofibrillary tangles and senile plaques isolated from human AD brain was investigated histochem.  These studies resulted in several tau-PHF and amyloid-β1-42 fibril selective ligands resp.  Supported by these results, we rationalized a model for the design of selective ligands for tau, PHF, and amyloid-β1-42 fibrils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmUckFrrYIfbVg90H21EOLACvtfcHk0liFcJyQdqfCqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sls7bF&md5=6a91548633b7d72a0c439f32bcc3af5a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaghavi%26aufirst%3DA.%26aulast%3DNasir%26aufirst%3DS.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DHeyny-von%2BHau%25CE%25B2en%26aufirst%3DR.%26aulast%3DMall%26aufirst%3DG.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DN-Benzylidene-benzohydrazides%2520as%2520novel%2520and%2520selective%2520tau-PHF%2520ligands%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D27%26spage%3D835%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><a href="http://clinicaltrials.gov/ct2/show/record/NCT02187627" class="extLink">http://clinicaltrials.gov/ct2/show/record/NCT02187627</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Frecord%2FNCT02187627."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Altman, M. D.; Fischer, C.; Katz, J. D.; Williams, T. M.; Zhang, X.-F.; Zhou, H.</span><span> </span><span class="NLM_article-title">Isotopically labeled biaryl urea compounds useful as tau tracers</span>. International Patent WO 2013/181075 A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+D.+Altman&author=C.+Fischer&author=J.+D.+Katz&author=T.+M.+Williams&author=X.-F.+Zhang&author=H.+Zhou&title=Isotopically+labeled+biaryl+urea+compounds+useful+as+tau+tracers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DM.%2BD.%26atitle%3DIsotopically%2520labeled%2520biaryl%2520urea%2520compounds%2520useful%2520as%2520tau%2520tracers%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Kemp, S. J.; Storey, L. J.; Storey, J. M. D.; Rickard, J.; Harrington, C. R.; Wischik, C. M.; Clunas, S.; Heinrich, T. K.</span><span> </span><span class="NLM_article-title">Ligands for aggregates tau molecules</span>. International Patent WO 2010/034982 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+J.+Kemp&author=L.+J.+Storey&author=J.+M.+D.+Storey&author=J.+Rickard&author=C.+R.+Harrington&author=C.+M.+Wischik&author=S.+Clunas&author=T.+K.+Heinrich&title=Ligands+for+aggregates+tau+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKemp%26aufirst%3DS.%2BJ.%26atitle%3DLigands%2520for%2520aggregates%2520tau%2520molecules%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Boländer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schön, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hölzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyny-von Haußen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetschy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knust, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils and β-amyloid plaques in Alzheimer’s disease models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9170</span><span class="NLM_x">–</span> <span class="NLM_lpage">9180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300653b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9170-9180&author=A.+Bol%C3%A4nderauthor=D.+Kieserauthor=C.+Vossauthor=S.+Bauerauthor=C.+Sch%C3%B6nauthor=S.+Burgoldauthor=T.+Bittnerauthor=J.+H%C3%B6lzerauthor=R.+Heyny-von+Hau%C3%9Fenauthor=G.+Mallauthor=V.+Goetschyauthor=C.+Czechauthor=H.+Knustauthor=R.+Bergerauthor=J.+Hermsauthor=I.+Hilgerauthor=B.+Schmidt&title=Bis%28arylvinyl%29pyrazines%2C+-pyrimidines%2C+and+-pyridazines+as+imaging+agents+for+tau+fibrils+and+%CE%B2-amyloid+plaques+in+Alzheimer%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm300653b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300653b%26sid%3Dliteratum%253Aachs%26aulast%3DBol%25C3%25A4nder%26aufirst%3DA.%26aulast%3DKieser%26aufirst%3DD.%26aulast%3DVoss%26aufirst%3DC.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DSch%25C3%25B6n%26aufirst%3DC.%26aulast%3DBurgold%26aufirst%3DS.%26aulast%3DBittner%26aufirst%3DT.%26aulast%3DH%25C3%25B6lzer%26aufirst%3DJ.%26aulast%3DHeyny-von%2BHau%25C3%259Fen%26aufirst%3DR.%26aulast%3DMall%26aufirst%3DG.%26aulast%3DGoetschy%26aufirst%3DV.%26aulast%3DCzech%26aufirst%3DC.%26aulast%3DKnust%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DHerms%26aufirst%3DJ.%26aulast%3DHilger%26aufirst%3DI.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DBis%2528arylvinyl%2529pyrazines%252C%2520-pyrimidines%252C%2520and%2520-pyridazines%2520as%2520imaging%2520agents%2520for%2520tau%2520fibrils%2520and%2520%25CE%25B2-amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9170%26epage%3D9180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petric, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G.</span><span> </span><span class="NLM_article-title">PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">S194</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=S194-195&author=J.+R.+Barrioauthor=S.+C.+Huangauthor=G.+Coleauthor=N.+Satyamurthyauthor=A.+Petricauthor=M.+E.+Phelpsauthor=G.+Small&title=PET+imaging+of+tangles+and+plaques+in+Alzheimer+disease+with+a+highly+hydrophobic+probe"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DCole%26aufirst%3DG.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DPetric%26aufirst%3DA.%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26aulast%3DSmall%26aufirst%3DG.%26atitle%3DPET%2520imaging%2520of%2520tangles%2520and%2520plaques%2520in%2520Alzheimer%2520disease%2520with%2520a%2520highly%2520hydrophobic%2520probe%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D1999%26volume%3D42%26spage%3DS194%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Small, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercoli, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bookheimer, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavretsky, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burggren, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">PET of brain amyloid and tau in mild cognitive impairment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2652</span><span class="NLM_x">–</span> <span class="NLM_lpage">2663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1056%2FNEJMoa054625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=17182990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGhtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2652-2663&author=G.+W.+Smallauthor=V.+Kepeauthor=L.+M.+Ercoliauthor=P.+Siddarthauthor=S.+Y.+Bookheimerauthor=K.+J.+Millerauthor=H.+Lavretskyauthor=A.+C.+Burggrenauthor=G.+M.+Coleauthor=H.+V.+Vintersauthor=P.+M.+Thompsonauthor=S.-C.+Huangauthor=N.+Satyamurthyauthor=M.+E.+Phelpsauthor=J.+R.+Barrio&title=PET+of+brain+amyloid+and+tau+in+mild+cognitive+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">PET of brain amyloid and tau in mild cognitive impairment</span></div><div class="casAuthors">Small, Gary W.; Kepe, Vladimir; Ercoli, Linda M.; Siddarth, Prabha; Bookheimer, Susan Y.; Miller, Karen J.; Lavretsky, Helen; Burggren, Alison C.; Cole, Greg M.; Vinters, Harry V.; Thompson, Paul M.; Huang, S.-C.; Satyamurthy, N.; Phelps, Michael E.; Barrio, Jorge R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2652-2663</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Amyloid senile plaques and tau neurofibrillary tangles are neuro-pathol. hallmarks of Alzheimer's disease that accumulate in the cortical regions of the brain in persons with mild cognitive impairment who are at risk for Alzheimer's disease.  Non-invasive methods to detect these abnormal proteins are potentially useful in developing surrogate markers for drug discovery and diagnostics.  We enrolled 83 volunteers with self-reported memory problems who had undergone neurol. and psychiatric evaluation and positron-emission tomog.  (PET).  On the basis of cognitive testing, 25 volunteers were classified as having Alzheimer's disease, 28 as having mild cognitive impairment, and 30 as having no cognitive impairment (healthy controls).  PET was performed after injection of 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile (FDDNP), a mol. that binds to plaques and tangles in vitro.  All subjects also underwent 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET, and 72 underwent magnetic resonance imaging (MRJ).  Global values for FDDNP-PET binding (av. of the values for the temporal, parietal, posterior cingulate, and frontal regions) were lower in the control group than in the group with mild cognitive impairment (P < 0.001), and the values for binding in the group with mild cognitive impairment were lower than in the group with Alzheimer's disease (P < 0.001).  FDDNP-PET binding differentiated among the diagnostic groups better than did metab. on FDG-PET or vol. on MRI.  FDDNP-PET scanning can differentiate persons with mild cognitive impairment from those with Alzheimer's disease and those with no cognitive impairment.  This technique is potentially useful as a non-invasive method to det. regional cerebral patterns of amyloid plaques and tau neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojzz2McPtDX7Vg90H21EOLACvtfcHk0lhMoWDBlr--wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGhtLvL&md5=93cd641aaad5b65d4a93a3b4780aff94</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa054625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa054625%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DG.%2BW.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DErcoli%26aufirst%3DL.%2BM.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DBookheimer%26aufirst%3DS.%2BY.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26aulast%3DLavretsky%26aufirst%3DH.%26aulast%3DBurggren%26aufirst%3DA.%2BC.%26aulast%3DCole%26aufirst%3DG.%2BM.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DThompson%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DS.-C.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DPET%2520of%2520brain%2520amyloid%2520and%2520tau%2520in%2520mild%2520cognitive%2520impairment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2652%26epage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Shin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G. W.</span><span> </span><span class="NLM_article-title">The merits of FDDNP-PET imaging in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21971458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12gs77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=135-145&author=J.+Shinauthor=V.+Kepeauthor=J.+R.+Barrioauthor=G.+W.+Small&title=The+merits+of+FDDNP-PET+imaging+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The Merits of FDDNP-PET Imaging in Alzheimer's Disease</span></div><div class="casAuthors">Ashford, J. Wesson; Rosen, Allyson; Adamson, Maheen; Bayley, Peter; Sabri, Osama; Furst, Ansgar; Black, Sandra E.; Weiner, Michael; Shin, Jonghan; Kepe, Vladimir; Barrio, Jorge R.; Small, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">135-145</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  2-(1-{6-[(2-[Fluorine-18]fluoroethyl)(methyl)amino]-2-naphthyl}-ethylidene)malononitrile (FDDNP) is the first positron emission tomog. (PET) mol. imaging probe to visualize Alzheimer's disease (AD) pathol. in living humans.  The most unique features of FDDNP are that (1) it is the only currently available radiotracer to image neurofibrillary tangles, beside amyloid aggregates, in living humans; and (2) it is also the only radiotracer to visualize AD pathol. in the hippocampal region of living humans.  In this article, we discuss FDDNP's unique ability to image tau pathol. in living humans.  Emphasizing tau pathol. imaging capability using FDDNP in AD, as well as other tauopathies, is timely and beneficial considering that (1) post mortem histopathol. studies using human specimens have consistently demonstrated that neurofibrillary tangles, compared with amyloid plaques, are better correlated with the disease severity and neuronal death; and (2) recently reported clin. trial failures of disease-modifying drugs in development, based on the amyloid-cascade hypothesis, suggest that some of the basic assumptions of AD causality warrant reassessment and redirection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSmfShnsgqf7Vg90H21EOLACvtfcHk0lhMoWDBlr--wA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12gs77J&md5=3f18072cd1d9516c234e493d2fc500ec</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DSmall%26aufirst%3DG.%2BW.%26atitle%3DThe%2520merits%2520of%2520FDDNP-PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D26%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Nelson, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheibel, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G. W.</span><span> </span><span class="NLM_article-title">Positron emission tomography of brain beta-amyloid and tau levels in adults with Down syndrome</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1001%2Farchneurol.2011.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21670401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3Mngt1GlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2011&pages=768-774&author=L.+D.+Nelsonauthor=P.+Siddarthauthor=V.+Kepeauthor=K.+E.+Scheibelauthor=S.-C.+Huangauthor=J.+R.+Barrioauthor=G.+W.+Small&title=Positron+emission+tomography+of+brain+beta-amyloid+and+tau+levels+in+adults+with+Down+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome</span></div><div class="casAuthors">Nelson Linda D; Siddarth Prabha; Kepe Vladimir; Scheibel Kevin E; Huang S C; Barrio Jorge R; Small Gary W</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">768-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To determine the neuropathological load in the living brain of nondemented adults with Down syndrome using positron emission tomography with 2-(1-{6-[(2-fluorine 18-labeled fluoroethyl)methylamino]-2-napthyl}ethylidene) malononitrile ([(18)F]FDDNP) and to assess the influence of age and cognitive and behavioral functioning.  For reference, [(18)F]FDDNP binding values and patterns were compared with those from patients with Alzheimer disease and cognitively intact control participants.  DESIGN:  Cross-sectional clinical study.  PARTICIPANTS:  Volunteer sample of 19 persons with Down syndrome without dementia (mean age, 36.7 years), 10 patients with Alzheimer disease (mean age, 66.5 years), and 10 controls (mean age, 43.8 years).  MAIN OUTCOME MEASURES:  Binding of [(18)F]FDDNP in brain regions of interest, including the parietal, medial temporal, lateral temporal, and frontal lobes and posterior cingulate gyrus, and the average of all regions (global binding).  RESULTS:  The [(18)F]FDDNP binding values were higher in all brain regions in the Down syndrome group than in controls.  Compared with the Alzheimer disease group, the Down syndrome group had higher [(18)F]FDDNP binding values in the parietal and frontal regions, whereas binding levels in other regions were comparable.  Within the Down syndrome group, age correlated with [(18)F]FDDNP binding values in all regions except the posterior cingulate, and several measures of behavioral dysfunction showed positive correlations with global, frontal, parietal, and posterior cingulate [(18)F]FDDNP binding.  CONCLUSIONS:  Consistent with neuropathological findings from postmortem studies, [(18)F]FDDNP positron emission tomography shows high binding levels in Down syndrome comparable to Alzheimer disease and greater levels than in members of a control group.  The positive associations between [(18)F]FDDNP binding levels and age as well as behavioral dysfunction in Down syndrome are consistent with the age-related progression of Alzheimer-type neuropathological findings in this population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpyMGWupRLkU2yPDyEFiigfW6udTcc2eb2RrtKVIcDRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mngt1GlsQ%253D%253D&md5=9a39c4b0f53a98d96c61791010618ae2</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2011.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2011.104%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DL.%2BD.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DScheibel%26aufirst%3DK.%2BE.%26aulast%3DHuang%26aufirst%3DS.-C.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DSmall%26aufirst%3DG.%2BW.%26atitle%3DPositron%2520emission%2520tomography%2520of%2520brain%2520beta-amyloid%2520and%2520tau%2520levels%2520in%2520adults%2520with%2520Down%2520syndrome%26jtitle%3DArch.%2520Neurol.%26date%3D2011%26volume%3D68%26spage%3D768%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Small, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercoli, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donoghue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bookheimer, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omalu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">PET scanning of brain tau in retired National Football League players: preliminary findings</span> <span class="citation_source-journal">Am. J. Geriatr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jagp.2012.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23343487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3szitFOlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=138-44&author=G.+W.+Smallauthor=V.+Kepeauthor=P.+Siddarthauthor=L.+M.+Ercoliauthor=D.+A.+Merrillauthor=N.+Donoghueauthor=S.+Y.+Bookheimerauthor=J.+Martinezauthor=B.+Omaluauthor=J.+Bailesauthor=J.+R.+Barrio&title=PET+scanning+of+brain+tau+in+retired+National+Football+League+players%3A+preliminary+findings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">PET scanning of brain tau in retired national football league players: preliminary findings</span></div><div class="casAuthors">Small Gary W; Kepe Vladimir; Siddarth Prabha; Ercoli Linda M; Merrill David A; Donoghue Natacha; Bookheimer Susan Y; Martinez Jacqueline; Omalu Bennet; Bailes Julian; Barrio Jorge R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">138-44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Mild traumatic brain injury due to contact sports may cause chronic behavioral, mood, and cognitive disturbances associated with pathological deposition of tau protein found at brain autopsy.  To explore whether brain tau deposits can be detected in living retired players, we used positron emission tomography (PET) scans after intravenous injections of 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile (FDDNP).  METHODS:  Five retired National Football League players (age range: 45 to 73 years) with histories of mood and cognitive symptoms received neuropsychiatric evaluations and FDDNP-PET.  PET signals in subcortical (caudate, putamen, thalamus, subthalamus, midbrain, cerebellar white matter) and cortical (amygdala, frontal, parietal, posterior cingulate, medial and lateral temporal) regions were compared with those of five male controls of comparable age, education, and body mass index.  RESULTS:  FDDNP signals were higher in players compared with controls in all subcortical regions and the amygdala, areas that produce tau deposits following trauma.  CONCLUSIONS:  The small sample size and lack of autopsy confirmation warrant larger, more definitive studies, but if future research confirms these initial findings, FDDNP-PET may offer a means for premorbid identification of neurodegeneration in contact-sports athletes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEcx5MNBJNkFm8bhe6roZYfW6udTcc2eb2RrtKVIcDRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szitFOlsg%253D%253D&md5=96ad1e1a1b643a87f63b27710049001b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.jagp.2012.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jagp.2012.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DG.%2BW.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DErcoli%26aufirst%3DL.%2BM.%26aulast%3DMerrill%26aufirst%3DD.%2BA.%26aulast%3DDonoghue%26aufirst%3DN.%26aulast%3DBookheimer%26aufirst%3DS.%2BY.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DOmalu%26aufirst%3DB.%26aulast%3DBailes%26aufirst%3DJ.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DPET%2520scanning%2520of%2520brain%2520tau%2520in%2520retired%2520National%2520Football%2520League%2520players%253A%2520preliminary%2520findings%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2013%26volume%3D21%26spage%3D138%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Thompson, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, A.</span><span> </span><span class="NLM_article-title">Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1111%2Fj.1471-4159.2009.05996.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=19226369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=623-630&author=P.+W.+Thompsonauthor=L.+Yeauthor=J.+L.+Morgensternauthor=L.+Sueauthor=T.+G.+Beachauthor=D.+J.+Juddauthor=N.+J.+Shipleyauthor=V.+Libriauthor=A.+Lockhart&title=Interaction+of+the+amyloid+imaging+tracer+FDDNP+with+hallmark+Alzheimer%E2%80%99s+disease+pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies</span></div><div class="casAuthors">Thompson, Paul W.; Ye, Liang; Morgenstern, Jennifer L.; Sue, Lucia; Beach, Thomas G.; Judd, Duncan J.; Shipley, Nicholas J.; Libri, Vincenzo; Lockhart, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">623-630</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The distinctive cortical uptake of the tracer 18F-FDDNP, 2-(1-{6-[2-fluoroethyl(methyl)amino]-2-naphthyl}(ethylidene)malononitrile), in Alzheimer's disease (AD) is believed to be because of its binding to both neurofibrillary tangles (NFTs) and highly fibrillar senile plaques.  We therefore investigated the binding of a tracer concn. of 3H-FDDNP to brain sections contg. AD hallmark pathologies.  Semi-adjacent sections were labeled with 3H-PIB (Pittsburgh compd.-B, 2-[4'-(methylamino)phenyl]-6-hydroxybenzothiazole) and 14C-SB13 (4-N-methylamino-4'-hydroxystilbene) for comparison.  Neocortical sections contg. widespread senile plaques and cerebrovascular amyloid angiopathy, produced a sparse and weak labeling following incubation with 3H-FDDNP.  Furthermore, in sections contg. NFTs, there was no over labeling of the pathol. by 3H-FDDNP.  In contrast, sections labeled with 3H-PIB displayed extensive labeling of diffuse plaques, classical plaques, cerebrovascular amyloid angiopathy and NFTs.  14C-SB13 produced a broadly similar binding pattern to PIB.  Radioligand binding assays employing in vitro generated amyloid-β peptide fibrils demonstrated a ∼10-fold reduced affinity for 3H-FDDNP (85.0 ± 2.0 nM) compared with 3H-PIB (8.5 ± 1.3 nM).  These data provide an alternative mechanistic explanation for the obsd. low cortical uptake of 18F-FDDNP in AD; in that the ligand is only weakly retained by the hallmark neuropathol. because of its low affinity for amyloid structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTa4J3oN2sHLVg90H21EOLACvtfcHk0lhFalR6YAZ57g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKnsro%253D&md5=30e1e565523c4fbc102c8dc51ee47c27</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.05996.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.05996.x%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DP.%2BW.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DMorgenstern%26aufirst%3DJ.%2BL.%26aulast%3DSue%26aufirst%3DL.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26aulast%3DJudd%26aufirst%3DD.%2BJ.%26aulast%3DShipley%26aufirst%3DN.%2BJ.%26aulast%3DLibri%26aufirst%3DV.%26aulast%3DLockhart%26aufirst%3DA.%26atitle%3DInteraction%2520of%2520the%2520amyloid%2520imaging%2520tracer%2520FDDNP%2520with%2520hallmark%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathologies%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D109%26spage%3D623%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartwright, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adlard, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnham, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-THK-523: a novel in vivo tau imaging ligand for Alzheimer’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2011&pages=1089-1100&author=M.+T.+Fodero-Tavolettiauthor=N.+Okamuraauthor=S.+Furumotoauthor=R.+S.+Mulliganauthor=A.+R.+Connorauthor=C.+A.+McLeanauthor=D.+Caoauthor=A.+Rigopoulosauthor=G.+A.+Cartwrightauthor=G.+O%E2%80%99Keefeauthor=S.+Gongauthor=P.+A.+Adlardauthor=K.+J.+Barnhamauthor=C.+C.+Roweauthor=C.+L.+Mastersauthor=Y.+Kudoauthor=R.+Cappaiauthor=K.+Yanaiauthor=V.+L.+Villemagne&title=18F-THK-523%3A+a+novel+in+vivo+tau+imaging+ligand+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DConnor%26aufirst%3DA.%2BR.%26aulast%3DMcLean%26aufirst%3DC.%2BA.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DRigopoulos%26aufirst%3DA.%26aulast%3DCartwright%26aufirst%3DG.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DG.%26aulast%3DGong%26aufirst%3DS.%26aulast%3DAdlard%26aufirst%3DP.%2BA.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DCappai%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3D18F-THK-523%253A%2520a%2520novel%2520in%2520vivo%2520tau%2520imaging%2520ligand%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2011%26volume%3D134%26spage%3D1089%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumuto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Novel <sup>18</sup>F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1420-1427&author=N.+Okamuraauthor=S.+Furumutoauthor=R.+Haradaauthor=T.+Tagoauthor=T.+Yoshikawaauthor=M.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=V.+L.+Villemagneauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Araiauthor=R.+Iwataauthor=K.+Yanaiauthor=Y.+Kudo&title=Novel+18F-labeled+arylquinoline+derivatives+for+noninvasive+imaging+of+tau+pathology+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumuto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DNovel%252018F-labeled%2520arylquinoline%2520derivatives%2520for%2520noninvasive%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1420%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doré, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs00259-013-2681-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24514874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitleht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=816-826&author=V.+L.+Villemagneauthor=S.+Furumotoauthor=M.+T.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=J.+Hodgesauthor=R.+Haradaauthor=P.+Yatesauthor=O.+Piguetauthor=S.+Pejoskaauthor=V.+Dor%C3%A9author=K.+Yanaiauthor=C.+L.+Mastersauthor=Y.+Kudoauthor=C.+C.+Roweauthor=N.+Okamura&title=In+vivo+evaluation+of+a+novel+tau+imaging+tracer+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease</span></div><div class="casAuthors">Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle T.; Mulligan, Rachel S.; Hodges, John; Harada, Ryuichi; Yates, Paul; Piguet, Olivier; Pejoska, Svetlana; Dore, Vincent; Yanai, Kazuhiko; Masters, Colin L.; Kudo, Yukitsuka; Rowe, Christopher C.; Okamura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Diagnosis of tauopathies such as Alzheimer's disease (AD) still relies on post-mortem examn. of the human brain.  A non-invasive method of detg. brain tau burden in vivo would allow a better understanding of the pathophysiol. of tauopathies.  The purpose of the study was to evaluate 18F-THK523 as a potential tau imaging tracer.  Methods: Ten healthy elderly controls, three semantic dementia (SD) and ten AD patients underwent neuropsychol. examn., MRI as well as 18F-THK523 and 11C-Pittsburgh compd. B (PIB) positron emission tomog. (PET) scans.  Composite memory and non-memory scores, global and hippocampal brain vol., and partial vol.-cor. tissue ratios for 18F-THK523 and 11C-PIB were estd. for all participants.  Correlational analyses were performed between global and regional 18F-THK523, 11C-PIB, cognition and brain volumetrics.  Results: 18F-THK523 presented with fast reversible kinetics.  Significantly higher 18F-THK523 retention was obsd. in the temporal, parietal, orbitofrontal and hippocampi of AD patients when compared to healthy controls and SD patients.  White matter retention was significantly higher than gray matter retention in all participants.  The pattern of cortical 18F-THK523 retention did not correlate with Aβ distribution as assessed by 11C-PIB and followed the known distribution of tau in the AD brain, being higher in temporal and parietal areas than in the frontal region.  Unlike 11C-PIB, hippocampal 18F-THK523 retention was correlated with several cognitive parameters and with hippocampal atrophy.  Conclusion: 18F-THK523 does not bind to Aβ in vivo, while following the known distribution of paired helical filaments (PHF)-tau in the brain.  Significantly higher cortical 18F-THK523 retention in AD patients as well as the assocn. of hippocampal 18F-THK523 retention with cognitive parameters and hippocampal vol. suggests 18F-THK523 selectively binds to tau in AD patients.  Unfortunately, the very high 18F-THK523 retention in white matter precludes simple visual inspection of the images, preventing its use in research or clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkefkNuzPCr7Vg90H21EOLACvtfcHk0lhsTB-7KFAdMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitleht7k%253D&md5=d995c47f394f706c5164913e7024f1fa</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1007%2Fs00259-013-2681-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-013-2681-7%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DHodges%26aufirst%3DJ.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DPiguet%26aufirst%3DO.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DDor%25C3%25A9%26aufirst%3DV.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520evaluation%2520of%2520a%2520novel%2520tau%2520imaging%2520tracer%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D816%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using <sup>18</sup>F-THK5105 PET</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1762</span><span class="NLM_x">–</span> <span class="NLM_lpage">1771</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=1762-1771&author=N.+Okamuraauthor=S.+Furumotoauthor=M.+T.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=R.+Haradaauthor=P.+Yatesauthor=S.+Pejoskaauthor=Y.+Kudoauthor=C.+L.+Mastersauthor=K.+Yanaiauthor=C.+C.+Roweauthor=V.+L.+Villemagne&title=Non-invasive+assessment+of+Alzheimer%E2%80%99s+disease+neurofibrillary+pathology+using+18F-THK5105+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DNon-invasive%2520assessment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurofibrillary%2520pathology%2520using%252018F-THK5105%2520PET%26jtitle%3DBrain%26date%3D2014%26volume%3D137%26spage%3D1762%26epage%3D1771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Bakhti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, M.</span><span> </span><span class="NLM_article-title">Myelin architecture: zippering membranes tightly together</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs00018-013-1492-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24165921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ykt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=1265-1277&author=M.+Bakhtiauthor=S.+Aggarwalauthor=M.+Simons&title=Myelin+architecture%3A+zippering+membranes+tightly+together"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Myelin architecture: zippering membranes tightly together</span></div><div class="casAuthors">Bakhti, Mostafa; Aggarwal, Shweta; Simons, Mikael</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1265-1277</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Rapid nerve conduction requires the coating of axons by a tightly packed multilayered myelin membrane.  In the central nervous system, myelin is formed from cellular processes that extend from oligodendrocytes and wrap in a spiral fashion around an axon, resulting in the close apposition of adjacent myelin membrane bilayers.  In this review, we discuss the phys. principles underlying the zippering of the plasma membrane of oligodendrocytes at the cytoplasmic and extracellular leaflet.  We propose that the interaction of the myelin basic protein with the cytoplasmic leaflet of the myelin bilayer triggers its polymn. into a fibrous network that drives membrane zippering and protein extrusion.  In contrast, the adhesion of the extracellular surfaces of myelin requires the down-regulation of repulsive components of the glycocalyx, in order to uncover weak and unspecific attractive forces that bring the extracellular surfaces into close contact.  Unveiling the mechanisms of myelin membrane assembly at the cytoplasmic and extracelluar sites may help to understand how the myelin bilayers are disrupted and destabilized in the different demyelinating diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGqmVlPlYIEbVg90H21EOLACvtfcHk0lgzOLtH-kXkGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ykt7fP&md5=d31524fc46f20d335cc086b4007bd904</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs00018-013-1492-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-013-1492-0%26sid%3Dliteratum%253Aachs%26aulast%3DBakhti%26aufirst%3DM.%26aulast%3DAggarwal%26aufirst%3DS.%26aulast%3DSimons%26aufirst%3DM.%26atitle%3DMyelin%2520architecture%253A%2520zippering%2520membranes%2520tightly%2520together%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2014%26volume%3D71%26spage%3D1265%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fjlcr.3133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24448742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ekt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=18-24&author=T.+Tagoauthor=S.+Furumotoauthor=N.+Okamuraauthor=R.+Haradaauthor=Y.+Ishikawaauthor=H.+Araiauthor=K.+Yanaiauthor=R.+Iwataauthor=Y.+Kudo&title=Synthesis+and+preliminary+evaluation+of+2-arylhydroxyquinoline+derivatives+for+tau+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging</span></div><div class="casAuthors">Tago, Tetsuro; Furumoto, Shozo; Okamura, Nobuyuki; Harada, Ryuichi; Ishikawa, Yoichi; Arai, Hiroyuki; Yanai, Kazuhiko; Iwata, Ren; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-24</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common cause of dementia.  Senile plaques, consisting of β-amyloid, and neurofibrillary tangles (NFTs), composed of tau protein, are representative pathol. hallmarks of AD.  It is believed that the accumulation of NFTs precedes the onset of clin. symptoms of AD and correlates with the progression of memory dysfunction.  Thus, the use of noninvasive detection techniques including radiolabeled probes and positron emission tomog. (PET) will facilitate early diagnosis or staging of AD.  In this study, we synthesized and evaluated novel hydroxylated 2-arylquinoline derivs. as tau imaging PET probes.  The binding affinities of compds. for tau were evaluated by fluorescent staining of the AD hippocampal section and a competitive binding assay using [18F]THK-523.  THK-951 (I) showed high binding affinity for tau pathol. in an AD brain section and K18Δ280K fibrils (Ki = 20.7 nM); thus, we radiosynthesized a 11C-labeled THK-951 and further studied its potential as a tau PET probe.  The [11C]THK-951 demonstrated excellent kinetics in a normal mouse brain (3.23% ID/g at 2 min postinjection and 0.15% ID/g at 30 min postinjection) and showed the labeling of NFTs in an AD brain section by autoradiog. assay.  These findings indicate the availability of [11C]THK-951 for in vivo PET imaging of tau pathol. in AD.  Copyright © 2013 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUoQriEvLubVg90H21EOLACvtfcHk0lgzOLtH-kXkGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ekt77K&md5=c0f8921a35e3787bfeea01994952014c</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3133%26sid%3Dliteratum%253Aachs%26aulast%3DTago%26aufirst%3DT.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520preliminary%2520evaluation%2520of%25202-arylhydroxyquinoline%2520derivatives%2520for%2520tau%2520imaging%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2014%26volume%3D57%26spage%3D18%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Characterization of 18F-THK-5351, a novel PET tracer for imaging tau pathology in Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">S260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=S260&author=N.+Okamuraauthor=S.+Furumotoauthor=R.+Haradaauthor=T.+Tagoauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Furukawaauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Characterization+of+18F-THK-5351%2C+a+novel+PET+tracer+for+imaging+tau+pathology+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DCharacterization%2520of%252018F-THK-5351%252C%2520a%2520novel%2520PET%2520tracer%2520for%2520imaging%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3DS260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">Imaging of tau pathology in mouse model and in Alzheimer patients compared to normal controls</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2013&pages=1-15&author=M.+Maruyamaauthor=H.+Shimadaauthor=T.+Suharaauthor=H.+Shinotohauthor=B.+Jiauthor=J.+Maedaauthor=M.-R.+Zhangauthor=J.+Q.+Trojanowskiauthor=V.+M.-Y.+Leeauthor=M.+Onoauthor=K.+Masamotoauthor=H.+Takanoauthor=N.+Saharaauthor=N.+Iwataauthor=N.+Okamuraauthor=S.+Furumotoauthor=Y.+Kudoauthor=Q.+Changauthor=T.+C.+Saidoauthor=A.+Takashimaauthor=J.+Lewisauthor=M.-K.+Jangauthor=I.+Aokiauthor=H.+Itoauthor=M.+Higuchi&title=Imaging+of+tau+pathology+in+mouse+model+and+in+Alzheimer+patients+compared+to+normal+controls"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.-Y.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DMasamoto%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DM.-K.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DImaging%2520of%2520tau%2520pathology%2520in%2520mouse%2520model%2520and%2520in%2520Alzheimer%2520patients%2520compared%2520to%2520normal%2520controls%26jtitle%3DNeuron%26date%3D2013%26volume%3D79%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Hashimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujishiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furutsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span> </span><span class="NLM_article-title">Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of <sup>11</sup>C-PBB3 as a clinically useful PET probe for imaging of tau pathology</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1532-1538&author=H.+Hashimotoauthor=K.+Kawamuraauthor=N.+Igarashiauthor=M.+Takeiauthor=T.+Fujishiroauthor=Y.+Aiharaauthor=S.+Shiomiauthor=M.+Mutoauthor=T.+Itoauthor=K.+Furutsukaauthor=T.+Yamasakiauthor=J.+Yuiauthor=L.+Xieauthor=M.+Onoauthor=A.+Hatoriauthor=K.+Nemotoauthor=T.+Suharaauthor=M.+Higuchiauthor=M.-R.+Zhang&title=Radiosynthesis%2C+photoisomerization%2C+biodistribution%2C+and+metabolite+analysis+of+11C-PBB3+as+a+clinically+useful+PET+probe+for+imaging+of+tau+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DN.%26aulast%3DTakei%26aufirst%3DM.%26aulast%3DFujishiro%26aufirst%3DT.%26aulast%3DAihara%26aufirst%3DY.%26aulast%3DShiomi%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DFurutsuka%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DNemoto%26aufirst%3DK.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.-R.%26atitle%3DRadiosynthesis%252C%2520photoisomerization%252C%2520biodistribution%252C%2520and%2520metabolite%2520analysis%2520of%252011C-PBB3%2520as%2520a%2520clinically%2520useful%2520PET%2520probe%2520for%2520imaging%2520of%2520tau%2520pathology%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1532%26epage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Lei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. H.</span><span> </span><span class="NLM_article-title">Landscapes of four-enantiomer conical intersections for photoisomerization of stilbene: CASSCF calculation</span> <span class="citation_source-journal">J. Phys. Chem. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">9021</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp5020109" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOjt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2014&pages=9021-903&author=Y.+Leiauthor=L.+Yuauthor=B.+Zhouauthor=C.+Zhuauthor=Z.+Wenauthor=S.+H.+Lin&title=Landscapes+of+four-enantiomer+conical+intersections+for+photoisomerization+of+stilbene%3A+CASSCF+calculation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Landscapes of Four-Enantiomer Conical Intersections for Photoisomerization of Stilbene: CASSCF Calculation</span></div><div class="casAuthors">Lei, Yibo; Yu, Le; Zhou, Bo; Zhu, Chaoyuan; Wen, Zhenyi; Lin, Sheng Hsien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9021-9031</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The photoisomerization of cis- and trans-stilbene through conical intersections (CI) is mainly governed by four dihedral angles around central C=C double bonds.  The two of them are C-C=C-C and H-C=C-H dihedral angles that are found to form a mirror rotation coordinate, and the mirror plane appears at the two dihedral angles equal to zeros with which the middle state is defined through partial optimization.  There exist the first-type of hula-twist-CI enantiomers, the second-type of hula-twist-CI enantiomers, the first-type of one-bond-flip-CI enantiomers, and the second type of one-bond-flip-CI enantiomers as well as cis-enantiomers and trans-enantiomers with respect to this mirror plane.  The complete active space SCF method is employed to calc. min. potential energy profile along the mirror rotation coordinate for each enantiomers, and it is found that the left-hand manifold and the right-hand manifold of potential energy surfaces can be energetically transferred via photoisomerization.  Furthermore, two-dimensional potential energy surfaces in terms of the branching plane g-h coordinates are constructed at vicinity of each conical intersection, and the landscapes of conical intersections show distinct feature, and in excited-state four potential wells sepd. in different section of g-h plane related to different conical intersections which indicate different photoisomerization pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqiZ-bTti1MbVg90H21EOLACvtfcHk0lhtaLrHWZ8jHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOjt7vM&md5=384c7477e3011ed14a4313abb88e6439</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjp5020109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp5020109%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DS.%2BH.%26atitle%3DLandscapes%2520of%2520four-enantiomer%2520conical%2520intersections%2520for%2520photoisomerization%2520of%2520stilbene%253A%2520CASSCF%2520calculation%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2014%26volume%3D118%26spage%3D9021%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Waldeck, D. H.</span><span> </span><span class="NLM_article-title">Photoisomerization dynamics of stilbene</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00003a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1991&pages=415-436&author=D.+H.+Waldeck&title=Photoisomerization+dynamics+of+stilbene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fcr00003a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00003a007%26sid%3Dliteratum%253Aachs%26aulast%3DWaldeck%26aufirst%3DD.%2BH.%26atitle%3DPhotoisomerization%2520dynamics%2520of%2520stilbene%26jtitle%3DChem.%2520Rev.%26date%3D1991%26volume%3D91%26spage%3D415%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Szardenings, A. K.; Kolb, H. C.; Walsh, J. C.; Chen, G.; Gangadharmath, U. B.; Kasi, D.; Liu, C.; Sinha, A.; Wang, E.; Yu, C.; Zhang, W.; Chen, K.; Mocharla, V. P.; Scott, P. J. H.</span><span> </span><span class="NLM_article-title">Imaging agents for detecting neurological dysfunction</span>. International Patent US 2012/0302755 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+K.+Szardenings&author=H.+C.+Kolb&author=J.+C.+Walsh&author=G.+Chen&author=U.+B.+Gangadharmath&author=D.+Kasi&author=C.+Liu&author=A.+Sinha&author=E.+Wang&author=C.+Yu&author=W.+Zhang&author=K.+Chen&author=V.+P.+Mocharla&author=P.+J.+H.+Scott&title=Imaging+agents+for+detecting+neurological+dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26atitle%3DImaging%2520agents%2520for%2520detecting%2520neurological%2520dysfunction%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Cashion, D. K.; Cheng, G.; Kasi, D.; Kolb, H. C.</span><span> </span><span class="NLM_article-title">Imaging agents for detecting neurological disorders</span>. International Patent WO 2011/119565 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+K.+Cashion&author=G.+Cheng&author=D.+Kasi&author=H.+C.+Kolb&title=Imaging+agents+for+detecting+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCashion%26aufirst%3DD.%2BK.%26atitle%3DImaging%2520agents%2520for%2520detecting%2520neurological%2520disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashion, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">A highly selective and specific PET tracer for imaging of tau pathologies</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.3233%2FJAD-2012-120712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=22683529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GhurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=601-612&author=W.+Zhangauthor=J.+Arteagaauthor=D.+K.+Cashionauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=A.+K.+Szardeningsauthor=E.+Wangauthor=J.+C.+Walshauthor=C.+Xiaauthor=C.+Yuauthor=T.+Zhaoauthor=H.+C.+Kolb&title=A+highly+selective+and+specific+PET+tracer+for+imaging+of+tau+pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies</span></div><div class="casAuthors">Zhang, Wei; Arteaga, Janna; Cashion, Daniel K.; Chen, Gang; Gangadharmath, Umesh; Gomez, Luis F.; Kasi, Dhanalakshmi; Lam, Chung; Liang, Qianwa; Liu, Changhui; Mocharla, Vani P.; Mu, Fanrong; Sinha, Anjana; Szardenings, A. Katrin; Wang, Eric; Walsh, Joseph C.; Xia, Chunfang; Yu, Chul; Zhao, Tieming; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-612</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Senile plaques and neurofibrillary tangles are prominent neuropathol. hallmarks in Alzheimer's disease and are considered to be targets for therapeutic intervention as well as biomarkers for diagnostic in vivo imaging agents.  While there are a no. of amyloid-β positron emission tomog. (PET) tracers currently in different stages of clin. development and commercialization, there have been very few reports on imaging agents selectively targeting tau aggregates.  In search of [18F]-PET tracers that possess great binding affinity and selectivity toward tau tangles, we tested more than 900 compds. utilizing a unique screening process.  A competitive autoradiog. assay was set up to test compds. for binding to native tau tangles and amyloid-β plaques on human brain tissue sections.  In our in vitro assays, the 18F labeled compd. [18F]-T808 displayed a high level of binding affinity and good selectivity for tau aggregates over amyloid-β plaques. [18F]-T808 showed rapid uptake and washout in rodent brains.  Our in vitro and preclin. in vivo studies suggest that [18F]-T808 possesses suitable properties and characteristics to be a specific and selective PET probe for imaging of paired helical filament tau in human brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCPcTCD2ucRLVg90H21EOLACvtfcHk0lgH21Ai5L35KA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GhurbI&md5=f9b40fa67928e2cbaa876fbaef62ff70</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120712%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DCashion%26aufirst%3DD.%2BK.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DA%2520highly%2520selective%2520and%2520specific%2520PET%2520tracer%2520for%2520imaging%2520of%2520tau%2520pathologies%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D31%26spage%3D601%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Xia, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.-F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B18F%5DT807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2ebEEXH4-EOlBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.-F.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B18F%255DT807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Radde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolmont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaeser, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coomaraswamy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltze, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calhoun, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeggi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolburg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gengler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span> </span><span class="NLM_article-title">Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">940</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=940-946&author=R.+Raddeauthor=T.+Bolmontauthor=S.+A.+Kaeserauthor=J.+Coomaraswamyauthor=D.+Lindauauthor=L.+Stoltzeauthor=M.+E.+Calhounauthor=F.+Jaeggiauthor=H.+Wolburgauthor=S.+Genglerauthor=C.+Haassauthor=B.+Ghettiauthor=C.+Czechauthor=C.+Hoelscherauthor=P.+M.+Mathewsauthor=M.+Jucker&title=A%CE%B242-driven+cerebral+amyloidosis+in+transgenic+mice+reveals+early+and+robust+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRadde%26aufirst%3DR.%26aulast%3DBolmont%26aufirst%3DT.%26aulast%3DKaeser%26aufirst%3DS.%2BA.%26aulast%3DCoomaraswamy%26aufirst%3DJ.%26aulast%3DLindau%26aufirst%3DD.%26aulast%3DStoltze%26aufirst%3DL.%26aulast%3DCalhoun%26aufirst%3DM.%2BE.%26aulast%3DJaeggi%26aufirst%3DF.%26aulast%3DWolburg%26aufirst%3DH.%26aulast%3DGengler%26aufirst%3DS.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DCzech%26aufirst%3DC.%26aulast%3DHoelscher%26aufirst%3DC.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DA%25CE%25B242-driven%2520cerebral%2520amyloidosis%2520in%2520transgenic%2520mice%2520reveals%2520early%2520and%2520robust%2520pathology%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26spage%3D940%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23234879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=457-468&author=D.+T.+Chienauthor=S.+Bahriauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=F.+Muauthor=M.-Y.+Suauthor=W.+R.+Shankleauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF-18%5D-T807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807</span></div><div class="casAuthors">Chien, David T.; Bahri, Shadfar; Szardenings, A. Katrin; Walsh, Joseph C.; Mu, Fanrong; Su, Min-Ying; Shankle, William R.; Elizarov, Arkadij; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-468</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have developed a novel PHF-tau targeting positron emission tomog. imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies.  Here in, we describe the first human brain images with [F-18]-T807.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofLFkBPeoi47Vg90H21EOLACvtfcHk0lhA0xoyamuJKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D&md5=578173de3104c8e470381f0812ce6356</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF-18%255D-T807%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D457%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shcherbinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Exploratory analyses of regional human brain distribution of the PET tau tracer F18-labeled T807 (AV-1541) in subjects with normal cognitive function or cognitive impairment thought to be due to AD</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">P842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P842&author=M.+Mintunauthor=A.+Schwarzauthor=A.+Joshiauthor=S.+Shcherbininauthor=D.+Chienauthor=A.+Elizarovauthor=M.-Y.+Suauthor=W.+Shankleauthor=M.+Pontecorvoauthor=J.+Tauscherauthor=D.+Skovronskyauthor=H.+C.+Kolb&title=Exploratory+analyses+of+regional+human+brain+distribution+of+the+PET+tau+tracer+F18-labeled+T807+%28AV-1541%29+in+subjects+with+normal+cognitive+function+or+cognitive+impairment+thought+to+be+due+to+AD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DShcherbinin%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DD.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%26aulast%3DPontecorvo%26aufirst%3DM.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DSkovronsky%26aufirst%3DD.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DExploratory%2520analyses%2520of%2520regional%2520human%2520brain%2520distribution%2520of%2520the%2520PET%2520tau%2520tracer%2520F18-labeled%2520T807%2520%2528AV-1541%2529%2520in%2520subjects%2520with%2520normal%2520cognitive%2520function%2520or%2520cognitive%2520impairment%2520thought%2520to%2520be%2520due%2520to%2520AD%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3DP842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Kolb, H. C.</span> Human amyloid imaging conference,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">, </span><a href="http://www.alzforum.org/news/conference-coverage/hai-spotlight-tau-tracers-human-amyloid-imaging-meeting" class="extLink">www.alzforum.org/news/conference-coverage/hai-spotlight-tau-tracers-human-amyloid-imaging-meeting</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kolb%2C+H.+C.+Human+amyloid+imaging+conference%2C+2013%2C+www.alzforum.org%2Fnews%2Fconference-coverage%2Fhai-spotlight-tau-tracers-human-amyloid-imaging-meeting."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23948934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=171-184&author=D.+T.+Chienauthor=A.+Katrinauthor=S.+Bahriauthor=J.+C.+Walshauthor=F.+Muauthor=C.+Xiaauthor=W.+R.+Shankleauthor=A.+J.+Lernerauthor=M.-Y.+Suauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF18%5D-T808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span></div><div class="casAuthors">Chien David T; Szardenings A Katrin; Bahri Shadfar; Walsh Joseph C; Mu Fanrong; Xia Chunfang; Shankle William R; Lerner Alan J; Su Min-Ying; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.  Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies.  Here, we describe the first human brain images with [F18]-T808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLqxQ2mb9Pu8fW6udTcc2eYGD8WIi7K7Orntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D&md5=757aaefcfe18524fdd4404c0cb351850</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DKatrin%26aufirst%3DA.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DLerner%26aufirst%3DA.%2BJ.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF18%255D-T808%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D171%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span> </span><span class="NLM_article-title">First case report: image to autopsy correlation for tau imaging with [18F]-T808 (AV-680)</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">P844</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P844-845&author=H.+C.+Kolbauthor=G.+Attardoauthor=M.+Mintunauthor=D.+Chienauthor=A.+Elizarovauthor=P.+Contiauthor=C.+Millerauthor=A.+Joshiauthor=D.+Skovronsky&title=First+case+report%3A+image+to+autopsy+correlation+for+tau+imaging+with+%5B18F%5D-T808+%28AV-680%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DChien%26aufirst%3DD.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DConti%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DSkovronsky%26aufirst%3DD.%26atitle%3DFirst%2520case%2520report%253A%2520image%2520to%2520autopsy%2520correlation%2520for%2520tau%2520imaging%2520with%2520%255B18F%255D-T808%2520%2528AV-680%2529%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3DP844%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Landau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laganowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Towards a pharmacophore for amyloid</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1001080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1371%2Fjournal.pbio.1001080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21695112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=e1001080&author=M.+Landauauthor=M.+R.+Sawayaauthor=K.+F.+Faullauthor=A.+Laganowskyauthor=L.+Jiangauthor=S.+A.+Sieversauthor=J.+Liuauthor=J.+R.+Barrioauthor=D.+Eisenberg&title=Towards+a+pharmacophore+for+amyloid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a pharmacophore for amyloid</span></div><div class="casAuthors">Landau, Meytal; Sawaya, Michael R.; Faull, Kym F.; Laganowsky, Arthur; Jiang, Lin; Sievers, Stuart A.; Liu, Jie; Barrio, Jorge R.; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1001080</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Diagnosing and treating Alzheimer's and other diseases assocd. with amyloid fibers remains a great challenge despite intensive research.  To aid in this effort, we present at. structures of fiber-forming segments of proteins involved in Alzheimer's disease in complex with small mol. binders, detd. by X-ray microcrystallog.  The fiber-like complexes consist of pairs of β-sheets, with small mols. binding between the sheets, roughly parallel to the fiber axis.  The structures suggest that apolar mols. drift along the fiber, consistent with the observation of nonspecific binding to a variety of amyloid proteins.  In contrast, neg. charged orange-G binds specifically to lysine side chains of adjacent sheets.  These structures provide mol. frameworks for the design of diagnostics and drugs for protein aggregation diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHJDf_wPbESrVg90H21EOLACvtfcHk0lisVhGY0CbkwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D&md5=6fedd1729b59ee89733ea5f127fc0b1d</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1001080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1001080%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DFaull%26aufirst%3DK.%2BF.%26aulast%3DLaganowsky%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DTowards%2520a%2520pharmacophore%2520for%2520amyloid%26jtitle%3DPLoS%2520Biol.%26date%3D2011%26volume%3D9%26spage%3De1001080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97','ref97_2'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 68 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ahmed A. Elbatrawy, Seung Jae Hyeon, Nan Yue, Essam Eldin A. Osman, Seung Hyeo Choi, Sungsu Lim, Yun Kyung Kim, Hoon Ryu, Mengchao Cui, <span class="NLM_string-name hlFld-ContribAuthor">Ghilsoo Nam</span>. </span><span class="cited-content_cbyCitation_article-title">“Turn-On” Quinoline-Based Fluorescent Probe for Selective Imaging of Tau Aggregates in Alzheimer’s Disease: Rational Design, Synthesis, and Molecular Docking. </span><span class="cited-content_cbyCitation_journal-name">ACS Sensors</span><span> <strong>2021,</strong> <em>6 </em>
                                    (6)
                                     , 2281-2289. <a href="https://doi.org/10.1021/acssensors.1c00338" title="DOI URL">https://doi.org/10.1021/acssensors.1c00338</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssensors.1c00338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssensors.1c00338%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sensors%26atitle%3D%2525E2%252580%25259CTurn-On%2525E2%252580%25259D%252BQuinoline-Based%252BFluorescent%252BProbe%252Bfor%252BSelective%252BImaging%252Bof%252BTau%252BAggregates%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BRational%252BDesign%25252C%252BSynthesis%25252C%252Band%252BMolecular%252BDocking%26aulast%3DElbatrawy%26aufirst%3DAhmed%2BA.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D28052021%26date%3D11062021%26volume%3D6%26issue%3D6%26spage%3D2281%26epage%3D2289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vinayak Juvekar, Hyo Won Lee, <span class="NLM_string-name hlFld-ContribAuthor">Hwan Myung Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Two-Photon Fluorescent Probes for Detecting Enzyme Activities in Live Tissues. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Bio Materials</span><span> <strong>2021,</strong> <em>4 </em>
                                    (4)
                                     , 2957-2973. <a href="https://doi.org/10.1021/acsabm.1c00063" title="DOI URL">https://doi.org/10.1021/acsabm.1c00063</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsabm.1c00063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsabm.1c00063%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Bio%2520Materials%26atitle%3DTwo-Photon%252BFluorescent%252BProbes%252Bfor%252BDetecting%252BEnzyme%252BActivities%252Bin%252BLive%252BTissues%26aulast%3DJuvekar%26aufirst%3DVinayak%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D18012021%26date%3D01032021%26date%3D11032021%26volume%3D4%26issue%3D4%26spage%3D2957%26epage%3D2973" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kaixiang Zhou, Fan Yang, Yuying Li, Yimin Chen, Xiaojun Zhang, Jinming Zhang, Junfeng Wang, Jiapei Dai, Lisheng Cai, <span class="NLM_string-name hlFld-ContribAuthor">Mengchao Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of Fluorine-18 Labeled 2-Phenylquinoxaline Derivatives as Potential Tau Imaging Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmaceutics</span><span> <strong>2021,</strong> <em>18 </em>
                                    (3)
                                     , 1176-1195. <a href="https://doi.org/10.1021/acs.molpharmaceut.0c01078" title="DOI URL">https://doi.org/10.1021/acs.molpharmaceut.0c01078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.molpharmaceut.0c01078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.molpharmaceut.0c01078%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmaceutics%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252BFluorine-18%252BLabeled%252B2-Phenylquinoxaline%252BDerivatives%252Bas%252BPotential%252BTau%252BImaging%252BAgents%26aulast%3DZhou%26aufirst%3DKaixiang%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D01112020%26date%3D28122020%26date%3D27122020%26date%3D21012021%26volume%3D18%26issue%3D3%26spage%3D1176%26epage%3D1195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Longfei Zhang, Xin Gong, Chuan Tian, Hualong Fu, Hongwei Tan, Jiapei Dai, <span class="NLM_string-name hlFld-ContribAuthor">Mengchao Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Near-Infrared Fluorescent Probes with Rotatable Polyacetylene Chains for the Detection of Amyloid-β Plaques. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2021,</strong> <em>125 </em>
                                    (2)
                                     , 497-506. <a href="https://doi.org/10.1021/acs.jpcb.0c08845" title="DOI URL">https://doi.org/10.1021/acs.jpcb.0c08845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.0c08845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.0c08845%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DNear-Infrared%252BFluorescent%252BProbes%252Bwith%252BRotatable%252BPolyacetylene%252BChains%252Bfor%252Bthe%252BDetection%252Bof%252BAmyloid-%2525CE%2525B2%252BPlaques%26aulast%3DZhang%26aufirst%3DLongfei%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D2020%26date%3D29092020%26date%3D16122020%26date%3D08012021%26volume%3D125%26issue%3D2%26spage%3D497%26epage%3D506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Longbin Liu, Michael E. Prime, Matt R. Lee, Vinod Khetarpal, Christopher J. Brown, Peter D. Johnson, Patricia Miranda-Azpiazu, Xuemei Chen, Daniel Clark-Frew, Samuel Coe, Randall Davis, Anthony Dickie, Andreas Ebneth, Simone Esposito, Elise Gadouleau, Xinjie Gai, Sebastien Galan, Samantha Green, Catherine Greenaway, Paul Giles, Christer Halldin, Sarah Hayes, Todd Herbst, Frank Herrmann, Manuela Heßmann, Zhisheng Jia, Alexander Kiselyov, Adrian Kotey, Thomas Krulle, John E. Mangette, Richard W. Marston, Sergio Menta, Matthew R. Mills, Edith Monteagudo, Sangram Nag, Martina Nibbio, Laura Orsatti, Sabine Schaertl, Christoph Scheich, Joanne Sproston, Vladimir Stepanov, Marie Svedberg, Akihiro Takano, Malcolm Taylor, Wayne Thomas, Miklós Toth, Darshan Vaidya, Katarina Vanräs, Derek Weddell, Ian Wigginton, John Wityak, Ladislav Mrzljak, Ignacio Munoz-Sanjuan, Jonathan A. Bard, <span class="NLM_string-name hlFld-ContribAuthor">Celia Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging Mutant Huntingtin Aggregates: Development of a Potential PET Ligand. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8608-8633. <a href="https://doi.org/10.1021/acs.jmedchem.0c00955" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00955</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00955&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00955%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DImaging%252BMutant%252BHuntingtin%252BAggregates%25253A%252BDevelopment%252Bof%252Ba%252BPotential%252BPET%252BLigand%26aulast%3DLiu%26aufirst%3DLongbin%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D11062020%26date%3D30072020%26date%3D14072020%26volume%3D63%26issue%3D15%26spage%3D8608%26epage%3D8633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Frederik J. R. Rombouts, Lieven Declercq, José-Ignacio Andrés, Astrid Bottelbergs, Lu Chen, Laura Iturrino, Joseph E. Leenaerts, Jonas Mariën, Fengbin Song, Cindy Wintmolders, Stijn Wuyts, Chunfang A. Xia, Paula te Riele, Guy Bormans, Rik Vandenberghe, Hartmuth Kolb, <span class="NLM_string-name hlFld-ContribAuthor">Diederik Moechars</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(4-[18F]Fluoro-5-methylpyridin-2-yl)isoquinolin-6-amine (JNJ-64326067), a New Promising Tau Positron Emission Tomography Imaging Tracer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (6)
                                     , 2974-2987. <a href="https://doi.org/10.1021/acs.jmedchem.8b01759" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01759</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01759%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%2525284-%25255B18F%25255DFluoro-5-methylpyridin-2-yl%252529isoquinolin-6-amine%252B%252528JNJ-64326067%252529%25252C%252Ba%252BNew%252BPromising%252BTau%252BPositron%252BEmission%252BTomography%252BImaging%252BTracer%26aulast%3DRombouts%26aufirst%3DFrederik%2BJ.%2BR.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D12112018%26date%3D19032019%26date%3D27022019%26volume%3D62%26issue%3D6%26spage%3D2974%26epage%3D2987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Verwilst</span>, <span class="hlFld-ContribAuthor ">Hye-Ri  Kim</span>, <span class="hlFld-ContribAuthor ">Jinho  Seo</span>, <span class="hlFld-ContribAuthor ">Nak-Won  Sohn</span>, <span class="hlFld-ContribAuthor ">Seung-Yun  Cha</span>, <span class="hlFld-ContribAuthor ">Yeongmin  Kim</span>, <span class="hlFld-ContribAuthor ">Sungho  Maeng</span>, <span class="hlFld-ContribAuthor ">Jung-Won  Shin</span>, <span class="hlFld-ContribAuthor ">Jong Hwan  Kwak</span>, <span class="hlFld-ContribAuthor ">Chulhun  Kang</span>, and <span class="hlFld-ContribAuthor ">Jong Seung  Kim</span>  . </span><span class="cited-content_cbyCitation_article-title">Rational Design of in Vivo Tau Tangle-Selective Near-Infrared Fluorophores: Expanding the BODIPY Universe. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2017,</strong> <em>139 </em>
                                    (38)
                                     , 13393-13403. <a href="https://doi.org/10.1021/jacs.7b05878" title="DOI URL">https://doi.org/10.1021/jacs.7b05878</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.7b05878&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.7b05878%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DRational%252BDesign%252Bof%252Bin%252BVivo%252BTau%252BTangle-Selective%252BNear-Infrared%252BFluorophores%25253A%252BExpanding%252Bthe%252BBODIPY%252BUniverse%26aulast%3DVerwilst%26aufirst%3DPeter%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D07062017%26date%3D15092017%26date%3D27092017%26date%3D31082017%26volume%3D139%26issue%3D38%26spage%3D13393%26epage%3D13403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca C.  Gobbi</span>, <span class="hlFld-ContribAuthor ">Henner  Knust</span>, <span class="hlFld-ContribAuthor ">Matthias  Körner</span>, <span class="hlFld-ContribAuthor ">Michael  Honer</span>, <span class="hlFld-ContribAuthor ">Christian  Czech</span>, <span class="hlFld-ContribAuthor ">Sara  Belli</span>, <span class="hlFld-ContribAuthor ">Dieter  Muri</span>, <span class="hlFld-ContribAuthor ">Martin R.  Edelmann</span>, <span class="hlFld-ContribAuthor ">Thomas  Hartung</span>, <span class="hlFld-ContribAuthor ">Isabella  Erbsmehl</span>, <span class="hlFld-ContribAuthor ">Sandra  Grall-Ulsemer</span>, <span class="hlFld-ContribAuthor ">Andreas  Koblet</span>, <span class="hlFld-ContribAuthor ">Marianne  Rueher</span>, <span class="hlFld-ContribAuthor ">Sandra  Steiner</span>, <span class="hlFld-ContribAuthor ">Hayden T.  Ravert</span>, <span class="hlFld-ContribAuthor ">William B.  Mathews</span>, <span class="hlFld-ContribAuthor ">Daniel P.  Holt</span>, <span class="hlFld-ContribAuthor ">Hiroto  Kuwabara</span>, <span class="hlFld-ContribAuthor ">Heather  Valentine</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Dean F.  Wong</span>, and <span class="hlFld-ContribAuthor ">Edilio  Borroni</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Three Novel Radiotracers for Imaging Aggregated Tau in Alzheimer’s Disease with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (17)
                                     , 7350-7370. <a href="https://doi.org/10.1021/acs.jmedchem.7b00632" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00632%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BThree%252BNovel%252BRadiotracers%252Bfor%252BImaging%252BAggregated%252BTau%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DGobbi%26aufirst%3DLuca%2BC.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D27042017%26date%3D12072017%26date%3D14092017%26date%3D27062017%26volume%3D60%26issue%3D17%26spage%3D7350%26epage%3D7370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik J. R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">José-Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Manuela  Ariza</span>, <span class="hlFld-ContribAuthor ">José Manuel  Alonso</span>, <span class="hlFld-ContribAuthor ">Nigel  Austin</span>, <span class="hlFld-ContribAuthor ">Astrid  Bottelbergs</span>, <span class="hlFld-ContribAuthor ">Lu  Chen</span>, <span class="hlFld-ContribAuthor ">Vladimir  Chupakhin</span>, <span class="hlFld-ContribAuthor ">Erna  Cleiren</span>, <span class="hlFld-ContribAuthor ">Katleen  Fierens</span>, <span class="hlFld-ContribAuthor ">Alberto  Fontana</span>, <span class="hlFld-ContribAuthor ">Xavier  Langlois</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Leenaerts</span>, <span class="hlFld-ContribAuthor ">Jonas  Mariën</span>, <span class="hlFld-ContribAuthor ">Carolina  Martínez Lamenca</span>, <span class="hlFld-ContribAuthor ">Rhys  Salter</span>, <span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Paula  Te Riele</span>, <span class="hlFld-ContribAuthor ">Cindy  Wintmolders</span>, <span class="hlFld-ContribAuthor ">Andrés A.  Trabanco</span>, <span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Gregor  Macdonald</span>, and <span class="hlFld-ContribAuthor ">Dieder  Moechars</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of N-(Pyridin-4-yl)-1,5-naphthyridin-2-amines as Potential Tau Pathology PET Tracers for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (4)
                                     , 1272-1291. <a href="https://doi.org/10.1021/acs.jmedchem.6b01173" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01173</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01173%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BN-%252528Pyridin-4-yl%252529-1%25252C5-naphthyridin-2-amines%252Bas%252BPotential%252BTau%252BPathology%252BPET%252BTracers%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DRombouts%26aufirst%3DFrederik%2BJ.%2BR.%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D12082016%26date%3D10022017%26date%3D23022017%26date%3D20012017%26volume%3D60%26issue%3D4%26spage%3D1272%26epage%3D1291" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujin  Seo</span>, <span class="hlFld-ContribAuthor ">Kwang-su  Park</span>, <span class="hlFld-ContribAuthor ">Taewoong  Ha</span>, <span class="hlFld-ContribAuthor ">Mi Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Yu Jin  Hwang</span>, <span class="hlFld-ContribAuthor ">Junghee  Lee</span>, <span class="hlFld-ContribAuthor ">Hoon  Ryu</span>, <span class="hlFld-ContribAuthor ">Hyunah  Choo</span>, and <span class="hlFld-ContribAuthor ">Youhoon  Chong</span>  . </span><span class="cited-content_cbyCitation_article-title">A Smart Near-Infrared Fluorescence Probe for Selective Detection of Tau Fibrils in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (11)
                                     , 1474-1481. <a href="https://doi.org/10.1021/acschemneuro.6b00174" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00174%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DA%252BSmart%252BNear-Infrared%252BFluorescence%252BProbe%252Bfor%252BSelective%252BDetection%252Bof%252BTau%252BFibrils%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DSeo%26aufirst%3DYujin%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D19062016%26date%3D30082016%26date%3D01092016%26date%3D16112016%26date%3D30082016%26volume%3D7%26issue%3D11%26spage%3D1474%26epage%3D1481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Annachiara  Gandini</span>, <span class="hlFld-ContribAuthor ">Federica  Prati</span>, and <span class="hlFld-ContribAuthor ">Elisa  Uliassi</span>  . </span><span class="cited-content_cbyCitation_article-title">From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer’s Disease?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 7759-7770. <a href="https://doi.org/10.1021/acs.jmedchem.6b00151" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00151%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BCompanion%252BDiagnostics%252Bto%252BTheranostics%25253A%252BA%252BNew%252BAvenue%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253F%26aulast%3DBolognesi%26aufirst%3DMaria%2BLaura%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D29012016%26date%3D06052016%26date%3D08092016%26date%3D28042016%26volume%3D59%26issue%3D17%26spage%3D7759%26epage%3D7770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abbas M.  Walji</span>, <span class="hlFld-ContribAuthor ">Eric D.  Hostetler</span>, <span class="hlFld-ContribAuthor ">Harold  Selnick</span>, <span class="hlFld-ContribAuthor ">Zhizhen  Zeng</span>, <span class="hlFld-ContribAuthor ">Patricia  Miller</span>, <span class="hlFld-ContribAuthor ">Idriss  Bennacef</span>, <span class="hlFld-ContribAuthor ">Cristian  Salinas</span>, <span class="hlFld-ContribAuthor ">Brett  Connolly</span>, <span class="hlFld-ContribAuthor ">Liza  Gantert</span>, <span class="hlFld-ContribAuthor ">Marie  Holahan</span>, <span class="hlFld-ContribAuthor ">Stacey  O’Malley</span>, <span class="hlFld-ContribAuthor ">Mona  Purcell</span>, <span class="hlFld-ContribAuthor ">Kerry  Riffel</span>, <span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Jaume  Balsells</span>, <span class="hlFld-ContribAuthor ">Julie A.  OBrien</span>, <span class="hlFld-ContribAuthor ">Stacey  Melquist</span>, <span class="hlFld-ContribAuthor ">Aileen  Soriano</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhang</span>, <span class="hlFld-ContribAuthor ">Aimie  Ogawa</span>, <span class="hlFld-ContribAuthor ">Serena  Xu</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Joshi</span>, <span class="hlFld-ContribAuthor ">Joseph  Della Rocca</span>, <span class="hlFld-ContribAuthor ">Fred J.  Hess</span>, <span class="hlFld-ContribAuthor ">Joel  Schachter</span>, <span class="hlFld-ContribAuthor ">David  Hesk</span>, <span class="hlFld-ContribAuthor ">David  Schenk</span>, <span class="hlFld-ContribAuthor ">Arie  Struyk</span>, <span class="hlFld-ContribAuthor ">Kerim  Babaoglu</span>, <span class="hlFld-ContribAuthor ">Talakad G.  Lohith</span>, <span class="hlFld-ContribAuthor ">Yaode  Wang</span>, <span class="hlFld-ContribAuthor ">Kun  Yang</span>, <span class="hlFld-ContribAuthor ">Jianmin  Fu</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Evelhoch</span>, and <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 6-(Fluoro-18F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([18F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4778-4789. <a href="https://doi.org/10.1021/acs.jmedchem.6b00166" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00166</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00166%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B6-%252528Fluoro-18F%252529-3-%2525281H-pyrrolo%25255B2%25252C3-c%25255Dpyridin-1-yl%252529isoquinolin-5-amine%252B%252528%25255B18F%25255D-MK-6240%252529%25253A%252BA%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%252BAgent%252Bfor%252BQuantification%252Bof%252BNeurofibrillary%252BTangles%252B%252528NFTs%252529%26aulast%3DWalji%26aufirst%3DAbbas%2BM.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01022016%26date%3D05052016%26date%3D26052016%26date%3D18042016%26volume%3D59%26issue%3D10%26spage%3D4778%26epage%3D4789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian P.  Cary</span>, <span class="hlFld-ContribAuthor ">Allen F.  Brooks</span>, <span class="hlFld-ContribAuthor ">Maria V.  Fawaz</span>, <span class="hlFld-ContribAuthor ">Lindsey R.  Drake</span>, <span class="hlFld-ContribAuthor ">Timothy J.  Desmond</span>, <span class="hlFld-ContribAuthor ">Phillip  Sherman</span>, <span class="hlFld-ContribAuthor ">Carole A.  Quesada</span>, and <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Evaluation of [18F]RAGER: A First Generation Small-Molecule PET Radioligand Targeting the Receptor for Advanced Glycation Endproducts. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (3)
                                     , 391-398. <a href="https://doi.org/10.1021/acschemneuro.5b00319" title="DOI URL">https://doi.org/10.1021/acschemneuro.5b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.5b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.5b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DSynthesis%252Band%252BEvaluation%252Bof%252B%25255B18F%25255DRAGER%25253A%252BA%252BFirst%252BGeneration%252BSmall-Molecule%252BPET%252BRadioligand%252BTargeting%252Bthe%252BReceptor%252Bfor%252BAdvanced%252BGlycation%252BEndproducts%26aulast%3DCary%26aufirst%3DBrian%2BP.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D04122015%26date%3D15012016%26date%3D01022016%26date%3D16032016%26date%3D15012016%26volume%3D7%26issue%3D3%26spage%3D391%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenhua  Chu</span>, <span class="hlFld-ContribAuthor ">Dong  Zhou</span>, <span class="hlFld-ContribAuthor ">Vrinda  Gaba</span>, <span class="hlFld-ContribAuthor ">Jialu  Liu</span>, <span class="hlFld-ContribAuthor ">Shihong  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Peng</span>, <span class="hlFld-ContribAuthor ">Jinbin  Xu</span>, <span class="hlFld-ContribAuthor ">Dhruva  Dhavale</span>, <span class="hlFld-ContribAuthor ">Devika P.  Bagchi</span>, <span class="hlFld-ContribAuthor ">André  d’Avignon</span>, <span class="hlFld-ContribAuthor ">Naomi B.  Shakerdge</span>, <span class="hlFld-ContribAuthor ">Brian J.  Bacskai</span>, <span class="hlFld-ContribAuthor ">Zhude  Tu</span>, <span class="hlFld-ContribAuthor ">Paul T.  Kotzbauer</span>, and <span class="hlFld-ContribAuthor ">Robert H.  Mach</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Characterization of 3-(Benzylidene)indolin-2-one Derivatives as Ligands for α-Synuclein Fibrils. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (15)
                                     , 6002-6017. <a href="https://doi.org/10.1021/acs.jmedchem.5b00571" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00571</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00571&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00571%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BCharacterization%252Bof%252B3-%252528Benzylidene%252529indolin-2-one%252BDerivatives%252Bas%252BLigands%252Bfor%252B%2525CE%2525B1-Synuclein%252BFibrils%26aulast%3DChu%26aufirst%3DWenhua%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D20042015%26date%3D31072015%26date%3D13082015%26date%3D15072015%26volume%3D58%26issue%3D15%26spage%3D6002%26epage%3D6017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Parul  Mittal</span>, <span class="hlFld-ContribAuthor ">Niharika  Singh</span>, <span class="hlFld-ContribAuthor ">Shubhra  Chaturvedi</span>, <span class="hlFld-ContribAuthor ">Amar  Jyoti</span>, <span class="hlFld-ContribAuthor ">Anil K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Puja Panwar  Hazari</span>. </span><span class="cited-content_cbyCitation_article-title">Comprehensive review on design perspective of PET ligands based on β-amyloids, tau and neuroinflammation for diagnostic intervention of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Imaging</span><span> <strong>2021,</strong> <em>9 </em>
                                    (2)
                                     , 153-175. <a href="https://doi.org/10.1007/s40336-021-00410-7" title="DOI URL">https://doi.org/10.1007/s40336-021-00410-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40336-021-00410-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40336-021-00410-7%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Imaging%26atitle%3DComprehensive%252Breview%252Bon%252Bdesign%252Bperspective%252Bof%252BPET%252Bligands%252Bbased%252Bon%252B%2525CE%2525B2-amyloids%25252C%252Btau%252Band%252Bneuroinflammation%252Bfor%252Bdiagnostic%252Bintervention%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DMittal%26aufirst%3DParul%26date%3D2021%26date%3D2021%26volume%3D9%26issue%3D2%26spage%3D153%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun  Toyohara</span>, <span class="hlFld-ContribAuthor ">Kosuke  Nishino</span>, <span class="hlFld-ContribAuthor ">Masanari  Sakai</span>, <span class="hlFld-ContribAuthor ">Tetsuro  Tago</span>, <span class="hlFld-ContribAuthor ">Takashi  Oda</span>. </span><span class="cited-content_cbyCitation_article-title">Automated production of [18F]MK-6240 on CFN-MPS200. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2021,</strong> <em>168 </em>, 109468. <a href="https://doi.org/10.1016/j.apradiso.2020.109468" title="DOI URL">https://doi.org/10.1016/j.apradiso.2020.109468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2020.109468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2020.109468%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DAutomated%252Bproduction%252Bof%252B%25255B18F%25255DMK-6240%252Bon%252BCFN-MPS200%26aulast%3DToyohara%26aufirst%3DJun%26date%3D2021%26volume%3D168%26spage%3D109468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Luc  Janssens</span>, <span class="hlFld-ContribAuthor ">Diederik  Moechars</span>, <span class="hlFld-ContribAuthor ">Frederik J. R.  Rombouts</span>, <span class="hlFld-ContribAuthor ">Maarten  Timmers</span>, <span class="hlFld-ContribAuthor ">Olivier  Barret</span>, <span class="hlFld-ContribAuthor ">Cristian C.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Jennifer  Madonia</span>, <span class="hlFld-ContribAuthor ">David S.  Russell</span>, <span class="hlFld-ContribAuthor ">Christine M.  Sandiego</span>, <span class="hlFld-ContribAuthor ">Hartmuth  Kolb</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical evaluation of [18F] JNJ-64326067, a novel candidate PET tracer for the detection of tau pathology in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2020,</strong> <em>47 </em>
                                    (13)
                                     , 3176-3185. <a href="https://doi.org/10.1007/s00259-020-04880-1" title="DOI URL">https://doi.org/10.1007/s00259-020-04880-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-020-04880-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-020-04880-1%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DClinical%252Bevaluation%252Bof%252B%25255B18F%25255D%252BJNJ-64326067%25252C%252Ba%252Bnovel%252Bcandidate%252BPET%252Btracer%252Bfor%252Bthe%252Bdetection%252Bof%252Btau%252Bpathology%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSchmidt%26aufirst%3DMark%2BE.%26date%3D2020%26date%3D2020%26volume%3D47%26issue%3D13%26spage%3D3176%26epage%3D3185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emanuele  Gabellieri</span>, <span class="hlFld-ContribAuthor ">Francesca  Capotosti</span>, <span class="hlFld-ContribAuthor ">Jerome  Molette</span>, <span class="hlFld-ContribAuthor ">Nampally  Sreenivasachary</span>, <span class="hlFld-ContribAuthor ">Andre  Mueller</span>, <span class="hlFld-ContribAuthor ">Mathias  Berndt</span>, <span class="hlFld-ContribAuthor ">Hanno  Schieferstein</span>, <span class="hlFld-ContribAuthor ">Tanja  Juergens</span>, <span class="hlFld-ContribAuthor ">Yvan  Varisco</span>, <span class="hlFld-ContribAuthor ">Felix  Oden</span>, <span class="hlFld-ContribAuthor ">Heribert  Schmitt-Willich</span>, <span class="hlFld-ContribAuthor ">David  Hickman</span>, <span class="hlFld-ContribAuthor ">Ludger  Dinkelborg</span>, <span class="hlFld-ContribAuthor ">Andrew  Stephens</span>, <span class="hlFld-ContribAuthor ">Andrea  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Heiko  Kroth</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c’]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer’s disease and other tauopathies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>204 </em>, 112615. <a href="https://doi.org/10.1016/j.ejmech.2020.112615" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112615%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B2-%2525284-%2525282-fluoroethoxy%252529piperidin-1-yl%252529-9-methyl-9H-pyrrolo%25255B2%25252C3-b%25253A4%25252C5-c%2525E2%252580%252599%25255Ddipyridine%252B%252528%25255B18F%25255DPI-2014%252529%252Bas%252BPET%252Btracer%252Bfor%252Bthe%252Bdetection%252Bof%252Bpathological%252Baggregated%252Btau%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bother%252Btauopathies%26aulast%3DGabellieri%26aufirst%3DEmanuele%26date%3D2020%26volume%3D204%26spage%3D112615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa  McSweeney</span>, <span class="hlFld-ContribAuthor ">Alexa  Pichet Binette</span>, <span class="hlFld-ContribAuthor ">Pierre-François  Meyer</span>, <span class="hlFld-ContribAuthor ">Julie  Gonneaud</span>, <span class="hlFld-ContribAuthor ">Christophe  Bedetti</span>, <span class="hlFld-ContribAuthor ">Hazal  Ozlen</span>, <span class="hlFld-ContribAuthor ">Anne  Labonté</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">John  Breitner</span>, <span class="hlFld-ContribAuthor ">Judes  Poirier</span>, <span class="hlFld-ContribAuthor ">Sylvia  Villeneuve</span>, . </span><span class="cited-content_cbyCitation_article-title">Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults. </span><span class="cited-content_cbyCitation_journal-name">Neurology</span><span> <strong>2020,</strong> <em>94 </em>
                                    (11)
                                     , e1190-e1200. <a href="https://doi.org/10.1212/WNL.0000000000008905" title="DOI URL">https://doi.org/10.1212/WNL.0000000000008905</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1212/WNL.0000000000008905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1212%2FWNL.0000000000008905%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurology%26atitle%3DIntermediate%252Bflortaucipir%252Buptake%252Bis%252Bassociated%252Bwith%252BA%2525CE%2525B2-PET%252Band%252BCSF%252Btau%252Bin%252Basymptomatic%252Badults%26aulast%3DMcSweeney%26aufirst%3DMelissa%26date%3D2020%26date%3D2020%26volume%3D94%26issue%3D11%26spage%3De1190%26epage%3De1200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bright Chukwunwike  Uzuegbunam</span>, <span class="hlFld-ContribAuthor ">Damiano  Librizzi</span>, <span class="hlFld-ContribAuthor ">Behrooz  Hooshyar Yousefi</span>. </span><span class="cited-content_cbyCitation_article-title">PET Radiopharmaceuticals for Alzheimer’s Disease and Parkinson’s Disease Diagnosis, the Current and Future Landscape. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (4)
                                     , 977. <a href="https://doi.org/10.3390/molecules25040977" title="DOI URL">https://doi.org/10.3390/molecules25040977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25040977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25040977%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPET%252BRadiopharmaceuticals%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%252Band%252BParkinson%2525E2%252580%252599s%252BDisease%252BDiagnosis%25252C%252Bthe%252BCurrent%252Band%252BFuture%252BLandscape%26aulast%3DUzuegbunam%26aufirst%3DBright%2BChukwunwike%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D4%26spage%3D977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannes  Ermert</span>, <span class="hlFld-ContribAuthor ">Martina  Benešová</span>, <span class="hlFld-ContribAuthor ">Verena  Hugenberg</span>, <span class="hlFld-ContribAuthor ">Viplav  Gupta</span>, <span class="hlFld-ContribAuthor ">Ingo  Spahn</span>, <span class="hlFld-ContribAuthor ">Hans-Jürgen  Pietzsch</span>, <span class="hlFld-ContribAuthor ">Christos  Liolios</span>, <span class="hlFld-ContribAuthor ">Klaus  Kopka</span>. </span><span class="cited-content_cbyCitation_article-title">Radiopharmaceutical Sciences. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 49-191. <a href="https://doi.org/10.1007/978-3-030-39457-8_2" title="DOI URL">https://doi.org/10.1007/978-3-030-39457-8_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-39457-8_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-39457-8_2%26sid%3Dliteratum%253Aachs%26atitle%3DRadiopharmaceutical%252BSciences%26aulast%3DErmert%26aufirst%3DJohannes%26date%3D2020%26date%3D2020%26spage%3D49%26epage%3D191%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DClinical%252BNuclear%252BMedicine%26aulast%3DAhmadzadehfar%26aufirst%3DHojjat%26date%3D2020%26volume%3D70-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heiko  Kroth</span>, <span class="hlFld-ContribAuthor ">Felix  Oden</span>, <span class="hlFld-ContribAuthor ">Jerome  Molette</span>, <span class="hlFld-ContribAuthor ">Hanno  Schieferstein</span>, <span class="hlFld-ContribAuthor ">Francesca  Capotosti</span>, <span class="hlFld-ContribAuthor ">Andre  Mueller</span>, <span class="hlFld-ContribAuthor ">Mathias  Berndt</span>, <span class="hlFld-ContribAuthor ">Heribert  Schmitt-Willich</span>, <span class="hlFld-ContribAuthor ">Vincent  Darmency</span>, <span class="hlFld-ContribAuthor ">Emanuele  Gabellieri</span>, <span class="hlFld-ContribAuthor ">Cédric  Boudou</span>, <span class="hlFld-ContribAuthor ">Tanja  Juergens</span>, <span class="hlFld-ContribAuthor ">Yvan  Varisco</span>, <span class="hlFld-ContribAuthor ">Efthymia  Vokali</span>, <span class="hlFld-ContribAuthor ">David T.  Hickman</span>, <span class="hlFld-ContribAuthor ">Gilles  Tamagnan</span>, <span class="hlFld-ContribAuthor ">Andrea  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Ludger  Dinkelborg</span>, <span class="hlFld-ContribAuthor ">Andreas  Muhs</span>, <span class="hlFld-ContribAuthor ">Andrew  Stephens</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2019,</strong> <em>46 </em>
                                    (10)
                                     , 2178-2189. <a href="https://doi.org/10.1007/s00259-019-04397-2" title="DOI URL">https://doi.org/10.1007/s00259-019-04397-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-019-04397-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-019-04397-2%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DDiscovery%252Band%252Bpreclinical%252Bcharacterization%252Bof%252B%25255B18F%25255DPI-2620%25252C%252Ba%252Bnext-generation%252Btau%252BPET%252Btracer%252Bfor%252Bthe%252Bassessment%252Bof%252Btau%252Bpathology%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bother%252Btauopathies%26aulast%3DKroth%26aufirst%3DHeiko%26date%3D2019%26date%3D2019%26volume%3D46%26issue%3D10%26spage%3D2178%26epage%3D2189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan  Yang</span>, <span class="hlFld-ContribAuthor ">Kan  Wang</span>, <span class="hlFld-ContribAuthor ">Kaixiang  Zhou</span>, <span class="hlFld-ContribAuthor ">Bin  Dai</span>, <span class="hlFld-ContribAuthor ">Jiapei  Dai</span>, <span class="hlFld-ContribAuthor ">Yi  Liang</span>, <span class="hlFld-ContribAuthor ">Mengchao  Cui</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and bioevaluation of technetium-99 m / rhenium labeled phenylquinoxaline derivatives as Tau imaging probes. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>177 </em>, 291-301. <a href="https://doi.org/10.1016/j.ejmech.2019.05.065" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.065</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.065&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.065%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbioevaluation%252Bof%252Btechnetium-99%2525E2%252580%2525AFm%252B%25252F%252Brhenium%252Blabeled%252Bphenylquinoxaline%252Bderivatives%252Bas%252BTau%252Bimaging%252Bprobes%26aulast%3DYang%26aufirst%3DFan%26date%3D2019%26volume%3D177%26spage%3D291%26epage%3D301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sho  Kaide</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Yoichi  Shimizu</span>, <span class="hlFld-ContribAuthor ">Haruka  Tatsumi</span>, <span class="hlFld-ContribAuthor ">Shimpei  Iikuni</span>, <span class="hlFld-ContribAuthor ">Yuji  Nakamoto</span>, <span class="hlFld-ContribAuthor ">Kaori  Togashi</span>, <span class="hlFld-ContribAuthor ">Masafumi  Ihara</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ono</span>. </span><span class="cited-content_cbyCitation_article-title">18F-labeled benzimidazopyridine derivatives for PET imaging of tau pathology in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (16)
                                     , 3587-3594. <a href="https://doi.org/10.1016/j.bmc.2019.06.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.06.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.06.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.06.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3D18F-labeled%252Bbenzimidazopyridine%252Bderivatives%252Bfor%252BPET%252Bimaging%252Bof%252Btau%252Bpathology%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DKaide%26aufirst%3DSho%26date%3D2019%26volume%3D27%26issue%3D16%26spage%3D3587%26epage%3D3594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroshi  Ikenuma</span>, <span class="hlFld-ContribAuthor ">Hiroko  Koyama</span>, <span class="hlFld-ContribAuthor ">Naoya  Kajino</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Kimura</span>, <span class="hlFld-ContribAuthor ">Aya  Ogata</span>, <span class="hlFld-ContribAuthor ">Junichiro  Abe</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Kawasumi</span>, <span class="hlFld-ContribAuthor ">Takashi  Kato</span>, <span class="hlFld-ContribAuthor ">Akihiko  Takashima</span>, <span class="hlFld-ContribAuthor ">Kengo  Ito</span>, <span class="hlFld-ContribAuthor ">Masaaki  Suzuki</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of (R,S)-isoproterenol, an inhibitor of tau aggregation, as an 11C-labeled PET tracer via reductive alkylation of (R,S)-norepinephrine with [2-11C]acetone. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (16)
                                     , 2107-2111. <a href="https://doi.org/10.1016/j.bmcl.2019.07.005" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.07.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.07.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.07.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252B%252528R%25252CS%252529-isoproterenol%25252C%252Ban%252Binhibitor%252Bof%252Btau%252Baggregation%25252C%252Bas%252Ban%252B11C-labeled%252BPET%252Btracer%252Bvia%252Breductive%252Balkylation%252Bof%252B%252528R%25252CS%252529-norepinephrine%252Bwith%252B%25255B2-11C%25255Dacetone%26aulast%3DIkenuma%26aufirst%3DHiroshi%26date%3D2019%26volume%3D29%26issue%3D16%26spage%3D2107%26epage%3D2111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Hopewell</span>, <span class="hlFld-ContribAuthor ">Karen  Ross</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Tharick A.  Pascoal</span>, <span class="hlFld-ContribAuthor ">Thais  Alberti</span>, <span class="hlFld-ContribAuthor ">Monica  Lacatus-Samoila</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Soucy</span>, <span class="hlFld-ContribAuthor ">Idriss  Bennacef</span>, <span class="hlFld-ContribAuthor ">Eliane  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Min Su  Kang</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Gassan  Massarweh</span>. </span><span class="cited-content_cbyCitation_article-title">A simplified radiosynthesis of [
              18
              F]MK-6240 for tau PET imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2019,</strong> <em>62 </em>
                                    (2)
                                     , 109-114. <a href="https://doi.org/10.1002/jlcr.3695" title="DOI URL">https://doi.org/10.1002/jlcr.3695</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3695&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3695%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DA%252Bsimplified%252Bradiosynthesis%252Bof%252B%25255B%252B18%252BF%25255DMK-6240%252Bfor%252Btau%252BPET%252Bimaging%26aulast%3DHopewell%26aufirst%3DRobert%26date%3D2019%26date%3D2018%26volume%3D62%26issue%3D2%26spage%3D109%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaos  Giagkou</span>, <span class="hlFld-ContribAuthor ">Günter U.  Höglinger</span>, <span class="hlFld-ContribAuthor ">Maria  Stamelou</span>. </span><span class="cited-content_cbyCitation_article-title">Progressive supranuclear palsy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 49-86. <a href="https://doi.org/10.1016/bs.irn.2019.10.013" title="DOI URL">https://doi.org/10.1016/bs.irn.2019.10.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.irn.2019.10.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.irn.2019.10.013%26sid%3Dliteratum%253Aachs%26atitle%3DProgressive%252Bsupranuclear%252Bpalsy%26aulast%3DGiagkou%26aufirst%3DNikolaos%26date%3D2019%26spage%3D49%26epage%3D86%26pub%3DElsevier%26atitle%3DParkinsonism%252BBeyond%252BParkinson%252527s%252BDisease%26date%3D2019%26volume%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ying-Hwey  Nai</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Watabe</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the Feasibility of Screening Tau Radiotracers Using an Amyloid Biomathematical Screening Methodology. </span><span class="cited-content_cbyCitation_journal-name">Computational and Mathematical Methods in Medicine</span><span> <strong>2018,</strong> <em>2018 </em>, 1-13. <a href="https://doi.org/10.1155/2018/6287913" title="DOI URL">https://doi.org/10.1155/2018/6287913</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2018/6287913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2018%2F6287913%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520and%2520Mathematical%2520Methods%2520in%2520Medicine%26atitle%3DEvaluation%252Bof%252Bthe%252BFeasibility%252Bof%252BScreening%252BTau%252BRadiotracers%252BUsing%252Ban%252BAmyloid%252BBiomathematical%252BScreening%252BMethodology%26aulast%3DNai%26aufirst%3DYing-Hwey%26date%3D2018%26volume%3D2018%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joerg  Neddens</span>, <span class="hlFld-ContribAuthor ">Magdalena  Temmel</span>, <span class="hlFld-ContribAuthor ">Stefanie  Flunkert</span>, <span class="hlFld-ContribAuthor ">Bianca  Kerschbaumer</span>, <span class="hlFld-ContribAuthor ">Christina  Hoeller</span>, <span class="hlFld-ContribAuthor ">Tina  Loeffler</span>, <span class="hlFld-ContribAuthor ">Vera  Niederkofler</span>, <span class="hlFld-ContribAuthor ">Guenther  Daum</span>, <span class="hlFld-ContribAuthor ">Johannes  Attems</span>, <span class="hlFld-ContribAuthor ">Birgit  Hutter-Paier</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphorylation of different tau sites during progression of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Acta Neuropathologica Communications</span><span> <strong>2018,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40478-018-0557-6" title="DOI URL">https://doi.org/10.1186/s40478-018-0557-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40478-018-0557-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40478-018-0557-6%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Neuropathologica%2520Communications%26atitle%3DPhosphorylation%252Bof%252Bdifferent%252Btau%252Bsites%252Bduring%252Bprogression%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DNeddens%26aufirst%3DJoerg%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Biyue  Zhu</span>, <span class="hlFld-ContribAuthor ">Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Jiang</span>, <span class="hlFld-ContribAuthor ">Ying  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Fu</span>, <span class="hlFld-ContribAuthor ">Jiapei  Dai</span>, <span class="hlFld-ContribAuthor ">Ge  Li</span>, <span class="hlFld-ContribAuthor ">Qingrong  Qi</span>, <span class="hlFld-ContribAuthor ">Yan  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of pyrazine and quinoxaline fluorophores for
              in vivo
              detection of cerebral tau tangles in Alzheimer's models. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2018,</strong> <em>54 </em>
                                    (82)
                                     , 11558-11561. <a href="https://doi.org/10.1039/C8CC06897F" title="DOI URL">https://doi.org/10.1039/C8CC06897F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8CC06897F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8CC06897F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bpyrazine%252Band%252Bquinoxaline%252Bfluorophores%252Bfor%252Bin%252Bvivo%252Bdetection%252Bof%252Bcerebral%252Btau%252Btangles%252Bin%252BAlzheimer%252527s%252Bmodels%26aulast%3DZhu%26aufirst%3DBiyue%26date%3D2018%26date%3D2018%26volume%3D54%26issue%3D82%26spage%3D11558%26epage%3D11561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gurleen K.  Samra</span>, <span class="hlFld-ContribAuthor ">Kenneth  Dang</span>, <span class="hlFld-ContribAuthor ">Heather  Ho</span>, <span class="hlFld-ContribAuthor ">Aparna  Baranwal</span>, <span class="hlFld-ContribAuthor ">Jogeshwar  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Dual targeting agents for Aβ plaque/P-glycoprotein and Aβ plaque/nicotinic acetylcholine α4β2* receptors—potential approaches to facilitate Aβ plaque removal in Alzheimer’s disease brain. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2018,</strong> <em>27 </em>
                                    (6)
                                     , 1634-1646. <a href="https://doi.org/10.1007/s00044-018-2178-9" title="DOI URL">https://doi.org/10.1007/s00044-018-2178-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-018-2178-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-018-2178-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDual%252Btargeting%252Bagents%252Bfor%252BA%2525CE%2525B2%252Bplaque%25252FP-glycoprotein%252Band%252BA%2525CE%2525B2%252Bplaque%25252Fnicotinic%252Bacetylcholine%252B%2525CE%2525B14%2525CE%2525B22%252A%252Breceptors%2525E2%252580%252594potential%252Bapproaches%252Bto%252Bfacilitate%252BA%2525CE%2525B2%252Bplaque%252Bremoval%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bbrain%26aulast%3DSamra%26aufirst%3DGurleen%2BK.%26date%3D2018%26date%3D2018%26volume%3D27%26issue%3D6%26spage%3D1634%26epage%3D1646" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Honer</span>, <span class="hlFld-ContribAuthor ">Luca  Gobbi</span>, <span class="hlFld-ContribAuthor ">Henner  Knust</span>, <span class="hlFld-ContribAuthor ">Hiroto  Kuwabara</span>, <span class="hlFld-ContribAuthor ">Dieter  Muri</span>, <span class="hlFld-ContribAuthor ">Matthias  Koerner</span>, <span class="hlFld-ContribAuthor ">Heather  Valentine</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dannals</span>, <span class="hlFld-ContribAuthor ">Dean F.  Wong</span>, <span class="hlFld-ContribAuthor ">Edilio  Borroni</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Evaluation of
              18
              F-RO6958948,
              11
              C-RO6931643, and
              11
              C-RO6924963 as Novel PET Radiotracers for Imaging Tau Aggregates in Alzheimer Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2018,</strong> <em>59 </em>
                                    (4)
                                     , 675-681. <a href="https://doi.org/10.2967/jnumed.117.196741" title="DOI URL">https://doi.org/10.2967/jnumed.117.196741</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.117.196741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.117.196741%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DPreclinical%252BEvaluation%252Bof%252B18%252BF-RO6958948%25252C%252B11%252BC-RO6931643%25252C%252Band%252B11%252BC-RO6924963%252Bas%252BNovel%252BPET%252BRadiotracers%252Bfor%252BImaging%252BTau%252BAggregates%252Bin%252BAlzheimer%252BDisease%26aulast%3DHoner%26aufirst%3DMichael%26date%3D2018%26date%3D2017%26volume%3D59%26issue%3D4%26spage%3D675%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Young Kyoung  Jang</span>, <span class="hlFld-ContribAuthor ">Chul Hyoung  Lyoo</span>, <span class="hlFld-ContribAuthor ">Seongbeom  Park</span>, <span class="hlFld-ContribAuthor ">Seung Jun  Oh</span>, <span class="hlFld-ContribAuthor ">Hanna  Cho</span>, <span class="hlFld-ContribAuthor ">Minyoung  Oh</span>, <span class="hlFld-ContribAuthor ">Young Hoon  Ryu</span>, <span class="hlFld-ContribAuthor ">Jae Yong  Choi</span>, <span class="hlFld-ContribAuthor ">Gil D.  Rabinovici</span>, <span class="hlFld-ContribAuthor ">Hee Jin  Kim</span>, <span class="hlFld-ContribAuthor ">Seung Hwan  Moon</span>, <span class="hlFld-ContribAuthor ">Hyemin  Jang</span>, <span class="hlFld-ContribAuthor ">Jin San  Lee</span>, <span class="hlFld-ContribAuthor ">William J.  Jagust</span>, <span class="hlFld-ContribAuthor ">Duk L.  Na</span>, <span class="hlFld-ContribAuthor ">Jae Seung  Kim</span>, <span class="hlFld-ContribAuthor ">Sang Won  Seo</span>. </span><span class="cited-content_cbyCitation_article-title">Head to head comparison of [18F] AV-1451 and [18F] THK5351 for tau imaging in Alzheimer’s disease and frontotemporal dementia. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2018,</strong> <em>45 </em>
                                    (3)
                                     , 432-442. <a href="https://doi.org/10.1007/s00259-017-3876-0" title="DOI URL">https://doi.org/10.1007/s00259-017-3876-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-017-3876-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-017-3876-0%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DHead%252Bto%252Bhead%252Bcomparison%252Bof%252B%25255B18F%25255D%252BAV-1451%252Band%252B%25255B18F%25255D%252BTHK5351%252Bfor%252Btau%252Bimaging%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Band%252Bfrontotemporal%252Bdementia%26aulast%3DJang%26aufirst%3DYoung%2BKyoung%26date%3D2018%26date%3D2017%26volume%3D45%26issue%3D3%26spage%3D432%26epage%3D442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bjoern  Bartels</span>, <span class="hlFld-ContribAuthor ">Philipp  Cueni</span>, <span class="hlFld-ContribAuthor ">Dieter  Muri</span>, <span class="hlFld-ContribAuthor ">Matthias  Koerner</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a safe and scalable route towards a tau PET tracer precursor. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (4)
                                     , 970-976. <a href="https://doi.org/10.1016/j.bmc.2017.10.007" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.10.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.10.007%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Ba%252Bsafe%252Band%252Bscalable%252Broute%252Btowards%252Ba%252Btau%252BPET%252Btracer%252Bprecursor%26aulast%3DBartels%26aufirst%3DBjoern%26date%3D2018%26volume%3D26%26issue%3D4%26spage%3D970%26epage%3D976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ai  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Masaki  Tokunaga</span>, <span class="hlFld-ContribAuthor ">Jun  Maeda</span>, <span class="hlFld-ContribAuthor ">Takeharu  Minamihisamatsu</span>, <span class="hlFld-ContribAuthor ">Masafumi  Shimojo</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Takuwa</span>, <span class="hlFld-ContribAuthor ">Maiko  Ono</span>, <span class="hlFld-ContribAuthor ">Ruiqing  Ni</span>, <span class="hlFld-ContribAuthor ">Shigeki  Hirano</span>, <span class="hlFld-ContribAuthor ">Satoshi  Kuwabara</span>, <span class="hlFld-ContribAuthor ">Bin  Ji</span>, <span class="hlFld-ContribAuthor ">Ming-Rong  Zhang</span>, <span class="hlFld-ContribAuthor ">Ichio  Aoki</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Suhara</span>, <span class="hlFld-ContribAuthor ">Makoto  Higuchi</span>, <span class="hlFld-ContribAuthor ">Naruhiko  Sahara</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1037-1052. <a href="https://doi.org/10.3233/JAD-170509" title="DOI URL">https://doi.org/10.3233/JAD-170509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-170509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-170509%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DIn%252BVivo%252BVisualization%252Bof%252BTau%252BAccumulation%25252C%252BMicroglial%252BActivation%25252C%252Band%252BBrain%252BAtrophy%252Bin%252Ba%252BMouse%252BModel%252Bof%252BTauopathy%252BrTg4510%26aulast%3DIshikawa%26aufirst%3DAi%26date%3D2018%26volume%3D61%26issue%3D3%26spage%3D1037%26epage%3D1052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen-Chen  Tan</span>, <span class="hlFld-ContribAuthor ">Xiao-Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Lan  Tan</span>, <span class="hlFld-ContribAuthor ">Jin-Tai  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Tauopathies: Mechanisms and Therapeutic Strategies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2017,</strong> <em>61 </em>
                                    (2)
                                     , 487-508. <a href="https://doi.org/10.3233/JAD-170187" title="DOI URL">https://doi.org/10.3233/JAD-170187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/JAD-170187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FJAD-170187%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DTauopathies%25253A%252BMechanisms%252Band%252BTherapeutic%252BStrategies%26aulast%3DTan%26aufirst%3DChen-Chen%26date%3D2017%26volume%3D61%26issue%3D2%26spage%3D487%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naruhiko  Sahara</span>, <span class="hlFld-ContribAuthor ">Masafumi  Shimojo</span>, <span class="hlFld-ContribAuthor ">Maiko  Ono</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Takuwa</span>, <span class="hlFld-ContribAuthor ">Marcelo  Febo</span>, <span class="hlFld-ContribAuthor ">Makoto  Higuchi</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Suhara</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Tau Imaging for a Diagnostic Platform of Tauopathy Using the rTg4510 Mouse Line. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neurology</span><span> <strong>2017,</strong> <em>8 </em><a href="https://doi.org/10.3389/fneur.2017.00663" title="DOI URL">https://doi.org/10.3389/fneur.2017.00663</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fneur.2017.00663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffneur.2017.00663%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neurology%26atitle%3DIn%252BVivo%252BTau%252BImaging%252Bfor%252Ba%252BDiagnostic%252BPlatform%252Bof%252BTauopathy%252BUsing%252Bthe%252BrTg4510%252BMouse%252BLine%26aulast%3DSahara%26aufirst%3DNaruhiko%26date%3D2017%26date%3D2017%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew V.  Mossine</span>, <span class="hlFld-ContribAuthor ">Allen F.  Brooks</span>, <span class="hlFld-ContribAuthor ">Bradford D.  Henderson</span>, <span class="hlFld-ContribAuthor ">Brian G.  Hockley</span>, <span class="hlFld-ContribAuthor ">Kirk A.  Frey</span>, <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">An updated radiosynthesis of [18F]AV1451 for tau PET imaging. </span><span class="cited-content_cbyCitation_journal-name">EJNMMI Radiopharmacy and Chemistry</span><span> <strong>2017,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s41181-017-0027-7" title="DOI URL">https://doi.org/10.1186/s41181-017-0027-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s41181-017-0027-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs41181-017-0027-7%26sid%3Dliteratum%253Aachs%26jtitle%3DEJNMMI%2520Radiopharmacy%2520and%2520Chemistry%26atitle%3DAn%252Bupdated%252Bradiosynthesis%252Bof%252B%25255B18F%25255DAV1451%252Bfor%252Btau%252BPET%252Bimaging%26aulast%3DMossine%26aufirst%3DAndrew%2BV.%26date%3D2017%26date%3D2017%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Mark  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry strategies for PET tracer discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>25 </em>, 11-17. <a href="https://doi.org/10.1016/j.ddtec.2017.10.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DMedicinal%252BChemistry%252Bstrategies%252Bfor%252BPET%252Btracer%252Bdiscovery%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BIgnacio%26date%3D2017%26volume%3D25%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anne-Sophie  Salabert</span>, <span class="hlFld-ContribAuthor ">Charlotte  Fontan</span>, <span class="hlFld-ContribAuthor ">Caroline  Fonta</span>, <span class="hlFld-ContribAuthor ">Mathieu  Alonso</span>, <span class="hlFld-ContribAuthor ">Najat  Loukh</span>, <span class="hlFld-ContribAuthor ">Marie Bernadette  Delisle</span>, <span class="hlFld-ContribAuthor ">Mathieu  Tafani</span>, <span class="hlFld-ContribAuthor ">Pierre  Payoux</span>. </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis of [18F]AV1451 in pharmaceutical conditions and its biological characteristics. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2017,</strong> <em>128 </em>, 101-107. <a href="https://doi.org/10.1016/j.apradiso.2017.06.032" title="DOI URL">https://doi.org/10.1016/j.apradiso.2017.06.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2017.06.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2017.06.032%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DRadiosynthesis%252Bof%252B%25255B18F%25255DAV1451%252Bin%252Bpharmaceutical%252Bconditions%252Band%252Bits%252Bbiological%252Bcharacteristics%26aulast%3DSalabert%26aufirst%3DAnne-Sophie%26date%3D2017%26volume%3D128%26spage%3D101%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy L.  Vāvere</span>, <span class="hlFld-ContribAuthor ">Peter J.H.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">Clinical Applications of Small-molecule PET Radiotracers: Current Progress and Future Outlook. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Nuclear Medicine</span><span> <strong>2017,</strong> <em>47 </em>
                                    (5)
                                     , 429-453. <a href="https://doi.org/10.1053/j.semnuclmed.2017.05.001" title="DOI URL">https://doi.org/10.1053/j.semnuclmed.2017.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.semnuclmed.2017.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.semnuclmed.2017.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Nuclear%2520Medicine%26atitle%3DClinical%252BApplications%252Bof%252BSmall-molecule%252BPET%252BRadiotracers%25253A%252BCurrent%252BProgress%252Band%252BFuture%252BOutlook%26aulast%3DV%25C4%2581vere%26aufirst%3DAmy%2BL.%26date%3D2017%26volume%3D47%26issue%3D5%26spage%3D429%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiel  Neumann</span>, <span class="hlFld-ContribAuthor ">Robert  Flavell</span>, <span class="hlFld-ContribAuthor ">David M.  Wilson</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Metabolism In Vivo Using Endogenous 11 C Metabolic Tracers. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Nuclear Medicine</span><span> <strong>2017,</strong> <em>47 </em>
                                    (5)
                                     , 461-473. <a href="https://doi.org/10.1053/j.semnuclmed.2017.05.003" title="DOI URL">https://doi.org/10.1053/j.semnuclmed.2017.05.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.semnuclmed.2017.05.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.semnuclmed.2017.05.003%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Nuclear%2520Medicine%26atitle%3DExploring%252BMetabolism%252BIn%252BVivo%252BUsing%252BEndogenous%252B11%252BC%252BMetabolic%252BTracers%26aulast%3DNeumann%26aufirst%3DKiel%26date%3D2017%26volume%3D47%26issue%3D5%26spage%3D461%26epage%3D473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas Lee  Collier</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Yokell</span>, <span class="hlFld-ContribAuthor ">Eli  Livni</span>, <span class="hlFld-ContribAuthor ">Peter A.  Rice</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, <span class="hlFld-ContribAuthor ">Kim  Serdons</span>, <span class="hlFld-ContribAuthor ">Ramesh  Neelamegam</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>, <span class="hlFld-ContribAuthor ">Dawn  Harris</span>, <span class="hlFld-ContribAuthor ">Abbas  Walji</span>, <span class="hlFld-ContribAuthor ">Eric D.  Hostetler</span>, <span class="hlFld-ContribAuthor ">Idriss  Bennacef</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">cGMP production of the radiopharmaceutical [
              18
              F]MK-6240 for PET imaging of human neurofibrillary tangles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2017,</strong> <em>60 </em>
                                    (5)
                                     , 263-269. <a href="https://doi.org/10.1002/jlcr.3496" title="DOI URL">https://doi.org/10.1002/jlcr.3496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3496%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DcGMP%252Bproduction%252Bof%252Bthe%252Bradiopharmaceutical%252B%25255B%252B18%252BF%25255DMK-6240%252Bfor%252BPET%252Bimaging%252Bof%252Bhuman%252Bneurofibrillary%252Btangles%26aulast%3DCollier%26aufirst%3DThomas%2BLee%26date%3D2017%26date%3D2017%26volume%3D60%26issue%3D5%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>. </span><span class="cited-content_cbyCitation_article-title">Tau Positron Emission Tomography Imaging. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Biology</span><span> <strong>2017,</strong> <em>9 </em>
                                    (5)
                                     , a023721. <a href="https://doi.org/10.1101/cshperspect.a023721" title="DOI URL">https://doi.org/10.1101/cshperspect.a023721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a023721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a023721%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Biology%26atitle%3DTau%252BPositron%252BEmission%252BTomography%252BImaging%26aulast%3DKolb%26aufirst%3DHartmuth%2BC.%26date%3D2017%26date%3D2016%26volume%3D9%26issue%3D5%26spage%3Da023721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E  Schmidt</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>. </span><span class="cited-content_cbyCitation_article-title">The value of PET ligand discovery to CNS drug development. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (4)
                                     , 351-356. <a href="https://doi.org/10.4155/fmc-2017-0018" title="DOI URL">https://doi.org/10.4155/fmc-2017-0018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0018%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bvalue%252Bof%252BPET%252Bligand%252Bdiscovery%252Bto%252BCNS%252Bdrug%252Bdevelopment%26aulast%3DSchmidt%26aufirst%3DMark%2BE%26date%3D2017%26volume%3D9%26issue%3D4%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dustin W.  Wooten</span>, <span class="hlFld-ContribAuthor ">Nicolas J.  Guehl</span>, <span class="hlFld-ContribAuthor ">Eline E.  Verwer</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Shoup</span>, <span class="hlFld-ContribAuthor ">Daniel L.  Yokell</span>, <span class="hlFld-ContribAuthor ">Nevena  Zubcevik</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>, <span class="hlFld-ContribAuthor ">Ross D.  Zafonte</span>, <span class="hlFld-ContribAuthor ">Keith A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Georges  El Fakhri</span>, <span class="hlFld-ContribAuthor ">Marc D.  Normandin</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacokinetic Evaluation of the Tau PET Radiotracer
              18
              F-T807 (
              18
              F-AV-1451) in Human Subjects. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2017,</strong> <em>58 </em>
                                    (3)
                                     , 484-491. <a href="https://doi.org/10.2967/jnumed.115.170910" title="DOI URL">https://doi.org/10.2967/jnumed.115.170910</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.115.170910&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.115.170910%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DPharmacokinetic%252BEvaluation%252Bof%252Bthe%252BTau%252BPET%252BRadiotracer%252B18%252BF-T807%252B%252528%252B18%252BF-AV-1451%252529%252Bin%252BHuman%252BSubjects%26aulast%3DWooten%26aufirst%3DDustin%2BW.%26date%3D2017%26date%3D2016%26volume%3D58%26issue%3D3%26spage%3D484%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of carbon-11-labeled isonicotinamides as new potential PET agents for imaging of GSK-3 enzyme in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (4)
                                     , 740-743. <a href="https://doi.org/10.1016/j.bmcl.2017.01.041" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.01.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.01.041%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Bcarbon-11-labeled%252Bisonicotinamides%252Bas%252Bnew%252Bpotential%252BPET%252Bagents%252Bfor%252Bimaging%252Bof%252BGSK-3%252Benzyme%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DGao%26aufirst%3DMingzhang%26date%3D2017%26volume%3D27%26issue%3D4%26spage%3D740%26epage%3D743" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karoline T.  Neumann</span>, <span class="hlFld-ContribAuthor ">Anders T.  Lindhardt</span>, <span class="hlFld-ContribAuthor ">Benny  Bang-Andersen</span>, <span class="hlFld-ContribAuthor ">Troels  Skrydstrup</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and selective
              2
              H-,
              13
              C-, and
              15
              N-labeling of the Tau protein binder THK-523. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 30-35. <a href="https://doi.org/10.1002/jlcr.3470" title="DOI URL">https://doi.org/10.1002/jlcr.3470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3470%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DSynthesis%252Band%252Bselective%252B2%252BH-%25252C%252B13%252BC-%25252C%252Band%252B15%252BN-labeling%252Bof%252Bthe%252BTau%252Bprotein%252Bbinder%252BTHK-523%26aulast%3DNeumann%26aufirst%3DKaroline%2BT.%26date%3D2017%26date%3D2016%26volume%3D60%26issue%3D1%26spage%3D30%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Perez-Soriano</span>, <span class="hlFld-ContribAuthor ">A. Jon  Stoessl</span>. </span><span class="cited-content_cbyCitation_article-title">Tau imaging in progressive supranuclear palsy. </span><span class="cited-content_cbyCitation_journal-name">Movement Disorders</span><span> <strong>2017,</strong> <em>32 </em>
                                    (1)
                                     , 91-93. <a href="https://doi.org/10.1002/mds.26851" title="DOI URL">https://doi.org/10.1002/mds.26851</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/mds.26851&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmds.26851%26sid%3Dliteratum%253Aachs%26jtitle%3DMovement%2520Disorders%26atitle%3DTau%252Bimaging%252Bin%252Bprogressive%252Bsupranuclear%252Bpalsy%26aulast%3DPerez-Soriano%26aufirst%3DAlexandra%26date%3D2017%26date%3D2016%26volume%3D32%26issue%3D1%26spage%3D91%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From Imaging Agents to Theranostic Drugs in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 74-106. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12285-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12285-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12285-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12285-1%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BImaging%252BAgents%252Bto%252BTheranostic%252BDrugs%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBolognesi%26aufirst%3DM.L.%26date%3D2017%26spage%3D74%26epage%3D106%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Mercier</span>, <span class="hlFld-ContribAuthor ">L.  Provins</span>, <span class="hlFld-ContribAuthor ">J.  Hannestad</span>. </span><span class="cited-content_cbyCitation_article-title">Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 20-64. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12437-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12437-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12437-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12437-0%26sid%3Dliteratum%253Aachs%26atitle%3DProgress%252Band%252BChallenges%252Bin%252Bthe%252BDevelopment%252Bof%252BPET%252BLigands%252Bto%252BAid%252BCNS%252BDrug%252BDiscovery%26aulast%3DMercier%26aufirst%3DJ.%26date%3D2017%26spage%3D20%26epage%3D64%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric D.  Hostetler</span>, <span class="hlFld-ContribAuthor ">Abbas M.  Walji</span>, <span class="hlFld-ContribAuthor ">Zhizhen  Zeng</span>, <span class="hlFld-ContribAuthor ">Patricia  Miller</span>, <span class="hlFld-ContribAuthor ">Idriss  Bennacef</span>, <span class="hlFld-ContribAuthor ">Cristian  Salinas</span>, <span class="hlFld-ContribAuthor ">Brett  Connolly</span>, <span class="hlFld-ContribAuthor ">Liza  Gantert</span>, <span class="hlFld-ContribAuthor ">Hyking  Haley</span>, <span class="hlFld-ContribAuthor ">Marie  Holahan</span>, <span class="hlFld-ContribAuthor ">Mona  Purcell</span>, <span class="hlFld-ContribAuthor ">Kerry  Riffel</span>, <span class="hlFld-ContribAuthor ">Talakad G.  Lohith</span>, <span class="hlFld-ContribAuthor ">Paul  Coleman</span>, <span class="hlFld-ContribAuthor ">Aileen  Soriano</span>, <span class="hlFld-ContribAuthor ">Aimie  Ogawa</span>, <span class="hlFld-ContribAuthor ">Serena  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhang</span>, <span class="hlFld-ContribAuthor ">Elizabeth  Joshi</span>, <span class="hlFld-ContribAuthor ">Joseph  Della Rocca</span>, <span class="hlFld-ContribAuthor ">David  Hesk</span>, <span class="hlFld-ContribAuthor ">David J.  Schenk</span>, <span class="hlFld-ContribAuthor ">Jeffrey L.  Evelhoch</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Characterization of
              18
              F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2016,</strong> <em>57 </em>
                                    (10)
                                     , 1599-1606. <a href="https://doi.org/10.2967/jnumed.115.171678" title="DOI URL">https://doi.org/10.2967/jnumed.115.171678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.115.171678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.115.171678%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3DPreclinical%252BCharacterization%252Bof%252B18%252BF-MK-6240%25252C%252Ba%252BPromising%252BPET%252BTracer%252Bfor%252BIn%252BVivo%252BQuantification%252Bof%252BHuman%252BNeurofibrillary%252BTangles%26aulast%3DHostetler%26aufirst%3DEric%2BD.%26date%3D2016%26date%3D2016%26volume%3D57%26issue%3D10%26spage%3D1599%26epage%3D1606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikolaus R.  McFarland</span>. </span><span class="cited-content_cbyCitation_article-title">Diagnostic Approach to Atypical Parkinsonian Syndromes. </span><span class="cited-content_cbyCitation_journal-name">CONTINUUM: Lifelong Learning in Neurology</span><span> <strong>2016,</strong> <em>22 </em>
                                    (4)
                                     , 1117-1142. <a href="https://doi.org/10.1212/CON.0000000000000348" title="DOI URL">https://doi.org/10.1212/CON.0000000000000348</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1212/CON.0000000000000348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1212%2FCON.0000000000000348%26sid%3Dliteratum%253Aachs%26jtitle%3DCONTINUUM%253A%2520Lifelong%2520Learning%2520in%2520Neurology%26atitle%3DDiagnostic%252BApproach%252Bto%252BAtypical%252BParkinsonian%252BSyndromes%26aulast%3DMcFarland%26aufirst%3DNikolaus%2BR.%26date%3D2016%26volume%3D22%26issue%3D4%26spage%3D1117%26epage%3D1142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min-Liang  Pan</span>, <span class="hlFld-ContribAuthor ">Meenakshi T.  Mukherjee</span>, <span class="hlFld-ContribAuthor ">Himika H.  Patel</span>, <span class="hlFld-ContribAuthor ">Bhavin  Patel</span>, <span class="hlFld-ContribAuthor ">Cristian C.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">M. Reza  Mirbolooki</span>, <span class="hlFld-ContribAuthor ">Christopher  Liang</span>, <span class="hlFld-ContribAuthor ">Jogeshwar  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of [
              11
              C]TAZA for amyloid β plaque imaging in postmortem human Alzheimer's disease brain region and whole body distribution in rodent PET/CT. </span><span class="cited-content_cbyCitation_journal-name">Synapse</span><span> <strong>2016,</strong> <em>70 </em>
                                    (4)
                                     , 163-176. <a href="https://doi.org/10.1002/syn.21893" title="DOI URL">https://doi.org/10.1002/syn.21893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/syn.21893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fsyn.21893%26sid%3Dliteratum%253Aachs%26jtitle%3DSynapse%26atitle%3DEvaluation%252Bof%252B%25255B%252B11%252BC%25255DTAZA%252Bfor%252Bamyloid%252B%2525CE%2525B2%252Bplaque%252Bimaging%252Bin%252Bpostmortem%252Bhuman%252BAlzheimer%252527s%252Bdisease%252Bbrain%252Bregion%252Band%252Bwhole%252Bbody%252Bdistribution%252Bin%252Brodent%252BPET%25252FCT%26aulast%3DPan%26aufirst%3DMin-Liang%26date%3D2016%26date%3D2016%26volume%3D70%26issue%3D4%26spage%3D163%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryuichi  Harada</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Okamura</span>, <span class="hlFld-ContribAuthor ">Shozo  Furumoto</span>, <span class="hlFld-ContribAuthor ">Tetsuro  Tago</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Yanai</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Arai</span>, <span class="hlFld-ContribAuthor ">Yukitsuka  Kudo</span>. </span><span class="cited-content_cbyCitation_article-title">Characteristics of Tau and Its Ligands in PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     , 7. <a href="https://doi.org/10.3390/biom6010007" title="DOI URL">https://doi.org/10.3390/biom6010007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom6010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom6010007%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DCharacteristics%252Bof%252BTau%252Band%252BIts%252BLigands%252Bin%252BPET%252BImaging%26aulast%3DHarada%26aufirst%3DRyuichi%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tomasz  Dziedzic</span>, <span class="hlFld-ContribAuthor ">Joanna  Pera</span>, <span class="hlFld-ContribAuthor ">Aleksandra  Klimkowicz-Mrowiec</span>, <span class="hlFld-ContribAuthor ">Barbara  Mroczko</span>, <span class="hlFld-ContribAuthor ">Agnieszka  Slowik</span>, . </span><span class="cited-content_cbyCitation_article-title">Biochemical and Radiological Markers of Alzheimer’s Disease Progression. </span><span class="cited-content_cbyCitation_journal-name">Journal of Alzheimer's Disease</span><span> <strong>2016,</strong> <em>50 </em>
                                    (3)
                                     , 623-644. <a href="https://doi.org/10.3233/IFS-150578" title="DOI URL">https://doi.org/10.3233/IFS-150578</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3233/IFS-150578&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3233%2FIFS-150578%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Alzheimer%2527s%2520Disease%26atitle%3DBiochemical%252Band%252BRadiological%252BMarkers%252Bof%2525C2%2525A0Alzheimer%2525E2%252580%252599s%252BDisease%252BProgression%26aulast%3DDziedzic%26aufirst%3DTomasz%26date%3D2016%26volume%3D50%26issue%3D3%26spage%3D623%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ryuichi  Harada</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Okamura</span>, <span class="hlFld-ContribAuthor ">Shozo  Furumoto</span>, <span class="hlFld-ContribAuthor ">Katsutoshi  Furukawa</span>, <span class="hlFld-ContribAuthor ">Aiko  Ishiki</span>, <span class="hlFld-ContribAuthor ">Naoki  Tomita</span>, <span class="hlFld-ContribAuthor ">Tetsuro  Tago</span>, <span class="hlFld-ContribAuthor ">Kotaro  Hiraoka</span>, <span class="hlFld-ContribAuthor ">Shoichi  Watanuki</span>, <span class="hlFld-ContribAuthor ">Miho  Shidahara</span>, <span class="hlFld-ContribAuthor ">Masayasu  Miyake</span>, <span class="hlFld-ContribAuthor ">Yoichi  Ishikawa</span>, <span class="hlFld-ContribAuthor ">Rin  Matsuda</span>, <span class="hlFld-ContribAuthor ">Akie  Inami</span>, <span class="hlFld-ContribAuthor ">Takeo  Yoshikawa</span>, <span class="hlFld-ContribAuthor ">Yoshihito  Funaki</span>, <span class="hlFld-ContribAuthor ">Ren  Iwata</span>, <span class="hlFld-ContribAuthor ">Manabu  Tashiro</span>, <span class="hlFld-ContribAuthor ">Kazuhiko  Yanai</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Arai</span>, <span class="hlFld-ContribAuthor ">Yukitsuka  Kudo</span>. </span><span class="cited-content_cbyCitation_article-title">18
              F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Nuclear Medicine</span><span> <strong>2016,</strong> <em>57 </em>
                                    (2)
                                     , 208-214. <a href="https://doi.org/10.2967/jnumed.115.164848" title="DOI URL">https://doi.org/10.2967/jnumed.115.164848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2967/jnumed.115.164848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2967%2Fjnumed.115.164848%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Nuclear%2520Medicine%26atitle%3D18%252BF-THK5351%25253A%252BA%252BNovel%252BPET%252BRadiotracer%252Bfor%252BImaging%252BNeurofibrillary%252BPathology%252Bin%252BAlzheimer%252BDisease%26aulast%3DHarada%26aufirst%3DRyuichi%26date%3D2016%26date%3D2015%26volume%3D57%26issue%3D2%26spage%3D208%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael S.  Wolfe</span>. </span><span class="cited-content_cbyCitation_article-title">Targets and Strategies Toward the Development of Alzheimer Therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 1-25. <a href="https://doi.org/10.1007/7355_2016_14" title="DOI URL">https://doi.org/10.1007/7355_2016_14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2016_14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2016_14%26sid%3Dliteratum%253Aachs%26atitle%3DTargets%252Band%252BStrategies%252BToward%252Bthe%252BDevelopment%252Bof%252BAlzheimer%252BTherapeutics%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2016%26date%3D2016%26spage%3D1%26epage%3D25%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAlzheimer%2525E2%252580%252599s%252BDisease%252BII%26aulast%3DWolfe%26aufirst%3DMichael%2BS.%26date%3D2017%26volume%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.E.  Schmidt</span>, <span class="hlFld-ContribAuthor ">D.C.  Matthews</span>, <span class="hlFld-ContribAuthor ">S.  Staelens</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Imaging in Alzheimer Clinical Trials. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 523-563. <a href="https://doi.org/10.1016/B978-0-12-802173-6.00020-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-802173-6.00020-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-802173-6.00020-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-802173-6.00020-4%26sid%3Dliteratum%253Aachs%26atitle%3DMolecular%252BImaging%252Bin%252BAlzheimer%252BClinical%252BTrials%26aulast%3DSchmidt%26aufirst%3DM.E.%26date%3D2016%26spage%3D523%26epage%3D563%26pub%3DElsevier%26atitle%3DDeveloping%252BTherapeutics%252Bfor%252BAlzheimer%252527s%252BDisease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">References. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 353-428. <a href="https://doi.org/10.1016/B978-0-12-804538-1.00036-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-804538-1.00036-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-804538-1.00036-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-804538-1.00036-5%26sid%3Dliteratum%253Aachs%26atitle%3DReferences%26date%3D2016%26spage%3D353%26epage%3D428%26pub%3DElsevier%26atitle%3DAlzheimer%252527s%252BDisease%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masahiro  Ono</span>, <span class="hlFld-ContribAuthor ">Yuki  Doi</span>, <span class="hlFld-ContribAuthor ">Hiroyuki  Watanabe</span>, <span class="hlFld-ContribAuthor ">Masafumi  Ihara</span>, <span class="hlFld-ContribAuthor ">Akihiko  Ozaki</span>, <span class="hlFld-ContribAuthor ">Hideo  Saji</span>. </span><span class="cited-content_cbyCitation_article-title">Structure–activity relationships of radioiodinated diphenyl derivatives with different conjugated double bonds as ligands for α-synuclein aggregates. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2016,</strong> <em>6 </em>
                                    (50)
                                     , 44305-44312. <a href="https://doi.org/10.1039/C6RA02710E" title="DOI URL">https://doi.org/10.1039/C6RA02710E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6RA02710E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6RA02710E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DStructure%2525E2%252580%252593activity%252Brelationships%252Bof%252Bradioiodinated%252Bdiphenyl%252Bderivatives%252Bwith%252Bdifferent%252Bconjugated%252Bdouble%252Bbonds%252Bas%252Bligands%252Bfor%252B%2525CE%2525B1-synuclein%252Baggregates%26aulast%3DOno%26aufirst%3DMasahiro%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D50%26spage%3D44305%26epage%3D44312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lieven  Declercq</span>, <span class="hlFld-ContribAuthor ">Sofie  Celen</span>, <span class="hlFld-ContribAuthor ">Joan  Lecina</span>, <span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>, <span class="hlFld-ContribAuthor ">Thomas  Tousseyn</span>, <span class="hlFld-ContribAuthor ">Diederik  Moechars</span>, <span class="hlFld-ContribAuthor ">Jesus  Alcazar</span>, <span class="hlFld-ContribAuthor ">Manuela  Ariza</span>, <span class="hlFld-ContribAuthor ">Katleen  Fierens</span>, <span class="hlFld-ContribAuthor ">Astrid  Bottelbergs</span>, <span class="hlFld-ContribAuthor ">Jonas  Mariën</span>, <span class="hlFld-ContribAuthor ">Rik  Vandenberghe</span>, <span class="hlFld-ContribAuthor ">Ignacio Jose  Andres</span>, <span class="hlFld-ContribAuthor ">Koen  Van Laere</span>, <span class="hlFld-ContribAuthor ">Alfons  Verbruggen</span>, <span class="hlFld-ContribAuthor ">Guy  Bormans</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of New Tau PET-Tracer Candidates With [
              18
              F]T808 and [
              18
              F]T807. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging</span><span> <strong>2016,</strong> <em>15 </em>, 153601211562492. <a href="https://doi.org/10.1177/1536012115624920" title="DOI URL">https://doi.org/10.1177/1536012115624920</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1536012115624920&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1536012115624920%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%26atitle%3DComparison%252Bof%252BNew%252BTau%252BPET-Tracer%252BCandidates%252BWith%252B%25255B%252B18%252BF%25255DT808%252Band%252B%25255B%252B18%252BF%25255DT807%26aulast%3DDeclercq%26aufirst%3DLieven%26date%3D2016%26date%3D2016%26volume%3D15%26spage%3D153601211562492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masafumi  Shimojo</span>, <span class="hlFld-ContribAuthor ">Makoto  Higuchi</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Suhara</span>, <span class="hlFld-ContribAuthor ">Naruhiko  Sahara</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2015,</strong> <em>9 </em><a href="https://doi.org/10.3389/fnins.2015.00482" title="DOI URL">https://doi.org/10.3389/fnins.2015.00482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2015.00482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2015.00482%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DImaging%252BMultimodalities%252Bfor%252BDissecting%252BAlzheimer%252527s%252BDisease%25253A%252BAdvanced%252BTechnologies%252Bof%252BPositron%252BEmission%252BTomography%252Band%252BFluorescence%252BImaging%26aulast%3DShimojo%26aufirst%3DMasafumi%26date%3D2015%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura E.M.  Wisse</span>, <span class="hlFld-ContribAuthor ">Nirali  Butala</span>, <span class="hlFld-ContribAuthor ">Sandhitsu R.  Das</span>, <span class="hlFld-ContribAuthor ">Christos  Davatzikos</span>, <span class="hlFld-ContribAuthor ">Bradford C.  Dickerson</span>, <span class="hlFld-ContribAuthor ">Sanjeev N.  Vaishnavi</span>, <span class="hlFld-ContribAuthor ">Paul A.  Yushkevich</span>, <span class="hlFld-ContribAuthor ">David A.  Wolk</span>. </span><span class="cited-content_cbyCitation_article-title">Suspected non-AD pathology in mild cognitive impairment. </span><span class="cited-content_cbyCitation_journal-name">Neurobiology of Aging</span><span> <strong>2015,</strong> <em>36 </em>
                                    (12)
                                     , 3152-3162. <a href="https://doi.org/10.1016/j.neurobiolaging.2015.08.029" title="DOI URL">https://doi.org/10.1016/j.neurobiolaging.2015.08.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neurobiolaging.2015.08.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neurobiolaging.2015.08.029%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurobiology%2520of%2520Aging%26atitle%3DSuspected%252Bnon-AD%252Bpathology%252Bin%252Bmild%252Bcognitive%252Bimpairment%26aulast%3DWisse%26aufirst%3DLaura%2BE.M.%26date%3D2015%26volume%3D36%26issue%3D12%26spage%3D3152%26epage%3D3162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhengtao  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of injectable radiopharmaceuticals for nuclear imaging and therapy: a new era in nuclear medicine. </span><span class="cited-content_cbyCitation_journal-name">Materials Technology</span><span> <strong>2015,</strong> <em>30 </em>
                                    (sup8)
                                     , B250-B255. <a href="https://doi.org/10.1080/10667857.2015.1104829" title="DOI URL">https://doi.org/10.1080/10667857.2015.1104829</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10667857.2015.1104829&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10667857.2015.1104829%26sid%3Dliteratum%253Aachs%26jtitle%3DMaterials%2520Technology%26atitle%3DRecent%252Badvances%252Bof%252Binjectable%252Bradiopharmaceuticals%252Bfor%252Bnuclear%252Bimaging%252Band%252Btherapy%25253A%252Ba%252Bnew%252Bera%252Bin%252Bnuclear%252Bmedicine%26aulast%3DQin%26aufirst%3DZhengtao%26date%3D2015%26date%3D2016%26volume%3D30%26issue%3Dsup8%26spage%3DB250%26epage%3DB255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Mingzhang  Gao</span>, <span class="hlFld-ContribAuthor ">Zhidong  Xu</span>, <span class="hlFld-ContribAuthor ">Qi-Huang  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a PET tau tracer [11C]PBB3 for imaging of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4587-4592. <a href="https://doi.org/10.1016/j.bmcl.2015.08.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.08.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.08.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.08.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Bof%252Ba%252BPET%252Btau%252Btracer%252B%25255B11C%25255DPBB3%252Bfor%252Bimaging%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DWang%26aufirst%3DMin%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4587%26epage%3D4592" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John E.  Morley</span>, <span class="hlFld-ContribAuthor ">John C.  Morris</span>, <span class="hlFld-ContribAuthor ">Marla  Berg-Weger</span>, <span class="hlFld-ContribAuthor ">Soo  Borson</span>, <span class="hlFld-ContribAuthor ">Brian D.  Carpenter</span>, <span class="hlFld-ContribAuthor ">Natalia  del Campo</span>, <span class="hlFld-ContribAuthor ">Bruno  Dubois</span>, <span class="hlFld-ContribAuthor ">Keith  Fargo</span>, <span class="hlFld-ContribAuthor ">L. Jaime  Fitten</span>, <span class="hlFld-ContribAuthor ">Joseph H.  Flaherty</span>, <span class="hlFld-ContribAuthor ">Mary  Ganguli</span>, <span class="hlFld-ContribAuthor ">George T.  Grossberg</span>, <span class="hlFld-ContribAuthor ">Theodore K.  Malmstrom</span>, <span class="hlFld-ContribAuthor ">Ronald D.  Petersen</span>, <span class="hlFld-ContribAuthor ">Carroll  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Saykin</span>, <span class="hlFld-ContribAuthor ">Philip  Scheltens</span>, <span class="hlFld-ContribAuthor ">Eric G.  Tangalos</span>, <span class="hlFld-ContribAuthor ">Joe  Verghese</span>, <span class="hlFld-ContribAuthor ">Gordon  Wilcock</span>, <span class="hlFld-ContribAuthor ">Bengt  Winblad</span>, <span class="hlFld-ContribAuthor ">Jean  Woo</span>, <span class="hlFld-ContribAuthor ">Bruno  Vellas</span>. </span><span class="cited-content_cbyCitation_article-title">Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus Conference. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Medical Directors Association</span><span> <strong>2015,</strong> <em>16 </em>
                                    (9)
                                     , 731-739. <a href="https://doi.org/10.1016/j.jamda.2015.06.017" title="DOI URL">https://doi.org/10.1016/j.jamda.2015.06.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jamda.2015.06.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jamda.2015.06.017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Medical%2520Directors%2520Association%26atitle%3DBrain%252BHealth%25253A%252BThe%252BImportance%252Bof%252BRecognizing%252BCognitive%252BImpairment%25253A%252BAn%252BIAGG%252BConsensus%252BConference%26aulast%3DMorley%26aufirst%3DJohn%2BE.%26date%3D2015%26volume%3D16%26issue%3D9%26spage%3D731%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aparna  Baranwal</span>, <span class="hlFld-ContribAuthor ">Jogeshwar  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">18F-Fluorodeoxyglucamines: Reductive amination of hydrophilic 18F-fluoro-2-deoxyglucose with lipophilic amines for the development of potential PET imaging agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (15)
                                     , 2902-2906. <a href="https://doi.org/10.1016/j.bmcl.2015.05.053" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.05.053</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.05.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.05.053%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D18F-Fluorodeoxyglucamines%25253A%252BReductive%252Bamination%252Bof%252Bhydrophilic%252B18F-fluoro-2-deoxyglucose%252Bwith%252Blipophilic%252Bamines%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bpotential%252BPET%252Bimaging%252Bagents%26aulast%3DBaranwal%26aufirst%3DAparna%26date%3D2015%26volume%3D25%26issue%3D15%26spage%3D2902%26epage%3D2906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of Aβ PET probes for AD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic representation of the human tau protein: (A) six human tau isoforms (reproduced from  <cite>Neurochemistry International</cite>, Vol. <em>58</em>, <contrib-group>Martin, L.; Latypova, X.; Terro, F.</contrib-group>, Post-translational modifications of tau protein: implications for Alzheimer’s disease, pp 458–471, Copyright <span class="NLM_year">2011</span>,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> with permission from Elsevier); (B) paper clip conformation (illustration based on ref <a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">58</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. 3D structure of the <sup>386</sup>TDHGAE<sup>391</sup> core of the PHF C-terminus.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Structures of benzimidazoles <b>6</b>, <b>12</b>–<b>18</b>; quinolines <b>7</b> and <b>8</b>; benzothiazoles <b>9</b>–<b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Diverse tau PET ligands: structures of compounds <b>19</b>–<b>25</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. [<sup>18</sup>F]<b>28</b> PET images in mild, moderate, and severe AD patients. In the mild AD case, specific <b>28</b> binding is confined to the medial, anterior, and inferior temporal cortex. The moderate AD case shows additional <b>28</b> retention in association areas. The severe AD case shows more extensive and higher <b>28</b> retention in the neocortex.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Reproduced from  <cite>Current Neurology and Neuroscience Reports</cite>, Vol. <em>14</em>, <contrib-group>Okamura, N.; Harada, R.; Furumoto, S.; Arai, H.; Yanai, K.; Kudo, Y.</contrib-group>, Tau PET imaging in Alzheimer’s disease, p 500, Copyright <span class="NLM_year">2014</span>,<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> with permission from Springer Science and Business Media.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Structures of <sup>11</sup>C-PBB3 (<b>29</b>) and a novel fluorinated <sup>18</sup>F-PBB3 derivative (<b>30</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. [<sup>18</sup>F]<b>31</b> autoradiography on brain sections from different groups and its comparison with PHF-tau and Aβ double IHC.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> [<sup>18</sup>F]<b>31</b> colocalized with PHF-tau but not with Aβ plaques: (top) low magnification; (bottom) high magnification from the framed areas. Shown are images of PHF-tau (left) and Aβ (right) IHC double immunostaining and autoradiogram image (middle) from two adjacent sections (10 μm) from a PHF-tau rich AD brain (frontal lobe). Fluorescent and autoradiographic images were obtained using a Fuji Film FLA-7000 imaging instrument. Scale bars = 2 mm.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. [<sup>18</sup>F]<b>31</b> PET images in a healthy subject (left), mild MCI, and mild and severe AD patients. SUVR means the target-to-cerebellum standardized uptake value. The PET data show increasing tau spread with increasing disease severity. The sensory motor cortex and the primary visual cortex (not visible in this projection) are largely spared even in the severe case, in agreement with Braak staging.<a onclick="showRef(event, 'ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref131 ref132">(131, 132)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/medium/jm-2014-017544_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. [<sup>18</sup>F]<b>31</b> target-to-cerebellum SUV ratio. Images of SUVR measured from 80 to 100 min after injection showed the highest cortical tracer retention by the severe AD subject. The increasing neocortical spread detected in the PET scans with increasing dementia severity agrees with the pathology-derived Braak staging system.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-11/jm5017544/20150605/images/large/jm-2014-017544_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5017544&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06383" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06383" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 135 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Khachaturian, Z. S.</span><span> </span><span class="NLM_article-title">Diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1105</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1001%2Farchneur.1985.04060100083029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=2864910" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADyaL28%252FisV2kug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1985&pages=1097-1105&author=Z.+S.+Khachaturian&title=Diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Khachaturian Z S</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1097-105</span>
        ISSN:<span class="NLM_cas:issn">0003-9942</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTc9SvEChaSAWGmni0r9GoKfW6udTcc2eYP4mhpxYNYFbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL28%252FisV2kug%253D%253D&md5=a47cb19684c6e17f83431a1aadd57cde</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1001%2Farchneur.1985.04060100083029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneur.1985.04060100083029%26sid%3Dliteratum%253Aachs%26aulast%3DKhachaturian%26aufirst%3DZ.%2BS.%26atitle%3DDiagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Neurol.%26date%3D1985%26volume%3D42%26spage%3D1097%26epage%3D1105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: strategies for disease modification</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=387-398&author=M.+Citron&title=Alzheimer%E2%80%99s+disease%3A+strategies+for+disease+modification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520strategies%2520for%2520disease%2520modification%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2010%26volume%3D9%26spage%3D387%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span>Alzheimer’s Association. <a href="http://www.alz.org" class="extLink">www.alz.org</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Association.+www.alz.org."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Anand, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dip Gill, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ali Mahdi, A.</span><span> </span><span class="NLM_article-title">Therapeutics of Alzheimer’s disease: past, present and future</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">50</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=27-50&author=R.+Anandauthor=K.+Dip+Gillauthor=A.+Ali+Mahdi&title=Therapeutics+of+Alzheimer%E2%80%99s+disease%3A+past%2C+present+and+future"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DR.%26aulast%3DDip%2BGill%26aufirst%3DK.%26aulast%3DAli%2BMahdi%26aufirst%3DA.%26atitle%3DTherapeutics%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520past%252C%2520present%2520and%2520future%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D76%26spage%3D27%26epage%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Fargo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleiler, L.</span><span> </span><span class="NLM_article-title">Alzheimer’s Association report</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">e47</span><span class="NLM_x">–</span> <span class="NLM_lpage">e92</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=e47-e92&author=K.+Fargoauthor=L.+Bleiler&title=Alzheimer%E2%80%99s+Association+report"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFargo%26aufirst%3DK.%26aulast%3DBleiler%26aufirst%3DL.%26atitle%3DAlzheimer%25E2%2580%2599s%2520Association%2520report%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2014%26volume%3D10%26spage%3De47%26epage%3De92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Jack, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKhann, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sperling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">257</span><span class="NLM_x">–</span> <span class="NLM_lpage">262</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=257-262&author=C.+R.+Jackauthor=M.+S.+Albertauthor=D.+S.+Knopmanauthor=G.+M.+McKhannauthor=R.+A.+Sperlingauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=C.+H.+Phelps&title=Introduction+to+the+recommendations+from+the+National+Institute+on+Aging-Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Jack Clifford R Jr; Albert Marilyn S; Knopman David S; McKhann Guy M; Sperling Reisa A; Carrillo Maria C; Thies Bill; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">257-62</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Criteria for the clinical diagnosis of Alzheimer's disease (AD) were established in 1984.  A broad consensus now exists that these criteria should be revised to incorporate state-of-the-art scientific knowledge.  METHODS:  The National Institute on Aging (NIA) and the Alzheimer's Association sponsored a series of advisory round table meetings in 2009 whose purpose was to establish a process for revising diagnostic and research criteria for AD.  The recommendation from these advisory meetings was that three separate work groups should be formed with each assigned the task of formulating diagnostic criteria for one phase of the disease: the dementia phase; the symptomatic, pre-dementia phase; and the asymptomatic, preclinical phase of AD.  RESULTS:  Two notable differences from the AD criteria published in 1984 are incorporation of biomarkers of the underlying disease state and formalization of different stages of disease in the diagnostic criteria.  There was a broad consensus within all three workgroups that much additional work is needed to validate the application of biomarkers for diagnostic purposes.  In the revised NIA-Alzheimer's Association criteria, a semantic and conceptual distinction is made between AD pathophysiological processes and clinically observable syndromes that result, whereas this distinction was blurred in the 1984 criteria.  CONCLUSIONS:  The new criteria for AD are presented in three documents.  The core clinical criteria of the recommendations regarding AD dementia and MCI due to AD are intended to guide diagnosis in the clinical setting.  However, the recommendations of the preclinical AD workgroup are intended purely for research purposes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSC-bLEOO4dYpfW6udTcc2eaX6Lz2ypdlmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktg%253D%253D&md5=348e60537bf1bed543d5572130fc2f3e</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DAlbert%26aufirst%3DM.%2BS.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DMcKhann%26aufirst%3DG.%2BM.%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DIntroduction%2520to%2520the%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging-Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D257%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">McKhann, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knopman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chertkow, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawash, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koroshetz, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manly, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayeux, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossor, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weintraub, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">263</span><span class="NLM_x">–</span> <span class="NLM_lpage">269</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514250" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=263-269&author=G.+M.+McKhannauthor=D.+S.+Knopmanauthor=H.+Chertkowauthor=B.+T.+Hymanauthor=C.+R.+Jackauthor=C.+H.+Kawashauthor=W.+E.+Klunkauthor=W.+J.+Koroshetzauthor=J.+J.+Manlyauthor=R.+Mayeuxauthor=R.+C.+Mohsauthor=J.+C.+Morrisauthor=M.+N.+Rossorauthor=P.+Scheltensauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=S.+Weintraubauthor=C.+H.+Phelps&title=The+diagnosis+of+dementia+due+to+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+National+Institute+on+Aging-Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">McKhann Guy M; Knopman David S; Chertkow Howard; Hyman Bradley T; Jack Clifford R Jr; Kawas Claudia H; Klunk William E; Koroshetz Walter J; Manly Jennifer J; Mayeux Richard; Mohs Richard C; Morris John C; Rossor Martin N; Scheltens Philip; Carrillo Maria C; Thies Bill; Weintraub Sandra; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">263-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of revising the 1984 criteria for Alzheimer's disease (AD) dementia.  The workgroup sought to ensure that the revised criteria would be flexible enough to be used by both general healthcare providers without access to neuropsychological testing, advanced imaging, and cerebrospinal fluid measures, and specialized investigators involved in research or in clinical trial studies who would have these tools available.  We present criteria for all-cause dementia and for AD dementia.  We retained the general framework of probable AD dementia from the 1984 criteria.  On the basis of the past 27 years of experience, we made several changes in the clinical criteria for the diagnosis.  We also retained the term possible AD dementia, but redefined it in a manner more focused than before.  Biomarker evidence was also integrated into the diagnostic formulations for probable and possible AD dementia for use in research settings.  The core clinical criteria for AD dementia will continue to be the cornerstone of the diagnosis in clinical practice, but biomarker evidence is expected to enhance the pathophysiological specificity of the diagnosis of AD dementia.  Much work lies ahead for validating the biomarker diagnosis of AD dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSIJKJbLTgsvCfW6udTcc2eaX6Lz2ypdlmLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktQ%253D%253D&md5=866f02e65270dc427366138022cc1feb</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.005%26sid%3Dliteratum%253Aachs%26aulast%3DMcKhann%26aufirst%3DG.%2BM.%26aulast%3DKnopman%26aufirst%3DD.%2BS.%26aulast%3DChertkow%26aufirst%3DH.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKawash%26aufirst%3DC.%2BH.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DKoroshetz%26aufirst%3DW.%2BJ.%26aulast%3DManly%26aufirst%3DJ.%2BJ.%26aulast%3DMayeux%26aufirst%3DR.%26aulast%3DMohs%26aufirst%3DR.%2BC.%26aulast%3DMorris%26aufirst%3DJ.%2BC.%26aulast%3DRossor%26aufirst%3DM.%2BN.%26aulast%3DScheltens%26aufirst%3DP.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DWeintraub%26aufirst%3DS.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DThe%2520diagnosis%2520of%2520dementia%2520due%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging-Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia.%26date%3D2011%26volume%3D7%26spage%3D263%26epage%3D269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Albert, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gamst, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holtzman, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snyder, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">270</span><span class="NLM_x">–</span> <span class="NLM_lpage">279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=270-279&author=M.+S.+Albertauthor=S.+T.+DeKoskyauthor=D.+Dicksonauthor=B.+Duboisauthor=H.+H.+Feldmanauthor=N.+C.+Foxauthor=A.+Gamstauthor=D.+M.+Holtzmanauthor=W.+J.+Jagustauthor=R.+C.+Petersenauthor=P.+J.+Snyderauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=C.+H.+Phelps&title=The+diagnosis+of+mild+cognitive+impairment+due+to+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+National+Institute+on+Aging-Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Albert Marilyn S; DeKosky Steven T; Dickson Dennis; Dubois Bruno; Feldman Howard H; Fox Nick C; Gamst Anthony; Holtzman David M; Jagust William J; Petersen Ronald C; Snyder Peter J; Carrillo Maria C; Thies Bill; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">270-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The National Institute on Aging and the Alzheimer's Association charged a workgroup with the task of developing criteria for the symptomatic predementia phase of Alzheimer's disease (AD), referred to in this article as mild cognitive impairment due to AD.  The workgroup developed the following two sets of criteria: (1) core clinical criteria that could be used by healthcare providers without access to advanced imaging techniques or cerebrospinal fluid analysis, and (2) research criteria that could be used in clinical research settings, including clinical trials.  The second set of criteria incorporate the use of biomarkers based on imaging and cerebrospinal fluid measures.  The final set of criteria for mild cognitive impairment due to AD has four levels of certainty, depending on the presence and nature of the biomarker findings.  Considerable work is needed to validate the criteria that use biomarkers and to standardize biomarker analysis for use in community settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSOqrn-c4Of3KfW6udTcc2ea4UDwtoCrGrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktA%253D%253D&md5=609df181936d75a42ae8db4826713f85</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DAlbert%26aufirst%3DM.%2BS.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DDickson%26aufirst%3DD.%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DGamst%26aufirst%3DA.%26aulast%3DHoltzman%26aufirst%3DD.%2BM.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DPetersen%26aufirst%3DR.%2BC.%26aulast%3DSnyder%26aufirst%3DP.%2BJ.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DThe%2520diagnosis%2520of%2520mild%2520cognitive%2520impairment%2520due%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging-Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D270%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Sperling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckett, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison-Bogorad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagster, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=280-292&author=R.+A.+Sperlingauthor=P.+S.+Aisenauthor=L.+A.+Beckettauthor=D.+A.+Bennettauthor=S.+Craftauthor=A.+M.+Faganauthor=T.+Iwatsuboauthor=C.+R.+Jackauthor=J.+Kayeauthor=T.+J.+Montineauthor=D.+C.+Parkauthor=E.+M.+Reimanauthor=C.+C.+Roweauthor=E.+Siemersauthor=Y.+Sternauthor=K.+Yaffeauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=M.+Morrison-Bogoradauthor=M.+V.+Wagsterauthor=C.+H.+Phelps&title=Toward+defining+the+preclinical+stages+of+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+National+Institute+on+Aging-Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Sperling Reisa A; Aisen Paul S; Beckett Laurel A; Bennett David A; Craft Suzanne; Fagan Anne M; Iwatsubo Takeshi; Jack Clifford R Jr; Kaye Jeffrey; Montine Thomas J; Park Denise C; Reiman Eric M; Rowe Christopher C; Siemers Eric; Stern Yaakov; Yaffe Kristine; Carrillo Maria C; Thies Bill; Morrison-Bogorad Marcelle; Wagster Molly V; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia.  This long "preclinical" phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the link between the pathological cascade of AD and the emergence of clinical symptoms.  The National Institute on Aging and the Alzheimer's Association convened an international workgroup to review the biomarker, epidemiological, and neuropsychological evidence, and to develop recommendations to determine the factors which best predict the risk of progression from "normal" cognition to mild cognitive impairment and AD dementia.  We propose a conceptual framework and operational research criteria, based on the prevailing scientific evidence to date, to test and refine these models with longitudinal clinical research studies.  These recommendations are solely intended for research purposes and do not have any clinical implications at this time.  It is hoped that these recommendations will provide a common rubric to advance the study of preclinical AD, and ultimately, aid the field in moving toward earlier intervention at a stage of AD when some disease-modifying therapies may be most efficacious.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSLt7lRqEFUJVfW6udTcc2ea4UDwtoCrGrbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktw%253D%253D&md5=116797e3769a70f38cac89730a967b4d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DBeckett%26aufirst%3DL.%2BA.%26aulast%3DBennett%26aufirst%3DD.%2BA.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DStern%26aufirst%3DY.%26aulast%3DYaffe%26aufirst%3DK.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DMorrison-Bogorad%26aufirst%3DM.%26aulast%3DWagster%26aufirst%3DM.%2BV.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DToward%2520defining%2520the%2520preclinical%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging-Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D280%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Neuropathological stageing of Alzheimer-related changes</span> <span class="citation_source-journal">Acta Neuropathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">259</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2FBF00308809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=1759558" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1991&pages=239-259&author=H.+Braakauthor=E.+Braak&title=Neuropathological+stageing+of+Alzheimer-related+changes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Neuropathological stageing of Alzheimer-related changes</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Acta neuropathologica</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-59</span>
        ISSN:<span class="NLM_cas:issn">0001-6322</span>.
    </div><div class="casAbstract">Eighty-three brains obtained at autopsy from nondemented and demented individuals were examined for extracellular amyloid deposits and intraneuronal neurofibrillary changes.  The distribution pattern and packing density of amyloid deposits turned out to be of limited significance for differentiation of neuropathological stages.  Neurofibrillary changes occurred in the form of neuritic plaques, neurofibrillary tangles and neuropil threads.  The distribution of neuritic plaques varied widely not only within architectonic units but also from one individual to another.  Neurofibrillary tangles and neuropil threads, in contrast, exhibited a characteristic distribution pattern permitting the differentiation of six stages.  The first two stages were characterized by an either mild or severe alteration of the transentorhinal layer Pre-alpha (transentorhinal stages I-II).  The two forms of limbic stages (stages III-IV) were marked by a conspicuous affection of layer Pre-alpha in both transentorhinal region and proper entorhinal cortex.  In addition, there was mild involvement of the first Ammon's horn sector.  The hallmark of the two isocortical stages (stages V-VI) was the destruction of virtually all isocortical association areas.  The investigation showed that recognition of the six stages required qualitative evaluation of only a few key preparations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQIZP19xbDelK_dlEzl_fBafW6udTcc2eZmp67dAKm_ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK387gtFOiug%253D%253D&md5=b3e2663c943c202f121efeb65527a280</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1007%2FBF00308809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00308809%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DNeuropathological%2520stageing%2520of%2520Alzheimer-related%2520changes%26jtitle%3DActa%2520Neuropathol.%26date%3D1991%26volume%3D82%26spage%3D239%26epage%3D259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Braak, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braak, E.</span><span> </span><span class="NLM_article-title">Frequency of stages of Alzheimer-related lesions in different age categories</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">351</span><span class="NLM_x">–</span> <span class="NLM_lpage">357</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS0197-4580%2897%2900056-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=9330961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADyaK2svnt1Sgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=351-357&author=H.+Braakauthor=E.+Braak&title=Frequency+of+stages+of+Alzheimer-related+lesions+in+different+age+categories"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Frequency of stages of Alzheimer-related lesions in different age categories</span></div><div class="casAuthors">Braak H; Braak E</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of aging</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">351-7</span>
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    </div><div class="casAbstract">Alzheimer's disease is a relentlessly progressing dementing disorder.  Major pathological hallmarks include extracellular deposits of amyloid protein and intraneuronal neurofibrillary changes.  No remissions occur in the course of the disease.  Initial amyloid deposits develop in poorly myelinated areas of the basal neocortex.  From there, they spread into adjoining areas and the hippocampus.  Deposits eventually infiltrate all cortical areas, including densely myelinated primary fields of the neocortex (stages A-C).  Intraneuronal lesions develop initially in the transentorhinal region, then spread in a predictable manner across other areas (stages I-VI).  At stages I-II, neurofibrillary changes develop preferentially in the absence of amyloid deposits.  A proportion of cases shows early development of amyloid deposits and/or intraneuronal changes.  Advanced age is thus not a prerequisite for the evolution of the lesions.  Alzheimer's disease is an age-related, not an age-dependent disease.  The degree of brain destruction at stages III-IV frequently leads to the appearance of initial clinical symptoms.  The stages V-VI representing fully developed Alzheimer's disease are increasingly prevalent with increasing age.  The arithmetic means of the stages of both the amyloid-depositing and the neurofibrillary pathology increase with age.  Age is a risk factor for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOL3vvMAZc7kwlCcfExbvbfW6udTcc2eZmp67dAKm_ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2svnt1Sgug%253D%253D&md5=8ec456cdc5b4a34af45d92871144eeda</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2FS0197-4580%2897%2900056-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0197-4580%252897%252900056-0%26sid%3Dliteratum%253Aachs%26aulast%3DBraak%26aufirst%3DH.%26aulast%3DBraak%26aufirst%3DE.%26atitle%3DFrequency%2520of%2520stages%2520of%2520Alzheimer-related%2520lesions%2520in%2520different%2520age%2520categories%26jtitle%3DNeurobiol.%2520Aging%26date%3D1997%26volume%3D18%26spage%3D351%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Delacourte, A.</span><span> </span><span class="NLM_article-title">Diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Ann. Biol. Clin.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=9754238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADyaK1cvis1yntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1998&pages=133-142&author=A.+Delacourte&title=Diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis of Alzheimer's disease</span></div><div class="casAuthors">Delacourte A</div><div class="citationInfo"><span class="NLM_cas:title">Annales de biologie clinique</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-42</span>
        ISSN:<span class="NLM_cas:issn">0003-3898</span>.
    </div><div class="casAbstract">Alzheimer's disease is a neurodegenerative disorder leading to cognitive impairment (amnesia, aphasia, apraxia and agnosia).  The prevalence of this age related disabling illness is increasing.  During the course of the disease, the clinical diagnosis will be that of "possible Alzheimer's disease", then "probable Alzheimer's disease".  But the diagnosis of "definite Alzheimer's disease" requires a post-mortem brain examination and the demonstration of numerous senile plaques and neurofibrillary tangles in hippocampal and association cortical areas.  The neuropathological examination confirms probable Alzheimer's disease clinical diagnosis in 85% of the cases examined in medical schools.  However, with much more than 15% errors, the early diagnosis of Alzheimer's disease must be improved since it is a key factor for the therapeutic approach, and more especially for the efficiency of drug trials.  At the present time, there are new leads for a biological diagnosis in the blood or the CSF.  However, the natural (and molecular) history of Alzheimer's disease points out that all biochemical dysfunctions remain in the CNS, and more particularly in association brain areas.  This is demonstrated using reliable biochemical markers such as A beta and pathological Tau proteins, which are the basic components of amyloid deposits and neurofibrillary tangles, respectively.  Also, a genetic diagnosis can be performed in half of familial autosomic dominant Alzheimer's disease, which represents less than 1% of all Alzheimer's disease cases.  Together, this shows that there is a lack of reliable Alzheimer's disease markers.  The search for new specific markers (clinical, epidemiological, genetic, biochemical, biological) must go on.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT1f1PBUrz3XdyzdcP07UmufW6udTcc2eZmp67dAKm_ELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1cvis1yntA%253D%253D&md5=3c95236af3100e692fad9515b72cfbdd</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDelacourte%26aufirst%3DA.%26atitle%3DDiagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAnn.%2520Biol.%2520Clin.%26date%3D1998%26volume%3D56%26spage%3D133%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arnold, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span> </span><span class="NLM_article-title">Strategies for improving the postmortem neuropathological diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">S75</span><span class="NLM_x">–</span> <span class="NLM_lpage">S79</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1997&pages=S75-S79&author=J.+Q.+Trojanowskiauthor=C.+M.+Clarkauthor=M.+L.+Schmidtauthor=S.+E.+Arnoldauthor=V.+M.+Lee&title=Strategies+for+improving+the+postmortem+neuropathological+diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DClark%26aufirst%3DC.%2BM.%26aulast%3DSchmidt%26aufirst%3DM.%2BL.%26aulast%3DArnold%26aufirst%3DS.%2BE.%26aulast%3DLee%26aufirst%3DV.%2BM.%26atitle%3DStrategies%2520for%2520improving%2520the%2520postmortem%2520neuropathological%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D1997%26volume%3D18%26spage%3DS75%26epage%3DS79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">9</span><span class="NLM_x">) </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&issue=9&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26issue%3D9%26spage%3D698%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Dubois, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacova, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barberger-Gateau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cummings, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delacourte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galasko, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jicha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Brien, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasquier, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossor, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salloway, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span> </span><span class="NLM_article-title">Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">734</span><span class="NLM_x">–</span> <span class="NLM_lpage">746</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS1474-4422%2807%2970178-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=17616482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BD2svhslKitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=734-746&author=B.+Duboisauthor=H.+H.+Feldmanauthor=C.+Jacovaauthor=S.+T.+DeKoskyauthor=P.+Barberger-Gateauauthor=J.+Cummingsauthor=A.+Delacourteauthor=D.+Galaskoauthor=S.+Gauthierauthor=G.+Jichaauthor=K.+Meguroauthor=J.+O%E2%80%99Brienauthor=F.+Pasquierauthor=P.+Robertauthor=M.+Rossorauthor=S.+Sallowayauthor=Y.+Sternauthor=P.+J.+Visserauthor=P.+Scheltens&title=Research+criteria+for+the+diagnosis+of+Alzheimer%E2%80%99s+disease%3A+revising+the+NINCDS-ADRDA+criteria"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria</span></div><div class="casAuthors">Dubois Bruno; Feldman Howard H; Jacova Claudia; Dekosky Steven T; Barberger-Gateau Pascale; Cummings Jeffrey; Delacourte Andre; Galasko Douglas; Gauthier Serge; Jicha Gregory; Meguro Kenichi; O'brien John; Pasquier Florence; Robert Philippe; Rossor Martin; Salloway Steven; Stern Yaakov; Visser Pieter J; Scheltens Philip</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">734-46</span>
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    </div><div class="casAbstract">The NINCDS-ADRDA and the DSM-IV-TR criteria for Alzheimer's disease (AD) are the prevailing diagnostic standards in research; however, they have now fallen behind the unprecedented growth of scientific knowledge.  Distinctive and reliable biomarkers of AD are now available through structural MRI, molecular neuroimaging with PET, and cerebrospinal fluid analyses.  This progress provides the impetus for our proposal of revised diagnostic criteria for AD.  Our framework was developed to capture both the earliest stages, before full-blown dementia, as well as the full spectrum of the illness.  These new criteria are centred on a clinical core of early and significant episodic memory impairment.  They stipulate that there must also be at least one or more abnormal biomarkers among structural neuroimaging with MRI, molecular neuroimaging with PET, and cerebrospinal fluid analysis of amyloid beta or tau proteins.  The timeliness of these criteria is highlighted by the many drugs in development that are directed at changing pathogenesis, particularly at the production and clearance of amyloid beta as well as at the hyperphosphorylation state of tau.  Validation studies in existing and prospective cohorts are needed to advance these criteria and optimise their sensitivity, specificity, and accuracy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSI_NH_wEZ5GZ6KlWarZTAzfW6udTcc2eZLORNPpUAJVbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svhslKitQ%253D%253D&md5=cfbed7fc82fae795e4739464f937c2c1</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2807%2970178-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252807%252970178-3%26sid%3Dliteratum%253Aachs%26aulast%3DDubois%26aufirst%3DB.%26aulast%3DFeldman%26aufirst%3DH.%2BH.%26aulast%3DJacova%26aufirst%3DC.%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DBarberger-Gateau%26aufirst%3DP.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DGalasko%26aufirst%3DD.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DJicha%26aufirst%3DG.%26aulast%3DMeguro%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DJ.%26aulast%3DPasquier%26aufirst%3DF.%26aulast%3DRobert%26aufirst%3DP.%26aulast%3DRossor%26aufirst%3DM.%26aulast%3DSalloway%26aufirst%3DS.%26aulast%3DStern%26aufirst%3DY.%26aulast%3DVisser%26aufirst%3DP.%2BJ.%26aulast%3DScheltens%26aufirst%3DP.%26atitle%3DResearch%2520criteria%2520for%2520the%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520revising%2520the%2520NINCDS-ADRDA%2520criteria%26jtitle%3DLancet%2520Neurol.%26date%3D2007%26volume%3D6%26spage%3D734%26epage%3D746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Isaac, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vamvakas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abadie, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gispen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pani, L.</span><span> </span><span class="NLM_article-title">Qualification opinion of novel methodologies in the predementia stage of Alzheimer’s disease: cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden—regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials</span> <span class="citation_source-journal">Eur. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">788</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.euroneuro.2011.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21903360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GrtLzE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=781-788&author=M.+Isaacauthor=S.+Vamvakasauthor=E.+Abadieauthor=B.+Jonssonauthor=C.+Gispenauthor=L.+Pani&title=Qualification+opinion+of+novel+methodologies+in+the+predementia+stage+of+Alzheimer%E2%80%99s+disease%3A+cerebro-spinal-fluid+related+biomarkers+for+drugs+affecting+amyloid+burden%E2%80%94regulatory+considerations+by+European+Medicines+Agency+focusing+in+improving+benefit%2Frisk+in+regulatory+trials"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden - Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials</span></div><div class="casAuthors">Isaac, Maria; Vamvakas, Spiros; Abadie, Eric; Jonsson, Bertil; Gispen, Christine; Pani, Luca</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">781-788</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The European Medicines Agency (EMA) in London is responsible for the Regulatory review of new medicinal products for Marketing Authorisation, through which pharmaceutical companies may obtain first Marketing Authorisation and subsequent Variations valid throughout the EU and EFTA.  The qualification opinion of novel methodologies is a new procedure where applicants can obtain scientific advice on new methodologies for regulatory clin. trials of efficacy of new compds.  It will help benefit/risk assessment of the CHMP.  The definition of prodromal AD is acceptable.  The "Dubois Criteria" as criteria to define the population must be validated in full at the time of the submission of the dossiers.  Including a pos. CSF biomarker profile is considered predictive for the evaluation of the AD-dementia type.  However, although high CSF tau and low CSF Aβ42 are predictive of Alzheimer's disease, the criterion "pos. CSF tau/Aβ42 ratio" is not well defined.  The qualification of biomarkers in the pre-dementia stage of Alzheimer's disease will allow better inclusion criteria of patients in pre-dementia trials in which the benefit/risk is higher for treatment with these novel compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR89C6L4ik77Vg90H21EOLACvtfcHk0lg51FXDxGWa0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GrtLzE&md5=c0f8433dfde0cdae9af86f0975478da9</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2011.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2011.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DIsaac%26aufirst%3DM.%26aulast%3DVamvakas%26aufirst%3DS.%26aulast%3DAbadie%26aufirst%3DE.%26aulast%3DJonsson%26aufirst%3DB.%26aulast%3DGispen%26aufirst%3DC.%26aulast%3DPani%26aufirst%3DL.%26atitle%3DQualification%2520opinion%2520of%2520novel%2520methodologies%2520in%2520the%2520predementia%2520stage%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520cerebro-spinal-fluid%2520related%2520biomarkers%2520for%2520drugs%2520affecting%2520amyloid%2520burden%25E2%2580%2594regulatory%2520considerations%2520by%2520European%2520Medicines%2520Agency%2520focusing%2520in%2520improving%2520benefit%252Frisk%2520in%2520regulatory%2520trials%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2011%26volume%3D21%26spage%3D781%26epage%3D788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Blennow, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hampel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zetterberg, H.</span><span> </span><span class="NLM_article-title">Biomarkers in amyloid-β immunotherapy trials in Alzheimer’s disease</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">201</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=189-201&author=K.+Blennowauthor=H.+Hampelauthor=H.+Zetterberg&title=Biomarkers+in+amyloid-%CE%B2+immunotherapy+trials+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBlennow%26aufirst%3DK.%26aulast%3DHampel%26aufirst%3DH.%26aulast%3DZetterberg%26aufirst%3DH.%26atitle%3DBiomarkers%2520in%2520amyloid-%25CE%25B2%2520immunotherapy%2520trials%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D189%26epage%3D201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Zetterberg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tullhög, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minthon, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Londos, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blennow, K.</span><span> </span><span class="NLM_article-title">Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients</span> <span class="citation_source-journal">Eur. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">326</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1159%2F000311703" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20516693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3cnmsV2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2010&pages=326-330&author=H.+Zetterbergauthor=K.+Tullh%C3%B6gauthor=O.+Hanssonauthor=L.+Minthonauthor=E.+Londosauthor=K.+Blennow&title=Low+incidence+of+post-lumbar+puncture+headache+in+1%2C089+consecutive+memory+clinic+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients</span></div><div class="casAuthors">Zetterberg Henrik; Tullhog Kristian; Hansson Oskar; Minthon Lennart; Londos Elisabet; Blennow Kaj</div><div class="citationInfo"><span class="NLM_cas:title">European neurology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">326-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">AIM:  To examine the incidence of post-lumbar puncture headache (PLPH) in patients admitted for cognitive disturbances.  METHODS:  The incidence of PLPH and other general (subdural hematoma, meningitis, encephalitis) or local (local pain, spinal hematoma, local infection) complications was evaluated in 1,089 consecutive patients (aged 23-89 years) who underwent lumbar puncture as a part of the routine diagnostic evaluation between February 2001 and March 2007 at a specialized memory clinic.  RESULTS:  28 (2.6%) of the patients reported PLPH of mild severity.  No other local or general complications occurred.  CONCLUSIONS:  The incidence of PLPH in patients with cognitive disturbances is low and CSF analyses can thus be part of the diagnostic work-up at memory clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWW9h57PWlOtK0qsdY6Nc1fW6udTcc2eZ79F1rxpa4brntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cnmsV2msA%253D%253D&md5=63d693a5c91fbcce3e41f423f62df042</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1159%2F000311703&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000311703%26sid%3Dliteratum%253Aachs%26aulast%3DZetterberg%26aufirst%3DH.%26aulast%3DTullh%25C3%25B6g%26aufirst%3DK.%26aulast%3DHansson%26aufirst%3DO.%26aulast%3DMinthon%26aufirst%3DL.%26aulast%3DLondos%26aufirst%3DE.%26aulast%3DBlennow%26aufirst%3DK.%26atitle%3DLow%2520incidence%2520of%2520post-lumbar%2520puncture%2520headache%2520in%25201%252C089%2520consecutive%2520memory%2520clinic%2520patients%26jtitle%3DEur.%2520Neurol.%26date%3D2010%26volume%3D63%26spage%3D326%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">DeKosky, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marek, K.</span><span> </span><span class="NLM_article-title">Looking backward to move forward: early detection of neurodegenerative disorders</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">302</span><span class="NLM_x">, </span> <span class="NLM_fpage">830</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=830-834&author=S.+T.+DeKoskyauthor=K.+Marek&title=Looking+backward+to+move+forward%3A+early+detection+of+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDeKosky%26aufirst%3DS.%2BT.%26aulast%3DMarek%26aufirst%3DK.%26atitle%3DLooking%2520backward%2520to%2520move%2520forward%253A%2520early%2520detection%2520of%2520neurodegenerative%2520disorders%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D830%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span> </span><span class="NLM_article-title">Brain imaging in the study of Alzheimer’s disease</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">–</span> <span class="NLM_lpage">516</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=505-516&author=E.+M.+Reimanauthor=W.+J.+Jagust&title=Brain+imaging+in+the+study+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DBrain%2520imaging%2520in%2520the%2520study%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeuroImage%26date%3D2012%26volume%3D61%26spage%3D505%26epage%3D516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Zhou, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, W.</span><span> </span><span class="NLM_article-title">Advances of molecular imaging probes for the diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">221</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.2174%2F1567205011666140131121259" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24484277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlt1eru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2014&pages=221-231&author=M.+Zhouauthor=X.+Wangauthor=Z.+Liuauthor=L.+Yuauthor=S.+Huauthor=L.+Chenauthor=W.+Zeng&title=Advances+of+molecular+imaging+probes+for+the+diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Advances of Molecular Imaging Probes for the Diagnosis of Alzheimer's Disease</span></div><div class="casAuthors">Zhou, Ming; Wang, Xiaobo; Liu, Zhiguo; Yu, Lun; Hu, Shuo; Chen, Lizhang; Zeng, Wenbin</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">221-231</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive decline in multiple cognitive domains and it becomes the most common cause of dementia in the elderly.  There is an urgent need for the early diagnosis and treatment of AD to ease caregiver burden and medical costs, as well as improve patients' living activities assocd. with the dramatic increasing no. of affected individuals.  Mol. imaging with target-specific probes is contributing to identify the underlying biol. in AD, which benefits to the early diagnosis of AD and the evaluation of anti-AD therapy.  Mol. imaging probes, such as 11C-PIB, 11C-MP4A, 18F-AV-45, and 18F-FDG, can selectively bind to special bimol. of AD or accurately accumulate at the location of damage areas, thus become an edge tool for a better management of the diseases in the clin. practice and new drug development.  In the past decades, a large variety of probes is being developed and tested to be useful for the early and accurate diagnosis of Alzheimer's disease, patient selection for disease-modifying therapeutic trials and monitoring the effect of anti-amyloid therapy.  Since imaging probes may also help to guide physicians to identify those patients that could best benefit from a given therapeutic regimen, dose, or duration of drug, this paper is to present a perspective of the available imaging probes for AD, classified on different modalities.  Meanwhile, recent advances of those probes that have been selected for clin. trials and are at the different stages of the US Food and Drugs Administration (FDA) approval are outlined.  Addnl., future directions and specific application of imaging strategies designed for both diagnosis and treatment for AD are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLa6ITw42ws7Vg90H21EOLACvtfcHk0lhMs_oevORL6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlt1eru7k%253D&md5=d919e86d68e5ba2243d1715db76c3d4d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1567205011666140131121259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1567205011666140131121259%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZeng%26aufirst%3DW.%26atitle%3DAdvances%2520of%2520molecular%2520imaging%2520probes%2520for%2520the%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2014%26volume%3D11%26spage%3D221%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Valk, P. E.; Bailey, D. L.; Townsend, D. W.; Maisey, M. N.</span> <span class="citation_source-book">Positron Emission Tomography: Basic Science</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=P.+E.+Valk&author=D.+L.+Bailey&author=D.+W.+Townsend&author=M.+N.+Maisey&title=Positron+Emission+Tomography%3A+Basic+Science"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DValk%26aufirst%3DP.%2BE.%26btitle%3DPositron%2520Emission%2520Tomography%253A%2520Basic%2520Science%26pub%3DSpringer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Matthews, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabiner, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">Positron emission tomography molecular imaging for drug development</span> <span class="citation_source-journal">Br. J. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1111%2Fj.1365-2125.2011.04085.x" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2011&pages=175-186&author=P.+M.+Matthewsauthor=E.+A.+Rabinerauthor=J.+Passchierauthor=R.+N.+Gunn&title=Positron+emission+tomography+molecular+imaging+for+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2125.2011.04085.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2125.2011.04085.x%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DP.%2BM.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DPositron%2520emission%2520tomography%2520molecular%2520imaging%2520for%2520drug%2520development%26jtitle%3DBr.%2520J.%2520Clin.%2520Pharmacol.%26date%3D2011%26volume%3D73%26spage%3D175%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Piel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösch, F.</span><span> </span><span class="NLM_article-title">Positron emission tomography in CNS drug discovery and drug monitoring</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">9232</span><span class="NLM_x">–</span> <span class="NLM_lpage">9258</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm5001858" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSns77E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=9232-9258&author=M.+Pielauthor=I.+Vernalekenauthor=F.+R%C3%B6sch&title=Positron+emission+tomography+in+CNS+drug+discovery+and+drug+monitoring"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring</span></div><div class="casAuthors">Piel, Markus; Vernaleken, Ingo; Roesch, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9232-9258</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Mol. imaging methods such as positron emission tomog. (PET) are increasingly involved in the development of new drugs.  Using radioactive tracers as imaging probes, PET allows the detn. of the pharmacokinetic and pharmacodynamic properties of a drug candidate, via recording target engagement, the pattern of distribution, and metab.  Because of the noninvasive nature and quant. end point obtainable by mol. imaging, it seems inherently suited for the examn. of a pharmaceutical's behavior in the brain.  Mol. imaging, most esp. PET, can therefore be a valuable tool in CNS drug research.  In this Perspective, we present the basic principles of PET, the importance of appropriate tracer selection, the impact of improved radiopharmaceutical chem. in radiotracer development, and the different roles that PET can fulfill in CNS drug research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGTZn1_mOVTLVg90H21EOLACvtfcHk0ljLRiji1labcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSns77E&md5=4b8af654ccd92d927b9b938afccd978e</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm5001858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5001858%26sid%3Dliteratum%253Aachs%26aulast%3DPiel%26aufirst%3DM.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26atitle%3DPositron%2520emission%2520tomography%2520in%2520CNS%2520drug%2520discovery%2520and%2520drug%2520monitoring%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D9232%26epage%3D9258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">The β-amyloid hypothesis in Alzheimer’s disease: seeing is believing</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">265</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300058m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=265-267&author=H.+F.+Kung&title=The+%CE%B2-amyloid+hypothesis+in+Alzheimer%E2%80%99s+disease%3A+seeing+is+believing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fml300058m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300058m%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DThe%2520%25CE%25B2-amyloid%2520hypothesis%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520seeing%2520is%2520believing%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D265%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fjlcr.2989" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24285314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=89-95&author=N.+S.+Masonauthor=C.+A.+Mathisauthor=W.+E.+Klunk&title=Positron+emission+tomography+radioligands+for+in+vivo+imaging+of+A%CE%B2+plaques"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography radioligands for in vivo imaging of Aβ plaques</span></div><div class="casAuthors">Mason, N. Scott; Mathis, Chester A.; Klunk, William E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">89-95</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  The development of positron emission tomog. (PET) radioligands for the non-invasive imaging of amyloid-β plaque burden has been the focus of intense research efforts over the last decade.  A variety of structural backbones have been investigated and several radiolabeled mols. have been evaluated in phase I (and later) clin. studies.  These efforts have been driven by the desire not only to develop a suitable diagnostic imaging agent but also to develop a means to evaluate potential therapies for Alzheimer's disease.  This review focuses on the development of these ligands, as well as the radiochem. and current regulatory status of these PET radioligands.  Particular attention is given to those ligands that have progressed to the later stages of drug development (phase II/III clin. trial studies) or approved New Drug Application status.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFhPmau7iHILVg90H21EOLACvtfcHk0ljLRiji1labcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlejtbs%253D&md5=423e02bcc2709e718d7a32adb552f81f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.2989&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.2989%26sid%3Dliteratum%253Aachs%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DPositron%2520emission%2520tomography%2520radioligands%2520for%2520in%2520vivo%2520imaging%2520of%2520A%25CE%25B2%2520plaques%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D89%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Noël, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gras, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hureau, C.</span><span> </span><span class="NLM_article-title">The benzazole scaffold: a SWAT to combat Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">7747</span><span class="NLM_x">–</span> <span class="NLM_lpage">7762</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2013&pages=7747-7762&author=S.+No%C3%ABlauthor=S.+Cadetauthor=E.+Grasauthor=C.+Hureau&title=The+benzazole+scaffold%3A+a+SWAT+to+combat+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNo%25C3%25ABl%26aufirst%3DS.%26aulast%3DCadet%26aufirst%3DS.%26aulast%3DGras%26aufirst%3DE.%26aulast%3DHureau%26aufirst%3DC.%26atitle%3DThe%2520benzazole%2520scaffold%253A%2520a%2520SWAT%2520to%2520combat%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2013%26volume%3D42%26spage%3D7747%26epage%3D7762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Amyloid imaging with PET in early Alzheimer disease diagnosis</span> <span class="citation_source-journal">Med. Clin. North Am.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">377</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.mcna.2012.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23642577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3sngvFCrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2013&pages=377-398&author=C.+C.+Roweauthor=V.+L.+Villemagne&title=Amyloid+imaging+with+PET+in+early+Alzheimer+disease+diagnosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid imaging with PET in early Alzheimer disease diagnosis</span></div><div class="casAuthors">Rowe Christopher C; Villemagne Victor L</div><div class="citationInfo"><span class="NLM_cas:title">The Medical clinics of North America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-98</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In vivo imaging of amyloid-β (Aβ) with positron emission tomography has moved from the research arena into clinical practice.  Clinicians working with cognitive decline and dementia must become familiar with its benefits and limitations.  Amyloid imaging allows earlier diagnosis of Alzheimer disease and better differential diagnosis of dementia and provides prognostic information for mild cognitive impairment.  It also has an increasingly important role in therapeutic trial recruitment and for evaluation of anti-Aβ treatments.  Longitudinal observations are required to elucidate the role of Aβ deposition in the course of Alzheimer disease and provide information needed to fully use the prognostic power of this investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ6G2K_LCaW1QHqQV89nF-2fW6udTcc2eZ7qqIIMXduBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sngvFCrug%253D%253D&md5=46ec97a002c90bbd2b1f14303b243fa3</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.mcna.2012.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mcna.2012.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DAmyloid%2520imaging%2520with%2520PET%2520in%2520early%2520Alzheimer%2520disease%2520diagnosis%26jtitle%3DMed.%2520Clin.%2520North%2520Am.%26date%3D2013%26volume%3D97%26spage%3D377%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Holland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotstein, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greguric, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasdev, N.</span><span> </span><span class="NLM_article-title">Alternative approaches for PET radiotracer development in Alzheimers disease: imaging beyond plaque</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">323</span><span class="NLM_x">–</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fjlcr.3158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24327420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFakur%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=323-331&author=J.+P.+Hollandauthor=S.+H.+Liangauthor=B.+H.+Rotsteinauthor=T.+L.+Collierauthor=N.+A.+Stephensonauthor=I.+Greguricauthor=N.+Vasdev&title=Alternative+approaches+for+PET+radiotracer+development+in+Alzheimers+disease%3A+imaging+beyond+plaque"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Alternative approaches for PET radiotracer development in Alzheimers disease: imaging beyond plaque</span></div><div class="casAuthors">Holland, Jason P.; Liang, Steven H.; Rotstein, Benjamin H.; Collier, Thomas L.; Stephenson, Nickeisha A.; Greguric, Ivan; Vasdev, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">323-331</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) and related dementias show increasing clin. prevalence, yet our understanding of the etiol. and pathobiol. of disease-related neurodegeneration remains limited.  In this regard, noninvasive imaging with radiotracers for positron emission tomog. (PET) presents a unique tool for quantifying spatial and temporal changes in characteristic biol. markers of brain disease and for assessing potential drug efficacy.  PET radiotracers targeting different protein markers are being developed to address questions pertaining to the mol. and/or genetic heterogeneity of AD and related dementias.  For example, radiotracers including [11C]-PiB and [18F]-AV-45 (Florbetapir) are being used to measure the d. of Aβ-plaques in AD patients and to interrogate the biol. mechanisms of disease initiation and progression.  Our focus is on the development of novel PET imaging agents, targeting proteins beyond Aβ-plaques, which can be used to investigate the broader mechanism of AD pathogenesis.  Here, we present the chem. basis of various radiotracers which show promise in preclin. or clin. studies for use in evaluating the phenotypic or biochem. characteristics of AD.  Radiotracers for PET imaging neuroinflammation, metal ion assocn. with Aβ-plaques, tau protein, cholinergic and cannabinoid receptors, and enzymes including glycogen-synthase kinase-3β and monoamine oxidase B amongst others, and their connection to AD are highlighted.  Copyright © 2013 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAGqOOrpGlyrVg90H21EOLACvtfcHk0lhrtsecyekYDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFakur%252FL&md5=d908d7a016b475367ebe86cb8693f01f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3158%26sid%3Dliteratum%253Aachs%26aulast%3DHolland%26aufirst%3DJ.%2BP.%26aulast%3DLiang%26aufirst%3DS.%2BH.%26aulast%3DRotstein%26aufirst%3DB.%2BH.%26aulast%3DCollier%26aufirst%3DT.%2BL.%26aulast%3DStephenson%26aufirst%3DN.%2BA.%26aulast%3DGreguric%26aufirst%3DI.%26aulast%3DVasdev%26aufirst%3DN.%26atitle%3DAlternative%2520approaches%2520for%2520PET%2520radiotracer%2520development%2520in%2520Alzheimers%2520disease%253A%2520imaging%2520beyond%2520plaque%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2014%26volume%3D57%26spage%3D323%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomqvist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitcheva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ausén, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koivisto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Långström, B.</span><span> </span><span class="NLM_article-title">Imaging brain amyloid in Alzheimer’s disease with Pittsburgh compound-B</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fana.20009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=14991808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFKntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=306-319&author=W.+E.+Klunkauthor=H.+Englerauthor=A.+Nordbergauthor=Y.+Wangauthor=G.+Blomqvistauthor=D.+P.+Holtauthor=M.+Bergstr%C3%B6mauthor=I.+Savitchevaauthor=G.+F.+Huangauthor=S.+Estradaauthor=B.+Aus%C3%A9nauthor=M.+L.+Debnathauthor=J.+Barlettaauthor=J.+C.+Priceauthor=J.+Sandellauthor=B.+J.+Loprestiauthor=A.+Wallauthor=P.+Koivistoauthor=G.+Antoniauthor=C.+A.+Mathisauthor=B.+L%C3%A5ngstr%C3%B6m&title=Imaging+brain+amyloid+in+Alzheimer%E2%80%99s+disease+with+Pittsburgh+compound-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B</span></div><div class="casAuthors">Klunk, William E.; Engler, Henry; Nordberg, Agneta; Wang, Yanming; Blomqvist, Gunnar; Holt, Daniel P.; Bergstrom, Mats; Savitcheva, Irina; Huang, Guo-feng; Estrada, Sergio; Ausen, Birgitta; Debnath, Manik L.; Barletta, Julien; Price, Julie C.; Sandell, Johan; Lopresti, Brian J.; Wall, Anders; Koivisto, Pernilla; Antoni, Gunnar; Mathis, Chester A.; Langstrom, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-319</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">This report describes the first human study of a novel amyloid-imaging positron emission tomog. (PET) tracer, termed Pittsburgh Compd.-B (PIB), in 16 patients with diagnosed mild AD and 9 controls.  Compared with controls, AD patients typically showed marked retention of PIB in areas of assocn. cortex known to contain large amts. of amyloid deposits in AD.  In the AD patient group, PIB retention was increased most prominently in frontal cortex (1.94-fold, p = 0.0001).  Large increases also were obsd. in parietal (1.71-fold, p = 0.0002), temporal (1.52-fold, p = 0.002), and occipital (1.54-fold, p = 0.002) cortex and the striatum (1.76-fold, p = 0.0001).  PIB retention was equiv. in AD patients and controls in areas known to be relatively unaffected by amyloid deposition (such as subcortical white matter, pons, and cerebellum).  Studies in three young (21 yr) and six older healthy controls (69.5±11 yr) showed low PIB retention in cortical areas and no significant group differences between young and older controls.  In cortical areas, PIB retention correlated inversely with cerebral glucose metab. detd. with 18F-fluorodeoxyglucose.  This relationship was most robust in the parietal cortex (r = -0.72; p = 0.0001).  The results suggest that PET imaging with the novel tracer, PIB, can provide quant. information on amyloid deposits in living subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXxBSvpITSxLVg90H21EOLACvtfcHk0lhlyYa-VU4Wew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFKntb8%253D&md5=3e036dca56dcb81e0cf131a5b100f95f</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1002%2Fana.20009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20009%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DEngler%26aufirst%3DH.%26aulast%3DNordberg%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBlomqvist%26aufirst%3DG.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSavitcheva%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DEstrada%26aufirst%3DS.%26aulast%3DAus%25C3%25A9n%26aufirst%3DB.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DBarletta%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DSandell%26aufirst%3DJ.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DKoivisto%26aufirst%3DP.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DL%25C3%25A5ngstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DImaging%2520brain%2520amyloid%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520Pittsburgh%2520compound-B%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D306%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Cohen, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rabinovici, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikonomovic, M. D.</span><span> </span><span class="NLM_article-title">Using Pittsburgh compound B for in vivo PET imaging of fibrillar amyloid-beta</span> <span class="citation_source-journal">Adv. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2012&pages=27-81&author=A.+D.+Cohenauthor=G.+D.+Rabinoviciauthor=C.+A.+Mathisauthor=W.+J.+Jagustauthor=W.+E.+Klunkauthor=M.+D.+Ikonomovic&title=Using+Pittsburgh+compound+B+for+in+vivo+PET+imaging+of+fibrillar+amyloid-beta"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DA.%2BD.%26aulast%3DRabinovici%26aufirst%3DG.%2BD.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DIkonomovic%26aufirst%3DM.%2BD.%26atitle%3DUsing%2520Pittsburgh%2520compound%2520B%2520for%2520in%2520vivo%2520PET%2520imaging%2520of%2520fibrillar%2520amyloid-beta%26jtitle%3DAdv.%2520Pharmacol.%26date%3D2012%26volume%3D64%26spage%3D27%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, M.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span> </span><span class="NLM_article-title">F-18 polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">809</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.nucmedbio.2005.06.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=16253804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2005&pages=799-809&author=W.+Zhangauthor=S.+Oyaauthor=M.-P.+Kungauthor=C.+Houauthor=D.+L.+Maierauthor=H.+F.+Kung&title=F-18+polyethyleneglycol+stilbenes+as+PET+imaging+agents+targeting+A%CE%B2+aggregates+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Aβ aggregates in the brain</span></div><div class="casAuthors">Zhang, Wei; Oya, Shunichi; Kung, Mei-Ping; Hou, Catherine; Maier, Donna L.; Kung, Hank F.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">799-809</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">This paper describes a novel series of 18F-labeled polyethyleneglycol (PEG)-stilbene derivs. as potential β-amyloid (Aβ) plaque-specific imaging agents for positron emission tomog. (PET).  In these series of compds., 18F is linked to the stilbene through a PEG chain, of which the no. of ethoxy groups ranges from 2 to 5.  The purpose of adding PEG groups is to lower the lipophilicity and improve bioavailability.  The syntheses of the "cold" compds. and the 18F-labeled PEG stilbene derivs. are successfully achieved.  All of the fluorinated stilbenes displayed high binding affinities in an assay using postmortem AD brain homogenates (Ki=2.9-6.7 nM).  Labeling was successfully performed by a substitution of the mesylate group of 10a-d by [18F]fluoride giving the target compds. [18F]12a-d (EOS, specific activity, 900-1500 Ci/mmol; radiochem. purity >99%).  In vivo biodistribution of these novel 18F ligands in normal mice exhibited excellent brain penetrations and rapid washouts after an i.v. injection (6.6-8.1 and 1.2-2.6 %dose/g at 2 and 60 min, resp.).  Autoradiog. of postmortem AD brain sections of [18F]12a-d confirmed the specific binding related to the presence of Aβ plaques.  In addn., in vivo plaque labeling can be clearly demonstrated with these 18F-labeled agents in transgenic mice (Tg2576), a useful animal model for Alzheimer's disease.  In conclusion, the preliminary results strongly suggest these fluorinated PEG stilbene derivs. are suitable candidates as Aβ plaque imaging agents for studying patients with Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRLVZvNjp7mrVg90H21EOLACvtfcHk0lhlyYa-VU4Wew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKhsb%252FN&md5=059e56c983730296968273991e30f0b8</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2005.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2005.06.001%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DOya%26aufirst%3DS.%26aulast%3DKung%26aufirst%3DM.-P.%26aulast%3DHou%26aufirst%3DC.%26aulast%3DMaier%26aufirst%3DD.%2BL.%26aulast%3DKung%26aufirst%3DH.%2BF.%26atitle%3DF-18%2520polyethyleneglycol%2520stilbenes%2520as%2520PET%2520imaging%2520agents%2520targeting%2520A%25CE%25B2%2520aggregates%2520in%2520the%2520brain%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2005%26volume%3D32%26spage%3D799%26epage%3D809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Dollé, F.</span><span> </span><span class="NLM_article-title">Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">–</span> <span class="NLM_lpage">67</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fjlcr.3037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24285311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtlaqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=65-67&author=F.+Doll%C3%A9&title=Carbon-11+and+fluorine-18+chemistry+devoted+to+molecular+probes+for+imaging+the+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography11C/18F chemistry devoted to molecular probes for imaging the brain with PETF. DolleCarbon-11 and fluorine-18 chemistry devoted to molecular probes for imaging the brain with positron emission tomography</span></div><div class="casAuthors">Dolle, Frederic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">65-67</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Exploration of the living human brain in real-time and in a noninvasive way was for centuries only a dream, made, however, possible today with the remarkable development during the four last decades of powerful mol. imaging techniques, and esp. positron emission tomog. (PET).  Mol. PET imaging relies, from a chem. point of view, on the use and prepn. of a positron-emitting radiolabeled probe or radiotracer, notably compds. incorporating one of two short-lived radionuclides fluorine-18 (T1/2: 109.8 min) and carbon-11 (T1/2: 20.38 min).  The growing availability and interest for the radiohalogen fluorine-18 in radiopharmaceutical chem. undoubtedly results from its convenient half-life and the successful use in clin. oncol. of 2-[18F]fluoro-2-deoxy-D-glucose ([18F]FDG).  The special interest of carbon-11 is not only that carbon is present in virtually all biomols. and drugs allowing therefore for isotopic labeling of their chem. structures but also that a given mol. could be radiolabeled at different functions or sites, permitting to explore (or to take advantage of) in vivo metabolic pathways.  PET chem. includes prodn. of these short-lived radioactive isotopes via nuclear transmutation reactions using a cyclotron, and is directed towards the development of rapid synthetic methods, at the trace level, for the introduction of these nuclides into a mol., as well as the use of fast purifn., anal. and formulation techniques.  PET chem. is the driving force in mol. PET imaging, and this special issue of the Journal of Labeled Compds. and Radiopharmaceuticals, which is strongly chem. and radiochem.-oriented, aims at illustrating, be it in part only, the state-of-the-art arsenal of reactions currently available and its potential for the research and development of specific mol. probes labeled with the positron emitters carbon-11 and fluorine-18, with optimal imaging properties for PET exploration of the brain.  Copyright © 2013 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4MdO4LHXnqLVg90H21EOLACvtfcHk0lgNnOzMNUYyuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtlaqtb8%253D&md5=731e38e4015a139fa653b30e48a10879</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3037%26sid%3Dliteratum%253Aachs%26aulast%3DDoll%25C3%25A9%26aufirst%3DF.%26atitle%3DCarbon-11%2520and%2520fluorine-18%2520chemistry%2520devoted%2520to%2520molecular%2520probes%2520for%2520imaging%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2013%26volume%3D56%26spage%3D65%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Serdons, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verduyckt, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderghinste, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleynhens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghgraef, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermaelen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwinghe, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Leuven, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span> </span><span class="NLM_article-title">Synthesis of <sup>18</sup>F-labeled 2-(4'-fluorophenyl)-1,3-benzothiazole and evaluation as amyloid imaging agent in comparison with [<sup>11</sup>C]-PIB</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">602</span><span class="NLM_x">–</span> <span class="NLM_lpage">605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=602-605&author=K.+Serdonsauthor=T.+Verduycktauthor=D.+Vanderghinsteauthor=J.+Cleynhensauthor=P.+Borghgraefauthor=P.+Vermaelenauthor=C.+Terwingheauthor=F.+Van+Leuvenauthor=K.+Van+Laereauthor=H.+Kungauthor=G.+Bormansauthor=A.+Verbruggen&title=Synthesis+of+18F-labeled+2-%284%27-fluorophenyl%29-1%2C3-benzothiazole+and+evaluation+as+amyloid+imaging+agent+in+comparison+with+%5B11C%5D-PIB"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSerdons%26aufirst%3DK.%26aulast%3DVerduyckt%26aufirst%3DT.%26aulast%3DVanderghinste%26aufirst%3DD.%26aulast%3DCleynhens%26aufirst%3DJ.%26aulast%3DBorghgraef%26aufirst%3DP.%26aulast%3DVermaelen%26aufirst%3DP.%26aulast%3DTerwinghe%26aufirst%3DC.%26aulast%3DVan%2BLeuven%26aufirst%3DF.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DKung%26aufirst%3DH.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVerbruggen%26aufirst%3DA.%26atitle%3DSynthesis%2520of%252018F-labeled%25202-%25284%2527-fluorophenyl%2529-1%252C3-benzothiazole%2520and%2520evaluation%2520as%2520amyloid%2520imaging%2520agent%2520in%2520comparison%2520with%2520%255B11C%255D-PIB%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D602%26epage%3D605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Jureus, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstroem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neelissen, J. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sunnemark, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S. P. S.</span><span> </span><span class="NLM_article-title">Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1111%2Fj.1471-4159.2010.06812.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20477945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpslygtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2010&pages=784-794&author=A.+Jureusauthor=B.-M.+Swahnauthor=J.+Sandellauthor=F.+Jeppssonauthor=A.+E.+Johnsonauthor=P.+Johnstroemauthor=J.+A.+M.+Neelissenauthor=D.+Sunnemarkauthor=L.+Fardeauthor=S.+P.+S.+Svensson&title=Characterization+of+AZD4694%2C+a+novel+fluorinated+A%CE%B2+plaque+neuroimaging+PET+radioligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of AZD4694, a novel fluorinated Aβ plaque neuroimaging PET radioligand</span></div><div class="casAuthors">Jureus, Anders; Swahn, Britt-Marie; Sandell, Johan; Jeppsson, Fredrik; Johnson, Allan E.; Johnstroem, Peter; Neelissen, Jan A. M.; Sunnemark, Dan; Farde, Lars; Svensson, Samuel P. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">784-794</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Positron emission tomog. (PET) radioligands that bind selectively to β-amyloid plaques (Aβ) are promising imaging tools aimed at supporting the diagnosis of Alzheimer's disease and the evaluation of new drugs aiming to modify amyloid plaque load.  For extended clin. use, there is a particular need for PET tracers labeled with fluorine-18, a radionuclide with 110 min half-life allowing for central synthesis followed by wide distribution.  The development of fluorinated radioligands is, however, challenging because of the lipophilic nature of arom. fluorine, rendering fluorinated ligands more prone to have high non-specific white matter binding.  We have here developed the new benzofuran-derived radioligand contg. fluorine, AZD4694 that shows high affinity for β-amyloid fibrils in vitro (Kd = 2.3 ± 0.3 nM).  In cortical sections from human Alzheimer's disease brain [3H]AZD4694 selectively labeled β-amyloid deposits in gray matter, whereas there was a lower level of non-displaceable binding in plaque devoid white matter.  Administration of unlabeled AZD4694 to rat showed that it has a pharmacokinetic profile consistent with good PET radioligands, i.e., it quickly entered and rapidly cleared from normal rat brain tissue.  Ex vivo binding data in aged Tg2576 mice after i.v. administration of [3H]AZD4694 showed selective binding to β-amyloid deposits in a reversible manner.  In Tg2576 mice, plaque bound [3H]AZD4694 could still be detected 80 min after i.v. administration.  Taken together, the preclin. profile of AZD4694 suggests that fluorine-18 labeled AZD4694 may have potential for PET-visualization of cerebral β-amyloid deposits in the living human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyIbO8Tjk5-rVg90H21EOLACvtfcHk0liZ3C5CT13onw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpslygtbY%253D&md5=2631a6a6ccf17cfc9041dfba4e4febe2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2010.06812.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2010.06812.x%26sid%3Dliteratum%253Aachs%26aulast%3DJureus%26aufirst%3DA.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DSandell%26aufirst%3DJ.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DJohnson%26aufirst%3DA.%2BE.%26aulast%3DJohnstroem%26aufirst%3DP.%26aulast%3DNeelissen%26aufirst%3DJ.%2BA.%2BM.%26aulast%3DSunnemark%26aufirst%3DD.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DSvensson%26aufirst%3DS.%2BP.%2BS.%26atitle%3DCharacterization%2520of%2520AZD4694%252C%2520a%2520novel%2520fluorinated%2520A%25CE%25B2%2520plaque%2520neuroimaging%2520PET%2520radioligand%26jtitle%3DJ.%2520Neurochem.%26date%3D2010%26volume%3D114%26spage%3D784%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Landau, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thurfjell, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margolin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jagust, W. J.</span><span> </span><span class="NLM_article-title">Amyloid PET imaging in Alzheimer’s disease: a comparison of three radiotracers</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1398</span><span class="NLM_x">–</span> <span class="NLM_lpage">1407</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs00259-014-2753-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24647577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslSqu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=1398-1407&author=S.+M.+Landauauthor=B.+A.+Thomasauthor=L.+Thurfjellauthor=M.+Schmidtauthor=R.+Margolinauthor=M.+Mintunauthor=M.+Pontecorvoauthor=S.+L.+Bakerauthor=W.+J.+Jagust&title=Amyloid+PET+imaging+in+Alzheimer%E2%80%99s+disease%3A+a+comparison+of+three+radiotracers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers</span></div><div class="casAuthors">Landau, S. M.; Thomas, B. A.; Thurfjell, L.; Schmidt, M.; Margolin, R.; Mintun, M.; Pontecorvo, M.; Baker, S. L.; Jagust, W. J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1398-1407</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The increasing use of amyloid PET in Alzheimer's disease research and clin. trials has motivated efforts to standardize methodol.  We compared retention of the 11C radiotracer Pittsburgh Compd. B (PiB) and that of two 18F amyloid radiotracers (florbetapir and flutemetamol) using two study populations.  We also examd. the feasibility of converting between tracer-specific measures, using PiB as the common link between the two 18F tracers.  Methods: One group of 40 subjects underwent PiB and flutemetamol imaging sessions and a sep. group of 32 subjects underwent PiB and florbetapir imaging sessions.  We compared cortical and white matter retention for each 18F tracer relative to that of PiB, as well as retention in several ref. regions and image anal. methods.  Correlations between tracer pairs were used to convert tracer-specific threshold values for amyloid positivity between tracers.  Results: Cortical retention for each pair of tracers was strongly correlated regardless of ref. region (PiB-flutemetamol, ρ = 0.84-0.99; PiB-florbetapir, ρ = 0.83-0.97) and anal. method (ρ = 0.90-0.99).  Compared to PiB, flutemetamol had higher white matter retention, while florbetapir had lower cortical retention.  Two previously established independent thresholds for amyloid positivity were highly consistent when values were converted between tracer pairs.  Conclusion: Despite differing white and gray matter retention characteristics, cortical retention for each 18F tracer was highly correlated with that of PiB, enabling conversion of thresholds across tracer measurement scales with a high level of internal consistency.  Standardization of anal. methods and measurement scales may facilitate the comparison of amyloid PET data obtained using different tracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn78zTuzp6drVg90H21EOLACvtfcHk0liZ3C5CT13onw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslSqu7o%253D&md5=dec3dc2c6e9eed9370697afa921ea999</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1007%2Fs00259-014-2753-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-014-2753-3%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DS.%2BM.%26aulast%3DThomas%26aufirst%3DB.%2BA.%26aulast%3DThurfjell%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DMargolin%26aufirst%3DR.%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DPontecorvo%26aufirst%3DM.%26aulast%3DBaker%26aufirst%3DS.%2BL.%26aulast%3DJagust%26aufirst%3DW.%2BJ.%26atitle%3DAmyloid%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520comparison%2520of%2520three%2520radiotracers%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D1398%26epage%3D1407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svensson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cselényi, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Head-to-head comparison of <sup>11</sup>C-PiB and <sup>18</sup>F-AZD4694 (NAV4694) for β-amyloid imaging in aging and dementia</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">880</span><span class="NLM_x">–</span> <span class="NLM_lpage">886</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=880-886&author=C.+C.+Roweauthor=S.+Pejoskaauthor=R.+S.+Mulliganauthor=G.+Jonesauthor=J.+G.+Chanauthor=S.+Svenssonauthor=Z.+Csel%C3%A9nyiauthor=C.+L.+Mastersauthor=V.+L.+Villemagne&title=Head-to-head+comparison+of+11C-PiB+and+18F-AZD4694+%28NAV4694%29+for+%CE%B2-amyloid+imaging+in+aging+and+dementia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DChan%26aufirst%3DJ.%2BG.%26aulast%3DSvensson%26aufirst%3DS.%26aulast%3DCsel%25C3%25A9nyi%26aufirst%3DZ.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DHead-to-head%2520comparison%2520of%252011C-PiB%2520and%252018F-AZD4694%2520%2528NAV4694%2529%2520for%2520%25CE%25B2-amyloid%2520imaging%2520in%2520aging%2520and%2520dementia%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D880%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moghbel, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langström, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudeet, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mishani, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoilund-Carlsen, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">Amyloid-β positron emission tomography imaging probes: a critical review</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">–</span> <span class="NLM_lpage">631</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23648516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Srt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=613-631&author=V.+Kepeauthor=M.+C.+Moghbelauthor=B.+Langstr%C3%B6mauthor=H.+Zaidiauthor=H.+V.+Vintersauthor=S.-C.+Huangauthor=N.+Satyamurthyauthor=D.+Doudeetauthor=E.+Mishaniauthor=R.+M.+Cohenauthor=P.+F.+Hoilund-Carlsenauthor=A.+Alaviauthor=J.+R.+Barrio&title=Amyloid-%CE%B2+positron+emission+tomography+imaging+probes%3A+a+critical+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β Positron Emission Tomography Imaging Probes: A Critical Review</span></div><div class="casAuthors">Kepe, Vladimir; Moghbel, Mateen C.; Langstroem, Bengt; Zaidi, Habib; Vinters, Harry V.; Huang, Sung-Cheng; Satyamurthy, Nagichettiar; Doudet, Doris; Mishani, Eyal; Cohen, Robert M.; Hoilund-Carlsen, Poul F.; Alavi, Abass; Barrio, Jorge R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">613-631</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  The rapidly rising prevalence and cost of Alzheimer's disease in recent decades has made the imaging of amyloid-β deposits the focus of intense research.  Several amyloid imaging probes with purported specificity for amyloid-β plaques are currently at various stages of FDA approval.  However, a no. of factors appear to preclude these probes from clin. utilization.  As the available "amyloid specific" positron emission tomog. imaging probes have failed to demonstrate diagnostic value and have shown limited utility for monitoring therapeutic interventions in humans, a debate on their significance has emerged.  The aim of this review is to identify and discuss critically the scientific issues contributing to the extensive inconsistencies reported in the literature on their purported in vivo amyloid specificity and potential utilization in patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDVE_xuB1karVg90H21EOLACvtfcHk0lhGYCe1rnYqnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Srt7zI&md5=deefdf403451d2621afdbc31ae9cc4a9</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DMoghbel%26aufirst%3DM.%2BC.%26aulast%3DLangstr%25C3%25B6m%26aufirst%3DB.%26aulast%3DZaidi%26aufirst%3DH.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DHuang%26aufirst%3DS.-C.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DDoudeet%26aufirst%3DD.%26aulast%3DMishani%26aufirst%3DE.%26aulast%3DCohen%26aufirst%3DR.%2BM.%26aulast%3DHoilund-Carlsen%26aufirst%3DP.%2BF.%26aulast%3DAlavi%26aufirst%3DA.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DAmyloid-%25CE%25B2%2520positron%2520emission%2520tomography%2520imaging%2520probes%253A%2520a%2520critical%2520review%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D36%26spage%3D613%26epage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Eckroat, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayhoub, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau-Tsodikova, S.</span><span> </span><span class="NLM_article-title">Amyloid-β probes: review of structure-activity and brain-kinetics relationships</span> <span class="citation_source-journal">Beilstein J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1012</span><span class="NLM_x">–</span> <span class="NLM_lpage">1044</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.3762%2Fbjoc.9.116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23766818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpsFemtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=1012-1044&author=T.+J.+Eckroatauthor=A.+S.+Mayhoubauthor=S.+Garneau-Tsodikova&title=Amyloid-%CE%B2+probes%3A+review+of+structure-activity+and+brain-kinetics+relationships"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid-β probes: review of structure-activity and brain-kinetics relationships</span></div><div class="casAuthors">Eckroat, Todd J.; Mayhoub, Abdelrahman S.; Garneau-Tsodikova, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Beilstein Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1012-1044, No. 116</span>CODEN:
                <span class="NLM_cas:coden">BJOCBH</span>;
        ISSN:<span class="NLM_cas:issn">1860-5397</span>.
    
            (<span class="NLM_cas:orgname">Beilstein-Institut zur Foerderung der Chemischen Wissenschaften</span>)
        </div><div class="casAbstract">A review.  The no. of people suffering from Alzheimer's disease (AD) is expected to increase dramatically in the coming years, placing a huge burden on society.  Current treatments for AD leave much to be desired, and numerous research efforts around the globe are focused on developing improved therapeutics.  In addn., current diagnostic tools for AD rely largely on subjective cognitive assessment rather than on identification of pathophysiol. changes assocd. with disease onset and progression.  These facts have led to numerous efforts to develop chem. probes to detect pathophysiol. hallmarks of AD, such as amyloid-β plaques, for diagnosis and monitoring of therapeutic efficacy.  This review provides a survey of chem. probes developed to date for AD with emphasis on synthetic methodologies and structure-activity relationships with regards to affinity for target and brain kinetics.  Several probes discussed herein show particularly promising results and will be of immense value moving forward in the fight against AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJR5Z0CHX_e7Vg90H21EOLACvtfcHk0lhGYCe1rnYqnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpsFemtbw%253D&md5=07672376d3d0eba52e3627d0b8cfff81</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.3762%2Fbjoc.9.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3762%252Fbjoc.9.116%26sid%3Dliteratum%253Aachs%26aulast%3DEckroat%26aufirst%3DT.%2BJ.%26aulast%3DMayhoub%26aufirst%3DA.%2BS.%26aulast%3DGarneau-Tsodikova%26aufirst%3DS.%26atitle%3DAmyloid-%25CE%25B2%2520probes%253A%2520review%2520of%2520structure-activity%2520and%2520brain-kinetics%2520relationships%26jtitle%3DBeilstein%2520J.%2520Org.%2520Chem.%26date%3D2013%26volume%3D9%26spage%3D1012%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">The challenges of tau imaging</span> <span class="citation_source-journal">Future Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">409</span><span class="NLM_x">–</span> <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.2217%2Ffnl.12.34" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSgs7nE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=409-421&author=V.+L.+Villemagneauthor=S.+Furumotoauthor=M.+Fodero-Tavolettiauthor=R.+Haradaauthor=R.+S.+Mulliganauthor=Y.+Kudoauthor=C.+L.+Mastersauthor=K.+Yanaiauthor=C.+C.+Roweauthor=N.+Okamura&title=The+challenges+of+tau+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">The challenges of tau imaging</span></div><div class="casAuthors">Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle; Harada, Ryuichi; Mulligan, Rachel S.; Kudo, Yukitsuka; Masters, Colin L.; Yanai, Kazuhiko; Rowe, Chistopher C.; Okamura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">Future Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">409-421</span>CODEN:
                <span class="NLM_cas:coden">FNUEAM</span>;
        ISSN:<span class="NLM_cas:issn">1479-6708</span>.
    
            (<span class="NLM_cas:orgname">Future Medicine Ltd.</span>)
        </div><div class="casAbstract">A review.  In vivo imaging of tau pathol. will provide new insights into tau deposition in the human brain, thus facilitating research into causes, diagnosis and treatment of major dementias, such as Alzheimer's disease, or some variants of frontotemporal lobar degeneration, in which tau plays a role.  Tau imaging poses several challenges, some related to the singularities of tau aggregation, and others related to radiotracer design.  Several groups around the world are working on the development of imaging agents that will allow the in vivo assessment of tau deposition in aging and in neurodegeneration.  Development of a tau imaging tracer will enable researchers to noninvasively examine the degree and extent of tau pathol. in the brain, quantify changes in tau deposition over time, evaluate its relation to cognition and assess the efficacy of anti-tau therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfIVpSOSew27Vg90H21EOLACvtfcHk0ljQotwQDyUQ4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSgs7nE&md5=bc3d8d6579bc07a7ab7065948bdfaa73</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.2217%2Ffnl.12.34&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2217%252Ffnl.12.34%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DThe%2520challenges%2520of%2520tau%2520imaging%26jtitle%3DFuture%2520Neurol.%26date%3D2012%26volume%3D7%26spage%3D409%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Sperling, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckett, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Craft, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jack, C. R.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaye, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montine, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiman, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yaffe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrillo, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thies, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrison-Bogorad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagster, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, C. H.</span><span> </span><span class="NLM_article-title">Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging and the Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">–</span> <span class="NLM_lpage">292</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2011.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21514248" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3MrhsFaktw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2011&pages=280-292&author=R.+A.+Sperlingauthor=P.+S.+Aisenauthor=L.+A.+Beckettauthor=D.+A.+Bennettauthor=S.+Craftauthor=A.+M.+Faganauthor=T.+Iwatsuboauthor=C.+R.+Jackauthor=J.+Kayeauthor=T.+J.+Montineauthor=D.+C.+Parkauthor=E.+M.+Reimanauthor=C.+C.+Roweauthor=E.+Siemersauthor=Y.+Sternauthor=K.+Yaffeauthor=M.+C.+Carrilloauthor=B.+Thiesauthor=M.+Morrison-Bogoradauthor=M.+V.+Wagsterauthor=C.+H.+Phelps&title=Toward+defining+the+preclinical+stages+of+Alzheimer%E2%80%99s+disease%3A+recommendations+from+the+National+Institute+on+Aging+and+the+Alzheimer%E2%80%99s+Association+workgroups+on+diagnostic+guidelines+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease</span></div><div class="casAuthors">Sperling Reisa A; Aisen Paul S; Beckett Laurel A; Bennett David A; Craft Suzanne; Fagan Anne M; Iwatsubo Takeshi; Jack Clifford R Jr; Kaye Jeffrey; Montine Thomas J; Park Denise C; Reiman Eric M; Rowe Christopher C; Siemers Eric; Stern Yaakov; Yaffe Kristine; Carrillo Maria C; Thies Bill; Morrison-Bogorad Marcelle; Wagster Molly V; Phelps Creighton H</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-92</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The pathophysiological process of Alzheimer's disease (AD) is thought to begin many years before the diagnosis of AD dementia.  This long "preclinical" phase of AD would provide a critical opportunity for therapeutic intervention; however, we need to further elucidate the link between the pathological cascade of AD and the emergence of clinical symptoms.  The National Institute on Aging and the Alzheimer's Association convened an international workgroup to review the biomarker, epidemiological, and neuropsychological evidence, and to develop recommendations to determine the factors which best predict the risk of progression from "normal" cognition to mild cognitive impairment and AD dementia.  We propose a conceptual framework and operational research criteria, based on the prevailing scientific evidence to date, to test and refine these models with longitudinal clinical research studies.  These recommendations are solely intended for research purposes and do not have any clinical implications at this time.  It is hoped that these recommendations will provide a common rubric to advance the study of preclinical AD, and ultimately, aid the field in moving toward earlier intervention at a stage of AD when some disease-modifying therapies may be most efficacious.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQog-HW7g5tSLt7lRqEFUJVfW6udTcc2ebqM_9Ng_nG2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MrhsFaktw%253D%253D&md5=116797e3769a70f38cac89730a967b4d</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2011.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2011.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DSperling%26aufirst%3DR.%2BA.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DBeckett%26aufirst%3DL.%2BA.%26aulast%3DBennett%26aufirst%3DD.%2BA.%26aulast%3DCraft%26aufirst%3DS.%26aulast%3DFagan%26aufirst%3DA.%2BM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DJack%26aufirst%3DC.%2BR.%26aulast%3DKaye%26aufirst%3DJ.%26aulast%3DMontine%26aufirst%3DT.%2BJ.%26aulast%3DPark%26aufirst%3DD.%2BC.%26aulast%3DReiman%26aufirst%3DE.%2BM.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DStern%26aufirst%3DY.%26aulast%3DYaffe%26aufirst%3DK.%26aulast%3DCarrillo%26aufirst%3DM.%2BC.%26aulast%3DThies%26aufirst%3DB.%26aulast%3DMorrison-Bogorad%26aufirst%3DM.%26aulast%3DWagster%26aufirst%3DM.%2BV.%26aulast%3DPhelps%26aufirst%3DC.%2BH.%26atitle%3DToward%2520defining%2520the%2520preclinical%2520stages%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520recommendations%2520from%2520the%2520National%2520Institute%2520on%2520Aging%2520and%2520the%2520Alzheimer%25E2%2580%2599s%2520Association%2520workgroups%2520on%2520diagnostic%2520guidelines%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2011%26volume%3D7%26spage%3D280%26epage%3D292" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span>U.S. Food and Drug Administration. <a href="http://www.fda.gov" class="extLink">www.fda.gov</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=U.S.+Food+and+Drug+Administration.+www.fda.gov."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Maccioni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farías, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morales, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navarrete, L.</span><span> </span><span class="NLM_article-title">The revitalized tau hypothesis on Alzheimer’s disease</span> <span class="citation_source-journal">Arch. Med. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">226</span><span class="NLM_x">–</span> <span class="NLM_lpage">231</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.arcmed.2010.03.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20682182" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXntVemt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2010&pages=226-231&author=R.+B.+Maccioniauthor=G.+Far%C3%ADasauthor=I.+Moralesauthor=L.+Navarrete&title=The+revitalized+tau+hypothesis+on+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The Revitalized Tau Hypothesis on Alzheimer's Disease</span></div><div class="casAuthors">Maccioni, Ricardo B.; Farias, Gonzalo; Morales, Inelia; Navarrete, Leonardo</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">226-231</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Many hypotheses have been raised regarding the pathophysiol. of Alzheimer's disease (AD).  Because amyloid beta peptide (Aβ) deposition in senile plaques appears as a late, nonspecific event, recent evidence points to tau phosphorylation and aggregation as the final common pathway in this multifactorial disease.  Current approaches that provide evidence in favor of neuroimmunomodulation in AD and the roles of tau pathol. modifications and aggregation into oligomers and filamentous forms are presented.  We propose an integrative model on the pathogenesis of AD that includes several damage signals such as Aβ oligomers, oxygen free radicals, iron overload, homocysteine, cholesterol and LDL species.  These activate microglia cells, releasing proinflammatory cytokines and producing neuronal degeneration and tau pathol. modifications.  Altered and aggregated forms of tau appear to act as a toxic stimuli contributing to neurodegeneration.  Recent findings provide further support to the central role of tau in the pathogenesis of AD, so this protein has turned into a diagnostic and therapeutic target for this disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos_mQZP6_GRrVg90H21EOLACvtfcHk0lifzG7hKPCpRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXntVemt7o%253D&md5=b8d948914ce470f13a3e8b36f0bb563d</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2010.03.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2010.03.007%26sid%3Dliteratum%253Aachs%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26aulast%3DFar%25C3%25ADas%26aufirst%3DG.%26aulast%3DMorales%26aufirst%3DI.%26aulast%3DNavarrete%26aufirst%3DL.%26atitle%3DThe%2520revitalized%2520tau%2520hypothesis%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2010%26volume%3D41%26spage%3D226%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Arriagada, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Growdon, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedley-Whyte, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyman, B. T.</span><span> </span><span class="NLM_article-title">Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">631</span><span class="NLM_x">–</span> <span class="NLM_lpage">639</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=631-639&author=P.+V.+Arriagadaauthor=J.+H.+Growdonauthor=E.+T.+Hedley-Whyteauthor=B.+T.+Hyman&title=Neurofibrillary+tangles+but+not+senile+plaques+parallel+duration+and+severity+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArriagada%26aufirst%3DP.%2BV.%26aulast%3DGrowdon%26aufirst%3DJ.%2BH.%26aulast%3DHedley-Whyte%26aufirst%3DE.%2BT.%26aulast%3DHyman%26aufirst%3DB.%2BT.%26atitle%3DNeurofibrillary%2520tangles%2520but%2520not%2520senile%2520plaques%2520parallel%2520duration%2520and%2520severity%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D1992%26volume%3D42%26spage%3D631%26epage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Ke, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suchowerska, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van der Hoven, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Silva, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Eersel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittner, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ittner, L. M.</span><span> </span><span class="NLM_article-title">Lessons from tau-deficient mice</span> <span class="citation_source-journal">Int. J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">2012</span><span class="NLM_x">, </span> <span class="NLM_fpage">873270</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=22720190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC38jjslCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=873270&author=Y.+D.+Keauthor=A.+K.+Suchowerskaauthor=J.+van+der+Hovenauthor=D.+M.+De+Silvaauthor=C.+W.+Wuauthor=J.+van+Eerselauthor=A.+Ittnerauthor=L.+M.+Ittner&title=Lessons+from+tau-deficient+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons from tau-deficient mice</span></div><div class="casAuthors">Ke Yazi D; Suchowerska Alexandra K; van der Hoven Julia; De Silva Dineeka M; Wu Christopher W; van Eersel Janet; Ittner Arne; Ittner Lars M</div><div class="citationInfo"><span class="NLM_cas:title">International journal of Alzheimer's disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">873270</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Both Alzheimer's disease (AD) and frontotemporal dementia (FTD) are characterized by the deposition of hyperphosphorylated forms of the microtubule-associated protein tau in neurons and/or glia.  This unifying pathology led to the umbrella term "tauopathies" for these conditions, also emphasizing the central role of tau in AD and FTD.  Generation of transgenic mouse models expressing human tau in the brain has contributed to the understanding of the pathomechanistic role of tau in disease.  To reveal the physiological functions of tau in vivo, several knockout mouse strains with deletion of the tau-encoding MAPT gene have been established over the past decade, using different gene targeting constructs.  Surprisingly, when initially introduced tau knockout mice presented with no overt phenotype or malformations.  The number of publications using tau knockout mice has recently markedly increased, and both behavioural changes and motor deficits have been identified in aged mice of certain strains.  Moreover, tau knockout mice have been instrumental in identifying novel functions of tau, both in cultured neurons and in vivo.  Importantly, tau knockout mice have significantly contributed to the understanding of the pathophysiological interplay between Aβ and tau in AD.  Here, we review the literature that involves tau knockout mice to summarize what we have learned so far from depleting tau in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAKliQebel62gRQsDqrjW_fW6udTcc2ebO-sLMFr9F7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jjslCjtw%253D%253D&md5=6cfa2953007f4967778e8bf7d100ec16</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKe%26aufirst%3DY.%2BD.%26aulast%3DSuchowerska%26aufirst%3DA.%2BK.%26aulast%3Dvan%2Bder%2BHoven%26aufirst%3DJ.%26aulast%3DDe%2BSilva%26aufirst%3DD.%2BM.%26aulast%3DWu%26aufirst%3DC.%2BW.%26aulast%3Dvan%2BEersel%26aufirst%3DJ.%26aulast%3DIttner%26aufirst%3DA.%26aulast%3DIttner%26aufirst%3DL.%2BM.%26atitle%3DLessons%2520from%2520tau-deficient%2520mice%26jtitle%3DInt.%2520J.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D2012%26spage%3D873270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Medeiros, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baglietto-Vargas, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFerla, F. M.</span><span> </span><span class="NLM_article-title">The role of tau in Alzheimer’s disease and related disorders</span> <span class="citation_source-journal">CNS Neurosci. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">514</span><span class="NLM_x">–</span> <span class="NLM_lpage">524</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1111%2Fj.1755-5949.2010.00177.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20553310" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlOntL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=514-524&author=R.+Medeirosauthor=D.+Baglietto-Vargasauthor=F.+M.+LaFerla&title=The+role+of+tau+in+Alzheimer%E2%80%99s+disease+and+related+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">The role of Tau in Alzheimer's disease and related disorders</span></div><div class="casAuthors">Medeiros, Rodrigo; Baglietto-Vargas, David; LaFerla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Neuroscience & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">514-524</span>CODEN:
                <span class="NLM_cas:coden">CNTNAB</span>;
        ISSN:<span class="NLM_cas:issn">1755-5930</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Tau, the microtubule-assocd. protein, forms insol. filaments that accumulate as neurofibrillary tangles in Alzheimer's disease (AD) and related tauopathies.  Under physiol. conditions, tau regulates the assembly and maintenance of the structural stability of microtubules.  In the diseased brain, however, tau becomes abnormally hyperphosphorylated, which ultimately causes the microtubules to disassemble, and the free tau mols. aggregate into paired helical filaments.  A large body of evidence suggests that tau hyperphosphorylation results from perturbation of cellular signaling, mainly through imbalance in the activities of different protein kinases and phosphatases.  In AD, it appears that β-amyloid peptide (Aβ) plays a pivotal role in triggering this imbalance.  In this review, we summarize our current understanding of the role of tau in AD and other tauopathies, and highlight key issues that need to be addressed to improve the success of developing novel therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPWguaVVJhw7Vg90H21EOLACvtfcHk0lhA0-YJYUDC4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlOntL%252FF&md5=b354d941e7e61c1c148a98dbe0b91aba</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1111%2Fj.1755-5949.2010.00177.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1755-5949.2010.00177.x%26sid%3Dliteratum%253Aachs%26aulast%3DMedeiros%26aufirst%3DR.%26aulast%3DBaglietto-Vargas%26aufirst%3DD.%26aulast%3DLaFerla%26aufirst%3DF.%2BM.%26atitle%3DThe%2520role%2520of%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520related%2520disorders%26jtitle%3DCNS%2520Neurosci.%2520Ther.%26date%3D2011%26volume%3D17%26spage%3D514%26epage%3D524" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">In vivo tau imaging: obstacles and progress</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">S254</span><span class="NLM_x">–</span> <span class="NLM_lpage">S264</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&pages=S254-S264&author=V.+L.+Villemagneauthor=N.+Okamura&title=In+vivo+tau+imaging%3A+obstacles+and+progress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520tau%2520imaging%253A%2520obstacles%2520and%2520progress%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2014%26volume%3D10%26spage%3DS254%26epage%3DS264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Shah, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Catafau, A. M.</span><span> </span><span class="NLM_article-title">Molecular imaging insights into neurodegeneration: focus on tau PET radiotracers</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">871</span><span class="NLM_x">–</span> <span class="NLM_lpage">874</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=871-874&author=M.+Shahauthor=A.+M.+Catafau&title=Molecular+imaging+insights+into+neurodegeneration%3A+focus+on+tau+PET+radiotracers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DM.%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26atitle%3DMolecular%2520imaging%2520insights%2520into%2520neurodegeneration%253A%2520focus%2520on%2520tau%2520PET%2520radiotracers%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D871%26epage%3D874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Mach, R. H.</span><span> </span><span class="NLM_article-title">New targets for the development of PET tracers for imaging neurodegeneration in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1221</span><span class="NLM_x">–</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1221-1224&author=R.+H.+Mach&title=New+targets+for+the+development+of+PET+tracers+for+imaging+neurodegeneration+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DNew%2520targets%2520for%2520the%2520development%2520of%2520PET%2520tracers%2520for%2520imaging%2520neurodegeneration%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1221%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Zimmer, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leuzy, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gauthier, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosa-Neto, P.</span><span> </span><span class="NLM_article-title">Developments in tau PET imaging</span> <span class="citation_source-journal">Can. J. Neurol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">547</span><span class="NLM_x">–</span> <span class="NLM_lpage">553</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1017%2Fcjn.2014.15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25424608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC2MzgvFKltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=547-553&author=E.+R.+Zimmerauthor=A.+Leuzyauthor=S.+Gauthierauthor=P.+Rosa-Neto&title=Developments+in+tau+PET+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Developments in Tau PET Imaging</span></div><div class="casAuthors">Zimmer Eduardo Rigon; Leuzy Antoine; Rosa-Neto Pedro; Gauthier Serge</div><div class="citationInfo"><span class="NLM_cas:title">The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">547-53</span>
        ISSN:<span class="NLM_cas:issn">0317-1671</span>.
    </div><div class="casAbstract">ABSTRACT The presence of neurofibrillary tangles in the brain is a hallmark feature of several neurodegenerative diseases termed "tauopathies," including Alzheimer's disease (AD) and the tau molecular subgroup of frontotemporal lobar degeneration (FTLD-tau).  Recently, several positron emission tomography (PET) radiopharmaceuticals targeting abnormal conformations of the tau protein have been developed.  To date, six novel tau imaging agents-[18F]THK523, [18F]THK5105, [18F]THK5117, [18F]T807, [18F]T808, and [11C]PBB3-have been described and are considered promising as potential tau radioligands.  Tau imaging agents offer the opportunity of in vivo topographical mapping and quantification of tau aggregates in parallel with clinical and cognitive assessments.  As such, tau imaging is considered of key importance for progress toward earlier and more accurate diagnosis of tauopathies as well as for the monitoring of therapeutic interventions and drug development.  Here, we shed light on the most important developments in tau radiopharmaceuticals, highlighting challenges, possibilities and future directions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSPHrSw-HxLgeIHSmpohpd0fW6udTcc2ebVW8iM6pWrRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MzgvFKltQ%253D%253D&md5=bf5b7d4ed0578fd1fe55dfde23d38544</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1017%2Fcjn.2014.15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252Fcjn.2014.15%26sid%3Dliteratum%253Aachs%26aulast%3DZimmer%26aufirst%3DE.%2BR.%26aulast%3DLeuzy%26aufirst%3DA.%26aulast%3DGauthier%26aufirst%3DS.%26aulast%3DRosa-Neto%26aufirst%3DP.%26atitle%3DDevelopments%2520in%2520tau%2520PET%2520imaging%26jtitle%3DCan.%2520J.%2520Neurol.%2520Sci.%26date%3D2014%26volume%3D41%26spage%3D547%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span> </span><span class="NLM_article-title">Tau imaging: early progress and future directions</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS1474-4422%2814%2970252-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25496902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=114-124&author=V.+L.+Villemagneauthor=M.+T.+Fodero-Tavolettiauthor=C.+L.+Mastersauthor=C.+C.+Rowe&title=Tau+imaging%3A+early+progress+and+future+directions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Tau imaging: early progress and future directions</span></div><div class="casAuthors">Villemagne Victor L; Fodero-Tavoletti Michelle T; Masters Colin L; Rowe Christopher C</div><div class="citationInfo"><span class="NLM_cas:title">The Lancet. Neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">114-24</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Use of selective in-vivo tau imaging will enable improved understanding of tau aggregation in the brain, facilitating research into causes, diagnosis, and treatment of major tauopathies such as Alzheimer's disease, progressive supranuclear palsy, corticobasal syndrome, chronic traumatic encephalopathy, and some variants of frontotemporal lobar degeneration.  Neuropathological studies of Alzheimer's disease show a strong association between tau deposits, decreased cognitive function, and neurodegenerative changes.  Selective tau imaging will allow the in-vivo exploration of such associations and measure the global and regional changes in tau deposits over time.  Such imaging studies will comprise non-invasive assessment of the spatial and temporal pattern of tau deposition over time, providing insight into the role tau plays in ageing and helping to establish the relation between cognition, genotype, neurodegeneration, and other biomarkers.  Once validated, selective tau imaging might be useful as a diagnostic, prognostic, and progression biomarker, and a surrogate marker for the monitoring of efficacy and patient recruitment for anti-tau therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTIuS1EFOTTc50d-O_J5C0AfW6udTcc2ebVW8iM6pWrRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MritFertg%253D%253D&md5=95eb0f9b98711e30caaf4a7c67bd46e0</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2814%2970252-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252814%252970252-2%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26atitle%3DTau%2520imaging%253A%2520early%2520progress%2520and%2520future%2520directions%26jtitle%3DLancet%2520Neurol.%26date%3D2015%26volume%3D14%26spage%3D114%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Tau PET imaging in Alzheimer’s disease</span> <span class="citation_source-journal">Curr. Neurol. Neurosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">500</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs11910-014-0500-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25239654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=500&author=N.+Okamuraauthor=R.+Haradaauthor=S.+Furumotoauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Tau+PET+imaging+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Tau PET imaging in Alzheimer's disease</span></div><div class="casAuthors">Okamura Nobuyuki; Harada Ryuichi; Furumoto Shozo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Current neurology and neuroscience reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">500</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">In several neurodegenerative diseases that are collectively called tauopathies, progressive accumulation of tau in the brain is closely associated with neurodegeneration and cognitive impairment.  Noninvasive detection of tau protein deposits in the brain would be useful to diagnose tauopathies as well as to track and predict disease progression.  Recently, several tau PET tracers including T807, THK-5117, and PBB3 have been developed and succeeded in imaging neurofibrillary pathology in vivo.  For use of tau PET as a biomarker of tau pathology in Alzheimer's disease, PET tracers should have high affinity to PHF-tau and high selectivity for tau over amyloid-β and other protein deposits.  PET tau imaging enables the longitudinal assessment of the spatial pattern of tau deposition and its relation to amyloid-β pathology and neurodegeneration.  This technology could also be applied to the pharmacological assessment of anti-tau therapy, thereby allowing preventive interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTy6LVoglwXzIqdXsLcGTEUfW6udTcc2ebVW8iM6pWrRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7jsFSrtA%253D%253D&md5=343715c63553be883942f9829da91648</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs11910-014-0500-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11910-014-0500-6%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DTau%2520PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Neurol.%2520Neurosci.%2520Rep.%26date%3D2014%26volume%3D14%26spage%3D500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Weingarten, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockwood, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwo, S.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschner, M. W.</span><span> </span><span class="NLM_article-title">A protein factor essential for microtubule assembly</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1858</span><span class="NLM_x">–</span> <span class="NLM_lpage">1862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1073%2Fpnas.72.5.1858" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=1057175" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADyaE2MXkt1ersbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1975&pages=1858-1862&author=M.+D.+Weingartenauthor=A.+H.+Lockwoodauthor=S.-Y.+Hwoauthor=M.+W.+Kirschner&title=A+protein+factor+essential+for+microtubule+assembly"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Protein factor essential for microtubule assembly</span></div><div class="casAuthors">Weingarten, Murray D.; Lockwood, Arthur H.; Hwo, Shu-Ying; Kirschner, Marc W.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1858-62</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">A heat stable protein essential for microtubule assembly was isolated.  This protein, designated tau (τ), was present in assocn. with tubulin purified from porcine brain by repeated cycles of polymerization.  Tau was sepd. from tubulin by ion exchange chromatog. on phosphocellulose.  In the absence of tau, tubulin existed entirely as a 6 S dimer of 2 polypeptide chains (α and β tubulin) with a mol. wt. of 120,000, which will not assemble into microtubules in vitro.  Addn. of tau completely restored tubule-forming capacity.  Under nonpolymerizing conditions, tau converted 6 S dimers to 36 S rings-structures implicated as intermediates in tubule formation.  Hence, tau appears to act on the 6 S tubulin dimer, activating it for polymerization.  The unique ability of tau to restore the normal features of in vitro microtubule assembly makes it likely that tau is a major regulator of microtubule formation in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpF1DLd-GTWGLVg90H21EOLACvtfcHk0lhZ63szsyBvGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2MXkt1ersbw%253D&md5=fb14f3b19fbd890adc61846ef868a943</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1073%2Fpnas.72.5.1858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.72.5.1858%26sid%3Dliteratum%253Aachs%26aulast%3DWeingarten%26aufirst%3DM.%2BD.%26aulast%3DLockwood%26aufirst%3DA.%2BH.%26aulast%3DHwo%26aufirst%3DS.-Y.%26aulast%3DKirschner%26aufirst%3DM.%2BW.%26atitle%3DA%2520protein%2520factor%2520essential%2520for%2520microtubule%2520assembly%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1975%26volume%3D72%26spage%3D1858%26epage%3D1862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Andreadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broderick, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosik, K. S.</span><span> </span><span class="NLM_article-title">Relative exon affinities and suboptimal splice site signals lead to non-equivalence of two cassette exons</span> <span class="citation_source-journal">Nucleic Acids Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">3585</span><span class="NLM_x">–</span> <span class="NLM_lpage">3593</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1995&pages=3585-3593&author=A.+Andreadisauthor=J.+A.+Broderickauthor=K.+S.+Kosik&title=Relative+exon+affinities+and+suboptimal+splice+site+signals+lead+to+non-equivalence+of+two+cassette+exons"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreadis%26aufirst%3DA.%26aulast%3DBroderick%26aufirst%3DJ.%2BA.%26aulast%3DKosik%26aufirst%3DK.%2BS.%26atitle%3DRelative%2520exon%2520affinities%2520and%2520suboptimal%2520splice%2520site%2520signals%2520lead%2520to%2520non-equivalence%2520of%2520two%2520cassette%2520exons%26jtitle%3DNucleic%2520Acids%2520Res.%26date%3D1995%26volume%3D23%26spage%3D3585%26epage%3D3593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Andreadis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kosik, K. S.</span><span> </span><span class="NLM_article-title">Structure and novel exons of the human tau gene</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">10626</span><span class="NLM_x">–</span> <span class="NLM_lpage">10633</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi00158a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1992&pages=10626-10633&author=A.+Andreadisauthor=W.+M.+Brownauthor=K.+S.+Kosik&title=Structure+and+novel+exons+of+the+human+tau+gene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Fbi00158a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi00158a027%26sid%3Dliteratum%253Aachs%26aulast%3DAndreadis%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DW.%2BM.%26aulast%3DKosik%26aufirst%3DK.%2BS.%26atitle%3DStructure%2520and%2520novel%2520exons%2520of%2520the%2520human%2520tau%2520gene%26jtitle%3DBiochemistry%26date%3D1992%26volume%3D31%26spage%3D10626%26epage%3D10633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Buée, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussière, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buée-Scherrerb, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delacourte, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hof, P. R.</span><span> </span><span class="NLM_article-title">Tau protein isoforms, phosphorylation and role in neurodegenerative disorders</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">95</span><span class="NLM_x">–</span> <span class="NLM_lpage">130</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS0165-0173%2800%2900019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=10967355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmtVCrtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=95-130&author=L.+Bu%C3%A9eauthor=T.+Bussi%C3%A8reauthor=V.+Bu%C3%A9e-Scherrerbauthor=A.+Delacourteauthor=P.+R.+Hof&title=Tau+protein+isoforms%2C+phosphorylation+and+role+in+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Tau protein isoforms, phosphorylation and role in neurodegenerative disorders</span></div><div class="casAuthors">Buee, L.; Bussiere, T.; Buee-Scherrer, V.; Delacourte, A.; Hof, P. R.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Reviews</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-130</span>CODEN:
                <span class="NLM_cas:coden">BRERD2</span>;
        ISSN:<span class="NLM_cas:issn">0165-0173</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A review, with 425 refs.  Tau proteins belong to the family of microtubule-assocd. proteins.  They are mainly expressed in neurons where they play an important role in the assembly of tubulin monomers into microtubules to constitute the neuronal microtubules network.  Microtubules are involved in maintaining the cell shape and serve as tracks for axonal transport.  Tau proteins also establish some links between microtubules and other cytoskeletal elements or proteins.  Tau proteins are translated from a single gene located on chromosome 17.  Their expression is developmentally regulated by an alternative splicing mechanism and six different isoforms exist in the human adult brain.  Tau proteins are the major constituents of intra-neuronal and glial fibrillar lesions described in Alzheimer's disease and numerous neurodegenerative disorders referred to as 'tauopathies'.  Mol. anal. has revealed that an abnormal phosphorylation might be one of the important events in the process leading to their aggregation.  Moreover, a specific set of pathol. tau proteins exhibiting a typical biochem. pattern, and a different regional and laminar distribution could characterize each of these disorders.  Finally, a direct correlation has been established between the progressive involvement of the neocortical areas and the increasing severity of dementia, suggesting that pathol. tau proteins are reliable marker of the neurodegenerative process.  The recent discovery of tau gene mutations in frontotemporal dementia with parkinsonism linked to chromosome 17 has reinforced the predominant role attributed to tau proteins in the pathogenesis of neurodegenerative disorders, and underlined the fact that distinct sets of tau isoforms expressed in different neuronal populations could lead to different pathologies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5KNCSKfZ8_7Vg90H21EOLACvtfcHk0lhZ63szsyBvGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmtVCrtbY%253D&md5=d51d14c9e8b56e9661db4ae4afc2c943</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2FS0165-0173%2800%2900019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0173%252800%252900019-9%26sid%3Dliteratum%253Aachs%26aulast%3DBu%25C3%25A9e%26aufirst%3DL.%26aulast%3DBussi%25C3%25A8re%26aufirst%3DT.%26aulast%3DBu%25C3%25A9e-Scherrerb%26aufirst%3DV.%26aulast%3DDelacourte%26aufirst%3DA.%26aulast%3DHof%26aufirst%3DP.%2BR.%26atitle%3DTau%2520protein%2520isoforms%252C%2520phosphorylation%2520and%2520role%2520in%2520neurodegenerative%2520disorders%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2000%26volume%3D33%26spage%3D95%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Levy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leboeuf, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massie, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstein, S. C.</span><span> </span><span class="NLM_article-title">Three- and four-repeat tau regulate the dynamic instability of two distinct microtubule subpopulations in qualitatively different manners. Implications for neurodegeneration</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">13520</span><span class="NLM_x">–</span> <span class="NLM_lpage">13528</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=13520-13528&author=S.+F.+Levyauthor=A.+C.+Leboeufauthor=M.+R.+Massieauthor=M.+A.+Jordanauthor=L.+Wilsonauthor=S.+C.+Feinstein&title=Three-+and+four-repeat+tau+regulate+the+dynamic+instability+of+two+distinct+microtubule+subpopulations+in+qualitatively+different+manners.+Implications+for+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLevy%26aufirst%3DS.%2BF.%26aulast%3DLeboeuf%26aufirst%3DA.%2BC.%26aulast%3DMassie%26aufirst%3DM.%2BR.%26aulast%3DJordan%26aufirst%3DM.%2BA.%26aulast%3DWilson%26aufirst%3DL.%26aulast%3DFeinstein%26aufirst%3DS.%2BC.%26atitle%3DThree-%2520and%2520four-repeat%2520tau%2520regulate%2520the%2520dynamic%2520instability%2520of%2520two%2520distinct%2520microtubule%2520subpopulations%2520in%2520qualitatively%2520different%2520manners.%2520Implications%2520for%2520neurodegeneration%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D13520%26epage%3D13528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hascher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Proline-directed pseudophosphorylation at AT8 and PHF1 epitopes induces a compaction of the paperclip folding of tau and generates a pathological (MC-1) conformation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">32066</span><span class="NLM_x">–</span> <span class="NLM_lpage">32076</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=2008&pages=32066-32076&author=S.+Jeganathanauthor=A.+Hascherauthor=S.+Chinnathambiauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Proline-directed+pseudophosphorylation+at+AT8+and+PHF1+epitopes+induces+a+compaction+of+the+paperclip+folding+of+tau+and+generates+a+pathological+%28MC-1%29+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3DHascher%26aufirst%3DA.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DProline-directed%2520pseudophosphorylation%2520at%2520AT8%2520and%2520PHF1%2520epitopes%2520induces%2520a%2520compaction%2520of%2520the%2520paperclip%2520folding%2520of%2520tau%2520and%2520generates%2520a%2520pathological%2520%2528MC-1%2529%2520conformation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2008%26volume%3D283%26spage%3D32066%26epage%3D32076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Mukrasch, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibow, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korukottu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeganathan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griesinger, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zweckstetter, M.</span><span> </span><span class="NLM_article-title">Structural polymorphism of 441-residue tau at single residue resolution</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">e34</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=e34&author=M.+D.+Mukraschauthor=S.+Bibowauthor=J.+Korukottuauthor=S.+Jeganathanauthor=J.+Biernatauthor=C.+Griesingerauthor=E.+Mandelkowauthor=M.+Zweckstetter&title=Structural+polymorphism+of+441-residue+tau+at+single+residue+resolution"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMukrasch%26aufirst%3DM.%2BD.%26aulast%3DBibow%26aufirst%3DS.%26aulast%3DKorukottu%26aufirst%3DJ.%26aulast%3DJeganathan%26aufirst%3DS.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DGriesinger%26aufirst%3DC.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DZweckstetter%26aufirst%3DM.%26atitle%3DStructural%2520polymorphism%2520of%2520441-residue%2520tau%2520at%2520single%2520residue%2520resolution%26jtitle%3DPLoS%2520Biol.%26date%3D2009%26volume%3D7%26spage%3De34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedhoff, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heberle, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming β structure</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">5129</span><span class="NLM_x">–</span> <span class="NLM_lpage">5134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=5129-5134&author=M.+von+Bergenauthor=P.+Friedhoffauthor=J.+Biernatauthor=J.+Heberleauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Assembly+of+tau+protein+into+Alzheimer+paired+helical+filaments+depends+on+a+local+sequence+motif+%28%28306%29VQIVYK%28311%29%29+forming+%CE%B2+structure"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvon%2BBergen%26aufirst%3DM.%26aulast%3DFriedhoff%26aufirst%3DP.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DHeberle%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DAssembly%2520of%2520tau%2520protein%2520into%2520Alzheimer%2520paired%2520helical%2520filaments%2520depends%2520on%2520a%2520local%2520sequence%2520motif%2520%2528%2528306%2529VQIVYK%2528311%2529%2529%2520forming%2520%25CE%25B2%2520structure%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D5129%26epage%3D5134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Von Bergen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barghorn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marx, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">276</span><span class="NLM_x">, </span> <span class="NLM_fpage">48165</span><span class="NLM_x">–</span> <span class="NLM_lpage">48174</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1074%2Fjbc.M105196200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=11606569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVWq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=48165-48174&author=M.+Von+Bergenauthor=S.+Barghornauthor=L.+Liauthor=A.+Marxauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkow&title=Mutations+of+tau+protein+in+frontotemporal+dementia+promote+aggregation+of+paired+helical+filaments+by+enhancing+local+%CE%B2-structure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local β-structure</span></div><div class="casAuthors">Von Bergen, Martin; Barghorn, Stefan; Li, Li; Marx, Alexander; Biernat, Jacek; Mandelkow, Eva-Maria; Mandelkow, Eckhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">48165-48174</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The microtubule-assocd. protein tau is a natively unfolded protein in soln., yet it is able to polymerize into the ordered paired helical filaments (PHF) of Alzheimer's disease.  In the splice isoforms lacking exon 10, this process is facilitated by the formation of β-structure around the hexapeptide motif PHF6 (306VQIVYK311) encoded by exon 11.  We have investigated the structural requirements for PHF polymn. in the context of adult tau isoforms contg. four repeats (including exon 10).  In addn. to the PHF6 motif there exists a related PHF6* motif (275VQIINK280) in the repeat encoded by the alternatively spliced exon 10.  We show that this PHF6* motif also promotes aggregation by the formation of β-structure and that there is a cross-talk between the two hexapeptide motifs during PHF aggregation.  We also show that two of the tau mutations found in hereditary frontotemporal dementias, ΔK280 and P301L, have a much stronger tendency for PHF aggregation which correlates with their high propensity for β-structure around the hexapeptide motifs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoio6uZlbctuLVg90H21EOLACvtfcHk0lhCpqnzQoZWCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVWq&md5=570cd75c036557ade8d4539ff2e2b054</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M105196200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M105196200%26sid%3Dliteratum%253Aachs%26aulast%3DVon%2BBergen%26aufirst%3DM.%26aulast%3DBarghorn%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMarx%26aufirst%3DA.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DMutations%2520of%2520tau%2520protein%2520in%2520frontotemporal%2520dementia%2520promote%2520aggregation%2520of%2520paired%2520helical%2520filaments%2520by%2520enhancing%2520local%2520%25CE%25B2-structure%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D48165%26epage%3D48174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Latypova, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terro, F.</span><span> </span><span class="NLM_article-title">Post-translational modifications of tau protein: implications for Alzheimer’s disease</span> <span class="citation_source-journal">Neurochem. Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">458</span><span class="NLM_x">–</span> <span class="NLM_lpage">471</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.neuint.2010.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21215781" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFGnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2011&pages=458-471&author=L.+Martinauthor=X.+Latypovaauthor=F.+Terro&title=Post-translational+modifications+of+tau+protein%3A+implications+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Post-translational modifications of tau protein: Implications for Alzheimer's disease</span></div><div class="casAuthors">Martin, Ludovic; Latypova, Xenia; Terro, Faraj</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">458-471</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) belongs to a group of neurodegenerative diseases collectively designated as "tauopathies", because they are characterized by the aggregation of abnormally phosphorylated tau protein.  The mechanisms responsible for tau aggregation and its contribution to neurodegeneration are still unknown.  Thereby, understanding the modes of regulation of tau is of high interest in the detn. of the possible causes at the origin of the formation of tau aggregates and to elaborate protection strategies to cope with these pathol. lesions.  The regulation of tau takes place predominantly through post-translational modifications.  Extensive reports have been published about tau phosphorylation; however, the other tau post-translational modifications have received much less attention.  Here, we review the different types of post-translational modifications of tau including phosphorylation, glycosylation, glycation, prolyl-isomerization, cleavage or truncation, nitration, polyamination, ubiquitination, sumoylation, oxidn. and aggregation, with a particular interest towards their relevance in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsG774y8lsNrVg90H21EOLACvtfcHk0ljRrqKbf2HiUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFGnsLo%253D&md5=dde6742c84b61e90575c394bbe05c55a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2010.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2010.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLatypova%26aufirst%3DX.%26aulast%3DTerro%26aufirst%3DF.%26atitle%3DPost-translational%2520modifications%2520of%2520tau%2520protein%253A%2520implications%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurochem.%2520Int.%26date%3D2011%26volume%3D58%26spage%3D458%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, C.-X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, F.</span><span> </span><span class="NLM_article-title">Microtubule-associated protein tau as a therapeutic target in Alzheimer’s disease</span> <span class="citation_source-journal">Expert Opin. Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">307</span><span class="NLM_x">–</span> <span class="NLM_lpage">318</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1517%2F14728222.2014.870156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24387228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXis1Cjtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=307-318&author=K.+Iqbalauthor=C.-X.+Gongauthor=F.+Liu&title=Microtubule-associated+protein+tau+as+a+therapeutic+target+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule-associated protein tau as a therapeutic target in Alzheimer's disease</span></div><div class="casAuthors">Iqbal, Khalid; Gong, Cheng-Xin; Liu, Fei</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">307-318</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: Alzheimer's disease (AD) is a major public health problem in modern society and as yet, other than a few symptomatic drugs, there is no disease-modifying treatment for this disease available.  Areas covered: Neurofibrillary pathol., which is made up from abnormally hyperphosphorylated microtubule-assocd. protein tau, is both a hallmark and key lesion of AD and related tauopathies.  The d. of neurofibrillary pathol. in the cerebral cortex correlates with the degree of dementia.  Both exptl. and transgenic animal studies have consistently shown that abnormal hyperphosphorylation of tau causes cognitive impairment.  Abnormal hyperphosphorylation of tau converts it from a microtubule assembly-promoting to a microtubule-disrupting protein and promotes its self-assembly into paired helical filaments.  To date, the bulk of studies have shown that abnormal hyperphosphorylation is the key gain of toxic function step though some cell culture and transgenic mouse studies have also reported that aggregated tau can lead to neurodegeneration.  In this article, we have reviewed data from our lab and that from PubMed search on the mol. mechanism of tau pathol. and the potential of tau as a therapeutic target for AD and related disorders.  Expert opinion: In our opinion, inhibition of abnormal hyperphosphorylation of tau is the most rational therapeutic target.  Therapeutic approaches include restoration of the activity of protein phosphatase-2A, which is the major regulator of tau phosphorylation and the activity of which is compromised in AD brain, inhibition of one or more tau protein kinases which include GSK-3β, cyclin-dependent protein kinase-5, dual-specificity tyrosine phosphorylated-regulated kinase 1A, Ca2+/calmodulin-activated protein kinase II and casein kinase I, enhancement of O-GlcNAcylation of tau, and tau immunization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUf6R7H9W1MLVg90H21EOLACvtfcHk0ljRrqKbf2HiUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXis1Cjtb4%253D&md5=67bb858f39c97e2a9312805d42187727</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.870156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.870156%26sid%3Dliteratum%253Aachs%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DGong%26aufirst%3DC.-X.%26aulast%3DLiu%26aufirst%3DF.%26atitle%3DMicrotubule-associated%2520protein%2520tau%2520as%2520a%2520therapeutic%2520target%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets%26date%3D2014%26volume%3D18%26spage%3D307%26epage%3D318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Spillantini, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span> </span><span class="NLM_article-title">Tau pathology and neurodegeneration</span> <span class="citation_source-journal">Lancet Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">609</span><span class="NLM_x">–</span> <span class="NLM_lpage">622</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS1474-4422%2813%2970090-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23684085" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=609-622&author=M.+G.+Spillantiniauthor=M.+Goedert&title=Tau+pathology+and+neurodegeneration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Tau pathology and neurodegeneration</span></div><div class="casAuthors">Spillantini, Maria Grazia; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">609-622</span>CODEN:
                <span class="NLM_cas:coden">LNAEAM</span>;
        ISSN:<span class="NLM_cas:issn">1474-4422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The pathway leading from sol. and monomeric to hyperphosphorylated, insol. and filamentous tau protein is at the center of many human neurodegenerative diseases, collectively referred to as tauopathies.  Dominantly inherited mutations in MAPT, the gene that encodes tau, cause forms of frontotemporal dementia and parkinsonism, proving that dysfunction of tau is sufficient to cause neurodegeneration and dementia.  However, most cases of tauopathy are not inherited in a dominant manner.  The first tau aggregates form in a few nerve cells in discrete brain areas.  These become self propagating and spread to distant brain regions in a prion-like manner.  The prevention of tau aggregation and propagation is the focus of attempts to develop mechanism-based treatments for tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoL-Mr15hi3grVg90H21EOLACvtfcHk0ljRrqKbf2HiUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVGkur0%253D&md5=532220e2bfffdb228277e80868bdde65</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS1474-4422%2813%2970090-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1474-4422%252813%252970090-5%26sid%3Dliteratum%253Aachs%26aulast%3DSpillantini%26aufirst%3DM.%2BG.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DTau%2520pathology%2520and%2520neurodegeneration%26jtitle%3DLancet%2520Neurol.%26date%3D2013%26volume%3D12%26spage%3D609%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Clavaguera, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grueninger, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tolnay, M.</span><span> </span><span class="NLM_article-title">Intercellular transfer of tau aggregates and spreading of tau pathology: implications for therapeutic strategies</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=9-15&author=F.+Clavagueraauthor=F.+Grueningerauthor=M.+Tolnay&title=Intercellular+transfer+of+tau+aggregates+and+spreading+of+tau+pathology%3A+implications+for+therapeutic+strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClavaguera%26aufirst%3DF.%26aulast%3DGrueninger%26aufirst%3DF.%26aulast%3DTolnay%26aufirst%3DM.%26atitle%3DIntercellular%2520transfer%2520of%2520tau%2520aggregates%2520and%2520spreading%2520of%2520tau%2520pathology%253A%2520implications%2520for%2520therapeutic%2520strategies%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D76%26spage%3D9%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span> </span><span class="NLM_article-title">Progress and developments in tau aggregation inhibitors for Alzheimer disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4135</span><span class="NLM_x">–</span> <span class="NLM_lpage">4155</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3017317" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4135-4155&author=B.+Bulicauthor=M.+Pickhardtauthor=E.+Mandelkow&title=Progress+and+developments+in+tau+aggregation+inhibitors+for+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm3017317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3017317%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DMandelkow%26aufirst%3DE.%26atitle%3DProgress%2520and%2520developments%2520in%2520tau%2520aggregation%2520inhibitors%2520for%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4135%26epage%3D4155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Ramachandran, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Udgaonkar, J. B.</span><span> </span><span class="NLM_article-title">Mechanistic studies unravel the complexity inherent in tau aggregation leading to Alzheimer’s disease and the tauopathies</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4107</span><span class="NLM_x">–</span> <span class="NLM_lpage">4126</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi400209z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=4107-4126&author=G.+Ramachandranauthor=J.+B.+Udgaonkar&title=Mechanistic+studies+unravel+the+complexity+inherent+in+tau+aggregation+leading+to+Alzheimer%E2%80%99s+disease+and+the+tauopathies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fbi400209z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400209z%26sid%3Dliteratum%253Aachs%26aulast%3DRamachandran%26aufirst%3DG.%26aulast%3DUdgaonkar%26aufirst%3DJ.%2BB.%26atitle%3DMechanistic%2520studies%2520unravel%2520the%2520complexity%2520inherent%2520in%2520tau%2520aggregation%2520leading%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520the%2520tauopathies%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26spage%3D4107%26epage%3D4126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Sevcik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skrabana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Csokova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iqbal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, M.</span><span> </span><span class="NLM_article-title">X-ray structure of the PHF core C terminus: insight into the folding of the intrinsically disordered protein tau in Alzheimer’s disease</span> <span class="citation_source-journal">FEBS Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">581</span><span class="NLM_x">, </span> <span class="NLM_fpage">5872</span><span class="NLM_x">–</span> <span class="NLM_lpage">5878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=581&publication_year=2007&pages=5872-5878&author=J.+Sevcikauthor=R.+Skrabanaauthor=R.+Dvorskyauthor=N.+Csokovaauthor=K.+Iqbalauthor=M.+Novak&title=X-ray+structure+of+the+PHF+core+C+terminus%3A+insight+into+the+folding+of+the+intrinsically+disordered+protein+tau+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSevcik%26aufirst%3DJ.%26aulast%3DSkrabana%26aufirst%3DR.%26aulast%3DDvorsky%26aufirst%3DR.%26aulast%3DCsokova%26aufirst%3DN.%26aulast%3DIqbal%26aufirst%3DK.%26aulast%3DNovak%26aufirst%3DM.%26atitle%3DX-ray%2520structure%2520of%2520the%2520PHF%2520core%2520C%2520terminus%253A%2520insight%2520into%2520the%2520folding%2520of%2520the%2520intrinsically%2520disordered%2520protein%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFEBS%2520Lett.%26date%3D2007%26volume%3D581%26spage%3D5872%26epage%3D5878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Skrabana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dvorsky, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sevcik, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, M.</span><span> </span><span class="NLM_article-title">Monoclonal antibody MN423 as a stable mold facilitates structure determination of disordered tau protein</span> <span class="citation_source-journal">J. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">171</span><span class="NLM_x">, </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=171&publication_year=2010&pages=74-81&author=R.+Skrabanaauthor=R.+Dvorskyauthor=J.+Sevcikauthor=M.+Novak&title=Monoclonal+antibody+MN423+as+a+stable+mold+facilitates+structure+determination+of+disordered+tau+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSkrabana%26aufirst%3DR.%26aulast%3DDvorsky%26aufirst%3DR.%26aulast%3DSevcik%26aufirst%3DJ.%26aulast%3DNovak%26aufirst%3DM.%26atitle%3DMonoclonal%2520antibody%2520MN423%2520as%2520a%2520stable%2520mold%2520facilitates%2520structure%2520determination%2520of%2520disordered%2520tau%2520protein%26jtitle%3DJ.%2520Struct.%2520Biol.%26date%3D2010%26volume%3D171%26spage%3D74%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Janke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holzer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bigl, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arendt, T.</span><span> </span><span class="NLM_article-title">Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2FS0169-328X%2899%2900079-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=10320789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADyaK1MXjs1eiurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1999&pages=119-128&author=C.+Jankeauthor=M.+Beckauthor=T.+Stahlauthor=M.+Holzerauthor=K.+Brauerauthor=V.+Biglauthor=T.+Arendt&title=Phylogenetic+diversity+of+the+expression+of+the+microtubule-associated+protein+tau%3A+implications+for+neurodegenerative+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Phylogenetic diversity of the expression of the microtubule-associated protein tau: implications for neurodegenerative disorders</span></div><div class="casAuthors">Janke, Carsten; Beck, Mike; Stahl, Tobias; Holzer, Max; Brauer, Kurt; Bigl, Volker; Arendt, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">1,2</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The microtubule-assocd. protein tau regulates the dynamic stability of the neuronal cytoskeleton by interacting with microtubules.  It is encoded by a single gene, but expressed in a variety of isoforms due to differential RNA splicing.  Six isoforms can be found in the human central nervous system.  These isoforms differ in their ability to promote the assembly of microtubules as well as in their capacity to stabilize existing microtubule structures.  Furthermore, some of the isoforms of tau are specifically involved in the pathogenesis of neurodegenerative disorders.  Thus, splicing of tau might critically influence the physiol. functions of tau protein as well as the pathogenesis of neurodegenerative diseases with tauopathy.  The present study addresses the differential expression of the six isoforms of tau in the central nervous system of 12 mammalian species including Homo sapiens.  The occurrence of each of the six tau isoforms was highly variable.  However, species that were phylogenetically related expressed a similar pattern of tau isoforms.  These results suggest a phylogenetic descent of splicing paradigms, which can be matched with known phylogenetic concepts based on morphol. and mol. genetical studies.  Esp., the unique expression pattern of tau isoforms in the human central nervous system implicates a possible link to the particular vulnerability of humans to neurodegenerative disorders with tauopathy, namely Alzheimer's disease, frontotemporal dementia and Pick's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdW04gm0vFAbVg90H21EOLACvtfcHk0liP3bfkRPAJqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjs1eiurs%253D&md5=a6c7c9bbde0c6831967e976ee0f9d6d0</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2FS0169-328X%2899%2900079-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-328X%252899%252900079-0%26sid%3Dliteratum%253Aachs%26aulast%3DJanke%26aufirst%3DC.%26aulast%3DBeck%26aufirst%3DM.%26aulast%3DStahl%26aufirst%3DT.%26aulast%3DHolzer%26aufirst%3DM.%26aulast%3DBrauer%26aufirst%3DK.%26aulast%3DBigl%26aufirst%3DV.%26aulast%3DArendt%26aufirst%3DT.%26atitle%3DPhylogenetic%2520diversity%2520of%2520the%2520expression%2520of%2520the%2520microtubule-associated%2520protein%2520tau%253A%2520implications%2520for%2520neurodegenerative%2520disorders%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1999%26volume%3D68%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Noble, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanger, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, J.-M.</span><span> </span><span class="NLM_article-title">Transgenic mouse models of tauopathy in drug discovery</span> <span class="citation_source-journal">CNS Neurol. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">428</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.2174%2F187152710791556131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20522014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVOlsLfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=403-428&author=W.+Nobleauthor=D.+P.+Hangerauthor=J.-M.+Gallo&title=Transgenic+mouse+models+of+tauopathy+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Transgenic mouse models of tauopathy in drug discovery</span></div><div class="casAuthors">Noble, W.; Hanger, D. P.; Gallo, J.-M.</div><div class="citationInfo"><span class="NLM_cas:title">CNS & Neurological Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-428</span>CODEN:
                <span class="NLM_cas:coden">CNDDA3</span>;
        ISSN:<span class="NLM_cas:issn">1871-5273</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Tauopathies, including Alzheimer's disease, are neurodegenerative diseases characterized by the deposition of hyperphosphorylated tau protein in the central nervous system, and are the major cause of dementia in later life.  Considerable advances have been made in developing mouse models that recapitulate, to varying extents, the development of human tau pathol., and the learning and memory deficits characteristic of some tauopathies.  Furthermore, such models have been used to show promising disease-modifying effects in pre-clin. testing of new therapeutics.  Various strategies have been utilized to generate mouse models of tauopathies.  Some of the most enlightening models developed to date either constitutively or inducibly express pathogenic tau mutations.  These animals have been instrumental in defining crit. disease-related mechanisms, including the observation that tangles are not the toxic form of tau in disease.  Here, we discuss the strengths and weaknesses of well characterized transgenic models that emulate human tauopathy, and include a comprehensive listing of the main phenotypic characteristics of all reported tau transgenic rodents.  We summarize the use of tau mice for the development and evaluation of new therapeutic approaches, and their utility in identifying novel drug targets.  In addn., we review the parameters to be considered in the development of the next generation of rodent models of tauopathy, aimed at further increasing our understanding of disease etiol. and in evaluating novel treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphmm6yFcZBKLVg90H21EOLACvtfcHk0liP3bfkRPAJqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVOlsLfN&md5=6c04ce9b630a690cb7397905e8576024</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.2174%2F187152710791556131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152710791556131%26sid%3Dliteratum%253Aachs%26aulast%3DNoble%26aufirst%3DW.%26aulast%3DHanger%26aufirst%3DD.%2BP.%26aulast%3DGallo%26aufirst%3DJ.-M.%26atitle%3DTransgenic%2520mouse%2520models%2520of%2520tauopathy%2520in%2520drug%2520discovery%26jtitle%3DCNS%2520Neurol.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2010%26volume%3D9%26spage%3D403%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Denk, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wade-Martins, R.</span><span> </span><span class="NLM_article-title">Knock-out and transgenic mouse models of tauopathies</span> <span class="citation_source-journal">Neurobiol. Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.neurobiolaging.2007.05.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=17590238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVWmsbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1-13&author=F.+Denkauthor=R.+Wade-Martins&title=Knock-out+and+transgenic+mouse+models+of+tauopathies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Knock-out and transgenic mouse models of tauopathies</span></div><div class="casAuthors">Denk, Franziska; Wade-Martins, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Tauopathies, characterized by the dysfunction and aggregation of the microtubule-assocd. protein tau (MAPT), represent some of the most devastating neurodegenerative disorders afflicting the elderly, including Alzheimer's disease and progressive supranuclear palsy.  Here we review the range of Mapt knock-out and MAPT transgenic mouse models which have proven successful at providing insights into the mol. mechanisms of neurodegenerative disease.  In this overview we highlight several themes, including the insights such models provide into the cellular and mol. mechanisms of tauopathy, the direct relationship between neuropathol. and behavior, and the use of mouse models to help provide a platform for testing novel therapies.  Mouse models have helped clarify the relationship between pathol. forms of tau, cell death, and the emergence of disease, as well as the interaction between tau and other disease-assocd. mols., such as the Aβ peptide.  Finally, we discuss potential future MAPT genomic DNA models to investigate the importance of alternative splicing of the MAPT locus and its role in sporadic tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLvPtTI3HK7rVg90H21EOLACvtfcHk0liP3bfkRPAJqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVWmsbzM&md5=b6facdcdd4bb4eca805f5658165c4771</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2007.05.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2007.05.010%26sid%3Dliteratum%253Aachs%26aulast%3DDenk%26aufirst%3DF.%26aulast%3DWade-Martins%26aufirst%3DR.%26atitle%3DKnock-out%2520and%2520transgenic%2520mouse%2520models%2520of%2520tauopathies%26jtitle%3DNeurobiol.%2520Aging%26date%3D2009%26volume%3D30%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Roberson, E. D.</span><span> </span><span class="NLM_article-title">Mouse models of frontotemporal dementia</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">837</span><span class="NLM_x">–</span> <span class="NLM_lpage">849</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fana.23722" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23280835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjs1ygsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=837-849&author=E.+D.+Roberson&title=Mouse+models+of+frontotemporal+dementia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse models of frontotemporal dementia</span></div><div class="casAuthors">Roberson, Erik D.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-849</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  The pace of discovery in frontotemporal dementia (FTD) has accelerated dramatically with the discovery of new genetic causes and pathol. substrates of the disease.  MAPT/tau, GRN/progranulin, and C9ORF72 have emerged as common FTD genes, and TARDBP/TDP-43, VCP, FUS, and CHMP2B have been identified as less common genetic causes.  TDP-43 and FUS have joined tau as common neuropathol. substrates of the disease.  Mouse models provide an important tool for understanding the role of these mols. in FTD pathogenesis.  Here, we review recent progress with mouse models based on tau, TDP-43, progranulin, VCP, and CHMP2B.  We also consider future prospects for FTD models, including developing new models to address unanswered questions.  There are also opportunities for capitalizing on conservation of the salience network, which is selectively vulnerable in FTD, and the availability of FTD-related behavioral paradigms to analyze mouse models of the disease.  Ann Neurol ANN NEUROL 2012;72:837-849.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6NAkoupeW_rVg90H21EOLACvtfcHk0lilC93MGeQR5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjs1ygsw%253D%253D&md5=55b7c71e48dbdfc6a04404d661af802c</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1002%2Fana.23722&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.23722%26sid%3Dliteratum%253Aachs%26aulast%3DRoberson%26aufirst%3DE.%2BD.%26atitle%3DMouse%2520models%2520of%2520frontotemporal%2520dementia%26jtitle%3DAnn.%2520Neurol.%26date%3D2012%26volume%3D72%26spage%3D837%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Peeraer, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottelbergs, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Kolen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stancu, I. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasconcelos, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahieu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duytschaever, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ver Donck, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torremans, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sluydts, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Acker, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemp, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dewachter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span> </span><span class="NLM_article-title">Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">95</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.nbd.2014.08.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25220759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFGltL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2015&pages=83-95&author=E.+Peeraerauthor=A.+Bottelbergsauthor=K.+Van+Kolenauthor=I.+C.+Stancuauthor=B.+Vasconcelosauthor=M.+Mahieuauthor=H.+Duytschaeverauthor=L.+Ver+Donckauthor=A.+Torremansauthor=E.+Sluydtsauthor=N.+Van+Ackerauthor=J.+A.+Kempauthor=M.+Merckenauthor=K.+R.+Brundenauthor=J.+Q.+Trojanowskiauthor=I.+Dewachterauthor=V.+M.+Leeauthor=D.+Moechars&title=Intracerebral+injection+of+preformed+synthetic+tau+fibrils+initiates+widespread+tauopathy+and+neuronal+loss+in+the+brains+of+tau+transgenic+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Intracerebral injection of preformed synthetic tau fibrils initiates widespread tauopathy and neuronal loss in the brains of tau transgenic mice</span></div><div class="casAuthors">Peeraer, Eve; Bottelbergs, Astrid; Van Kolen, Kristof; Stancu, Ilie-Cosmin; Vasconcelos, Bruno; Mahieu, Michel; Duytschaever, Hilde; Ver Donck, Luc; Torremans, An; Sluydts, Ellen; Van Acker, Nathalie; Kemp, John A.; Mercken, Marc; Brunden, Kurt R.; Trojanowski, John Q.; Dewachter, Ilse; Lee, Virginia M. Y.; Moechars, Diederik</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">83-95</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Neurofibrillary tangles composed of hyperphosphorylated fibrillized tau are found in numerous tauopathies including Alzheimer's disease.  Increasing evidence suggests that tau pathol. can be transmitted from cell-to-cell; however the mechanisms involved in the initiation of tau fibrillization and spreading of disease linked to progression of tau pathol. are poorly understood.  We show here that intracerebral injections of preformed synthetic tau fibrils into the hippocampus or frontal cortex of young tau transgenic mice expressing mutant human P301L tau induces tau hyperphosphorylation and aggregation around the site of injection, as well as a time-dependent propagation of tau pathol. to interconnected brain areas distant from the injection site.  Furthermore, we show that the tau pathol. as a consequence of injection of tau preformed fibrils into the hippocampus induces selective loss of CA1 neurons.  Together, our data confirm previous studies on the seeded induction and the spreading of tau pathol. in a different tau transgenic mouse model and reveals neuronal loss assocd. with seeded tau pathol. in tau transgenic mouse brain.  These results further validate the utility of the tau seeding model in studying disease transmission, and provide a more complete in vivo tauopathy model with assocd. neurodegeneration which can be used to investigate the mechanisms involved in tau aggregation and spreading, as well as aid in the search for disease modifying treatments for Alzheimer's disease and related tauopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKWwdTyPoIEbVg90H21EOLACvtfcHk0lilC93MGeQR5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFGltL3P&md5=56c876e8ab01a9607d84e5a5c3732b27</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2014.08.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2014.08.032%26sid%3Dliteratum%253Aachs%26aulast%3DPeeraer%26aufirst%3DE.%26aulast%3DBottelbergs%26aufirst%3DA.%26aulast%3DVan%2BKolen%26aufirst%3DK.%26aulast%3DStancu%26aufirst%3DI.%2BC.%26aulast%3DVasconcelos%26aufirst%3DB.%26aulast%3DMahieu%26aufirst%3DM.%26aulast%3DDuytschaever%26aufirst%3DH.%26aulast%3DVer%2BDonck%26aufirst%3DL.%26aulast%3DTorremans%26aufirst%3DA.%26aulast%3DSluydts%26aufirst%3DE.%26aulast%3DVan%2BAcker%26aufirst%3DN.%26aulast%3DKemp%26aufirst%3DJ.%2BA.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DDewachter%26aufirst%3DI.%26aulast%3DLee%26aufirst%3DV.%2BM.%26aulast%3DMoechars%26aufirst%3DD.%26atitle%3DIntracerebral%2520injection%2520of%2520preformed%2520synthetic%2520tau%2520fibrils%2520initiates%2520widespread%2520tauopathy%2520and%2520neuronal%2520loss%2520in%2520the%2520brains%2520of%2520tau%2520transgenic%2520mice%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2015%26volume%3D73%26spage%3D83%26epage%3D95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Pike, V. W.</span><span> </span><span class="NLM_article-title">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">431</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.tips.2009.05.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=19616318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=431-440&author=V.+W.+Pike&title=PET+radiotracers%3A+crossing+the+blood-brain+barrier+and+surviving+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">PET radiotracers: crossing the blood-brain barrier and surviving metabolism</span></div><div class="casAuthors">Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">431-440</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Radiotracers for imaging protein targets in the living human brain with positron emission tomog. (PET) are increasingly useful in clin. research and in drug development.  Such radiotracers must fulfill many criteria, among which an ability to enter brain adequately and reversibly without contamination by troublesome radiometabolites is desirable for accurate measurement of the d. of a target protein (e.g. neuroreceptor, transporter, enzyme or plaque).  Candidate radiotracers can fail as a result of poor passive brain entry, rejection from brain by efflux transporters or undesirable metab.  These issues are reviewed.  Emerging PET radiotracers for measuring efflux transporter function and new strategies for ameliorating radiotracer metab. are discussed.  A growing understanding of the mol. features affecting the brain penetration, metab. and efflux transporter sensitivity of prospective radiotracers should ultimately lead to their more rational and efficient design, and also to their greater efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ftMCpkOSmrVg90H21EOLACvtfcHk0ljTwLXrtFLQSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXpt1KgsLg%253D&md5=97704995fecd968baf1e0892bf70324e</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2009.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2009.05.005%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DPET%2520radiotracers%253A%2520crossing%2520the%2520blood-brain%2520barrier%2520and%2520surviving%2520metabolism%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2009%26volume%3D30%26spage%3D431%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span> </span><span class="NLM_article-title">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">363</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.mibio.2003.09.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=14667491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=363-375&author=M.+Laruelleauthor=M.+Slifsteinauthor=Y.+Huang&title=Relationships+between+radiotracer+properties+and+image+quality+in+molecular+imaging+of+the+brain+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Relationships between radiotracer properties and image quality in molecular imaging of the brain with positron emission tomography</span></div><div class="casAuthors">Laruelle Marc; Slifstein Mark; Huang Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">363-75</span>
        ISSN:<span class="NLM_cas:issn">1536-1632</span>.
    </div><div class="casAbstract">In molecular imaging of the brain, many factors affect the reliability of the quantitative information that can be derived from the imaging process.  This article discusses factors impacting on the imaging quality that are related to the radiotracer per se.  Following a brief summary of key concepts in receptor quantification, a number of these factors are discussed, including selectivity, affinity, delivery, and lipophilicity.  Concepts discussed in the theoretical section are then illustrated, by reviewing a recent comparative evaluation of four agents developed to label the serotonin transporter ([(11)C]ADAM, [(11)C]DASB, [(11)C]DAPA, and [(11)C]AFM).  Specifically, the relationship between affinity and lipophilicity, measured in vitro, and several scanning parameters are investigated.  These include peripherical metabolism, brain uptake, required scanning time, nonspecific binding, and binding potential.  It is shown that, within a given structural family, affinity and lipophilicity are associated with scan outcome in a relatively predictable manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8o2y4bB4mnvYfW6udTcc2eaiQgOapUxgBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslehtg%253D%253D&md5=b38c23d5032e968cc119f5b4197670d1</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1016%2Fj.mibio.2003.09.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mibio.2003.09.009%26sid%3Dliteratum%253Aachs%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DRelationships%2520between%2520radiotracer%2520properties%2520and%2520image%2520quality%2520in%2520molecular%2520imaging%2520of%2520the%2520brain%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2003%26volume%3D5%26spage%3D363%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hech, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasadny, K.</span><span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Hechauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0ljCX4GZompZcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHech%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Honer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gobbi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martarello, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comley, R. A.</span><span> </span><span class="NLM_article-title">Radioligand development for molecular imaging of the central nervous system with positron emission tomography</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1936</span><span class="NLM_x">–</span> <span class="NLM_lpage">1944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.drudis.2014.08.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=25173703" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtrbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2014&pages=1936-1944&author=M.+Honerauthor=L.+Gobbiauthor=L.+Martarelloauthor=R.+A.+Comley&title=Radioligand+development+for+molecular+imaging+of+the+central+nervous+system+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Radioligand development for molecular imaging of the central nervous system with positron emission tomography</span></div><div class="casAuthors">Honer, Michael; Gobbi, Luca; Martarello, Laurent; Comley, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1936-1944</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Positron emission tomog. (PET) is routinely used to support the development of drugs to treat neurol. and psychiatric disorders.  PET radioligands must not only be selective for the target of interest but must also possess a range of physicochem. and pharmacol. characteristics that allow them to be radiolabeled with short-lived positron-emitting isotopes, safely administered to humans, and for the degree of target binding to be quantified in vivo.  We review the ligand development process, including target selection, radioligand discovery (in vitro and preclin. evaluation), radiochem. and evaluation in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMOrjEdZ64wLVg90H21EOLACvtfcHk0ljCX4GZompZcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVyhtrbE&md5=9ae3bb3030cdc3a701be1df568190371</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2014.08.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2014.08.012%26sid%3Dliteratum%253Aachs%26aulast%3DHoner%26aufirst%3DM.%26aulast%3DGobbi%26aufirst%3DL.%26aulast%3DMartarello%26aufirst%3DL.%26aulast%3DComley%26aufirst%3DR.%2BA.%26atitle%3DRadioligand%2520development%2520for%2520molecular%2520imaging%2520of%2520the%2520central%2520nervous%2520system%2520with%2520positron%2520emission%2520tomography%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2014%26volume%3D19%26spage%3D1936%26epage%3D1944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, R.</span><span> </span><span class="NLM_article-title">In vivo site-directed radiotracers: a minireview</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">805</span><span class="NLM_x">–</span> <span class="NLM_lpage">815</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.nucmedbio.2008.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=19026942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2008&pages=805-815&author=S.+Patelauthor=R.+Gibson&title=In+vivo+site-directed+radiotracers%3A+a+minireview"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo site-directed radiotracers: a mini-review</span></div><div class="casAuthors">Patel, Shil; Gibson, Raymond</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">805-815</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review on the process for developing reversible, monovalent site-specific radiotracers in drug design.  It is concerned with the characteristics of radiotracers such as binding, lipophilicity, and binding specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYUEhMFA7d7bVg90H21EOLACvtfcHk0ljCX4GZompZcA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsVaisLvL&md5=869985e0741d52a76cb546972097e2a8</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2008.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2008.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DR.%26atitle%3DIn%2520vivo%2520site-directed%2520radiotracers%253A%2520a%2520minireview%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2008%26volume%3D35%26spage%3D805%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitneni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeurwaerdere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1584-1591&author=S.+Celenauthor=M.+Kooleauthor=M.+De+Angelisauthor=I.+Sannenauthor=S.+K.+Chitneniauthor=J.+Alcazarauthor=S.+Dedeurwaerdereauthor=D.+Moecharsauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andr%C3%A9sauthor=G.+Bormans&title=Preclinical+evaluation+of+18F-JNJ41510417+as+a+radioligand+for+PET+imaging+of+phosphodiesterase-10A+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DChitneni%26aufirst%3DS.%2BK.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ41510417%2520as%2520a%2520radioligand%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase-10A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D1584%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcázar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cid, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavreysen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Synthesis, evaluation and radiolabeling of new potent positive allosteric modulators of the metabotropic glutamate receptor 2 as potential tracers for positron emission tomography imaging</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">8685</span><span class="NLM_x">–</span> <span class="NLM_lpage">8699</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300912k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8685-8699&author=J.+I.+Andr%C3%A9sauthor=J.+Alc%C3%A1zarauthor=J.+M.+Cidauthor=M.+De+Angelisauthor=L.+Iturrinoauthor=X.+Langloisauthor=H.+Lavreysenauthor=A.+A.+Trabancoauthor=S.+Celenauthor=G.+Bormans&title=Synthesis%2C+evaluation+and+radiolabeling+of+new+potent+positive+allosteric+modulators+of+the+metabotropic+glutamate+receptor+2+as+potential+tracers+for+positron+emission+tomography+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm300912k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300912k%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DAlc%25C3%25A1zar%26aufirst%3DJ.%26aulast%3DCid%26aufirst%3DJ.%2BM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DIturrino%26aufirst%3DL.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DLavreysen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520evaluation%2520and%2520radiolabeling%2520of%2520new%2520potent%2520positive%2520allosteric%2520modulators%2520of%2520the%2520metabotropic%2520glutamate%2520receptor%25202%2520as%2520potential%2520tracers%2520for%2520positron%2520emission%2520tomography%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8685%26epage%3D8699" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Clinton, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blurton-Jones, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myczek, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Ferla, F. M.</span><span> </span><span class="NLM_article-title">Synergistic interactions between Aβ, tau, and α-synuclein: acceleration of neuropathology and cognitive decline</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">7281</span><span class="NLM_x">–</span> <span class="NLM_lpage">7289</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1523%2FJNEUROSCI.0490-10.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20505094" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVOisLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2010&pages=7281-7289&author=L.+K.+Clintonauthor=M.+Blurton-Jonesauthor=K.+Myczekauthor=J.+Q.+Trojanowskiauthor=F.+M.+La+Ferla&title=Synergistic+interactions+between+A%CE%B2%2C+tau%2C+and+%CE%B1-synuclein%3A+acceleration+of+neuropathology+and+cognitive+decline"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Synergistic interactions between Aβ, Tau, and α-synuclein: acceleration of neuropathology and cognitive decline</span></div><div class="casAuthors">Clinton, Lani K.; Blurton-Jones, Mathew; Myczek, Kristoffer; Trojanowski, John Q.; La Ferla, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7281-7289</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), the most prevalent age-related neurodegenerative disorder, is characterized pathol. by the accumulation of β-amyloid (Aβ) plaques and tau-laden neurofibrillary tangles.  Interestingly, up to 50% of AD cases exhibit a third prevalent neuropathol.: the aggregation of α-synuclein into Lewy bodies.  Importantly, the presence of Lewy body pathol. in AD is assocd. with a more aggressive disease course and accelerated cognitive dysfunction.  Thus, Aβ, tau, and α-synuclein may interact synergistically to promote the accumulation of each other.  In this study, we used a genetic approach to generate a model that exhibits the combined pathologies of AD and dementia with Lewy bodies (DLB).  To achieve this goal, we introduced a mutant human α-synuclein transgene into 3×Tg-AD mice.  As occurs in human disease, transgenic mice that develop both DLB and AD pathologies (DLB-AD mice) exhibit accelerated cognitive decline assocd. with a dramatic enhancement of Aβ, tau, and α-synuclein pathologies.  These findings also provide addnl. evidence that the accumulation of α-synuclein alone can significantly disrupt cognition.  Together,these data support the notion that Aβ, tau, and α-synuclein interact in vivo to promote the aggregation and accumulation of each other and accelerate cognitive dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLHhbVKUf-KbVg90H21EOLACvtfcHk0lh2TSXl3656Nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVOisLw%253D&md5=b3580778e574ff9c53123d02a21f4290</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0490-10.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0490-10.2010%26sid%3Dliteratum%253Aachs%26aulast%3DClinton%26aufirst%3DL.%2BK.%26aulast%3DBlurton-Jones%26aufirst%3DM.%26aulast%3DMyczek%26aufirst%3DK.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLa%2BFerla%26aufirst%3DF.%2BM.%26atitle%3DSynergistic%2520interactions%2520between%2520A%25CE%25B2%252C%2520tau%252C%2520and%2520%25CE%25B1-synuclein%253A%2520acceleration%2520of%2520neuropathology%2520and%2520cognitive%2520decline%26jtitle%3DJ.%2520Neurosci.%26date%3D2010%26volume%3D30%26spage%3D7281%26epage%3D7289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Irwin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span> </span><span class="NLM_article-title">Parkinson’s disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies</span> <span class="citation_source-journal">Nat. Rev. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">626</span><span class="NLM_x">–</span> <span class="NLM_lpage">636</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1038%2Fnrn3549" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23900411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=626-636&author=D.+J.+Irwinauthor=V.+M.-Y.+Leeauthor=J.+Q.+Trojanowski&title=Parkinson%E2%80%99s+disease+dementia%3A+convergence+of+%CE%B1-synuclein%2C+tau+and+amyloid-%CE%B2+pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies</span></div><div class="casAuthors">Irwin, David J.; Lee, Virginia M.-Y.; Trojanowski, John Q.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">626-636</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Dementia is increasingly being recognized in cases of Parkinson's disease (PD); such cases are termed PD dementia (PDD).  The spread of fibrillar α-synuclein (α-syn) pathol. from the brainstem to limbic and neocortical structures seems to be the strongest neuropathol. correlate of emerging dementia in PD.  In addn., up to 50% of patients with PDD also develop sufficient nos. of amyloid-β plaques and tau-contg. neurofibrillary tangles for a secondary diagnosis of Alzheimer's disease, and these pathologies may act synergistically with α-syn pathol. to confer a worse prognosis.  An understanding of the relationships between these three distinct pathologies and their resultant clin. phenotypes is crucial for the development of effective disease-modifying treatments for PD and PDD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQHKxvVpPusLVg90H21EOLACvtfcHk0liT2QiSb3Fm3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2iu7bN&md5=e8de266b3d41136269251f1857ec72db</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1038%2Fnrn3549&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3549%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DD.%2BJ.%26aulast%3DLee%26aufirst%3DV.%2BM.-Y.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26atitle%3DParkinson%25E2%2580%2599s%2520disease%2520dementia%253A%2520convergence%2520of%2520%25CE%25B1-synuclein%252C%2520tau%2520and%2520amyloid-%25CE%25B2%2520pathologies%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D626%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Wegmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, Y.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chinnathambi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, D. J.</span><span> </span><span class="NLM_article-title">Human tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">27302</span><span class="NLM_x">–</span> <span class="NLM_lpage">27313</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=27302-27313&author=S.+Wegmannauthor=Y.-J.+Jungauthor=S.+Chinnathambiauthor=E.-M.+Mandelkowauthor=E.+Mandelkowauthor=D.+J.+Muller&title=Human+tau+isoforms+assemble+into+ribbon-like+fibrils+that+display+polymorphic+structure+and+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWegmann%26aufirst%3DS.%26aulast%3DJung%26aufirst%3DY.-J.%26aulast%3DChinnathambi%26aufirst%3DS.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMuller%26aufirst%3DD.%2BJ.%26atitle%3DHuman%2520tau%2520isoforms%2520assemble%2520into%2520ribbon-like%2520fibrils%2520that%2520display%2520polymorphic%2520structure%2520and%2520stability%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D27302%26epage%3D27313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimadzu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujiwara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Quinoline and benzimidazole derivatives: candidate probes for in vivo imaging of tau pathology in Alzheimer’s disease</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">10857</span><span class="NLM_x">–</span> <span class="NLM_lpage">10862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1523%2FJNEUROSCI.1738-05.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=16306398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1yks77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=10857-10862&author=N.+Okamuraauthor=T.+Suemotoauthor=S.+Furumotoauthor=M.+Suzukiauthor=H.+Shimadzuauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Fujiwaraauthor=M.+Nemotoauthor=M.+Maruyamaauthor=H.+Araiauthor=K.+Yanaiauthor=T.+Sawadaauthor=Y.+Kudo&title=Quinoline+and+benzimidazole+derivatives%3A+candidate+probes+for+in+vivo+imaging+of+tau+pathology+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Quinoline and benzimidazole derivatives: Candidate probes for in vivo imaging of tau pathology in Alzheimer's disease</span></div><div class="casAuthors">Okamura, Nobuyuki; Suemoto, Takahiro; Furumoto, Shozo; Suzuki, Masako; Shimadzu, Hiroshi; Akatsu, Hiroyasu; Yamamoto, Takayuki; Fujiwara, Hironori; Nemoto, Miyako; Maruyama, Masahiro; Arai, Hiroyuki; Yanai, Kazuhiko; Sawada, Tohru; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">47</span>),
    <span class="NLM_cas:pages">10857-10862</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Neurofibrillary tangles (NFTs), neuropil threads, and neuritic elements of senile plaques predominantly comprise hyperphosphorylated tau protein and represent pathol. characteristics of Alzheimer's disease (AD).  These lesions occur before the presentation of clin. symptoms and correlate with the severity of dementia.  In vivo detection of these lesions would thus prove useful for preclin. diagnosis of AD and for tracking disease progression.  The present study introduces three novel compds., 4-[2-(2-benzoimidazolyl)ethenyl]-N,N-diethylbenzenamine (BF-126), 2-[(4-methylamino)phenyl]quinoline (BF-158), and 2-(4-aminophenyl)quinoline (BF-170), as candidate probes for in vivo imaging of tau pathol. in the AD brain.  When solns. of these compds. are injected i.v. into normal mice, these agents exhibit excellent brain uptake and rapid clearance from normal brain tissue.  These compds. display relatively lower binding affinity to β-amyloid fibrils and higher binding affinity to tau fibrils, compared with previously reported probe BF-168.  In neuropathol. examn. using AD brain sections, BF-126, BF-158, and BF-170 clearly visualize NFTs, neuropil threads, and paired helical filament-type neuritis.  Autoradiog. using 11C-labeled BF-158 further demonstrated labeling of NFTs in AD brain sections.  These findings suggest the potential usefulness of quinoline and benzimidazole derivs. for in vivo imaging of tau pathol. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1dHoJmFJtNLVg90H21EOLACvtfcHk0liT2QiSb3Fm3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1yks77K&md5=4b0bc18420a2429789d47bcb91eeb11c</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.1738-05.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.1738-05.2005%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DSuemoto%26aufirst%3DT.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShimadzu%26aufirst%3DH.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DFujiwara%26aufirst%3DH.%26aulast%3DNemoto%26aufirst%3DM.%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DSawada%26aufirst%3DT.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DQuinoline%2520and%2520benzimidazole%2520derivatives%253A%2520candidate%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D2005%26volume%3D25%26spage%3D10857%26epage%3D10862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Honson, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inglese, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuret, J.</span><span> </span><span class="NLM_article-title">Differentiating Alzheimer disease-associated aggregates with small molecules</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">260</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.nbd.2007.07.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=17761424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGgsrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2007&pages=251-260&author=N.+S.+Honsonauthor=R.+L.+Johnsonauthor=W.+Huangauthor=J.+Ingleseauthor=C.+P.+Austinauthor=J.+Kuret&title=Differentiating+Alzheimer+disease-associated+aggregates+with+small+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Differentiating Alzheimer disease-associated aggregates with small molecules</span></div><div class="casAuthors">Honson, Nicolette S.; Johnson, Ronald L.; Huang, Wenwei; Inglese, James; Austin, Christopher P.; Kuret, Jeff</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">251-260</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Alzheimer disease is diagnosed postmortem by the d. and spatial distribution of β-amyloid plaques and tau-bearing neurofibrillary tangles.  The major protein component of each lesion adopts cross-β-sheet conformation capable of binding small mols. with submicromolar affinity.  In many cases, however, Alzheimer pathol. overlaps with Lewy body disease, characterized by the accumulation of a third cross-β-sheet forming protein, α-synuclein.  To det. the feasibility of distinguishing tau aggregates from β-amyloid and α-synuclein aggregates with small mol. probes, a library contg. 72,455 small mols. was screened for antagonists of tau-aggregate-mediated changes in Thioflavin S fluorescence, followed by secondary screens to distinguish the relative affinity for each substrate protein.  Results showed that > 10-fold binding selectivity among substrates could be achieved, with mols. selective for tau aggregates contg. at least three arom. or rigid moieties connected by two rotatable bonds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqu9wia16OfSrVg90H21EOLACvtfcHk0ljfTtsaNLUdCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGgsrzO&md5=70434cbb21ca7e4380e06bf5113ee868</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2007.07.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2007.07.018%26sid%3Dliteratum%253Aachs%26aulast%3DHonson%26aufirst%3DN.%2BS.%26aulast%3DJohnson%26aufirst%3DR.%2BL.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DInglese%26aufirst%3DJ.%26aulast%3DAustin%26aufirst%3DC.%2BP.%26aulast%3DKuret%26aufirst%3DJ.%26atitle%3DDifferentiating%2520Alzheimer%2520disease-associated%2520aggregates%2520with%2520small%2520molecules%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2007%26volume%3D28%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moric, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Phenyldiazenyl benzothiazole derivatives as probes for in vivo imaging of neurofibrillary tangles in Alzheimer’s disease brains</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">596</span><span class="NLM_x">–</span> <span class="NLM_lpage">600</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1039%2Fc1md00034a" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=596-600&author=K.+Matsumuraauthor=M.+Onoauthor=S.+Hayashiauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Moricauthor=H.+Saji&title=Phenyldiazenyl+benzothiazole+derivatives+as+probes+for+in+vivo+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease+brains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1039%2Fc1md00034a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00034a%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMoric%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DPhenyldiazenyl%2520benzothiazole%2520derivatives%2520as%2520probes%2520for%2520in%2520vivo%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D596%26epage%3D600" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Togashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-Labeled phenyldiazenyl benzothiazole for in vivo imaging of neurofibrillary tangles in Alzheimer’s disease brains</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">58</span><span class="NLM_x">–</span> <span class="NLM_lpage">62</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200230e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=58-62&author=K.+Matsumuraauthor=M.+Onoauthor=H.+Kimuraauthor=M.+Uedaauthor=Y.+Nakamotoauthor=K.+Togashiauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=18F-Labeled+phenyldiazenyl+benzothiazole+for+in+vivo+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease+brains"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Fml200230e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200230e%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DUeda%26aufirst%3DM.%26aulast%3DNakamoto%26aufirst%3DY.%26aulast%3DTogashi%26aufirst%3DK.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3D18F-Labeled%2520phenyldiazenyl%2520benzothiazole%2520for%2520in%2520vivo%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520brains%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D58%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshimura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of novel styryl benzimidazole derivatives as probes for imaging of neurofibrillary tangles in Alzheimer’s disease</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">3356</span><span class="NLM_x">–</span> <span class="NLM_lpage">3362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3356-3362&author=K.+Matsumuraauthor=M.+Onoauthor=M.+Yoshimuraauthor=H.+Kimuraauthor=H.+Watanabeauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Saji&title=Synthesis+and+biological+evaluation+of+novel+styryl+benzimidazole+derivatives+as+probes+for+imaging+of+neurofibrillary+tangles+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DWatanabe%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520styryl%2520benzimidazole%2520derivatives%2520as%2520probes%2520for%2520imaging%2520of%2520neurofibrillary%2520tangles%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3356%26epage%3D3362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer’s disease brain</span> <span class="citation_source-journal">Mol. Imaging Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">19</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs11307-013-0667-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23868612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3sfitFWhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=19-27&author=R.+Haradaauthor=N.+Okamuraauthor=S.+Furumotoauthor=T.+Yoshikawaauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Use+of+a+benzimidazole+derivative+BF-188+in+fluorescence+multispectral+imaging+for+selective+visualization+of+tau+protein+fibrils+in+the+Alzheimer%E2%80%99s+disease+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Use of a benzimidazole derivative BF-188 in fluorescence multispectral imaging for selective visualization of tau protein fibrils in the Alzheimer's disease brain</span></div><div class="casAuthors">Harada Ryuichi; Okamura Nobuyuki; Furumoto Shozo; Yoshikawa Takeo; Arai Hiroyuki; Yanai Kazuhiko; Kudo Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">19-27</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Selective visualization of amyloid-β and tau protein deposits will help to understand the pathophysiology of Alzheimer's disease (AD).  Here, we introduce a novel fluorescent probe that can distinguish between these two deposits by multispectral fluorescence imaging technique.  PROCEDURES:  Fluorescence spectral analysis was performed using AD brain sections stained with novel fluorescence compounds.  Competitive binding assay using [(3)H]-PiB was performed to evaluate the binding affinity of BF-188 for synthetic amyloid-β (Aβ) and tau fibrils.  RESULTS:  In AD brain sections, BF-188 clearly stained Aβ and tau protein deposits with different fluorescence spectra.  In vitro binding assays indicated that BF-188 bound to both amyloid-β and tau fibrils with high affinity (K i  < 10 nM).  In addition, BF-188 showed an excellent blood-brain barrier permeability in mice.  CONCLUSION:  Multispectral imaging with BF-188 could potentially be used for selective in vivo imaging of tau deposits as well as amyloid-β in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQkJCOOHC_nB-3MPKNEWB5RfW6udTcc2eaSBEp181AJirntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sfitFWhuw%253D%253D&md5=2b4d4aa9b23c8430946fc594d392a108</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1007%2Fs11307-013-0667-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-013-0667-2%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DUse%2520of%2520a%2520benzimidazole%2520derivative%2520BF-188%2520in%2520fluorescence%2520multispectral%2520imaging%2520for%2520selective%2520visualization%2520of%2520tau%2520protein%2520fibrils%2520in%2520the%2520Alzheimer%25E2%2580%2599s%2520disease%2520brain%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2014%26volume%3D16%26spage%3D19%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Rojo, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alzate-Morales, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saavedraa, I. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maccioni, R. B.</span><span> </span><span class="NLM_article-title">Selective interaction of lansoprazole and astemizole with tau polymers: potential new clinical use in diagnosis of Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">573</span><span class="NLM_x">–</span> <span class="NLM_lpage">589</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=20110603" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1Slt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2010&pages=573-589&author=L.+E.+Rojoauthor=J.+Alzate-Moralesauthor=I.+N.+Saavedraaauthor=P.+Daviesauthor=R.+B.+Maccioni&title=Selective+interaction+of+lansoprazole+and+astemizole+with+tau+polymers%3A+potential+new+clinical+use+in+diagnosis+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease</span></div><div class="casAuthors">Rojo, Leonel E.; Alzate-Morales, Jans; Saavedra, Ivan N.; Davies, Peter; Maccioni, Ricardo B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">573-589</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">We describe the interactions of two benzimidazole derivs., astemizole (AST) and lansoprazole (LNS), with anomalous aggregates of tau protein (neurofibrillary tangles).  Interestingly, these compds., with important medical applications in the treatment of allergies and gastrointestinal disorders resp., specifically bind to aggregated variants of tau protein and to paired helical filaments isolated from brains of Alzheimer's disease (AD) patients.  These ligands appear to be a powerful tool to tag brain-isolated tau-aggregates and heparin-induced polymers of recombinant tau.  The interactions of AST and LNS with tau aggregates were assessed by classical radioligand assays, surface plasmon resonance, and bioinformatic approaches.  The affinity of AST and LNS for tau aggregates was comparatively higher than that for amyloid-β polymers according to our data.  This is relevant since senile plaques are also abundant but are not pathognomonic in AD patients.  Immunochem. studies on paired helical filaments from brains of AD patients and surface plasmon resonance studies confirm these findings.  The capacity of these drugs to penetrate the blood-brain barrier was evaluated: (i) in vitro by parallel artificial membrane permeability assay followed by exptl. Log P detns.; and (ii) in vivo by pharmacokinetic studies comparing distribution profiles in blood and brain of mice using HPLC/UV.  Importantly, our studies indicate that the brain/blood concn. ratios for these compds. were suitable for their use as PET radiotracers.  Since neurofibrillary tangles are pos. correlated with cognitive impairment, we concluded that LNS and AST have a great potential in PET neuroimaing for in vivo early detection of AD and in reducing the formation of neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJZHJBdFsZE7Vg90H21EOLACvtfcHk0litRRi8NIM3yg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1Slt7s%253D&md5=db44a10a6d6cf5665e71e10537aaf12f</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRojo%26aufirst%3DL.%2BE.%26aulast%3DAlzate-Morales%26aufirst%3DJ.%26aulast%3DSaavedraa%26aufirst%3DI.%2BN.%26aulast%3DDavies%26aufirst%3DP.%26aulast%3DMaccioni%26aufirst%3DR.%2BB.%26atitle%3DSelective%2520interaction%2520of%2520lansoprazole%2520and%2520astemizole%2520with%2520tau%2520polymers%253A%2520potential%2520new%2520clinical%2520use%2520in%2520diagnosis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2010%26volume%3D19%26spage%3D573%26epage%3D589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brichard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrari, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F. I.</span><span> </span><span class="NLM_article-title">Radiosynthesis and characterization of astemizole derivatives as lead compounds toward PET imaging of τ-pathology</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">–</span> <span class="NLM_lpage">855</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1039%2Fc3md00017f" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=852-855&author=P.+J.+Rissauthor=L.+Brichardauthor=V.+Ferrariauthor=D.+J.+Williamsonauthor=T.+D.+Fryerauthor=Y.+T.+Hongauthor=J.-C.+Baronauthor=F.+I.+Aigbirhio&title=Radiosynthesis+and+characterization+of+astemizole+derivatives+as+lead+compounds+toward+PET+imaging+of+%CF%84-pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1039%2Fc3md00017f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc3md00017f%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DBrichard%26aufirst%3DL.%26aulast%3DFerrari%26aufirst%3DV.%26aulast%3DWilliamson%26aufirst%3DD.%2BJ.%26aulast%3DFryer%26aufirst%3DT.%2BD.%26aulast%3DHong%26aufirst%3DY.%2BT.%26aulast%3DBaron%26aufirst%3DJ.-C.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26atitle%3DRadiosynthesis%2520and%2520characterization%2520of%2520astemizole%2520derivatives%2520as%2520lead%2520compounds%2520toward%2520PET%2520imaging%2520of%2520%25CF%2584-pathology%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2013%26volume%3D4%26spage%3D852%26epage%3D855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fawaz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J. H.</span><span> </span><span class="NLM_article-title">Evaluation of [<sup>11</sup>C]N-methyl lansoprazole as a radiopharmaceutical for PET imaging of tau neurofibrillary tangles</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">936</span><span class="NLM_x">–</span> <span class="NLM_lpage">941</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml300216t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=936-941&author=X.+Shaoauthor=G.+M.+Carpenterauthor=T.+J.+Desmondauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=M.+Fawazauthor=A.+F.+Brooksauthor=M.+R.+Kilbournauthor=R.+L.+Albinauthor=K.+A.+Freyauthor=P.+J.+H.+Scott&title=Evaluation+of+%5B11C%5DN-methyl+lansoprazole+as+a+radiopharmaceutical+for+PET+imaging+of+tau+neurofibrillary+tangles"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of [11C]N-Methyl Lansoprazole as a Radiopharmaceutical for PET Imaging of Tau Neurofibrillary Tangles</span></div><div class="casAuthors">Shao, Xia; Carpenter, Garrett M.; Desmond, Timothy J.; Sherman, Phillip; Quesada, Carole A.; Fawaz, Maria; Brooks, Allen F.; Kilbourn, Michael R.; Albin, Roger L.; Frey, Kirk A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">936-941</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">[11C]N-Me lansoprazole ([11C]NML, 3) was synthesized and evaluated as a radiopharmaceutical for quantifying tau neurofibrillary tangle (NFT) burden using positron emission tomog. (PET) imaging. [11C]NML was synthesized from com. available lansoprazole in 4.6% radiochem. yield (noncorrected RCY, based upon [11C]MeI), 99% radiochem. purity, and 16095 Ci/mmol specific activity (n = 5).  Log P was detd. to be 2.18.  A lack of brain uptake in rodent microPET imaging revealed [11C]NML to be a substrate for the rodent permeability-glycoprotein 1 (PGP) transporter, but this could be overcome by pretreating with cyclosporin A to block the PGP.  Contrastingly, [11C]NML was not found to be a substrate for the primate PGP, and microPET imaging in rhesus revealed [11C]NML uptake in the healthy primate brain of ∼1600 nCi/cc max. at 3 min followed by rapid egress to 500 nCi/cc.  Comparative autoradiog. between wild-type rats and transgenic rats expressing human tau (hTau +/+) revealed 12% higher uptake of [11C]NML in the cortex of brains expressing human tau.  Further autoradiog. with tau pos. brain samples from progressive supranuclear palsy (PSP) patients revealed colocalization of [11C]NML with tau NFTs identified using modified Bielschowsky staining.  Finally, satn. binding expts. with heparin-induced tau confirmed Kd and Bmax values of [11C]NML as 700 pM and 0.214 fmol/μg, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjXJkNjeWv4rVg90H21EOLACvtfcHk0lgcW6b4-1lOrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2lsr%252FI&md5=a1fd3561aca6b2d9366271582e9bf60f</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Fml300216t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml300216t%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DX.%26aulast%3DCarpenter%26aufirst%3DG.%2BM.%26aulast%3DDesmond%26aufirst%3DT.%2BJ.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DFawaz%26aufirst%3DM.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DAlbin%26aufirst%3DR.%2BL.%26aulast%3DFrey%26aufirst%3DK.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26atitle%3DEvaluation%2520of%2520%255B11C%255DN-methyl%2520lansoprazole%2520as%2520a%2520radiopharmaceutical%2520for%2520PET%2520imaging%2520of%2520tau%2520neurofibrillary%2520tangles%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D936%26epage%3D941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Fawaz, M. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodnick, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpenter, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desmond, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quesada, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hockley, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albin, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frey, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, P. J. H.</span><span> </span><span class="NLM_article-title">High affinity radiopharmaceuticals based upon lansoprazole for PET imaging of aggregated tau in Alzheimer’s disease and progressive supranuclear palsy: synthesis, pre-clinical evaluation and lead selection</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">718</span><span class="NLM_x">–</span> <span class="NLM_lpage">730</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn500103u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpt1Sqs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=718-730&author=M.+V.+Fawazauthor=A.+F.+Brooksauthor=M.+E.+Rodnickauthor=G.+M.+Carpenterauthor=X.+Shaoauthor=T.+J.+Desmondauthor=P.+Shermanauthor=C.+A.+Quesadaauthor=B.+G.+Hockleyauthor=M.+R.+Kilbournauthor=R.+L.+Albinauthor=K.+A.+Freyauthor=P.+J.+H.+Scott&title=High+affinity+radiopharmaceuticals+based+upon+lansoprazole+for+PET+imaging+of+aggregated+tau+in+Alzheimer%E2%80%99s+disease+and+progressive+supranuclear+palsy%3A+synthesis%2C+pre-clinical+evaluation+and+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">High Affinity Radiopharmaceuticals Based Upon Lansoprazole for PET Imaging of Aggregated Tau in Alzheimer's Disease and Progressive Supranuclear Palsy: Synthesis, Preclinical Evaluation, and Lead Selection</span></div><div class="casAuthors">Fawaz, Maria V.; Brooks, Allen F.; Rodnick, Melissa E.; Carpenter, Garrett M.; Shao, Xia; Desmond, Timothy J.; Sherman, Phillip; Quesada, Carole A.; Hockley, Brian G.; Kilbourn, Michael R.; Albin, Roger L.; Frey, Kirk A.; Scott, Peter J. H.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">718-730</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Abnormally aggregated tau is the hallmark pathol. of tauopathy neurodegenerative disorders and is a target for development of both diagnostic tools and therapeutic strategies across the tauopathy disease spectrum.  Development of carbon-11- or fluorine-18-labeled radiotracers with appropriate affinity and specificity for tau would allow noninvasive quantification of tau burden using positron emission tomog. (PET) imaging.  We have synthesized [18F]lansoprazole, [11C]N-Me lansoprazole, and [18F]N-Me lansoprazole and identified them as high affinity radiotracers for tau with low to subnanomolar binding affinities.  Herein, we report radiosyntheses and extensive preclin. evaluation with the aim of selecting a lead radiotracer for translation into human PET imaging trials.  We demonstrate that [18F]N-Me lansoprazole, on account of the favorable half-life of fluorine-18 and its rapid brain entry in nonhuman primates, favorable kinetics, low white matter binding, and selectivity for binding to tau over amyloid, is the lead compd. for progression into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpII8L0rzeJ2LVg90H21EOLACvtfcHk0lgcW6b4-1lOrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpt1Sqs7o%253D&md5=2b2c7c0e014296ec6865430167067066</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Fcn500103u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn500103u%26sid%3Dliteratum%253Aachs%26aulast%3DFawaz%26aufirst%3DM.%2BV.%26aulast%3DBrooks%26aufirst%3DA.%2BF.%26aulast%3DRodnick%26aufirst%3DM.%2BE.%26aulast%3DCarpenter%26aufirst%3DG.%2BM.%26aulast%3DShao%26aufirst%3DX.%26aulast%3DDesmond%26aufirst%3DT.%2BJ.%26aulast%3DSherman%26aufirst%3DP.%26aulast%3DQuesada%26aufirst%3DC.%2BA.%26aulast%3DHockley%26aufirst%3DB.%2BG.%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DAlbin%26aufirst%3DR.%2BL.%26aulast%3DFrey%26aufirst%3DK.%2BA.%26aulast%3DScott%26aufirst%3DP.%2BJ.%2BH.%26atitle%3DHigh%2520affinity%2520radiopharmaceuticals%2520based%2520upon%2520lansoprazole%2520for%2520PET%2520imaging%2520of%2520aggregated%2520tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520progressive%2520supranuclear%2520palsy%253A%2520synthesis%252C%2520pre-clinical%2520evaluation%2520and%2520lead%2520selection%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2014%26volume%3D5%26spage%3D718%26epage%3D730" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamoto, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihara, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saji, H.</span><span> </span><span class="NLM_article-title">Rhodanine and thiohydantoin derivatives for detecting tau pathology in Alzheimer’s brains</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn200002t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=269-275&author=M.+Onoauthor=S.+Hayashiauthor=K.+Matsumuraauthor=H.+Kimuraauthor=Y.+Okamotoauthor=M.+Iharaauthor=R.+Takahashiauthor=H.+Moriauthor=H.+Saji&title=Rhodanine+and+thiohydantoin+derivatives+for+detecting+tau+pathology+in+Alzheimer%E2%80%99s+brains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Rhodanine and Thiohydantoin Derivatives for Detecting Tau Pathology in Alzheimer's Brains</span></div><div class="casAuthors">Ono, Masahiro; Hayashi, Shun; Matsumura, Kenji; Kimura, Hiroyuki; Okamoto, Yoko; Ihara, Masafumi; Takahashi, Ryosuke; Mori, Hiroshi; Saji, Hideo</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">269-275</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of rhodanine (RH) and thiohydantoin (TH) derivs. were designed and synthesized for detecting tau pathol. in the brains of patients with Alzheimer's disease (AD).  In expts. in vitro using tau and β-amyloid (Aβ) aggregates, the TH deriv., TH2, showed high specific binding to tau aggregates.  In hippocampal sections obtained from AD patients, TH2 intensely stained neurofibrillary tangles.  In expts. using normal mice, [125I]TH2 showed good uptake (1.54%ID/g, 2 min postinjection) into and a rapid washout (0.25%ID/g, 60 min postinjection) from the brain. [123I]TH2 should be further investigated as a potential imaging agent for detecting tau pathol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvU2DzEOu6ubVg90H21EOLACvtfcHk0li3MmHIoyaBtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVygsbY%253D&md5=6f4924eaa828e075a59d9ead25ed3c36</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Fcn200002t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn200002t%26sid%3Dliteratum%253Aachs%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHayashi%26aufirst%3DS.%26aulast%3DMatsumura%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DOkamoto%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DTakahashi%26aufirst%3DR.%26aulast%3DMori%26aufirst%3DH.%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRhodanine%2520and%2520thiohydantoin%2520derivatives%2520for%2520detecting%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520brains%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D269%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Saji, H.; Ono, M.; Seki, I.</span><span> </span><span class="NLM_article-title">Radioactive iodine labeled organic compound or salt thereof</span>. International Patent WO2011/108236 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=H.+Saji&author=M.+Ono&author=I.+Seki&title=Radioactive+iodine+labeled+organic+compound+or+salt+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSaji%26aufirst%3DH.%26atitle%3DRadioactive%2520iodine%2520labeled%2520organic%2520compound%2520or%2520salt%2520thereof%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Ballatore, C.; Smith, A. B.,  III; Lee, V. M.-Y.; Trojanowski, J. Q.; Brunden, K. R.</span><span> </span><span class="NLM_article-title">Aminothienopyridazines as imaging probes of tau pathology</span>: a patent evaluation of WO2013090497,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Ballatore&author=A.+B.+Smith&author=V.+M.-Y.+Lee&author=J.+Q.+Trojanowski&author=K.+R.+Brunden&title=Aminothienopyridazines+as+imaging+probes+of+tau+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26atitle%3DAminothienopyridazines%2520as%2520imaging%2520probes%2520of%2520tau%2520pathology%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-ref97_2"><span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">360</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/ref97_2&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1517%2F13543776.2014.871526" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/ref97_2&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24387030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/ref97_2&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisF2gsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Expert+Opin.+Ther.+Pat.+2014%2C+24%2C+355%E2%80%93360."target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_ref97_2R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Aminothienopyridazines as imaging probes of tau pathology: a patent evaluation of WO2013090497</span></div><div class="casAuthors">Ballatore, Carlo; Smith, Amos B., III; Lee, Virginia M.-Y.; Trojanowski, John Q.; Brunden, Kurt R.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-360</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Small-mol. ligands, amenable to positron emission tomog. (PET) imaging of different types of neurodegenerative disease-assocd. amyloid deposits in the CNS of living patients, hold considerable promise for diagnostic purposes, as well as for monitoring disease progression and the effectiveness of treatments.  The patent entitled 'Heterocyclic Compds. as Imaging Probes of Tau Pathol.' (WO2013090497) discloses the identification of a novel class of tau imaging agents, the aminothienopyridazines.  Selected compds. from this class are described that can stain selectively tau pathol. in brain tissue sections.  Moreover, examples of this class of compds. exhibit absorption, distribution, metab., excretion and pharmacokinetics (ADME-PK) properties that are appropriate for CNS PET ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFRrV4O-pbXLVg90H21EOLACvtfcHk0li3MmHIoyaBtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisF2gsb8%253D&md5=4665c60b9d2534819012a472964cf034</span></div><a href="/servlet/linkout?suffix=ref97_2&amp;dbid=16384&amp;doi=10.1517%2F13543776.2014.871526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2014.871526%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2014%26volume%3D24%26spage%3D355%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Jones, C.; Glaser, M. E.; Wynn, D.; Nairne, J.; Mokkapati, U. P.; Newington, I. M.; Rangaswamy, C.; Jose, J.; Johansson, S.</span><span> </span><span class="NLM_article-title">Heterocyclic compounds as imaging probes of tau pathology</span>. International Patent WO2013/090497,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=C.+Jones&author=M.+E.+Glaser&author=D.+Wynn&author=J.+Nairne&author=U.+P.+Mokkapati&author=I.+M.+Newington&author=C.+Rangaswamy&author=J.+Jose&author=S.+Johansson&title=Heterocyclic+compounds+as+imaging+probes+of+tau+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DC.%26atitle%3DHeterocyclic%2520compounds%2520as%2520imaging%2520probes%2520of%2520tau%2520pathology%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Bulic, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khlistunova, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biernat, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waldmann, H.</span><span> </span><span class="NLM_article-title">Rhodanine-based tau aggregation inhibitors in cell models of tauopathy</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">9215</span><span class="NLM_x">–</span> <span class="NLM_lpage">9219</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=9215-9219&author=B.+Bulicauthor=M.+Pickhardtauthor=I.+Khlistunovaauthor=J.+Biernatauthor=E.+M.+Mandelkowauthor=E.+Mandelkowauthor=H.+Waldmann&title=Rhodanine-based+tau+aggregation+inhibitors+in+cell+models+of+tauopathy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBulic%26aufirst%3DB.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DKhlistunova%26aufirst%3DI.%26aulast%3DBiernat%26aufirst%3DJ.%26aulast%3DMandelkow%26aufirst%3DE.%2BM.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DRhodanine-based%2520tau%2520aggregation%2520inhibitors%2520in%2520cell%2520models%2520of%2520tauopathy%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D9215%26epage%3D9219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piscitelli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  III.</span><span> </span><span class="NLM_article-title">Discovery of brain-penetrant, orally bioavailable aminothienopyridazine inhibitors of tau aggregation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">3739</span><span class="NLM_x">–</span> <span class="NLM_lpage">3747</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100138f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3739-3747&author=C.+Ballatoreauthor=K.+R.+Brundenauthor=F.+Piscitelliauthor=M.+J.+Jamesauthor=A.+Croweauthor=Y.+Yaoauthor=E.+Hydeauthor=J.+Q.+Trojanowskiauthor=V.+M.-Y.+Leeauthor=A.+B.+Smith&title=Discovery+of+brain-penetrant%2C+orally+bioavailable+aminothienopyridazine+inhibitors+of+tau+aggregation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm100138f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100138f%26sid%3Dliteratum%253Aachs%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26aulast%3DPiscitelli%26aufirst%3DF.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DHyde%26aufirst%3DE.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.-Y.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26atitle%3DDiscovery%2520of%2520brain-penetrant%252C%2520orally%2520bioavailable%2520aminothienopyridazine%2520inhibitors%2520of%2520tau%2520aggregation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3739%26epage%3D3747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Crowe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, A. B.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballatore, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunden, K. R.</span><span> </span><span class="NLM_article-title">Aminothienopyridazines and methylene blue affect tau fibrillization via cysteine oxidation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x">, </span> <span class="NLM_fpage">11024</span><span class="NLM_x">–</span> <span class="NLM_lpage">11037</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2013&pages=11024-11037&author=A.+Croweauthor=M.+J.+Jamesauthor=V.+M.-Y.+Leeauthor=A.+B.+Smithauthor=J.+Q.+Trojanowskiauthor=C.+Ballatoreauthor=K.+R.+Brunden&title=Aminothienopyridazines+and+methylene+blue+affect+tau+fibrillization+via+cysteine+oxidation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCrowe%26aufirst%3DA.%26aulast%3DJames%26aufirst%3DM.%2BJ.%26aulast%3DLee%26aufirst%3DV.%2BM.-Y.%26aulast%3DSmith%26aufirst%3DA.%2BB.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DBallatore%26aufirst%3DC.%26aulast%3DBrunden%26aufirst%3DK.%2BR.%26atitle%3DAminothienopyridazines%2520and%2520methylene%2520blue%2520affect%2520tau%2520fibrillization%2520via%2520cysteine%2520oxidation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2013%26volume%3D288%26spage%3D11024%26epage%3D11037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Gobbi, L.; Knust, H.; Koblet, A.</span><span> </span><span class="NLM_article-title">Imidazo[2,1]thiazol-3-one derivatives useful as diagnostic agents for Alzheimer’s disease</span>. International Patent WO2014/026881 A1,<span class="NLM_x"> </span><span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=L.+Gobbi&author=H.+Knust&author=A.+Koblet&title=Imidazo%5B2%2C1%5Dthiazol-3-one+derivatives+useful+as+diagnostic+agents+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGobbi%26aufirst%3DL.%26atitle%3DImidazo%255B2%252C1%255Dthiazol-3-one%2520derivatives%2520useful%2520as%2520diagnostic%2520agents%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Taghavi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nasir, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pickhardt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyny-von Hauβen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkow, E.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title"><i>N</i>-Benzylidene-benzohydrazides as novel and selective tau-PHF ligands</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">835</span><span class="NLM_x">–</span> <span class="NLM_lpage">843</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21891864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1Sls7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2011&pages=835-843&author=A.+Taghaviauthor=S.+Nasirauthor=M.+Pickhardtauthor=R.+Heyny-von+Hau%CE%B2enauthor=G.+Mallauthor=E.+Mandelkowauthor=E.-M.+Mandelkowauthor=B.+Schmidt&title=N-Benzylidene-benzohydrazides+as+novel+and+selective+tau-PHF+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">N'-Benzylidene-Benzohydrazides as Novel and Selective Tau-PHF Ligands</span></div><div class="casAuthors">Taghavi, Ali; Nasir, Samir; Pickhardt, Marcus; Heyny-von Haussen, Roland; Mall, Gerhard; Mandelkow, Eckhard; Mandelkow, Eva-Maria; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">835-843</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">The structure activity relationship of N'-benzylidene-benzohydrazide (NBB) binding to tau and paired helical filament (PHF) proteins as well as amyloid-β1-42 fibrils indicate differential selectivity for these protein aggregates.  The ability of the compds. to stain neurofibrillary tangles and senile plaques isolated from human AD brain was investigated histochem.  These studies resulted in several tau-PHF and amyloid-β1-42 fibril selective ligands resp.  Supported by these results, we rationalized a model for the design of selective ligands for tau, PHF, and amyloid-β1-42 fibrils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmUckFrrYIfbVg90H21EOLACvtfcHk0lgjaZ5_0_EebQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1Sls7bF&md5=6a91548633b7d72a0c439f32bcc3af5a</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTaghavi%26aufirst%3DA.%26aulast%3DNasir%26aufirst%3DS.%26aulast%3DPickhardt%26aufirst%3DM.%26aulast%3DHeyny-von%2BHau%25CE%25B2en%26aufirst%3DR.%26aulast%3DMall%26aufirst%3DG.%26aulast%3DMandelkow%26aufirst%3DE.%26aulast%3DMandelkow%26aufirst%3DE.-M.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DN-Benzylidene-benzohydrazides%2520as%2520novel%2520and%2520selective%2520tau-PHF%2520ligands%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D27%26spage%3D835%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><a href="http://clinicaltrials.gov/ct2/show/record/NCT02187627" class="extLink">http://clinicaltrials.gov/ct2/show/record/NCT02187627</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Fclinicaltrials.gov%2Fct2%2Fshow%2Frecord%2FNCT02187627."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Altman, M. D.; Fischer, C.; Katz, J. D.; Williams, T. M.; Zhang, X.-F.; Zhou, H.</span><span> </span><span class="NLM_article-title">Isotopically labeled biaryl urea compounds useful as tau tracers</span>. International Patent WO 2013/181075 A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=M.+D.+Altman&author=C.+Fischer&author=J.+D.+Katz&author=T.+M.+Williams&author=X.-F.+Zhang&author=H.+Zhou&title=Isotopically+labeled+biaryl+urea+compounds+useful+as+tau+tracers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAltman%26aufirst%3DM.%2BD.%26atitle%3DIsotopically%2520labeled%2520biaryl%2520urea%2520compounds%2520useful%2520as%2520tau%2520tracers%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Kemp, S. J.; Storey, L. J.; Storey, J. M. D.; Rickard, J.; Harrington, C. R.; Wischik, C. M.; Clunas, S.; Heinrich, T. K.</span><span> </span><span class="NLM_article-title">Ligands for aggregates tau molecules</span>. International Patent WO 2010/034982 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+J.+Kemp&author=L.+J.+Storey&author=J.+M.+D.+Storey&author=J.+Rickard&author=C.+R.+Harrington&author=C.+M.+Wischik&author=S.+Clunas&author=T.+K.+Heinrich&title=Ligands+for+aggregates+tau+molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKemp%26aufirst%3DS.%2BJ.%26atitle%3DLigands%2520for%2520aggregates%2520tau%2520molecules%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Boländer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieser, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voss, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schön, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hölzer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heyny-von Haußen, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goetschy, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knust, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herms, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilger, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, B.</span><span> </span><span class="NLM_article-title">Bis(arylvinyl)pyrazines, -pyrimidines, and -pyridazines as imaging agents for tau fibrils and β-amyloid plaques in Alzheimer’s disease models</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9170</span><span class="NLM_x">–</span> <span class="NLM_lpage">9180</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300653b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9170-9180&author=A.+Bol%C3%A4nderauthor=D.+Kieserauthor=C.+Vossauthor=S.+Bauerauthor=C.+Sch%C3%B6nauthor=S.+Burgoldauthor=T.+Bittnerauthor=J.+H%C3%B6lzerauthor=R.+Heyny-von+Hau%C3%9Fenauthor=G.+Mallauthor=V.+Goetschyauthor=C.+Czechauthor=H.+Knustauthor=R.+Bergerauthor=J.+Hermsauthor=I.+Hilgerauthor=B.+Schmidt&title=Bis%28arylvinyl%29pyrazines%2C+-pyrimidines%2C+and+-pyridazines+as+imaging+agents+for+tau+fibrils+and+%CE%B2-amyloid+plaques+in+Alzheimer%E2%80%99s+disease+models"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1021%2Fjm300653b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300653b%26sid%3Dliteratum%253Aachs%26aulast%3DBol%25C3%25A4nder%26aufirst%3DA.%26aulast%3DKieser%26aufirst%3DD.%26aulast%3DVoss%26aufirst%3DC.%26aulast%3DBauer%26aufirst%3DS.%26aulast%3DSch%25C3%25B6n%26aufirst%3DC.%26aulast%3DBurgold%26aufirst%3DS.%26aulast%3DBittner%26aufirst%3DT.%26aulast%3DH%25C3%25B6lzer%26aufirst%3DJ.%26aulast%3DHeyny-von%2BHau%25C3%259Fen%26aufirst%3DR.%26aulast%3DMall%26aufirst%3DG.%26aulast%3DGoetschy%26aufirst%3DV.%26aulast%3DCzech%26aufirst%3DC.%26aulast%3DKnust%26aufirst%3DH.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DHerms%26aufirst%3DJ.%26aulast%3DHilger%26aufirst%3DI.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DBis%2528arylvinyl%2529pyrazines%252C%2520-pyrimidines%252C%2520and%2520-pyridazines%2520as%2520imaging%2520agents%2520for%2520tau%2520fibrils%2520and%2520%25CE%25B2-amyloid%2520plaques%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520models%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9170%26epage%3D9180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petric, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G.</span><span> </span><span class="NLM_article-title">PET imaging of tangles and plaques in Alzheimer disease with a highly hydrophobic probe</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">S194</span><span class="NLM_x">–</span> <span class="NLM_lpage">195</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=S194-195&author=J.+R.+Barrioauthor=S.+C.+Huangauthor=G.+Coleauthor=N.+Satyamurthyauthor=A.+Petricauthor=M.+E.+Phelpsauthor=G.+Small&title=PET+imaging+of+tangles+and+plaques+in+Alzheimer+disease+with+a+highly+hydrophobic+probe"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DCole%26aufirst%3DG.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DPetric%26aufirst%3DA.%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26aulast%3DSmall%26aufirst%3DG.%26atitle%3DPET%2520imaging%2520of%2520tangles%2520and%2520plaques%2520in%2520Alzheimer%2520disease%2520with%2520a%2520highly%2520hydrophobic%2520probe%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D1999%26volume%3D42%26spage%3DS194%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Small, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercoli, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bookheimer, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lavretsky, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burggren, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vinters, H. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Satyamurthy, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phelps, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">PET of brain amyloid and tau in mild cognitive impairment</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">355</span><span class="NLM_x">, </span> <span class="NLM_fpage">2652</span><span class="NLM_x">–</span> <span class="NLM_lpage">2663</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1056%2FNEJMoa054625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=17182990" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtlGhtLvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=2652-2663&author=G.+W.+Smallauthor=V.+Kepeauthor=L.+M.+Ercoliauthor=P.+Siddarthauthor=S.+Y.+Bookheimerauthor=K.+J.+Millerauthor=H.+Lavretskyauthor=A.+C.+Burggrenauthor=G.+M.+Coleauthor=H.+V.+Vintersauthor=P.+M.+Thompsonauthor=S.-C.+Huangauthor=N.+Satyamurthyauthor=M.+E.+Phelpsauthor=J.+R.+Barrio&title=PET+of+brain+amyloid+and+tau+in+mild+cognitive+impairment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">PET of brain amyloid and tau in mild cognitive impairment</span></div><div class="casAuthors">Small, Gary W.; Kepe, Vladimir; Ercoli, Linda M.; Siddarth, Prabha; Bookheimer, Susan Y.; Miller, Karen J.; Lavretsky, Helen; Burggren, Alison C.; Cole, Greg M.; Vinters, Harry V.; Thompson, Paul M.; Huang, S.-C.; Satyamurthy, N.; Phelps, Michael E.; Barrio, Jorge R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2652-2663</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Amyloid senile plaques and tau neurofibrillary tangles are neuro-pathol. hallmarks of Alzheimer's disease that accumulate in the cortical regions of the brain in persons with mild cognitive impairment who are at risk for Alzheimer's disease.  Non-invasive methods to detect these abnormal proteins are potentially useful in developing surrogate markers for drug discovery and diagnostics.  We enrolled 83 volunteers with self-reported memory problems who had undergone neurol. and psychiatric evaluation and positron-emission tomog.  (PET).  On the basis of cognitive testing, 25 volunteers were classified as having Alzheimer's disease, 28 as having mild cognitive impairment, and 30 as having no cognitive impairment (healthy controls).  PET was performed after injection of 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile (FDDNP), a mol. that binds to plaques and tangles in vitro.  All subjects also underwent 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET, and 72 underwent magnetic resonance imaging (MRJ).  Global values for FDDNP-PET binding (av. of the values for the temporal, parietal, posterior cingulate, and frontal regions) were lower in the control group than in the group with mild cognitive impairment (P < 0.001), and the values for binding in the group with mild cognitive impairment were lower than in the group with Alzheimer's disease (P < 0.001).  FDDNP-PET binding differentiated among the diagnostic groups better than did metab. on FDG-PET or vol. on MRI.  FDDNP-PET scanning can differentiate persons with mild cognitive impairment from those with Alzheimer's disease and those with no cognitive impairment.  This technique is potentially useful as a non-invasive method to det. regional cerebral patterns of amyloid plaques and tau neurofibrillary tangles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojzz2McPtDX7Vg90H21EOLACvtfcHk0lgu4h7r4_NXbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtlGhtLvL&md5=93cd641aaad5b65d4a93a3b4780aff94</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa054625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa054625%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DG.%2BW.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DErcoli%26aufirst%3DL.%2BM.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DBookheimer%26aufirst%3DS.%2BY.%26aulast%3DMiller%26aufirst%3DK.%2BJ.%26aulast%3DLavretsky%26aufirst%3DH.%26aulast%3DBurggren%26aufirst%3DA.%2BC.%26aulast%3DCole%26aufirst%3DG.%2BM.%26aulast%3DVinters%26aufirst%3DH.%2BV.%26aulast%3DThompson%26aufirst%3DP.%2BM.%26aulast%3DHuang%26aufirst%3DS.-C.%26aulast%3DSatyamurthy%26aufirst%3DN.%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DPET%2520of%2520brain%2520amyloid%2520and%2520tau%2520in%2520mild%2520cognitive%2520impairment%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2006%26volume%3D355%26spage%3D2652%26epage%3D2663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Shin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G. W.</span><span> </span><span class="NLM_article-title">The merits of FDDNP-PET imaging in Alzheimer’s disease</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">135</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21971458" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12gs77J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=135-145&author=J.+Shinauthor=V.+Kepeauthor=J.+R.+Barrioauthor=G.+W.+Small&title=The+merits+of+FDDNP-PET+imaging+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">The Merits of FDDNP-PET Imaging in Alzheimer's Disease</span></div><div class="casAuthors">Ashford, J. Wesson; Rosen, Allyson; Adamson, Maheen; Bayley, Peter; Sabri, Osama; Furst, Ansgar; Black, Sandra E.; Weiner, Michael; Shin, Jonghan; Kepe, Vladimir; Barrio, Jorge R.; Small, Gary W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">135-145</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  2-(1-{6-[(2-[Fluorine-18]fluoroethyl)(methyl)amino]-2-naphthyl}-ethylidene)malononitrile (FDDNP) is the first positron emission tomog. (PET) mol. imaging probe to visualize Alzheimer's disease (AD) pathol. in living humans.  The most unique features of FDDNP are that (1) it is the only currently available radiotracer to image neurofibrillary tangles, beside amyloid aggregates, in living humans; and (2) it is also the only radiotracer to visualize AD pathol. in the hippocampal region of living humans.  In this article, we discuss FDDNP's unique ability to image tau pathol. in living humans.  Emphasizing tau pathol. imaging capability using FDDNP in AD, as well as other tauopathies, is timely and beneficial considering that (1) post mortem histopathol. studies using human specimens have consistently demonstrated that neurofibrillary tangles, compared with amyloid plaques, are better correlated with the disease severity and neuronal death; and (2) recently reported clin. trial failures of disease-modifying drugs in development, based on the amyloid-cascade hypothesis, suggest that some of the basic assumptions of AD causality warrant reassessment and redirection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSmfShnsgqf7Vg90H21EOLACvtfcHk0lgu4h7r4_NXbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12gs77J&md5=3f18072cd1d9516c234e493d2fc500ec</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DJ.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DSmall%26aufirst%3DG.%2BW.%26atitle%3DThe%2520merits%2520of%2520FDDNP-PET%2520imaging%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D26%26spage%3D135%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Nelson, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheibel, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Small, G. W.</span><span> </span><span class="NLM_article-title">Positron emission tomography of brain beta-amyloid and tau levels in adults with Down syndrome</span> <span class="citation_source-journal">Arch. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">768</span><span class="NLM_x">–</span> <span class="NLM_lpage">774</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1001%2Farchneurol.2011.104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21670401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3Mngt1GlsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=2011&pages=768-774&author=L.+D.+Nelsonauthor=P.+Siddarthauthor=V.+Kepeauthor=K.+E.+Scheibelauthor=S.-C.+Huangauthor=J.+R.+Barrioauthor=G.+W.+Small&title=Positron+emission+tomography+of+brain+beta-amyloid+and+tau+levels+in+adults+with+Down+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography of brain β-amyloid and τ levels in adults with Down syndrome</span></div><div class="casAuthors">Nelson Linda D; Siddarth Prabha; Kepe Vladimir; Scheibel Kevin E; Huang S C; Barrio Jorge R; Small Gary W</div><div class="citationInfo"><span class="NLM_cas:title">Archives of neurology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">68</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">768-74</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVES:  To determine the neuropathological load in the living brain of nondemented adults with Down syndrome using positron emission tomography with 2-(1-{6-[(2-fluorine 18-labeled fluoroethyl)methylamino]-2-napthyl}ethylidene) malononitrile ([(18)F]FDDNP) and to assess the influence of age and cognitive and behavioral functioning.  For reference, [(18)F]FDDNP binding values and patterns were compared with those from patients with Alzheimer disease and cognitively intact control participants.  DESIGN:  Cross-sectional clinical study.  PARTICIPANTS:  Volunteer sample of 19 persons with Down syndrome without dementia (mean age, 36.7 years), 10 patients with Alzheimer disease (mean age, 66.5 years), and 10 controls (mean age, 43.8 years).  MAIN OUTCOME MEASURES:  Binding of [(18)F]FDDNP in brain regions of interest, including the parietal, medial temporal, lateral temporal, and frontal lobes and posterior cingulate gyrus, and the average of all regions (global binding).  RESULTS:  The [(18)F]FDDNP binding values were higher in all brain regions in the Down syndrome group than in controls.  Compared with the Alzheimer disease group, the Down syndrome group had higher [(18)F]FDDNP binding values in the parietal and frontal regions, whereas binding levels in other regions were comparable.  Within the Down syndrome group, age correlated with [(18)F]FDDNP binding values in all regions except the posterior cingulate, and several measures of behavioral dysfunction showed positive correlations with global, frontal, parietal, and posterior cingulate [(18)F]FDDNP binding.  CONCLUSIONS:  Consistent with neuropathological findings from postmortem studies, [(18)F]FDDNP positron emission tomography shows high binding levels in Down syndrome comparable to Alzheimer disease and greater levels than in members of a control group.  The positive associations between [(18)F]FDDNP binding levels and age as well as behavioral dysfunction in Down syndrome are consistent with the age-related progression of Alzheimer-type neuropathological findings in this population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTpyMGWupRLkU2yPDyEFiigfW6udTcc2eZZJWApycUQtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mngt1GlsQ%253D%253D&md5=9a39c4b0f53a98d96c61791010618ae2</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1001%2Farchneurol.2011.104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchneurol.2011.104%26sid%3Dliteratum%253Aachs%26aulast%3DNelson%26aufirst%3DL.%2BD.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DScheibel%26aufirst%3DK.%2BE.%26aulast%3DHuang%26aufirst%3DS.-C.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DSmall%26aufirst%3DG.%2BW.%26atitle%3DPositron%2520emission%2520tomography%2520of%2520brain%2520beta-amyloid%2520and%2520tau%2520levels%2520in%2520adults%2520with%2520Down%2520syndrome%26jtitle%3DArch.%2520Neurol.%26date%3D2011%26volume%3D68%26spage%3D768%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Small, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepe, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siddarth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ercoli, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrill, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donoghue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bookheimer, S. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omalu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span> </span><span class="NLM_article-title">PET scanning of brain tau in retired National Football League players: preliminary findings</span> <span class="citation_source-journal">Am. J. Geriatr. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">138</span><span class="NLM_x">–</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jagp.2012.11.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23343487" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3szitFOlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=138-44&author=G.+W.+Smallauthor=V.+Kepeauthor=P.+Siddarthauthor=L.+M.+Ercoliauthor=D.+A.+Merrillauthor=N.+Donoghueauthor=S.+Y.+Bookheimerauthor=J.+Martinezauthor=B.+Omaluauthor=J.+Bailesauthor=J.+R.+Barrio&title=PET+scanning+of+brain+tau+in+retired+National+Football+League+players%3A+preliminary+findings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">PET scanning of brain tau in retired national football league players: preliminary findings</span></div><div class="casAuthors">Small Gary W; Kepe Vladimir; Siddarth Prabha; Ercoli Linda M; Merrill David A; Donoghue Natacha; Bookheimer Susan Y; Martinez Jacqueline; Omalu Bennet; Bailes Julian; Barrio Jorge R</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">138-44</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Mild traumatic brain injury due to contact sports may cause chronic behavioral, mood, and cognitive disturbances associated with pathological deposition of tau protein found at brain autopsy.  To explore whether brain tau deposits can be detected in living retired players, we used positron emission tomography (PET) scans after intravenous injections of 2-(1-{6-[(2-[F-18]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile (FDDNP).  METHODS:  Five retired National Football League players (age range: 45 to 73 years) with histories of mood and cognitive symptoms received neuropsychiatric evaluations and FDDNP-PET.  PET signals in subcortical (caudate, putamen, thalamus, subthalamus, midbrain, cerebellar white matter) and cortical (amygdala, frontal, parietal, posterior cingulate, medial and lateral temporal) regions were compared with those of five male controls of comparable age, education, and body mass index.  RESULTS:  FDDNP signals were higher in players compared with controls in all subcortical regions and the amygdala, areas that produce tau deposits following trauma.  CONCLUSIONS:  The small sample size and lack of autopsy confirmation warrant larger, more definitive studies, but if future research confirms these initial findings, FDDNP-PET may offer a means for premorbid identification of neurodegeneration in contact-sports athletes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEcx5MNBJNkFm8bhe6roZYfW6udTcc2eZZJWApycUQtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szitFOlsg%253D%253D&md5=96ad1e1a1b643a87f63b27710049001b</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2Fj.jagp.2012.11.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jagp.2012.11.019%26sid%3Dliteratum%253Aachs%26aulast%3DSmall%26aufirst%3DG.%2BW.%26aulast%3DKepe%26aufirst%3DV.%26aulast%3DSiddarth%26aufirst%3DP.%26aulast%3DErcoli%26aufirst%3DL.%2BM.%26aulast%3DMerrill%26aufirst%3DD.%2BA.%26aulast%3DDonoghue%26aufirst%3DN.%26aulast%3DBookheimer%26aufirst%3DS.%2BY.%26aulast%3DMartinez%26aufirst%3DJ.%26aulast%3DOmalu%26aufirst%3DB.%26aulast%3DBailes%26aufirst%3DJ.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26atitle%3DPET%2520scanning%2520of%2520brain%2520tau%2520in%2520retired%2520National%2520Football%2520League%2520players%253A%2520preliminary%2520findings%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2013%26volume%3D21%26spage%3D138%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Thompson, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgenstern, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beach, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shipley, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lockhart, A.</span><span> </span><span class="NLM_article-title">Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer’s disease pathologies</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">623</span><span class="NLM_x">–</span> <span class="NLM_lpage">630</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1111%2Fj.1471-4159.2009.05996.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=19226369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVKnsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2009&pages=623-630&author=P.+W.+Thompsonauthor=L.+Yeauthor=J.+L.+Morgensternauthor=L.+Sueauthor=T.+G.+Beachauthor=D.+J.+Juddauthor=N.+J.+Shipleyauthor=V.+Libriauthor=A.+Lockhart&title=Interaction+of+the+amyloid+imaging+tracer+FDDNP+with+hallmark+Alzheimer%E2%80%99s+disease+pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of the amyloid imaging tracer FDDNP with hallmark Alzheimer's disease pathologies</span></div><div class="casAuthors">Thompson, Paul W.; Ye, Liang; Morgenstern, Jennifer L.; Sue, Lucia; Beach, Thomas G.; Judd, Duncan J.; Shipley, Nicholas J.; Libri, Vincenzo; Lockhart, Andrew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">623-630</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The distinctive cortical uptake of the tracer 18F-FDDNP, 2-(1-{6-[2-fluoroethyl(methyl)amino]-2-naphthyl}(ethylidene)malononitrile), in Alzheimer's disease (AD) is believed to be because of its binding to both neurofibrillary tangles (NFTs) and highly fibrillar senile plaques.  We therefore investigated the binding of a tracer concn. of 3H-FDDNP to brain sections contg. AD hallmark pathologies.  Semi-adjacent sections were labeled with 3H-PIB (Pittsburgh compd.-B, 2-[4'-(methylamino)phenyl]-6-hydroxybenzothiazole) and 14C-SB13 (4-N-methylamino-4'-hydroxystilbene) for comparison.  Neocortical sections contg. widespread senile plaques and cerebrovascular amyloid angiopathy, produced a sparse and weak labeling following incubation with 3H-FDDNP.  Furthermore, in sections contg. NFTs, there was no over labeling of the pathol. by 3H-FDDNP.  In contrast, sections labeled with 3H-PIB displayed extensive labeling of diffuse plaques, classical plaques, cerebrovascular amyloid angiopathy and NFTs.  14C-SB13 produced a broadly similar binding pattern to PIB.  Radioligand binding assays employing in vitro generated amyloid-β peptide fibrils demonstrated a ∼10-fold reduced affinity for 3H-FDDNP (85.0 ± 2.0 nM) compared with 3H-PIB (8.5 ± 1.3 nM).  These data provide an alternative mechanistic explanation for the obsd. low cortical uptake of 18F-FDDNP in AD; in that the ligand is only weakly retained by the hallmark neuropathol. because of its low affinity for amyloid structures.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTa4J3oN2sHLVg90H21EOLACvtfcHk0liuOuz_8JC-jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVKnsro%253D&md5=30e1e565523c4fbc102c8dc51ee47c27</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.2009.05996.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.2009.05996.x%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DP.%2BW.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DMorgenstern%26aufirst%3DJ.%2BL.%26aulast%3DSue%26aufirst%3DL.%26aulast%3DBeach%26aufirst%3DT.%2BG.%26aulast%3DJudd%26aufirst%3DD.%2BJ.%26aulast%3DShipley%26aufirst%3DN.%2BJ.%26aulast%3DLibri%26aufirst%3DV.%26aulast%3DLockhart%26aufirst%3DA.%26atitle%3DInteraction%2520of%2520the%2520amyloid%2520imaging%2520tracer%2520FDDNP%2520with%2520hallmark%2520Alzheimer%25E2%2580%2599s%2520disease%2520pathologies%26jtitle%3DJ.%2520Neurochem.%26date%3D2009%26volume%3D109%26spage%3D623%26epage%3D630" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigopoulos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartwright, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Keefe, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adlard, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnham, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F-THK-523: a novel in vivo tau imaging ligand for Alzheimer’s disease</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">1089</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2011&pages=1089-1100&author=M.+T.+Fodero-Tavolettiauthor=N.+Okamuraauthor=S.+Furumotoauthor=R.+S.+Mulliganauthor=A.+R.+Connorauthor=C.+A.+McLeanauthor=D.+Caoauthor=A.+Rigopoulosauthor=G.+A.+Cartwrightauthor=G.+O%E2%80%99Keefeauthor=S.+Gongauthor=P.+A.+Adlardauthor=K.+J.+Barnhamauthor=C.+C.+Roweauthor=C.+L.+Mastersauthor=Y.+Kudoauthor=R.+Cappaiauthor=K.+Yanaiauthor=V.+L.+Villemagne&title=18F-THK-523%3A+a+novel+in+vivo+tau+imaging+ligand+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DConnor%26aufirst%3DA.%2BR.%26aulast%3DMcLean%26aufirst%3DC.%2BA.%26aulast%3DCao%26aufirst%3DD.%26aulast%3DRigopoulos%26aufirst%3DA.%26aulast%3DCartwright%26aufirst%3DG.%2BA.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DG.%26aulast%3DGong%26aufirst%3DS.%26aulast%3DAdlard%26aufirst%3DP.%2BA.%26aulast%3DBarnham%26aufirst%3DK.%2BJ.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DCappai%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3D18F-THK-523%253A%2520a%2520novel%2520in%2520vivo%2520tau%2520imaging%2520ligand%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2011%26volume%3D134%26spage%3D1089%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumuto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Novel <sup>18</sup>F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">1420</span><span class="NLM_x">–</span> <span class="NLM_lpage">1427</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1420-1427&author=N.+Okamuraauthor=S.+Furumutoauthor=R.+Haradaauthor=T.+Tagoauthor=T.+Yoshikawaauthor=M.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=V.+L.+Villemagneauthor=H.+Akatsuauthor=T.+Yamamotoauthor=H.+Araiauthor=R.+Iwataauthor=K.+Yanaiauthor=Y.+Kudo&title=Novel+18F-labeled+arylquinoline+derivatives+for+noninvasive+imaging+of+tau+pathology+in+Alzheimer+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumuto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DYoshikawa%26aufirst%3DT.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DAkatsu%26aufirst%3DH.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DNovel%252018F-labeled%2520arylquinoline%2520derivatives%2520for%2520noninvasive%2520imaging%2520of%2520tau%2520pathology%2520in%2520Alzheimer%2520disease%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1420%26epage%3D1427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Villemagne, V. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodges, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piguet, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doré, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span> </span><span class="NLM_article-title">In vivo evaluation of a novel tau imaging tracer for Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">816</span><span class="NLM_x">–</span> <span class="NLM_lpage">826</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs00259-013-2681-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24514874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitleht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=816-826&author=V.+L.+Villemagneauthor=S.+Furumotoauthor=M.+T.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=J.+Hodgesauthor=R.+Haradaauthor=P.+Yatesauthor=O.+Piguetauthor=S.+Pejoskaauthor=V.+Dor%C3%A9author=K.+Yanaiauthor=C.+L.+Mastersauthor=Y.+Kudoauthor=C.+C.+Roweauthor=N.+Okamura&title=In+vivo+evaluation+of+a+novel+tau+imaging+tracer+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo evaluation of a novel tau imaging tracer for Alzheimer's disease</span></div><div class="casAuthors">Villemagne, Victor L.; Furumoto, Shozo; Fodero-Tavoletti, Michelle T.; Mulligan, Rachel S.; Hodges, John; Harada, Ryuichi; Yates, Paul; Piguet, Olivier; Pejoska, Svetlana; Dore, Vincent; Yanai, Kazuhiko; Masters, Colin L.; Kudo, Yukitsuka; Rowe, Christopher C.; Okamura, Nobuyuki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: Diagnosis of tauopathies such as Alzheimer's disease (AD) still relies on post-mortem examn. of the human brain.  A non-invasive method of detg. brain tau burden in vivo would allow a better understanding of the pathophysiol. of tauopathies.  The purpose of the study was to evaluate 18F-THK523 as a potential tau imaging tracer.  Methods: Ten healthy elderly controls, three semantic dementia (SD) and ten AD patients underwent neuropsychol. examn., MRI as well as 18F-THK523 and 11C-Pittsburgh compd. B (PIB) positron emission tomog. (PET) scans.  Composite memory and non-memory scores, global and hippocampal brain vol., and partial vol.-cor. tissue ratios for 18F-THK523 and 11C-PIB were estd. for all participants.  Correlational analyses were performed between global and regional 18F-THK523, 11C-PIB, cognition and brain volumetrics.  Results: 18F-THK523 presented with fast reversible kinetics.  Significantly higher 18F-THK523 retention was obsd. in the temporal, parietal, orbitofrontal and hippocampi of AD patients when compared to healthy controls and SD patients.  White matter retention was significantly higher than gray matter retention in all participants.  The pattern of cortical 18F-THK523 retention did not correlate with Aβ distribution as assessed by 11C-PIB and followed the known distribution of tau in the AD brain, being higher in temporal and parietal areas than in the frontal region.  Unlike 11C-PIB, hippocampal 18F-THK523 retention was correlated with several cognitive parameters and with hippocampal atrophy.  Conclusion: 18F-THK523 does not bind to Aβ in vivo, while following the known distribution of paired helical filaments (PHF)-tau in the brain.  Significantly higher cortical 18F-THK523 retention in AD patients as well as the assocn. of hippocampal 18F-THK523 retention with cognitive parameters and hippocampal vol. suggests 18F-THK523 selectively binds to tau in AD patients.  Unfortunately, the very high 18F-THK523 retention in white matter precludes simple visual inspection of the images, preventing its use in research or clin. settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkefkNuzPCr7Vg90H21EOLACvtfcHk0ljYO3TYztGm-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitleht7k%253D&md5=d995c47f394f706c5164913e7024f1fa</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1007%2Fs00259-013-2681-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-013-2681-7%26sid%3Dliteratum%253Aachs%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DHodges%26aufirst%3DJ.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DPiguet%26aufirst%3DO.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DDor%25C3%25A9%26aufirst%3DV.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DOkamura%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520evaluation%2520of%2520a%2520novel%2520tau%2520imaging%2520tracer%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D816%26epage%3D826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fodero-Tavoletti, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pejoska, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masters, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowe, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villemagne, V. L.</span><span> </span><span class="NLM_article-title">Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using <sup>18</sup>F-THK5105 PET</span> <span class="citation_source-journal">Brain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">137</span><span class="NLM_x">, </span> <span class="NLM_fpage">1762</span><span class="NLM_x">–</span> <span class="NLM_lpage">1771</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2014&pages=1762-1771&author=N.+Okamuraauthor=S.+Furumotoauthor=M.+T.+Fodero-Tavolettiauthor=R.+S.+Mulliganauthor=R.+Haradaauthor=P.+Yatesauthor=S.+Pejoskaauthor=Y.+Kudoauthor=C.+L.+Mastersauthor=K.+Yanaiauthor=C.+C.+Roweauthor=V.+L.+Villemagne&title=Non-invasive+assessment+of+Alzheimer%E2%80%99s+disease+neurofibrillary+pathology+using+18F-THK5105+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DFodero-Tavoletti%26aufirst%3DM.%2BT.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DYates%26aufirst%3DP.%26aulast%3DPejoska%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DMasters%26aufirst%3DC.%2BL.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DRowe%26aufirst%3DC.%2BC.%26aulast%3DVillemagne%26aufirst%3DV.%2BL.%26atitle%3DNon-invasive%2520assessment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%2520neurofibrillary%2520pathology%2520using%252018F-THK5105%2520PET%26jtitle%3DBrain%26date%3D2014%26volume%3D137%26spage%3D1762%26epage%3D1771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Bakhti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aggarwal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simons, M.</span><span> </span><span class="NLM_article-title">Myelin architecture: zippering membranes tightly together</span> <span class="citation_source-journal">Cell. Mol. Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">1265</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1007%2Fs00018-013-1492-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24165921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ykt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=1265-1277&author=M.+Bakhtiauthor=S.+Aggarwalauthor=M.+Simons&title=Myelin+architecture%3A+zippering+membranes+tightly+together"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Myelin architecture: zippering membranes tightly together</span></div><div class="casAuthors">Bakhti, Mostafa; Aggarwal, Shweta; Simons, Mikael</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1265-1277</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">A review.  Rapid nerve conduction requires the coating of axons by a tightly packed multilayered myelin membrane.  In the central nervous system, myelin is formed from cellular processes that extend from oligodendrocytes and wrap in a spiral fashion around an axon, resulting in the close apposition of adjacent myelin membrane bilayers.  In this review, we discuss the phys. principles underlying the zippering of the plasma membrane of oligodendrocytes at the cytoplasmic and extracellular leaflet.  We propose that the interaction of the myelin basic protein with the cytoplasmic leaflet of the myelin bilayer triggers its polymn. into a fibrous network that drives membrane zippering and protein extrusion.  In contrast, the adhesion of the extracellular surfaces of myelin requires the down-regulation of repulsive components of the glycocalyx, in order to uncover weak and unspecific attractive forces that bring the extracellular surfaces into close contact.  Unveiling the mechanisms of myelin membrane assembly at the cytoplasmic and extracelluar sites may help to understand how the myelin bilayers are disrupted and destabilized in the different demyelinating diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGqmVlPlYIEbVg90H21EOLACvtfcHk0ljYO3TYztGm-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ykt7fP&md5=d31524fc46f20d335cc086b4007bd904</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1007%2Fs00018-013-1492-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-013-1492-0%26sid%3Dliteratum%253Aachs%26aulast%3DBakhti%26aufirst%3DM.%26aulast%3DAggarwal%26aufirst%3DS.%26aulast%3DSimons%26aufirst%3DM.%26atitle%3DMyelin%2520architecture%253A%2520zippering%2520membranes%2520tightly%2520together%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2014%26volume%3D71%26spage%3D1265%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">18</span><span class="NLM_x">–</span> <span class="NLM_lpage">24</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1002%2Fjlcr.3133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=24448742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1ekt77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=18-24&author=T.+Tagoauthor=S.+Furumotoauthor=N.+Okamuraauthor=R.+Haradaauthor=Y.+Ishikawaauthor=H.+Araiauthor=K.+Yanaiauthor=R.+Iwataauthor=Y.+Kudo&title=Synthesis+and+preliminary+evaluation+of+2-arylhydroxyquinoline+derivatives+for+tau+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and preliminary evaluation of 2-arylhydroxyquinoline derivatives for tau imaging</span></div><div class="casAuthors">Tago, Tetsuro; Furumoto, Shozo; Okamura, Nobuyuki; Harada, Ryuichi; Ishikawa, Yoichi; Arai, Hiroyuki; Yanai, Kazuhiko; Iwata, Ren; Kudo, Yukitsuka</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">18-24</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is the most common cause of dementia.  Senile plaques, consisting of β-amyloid, and neurofibrillary tangles (NFTs), composed of tau protein, are representative pathol. hallmarks of AD.  It is believed that the accumulation of NFTs precedes the onset of clin. symptoms of AD and correlates with the progression of memory dysfunction.  Thus, the use of noninvasive detection techniques including radiolabeled probes and positron emission tomog. (PET) will facilitate early diagnosis or staging of AD.  In this study, we synthesized and evaluated novel hydroxylated 2-arylquinoline derivs. as tau imaging PET probes.  The binding affinities of compds. for tau were evaluated by fluorescent staining of the AD hippocampal section and a competitive binding assay using [18F]THK-523.  THK-951 (I) showed high binding affinity for tau pathol. in an AD brain section and K18Δ280K fibrils (Ki = 20.7 nM); thus, we radiosynthesized a 11C-labeled THK-951 and further studied its potential as a tau PET probe.  The [11C]THK-951 demonstrated excellent kinetics in a normal mouse brain (3.23% ID/g at 2 min postinjection and 0.15% ID/g at 30 min postinjection) and showed the labeling of NFTs in an AD brain section by autoradiog. assay.  These findings indicate the availability of [11C]THK-951 for in vivo PET imaging of tau pathol. in AD.  Copyright © 2013 John Wiley & Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowUoQriEvLubVg90H21EOLACvtfcHk0lgwskFjZnH1Sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1ekt77K&md5=c0f8921a35e3787bfeea01994952014c</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3133%26sid%3Dliteratum%253Aachs%26aulast%3DTago%26aufirst%3DT.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DIshikawa%26aufirst%3DY.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DSynthesis%2520and%2520preliminary%2520evaluation%2520of%25202-arylhydroxyquinoline%2520derivatives%2520for%2520tau%2520imaging%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2014%26volume%3D57%26spage%3D18%26epage%3D24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tago, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tashiro, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furukawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yanai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span> </span><span class="NLM_article-title">Characterization of 18F-THK-5351, a novel PET tracer for imaging tau pathology in Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">S260</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=S260&author=N.+Okamuraauthor=S.+Furumotoauthor=R.+Haradaauthor=T.+Tagoauthor=R.+Iwataauthor=M.+Tashiroauthor=K.+Furukawaauthor=H.+Araiauthor=K.+Yanaiauthor=Y.+Kudo&title=Characterization+of+18F-THK-5351%2C+a+novel+PET+tracer+for+imaging+tau+pathology+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DHarada%26aufirst%3DR.%26aulast%3DTago%26aufirst%3DT.%26aulast%3DIwata%26aufirst%3DR.%26aulast%3DTashiro%26aufirst%3DM.%26aulast%3DFurukawa%26aufirst%3DK.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DYanai%26aufirst%3DK.%26aulast%3DKudo%26aufirst%3DY.%26atitle%3DCharacterization%2520of%252018F-THK-5351%252C%2520a%2520novel%2520PET%2520tracer%2520for%2520imaging%2520tau%2520pathology%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3DS260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Maruyama, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shinotoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trojanowski, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, V. M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sahara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okamura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furumoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saido, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takashima, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jang, M.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span> </span><span class="NLM_article-title">Imaging of tau pathology in mouse model and in Alzheimer patients compared to normal controls</span> <span class="citation_source-journal">Neuron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2013&pages=1-15&author=M.+Maruyamaauthor=H.+Shimadaauthor=T.+Suharaauthor=H.+Shinotohauthor=B.+Jiauthor=J.+Maedaauthor=M.-R.+Zhangauthor=J.+Q.+Trojanowskiauthor=V.+M.-Y.+Leeauthor=M.+Onoauthor=K.+Masamotoauthor=H.+Takanoauthor=N.+Saharaauthor=N.+Iwataauthor=N.+Okamuraauthor=S.+Furumotoauthor=Y.+Kudoauthor=Q.+Changauthor=T.+C.+Saidoauthor=A.+Takashimaauthor=J.+Lewisauthor=M.-K.+Jangauthor=I.+Aokiauthor=H.+Itoauthor=M.+Higuchi&title=Imaging+of+tau+pathology+in+mouse+model+and+in+Alzheimer+patients+compared+to+normal+controls"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaruyama%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DShinotoh%26aufirst%3DH.%26aulast%3DJi%26aufirst%3DB.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DTrojanowski%26aufirst%3DJ.%2BQ.%26aulast%3DLee%26aufirst%3DV.%2BM.-Y.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DMasamoto%26aufirst%3DK.%26aulast%3DTakano%26aufirst%3DH.%26aulast%3DSahara%26aufirst%3DN.%26aulast%3DIwata%26aufirst%3DN.%26aulast%3DOkamura%26aufirst%3DN.%26aulast%3DFurumoto%26aufirst%3DS.%26aulast%3DKudo%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DQ.%26aulast%3DSaido%26aufirst%3DT.%2BC.%26aulast%3DTakashima%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DJ.%26aulast%3DJang%26aufirst%3DM.-K.%26aulast%3DAoki%26aufirst%3DI.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DImaging%2520of%2520tau%2520pathology%2520in%2520mouse%2520model%2520and%2520in%2520Alzheimer%2520patients%2520compared%2520to%2520normal%2520controls%26jtitle%3DNeuron%26date%3D2013%26volume%3D79%26spage%3D1%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Hashimoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Igarashi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujishiro, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aihara, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furutsuka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ono, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nemoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M.-R.</span><span> </span><span class="NLM_article-title">Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of <sup>11</sup>C-PBB3 as a clinically useful PET probe for imaging of tau pathology</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1538</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1532-1538&author=H.+Hashimotoauthor=K.+Kawamuraauthor=N.+Igarashiauthor=M.+Takeiauthor=T.+Fujishiroauthor=Y.+Aiharaauthor=S.+Shiomiauthor=M.+Mutoauthor=T.+Itoauthor=K.+Furutsukaauthor=T.+Yamasakiauthor=J.+Yuiauthor=L.+Xieauthor=M.+Onoauthor=A.+Hatoriauthor=K.+Nemotoauthor=T.+Suharaauthor=M.+Higuchiauthor=M.-R.+Zhang&title=Radiosynthesis%2C+photoisomerization%2C+biodistribution%2C+and+metabolite+analysis+of+11C-PBB3+as+a+clinically+useful+PET+probe+for+imaging+of+tau+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DH.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DIgarashi%26aufirst%3DN.%26aulast%3DTakei%26aufirst%3DM.%26aulast%3DFujishiro%26aufirst%3DT.%26aulast%3DAihara%26aufirst%3DY.%26aulast%3DShiomi%26aufirst%3DS.%26aulast%3DMuto%26aufirst%3DM.%26aulast%3DIto%26aufirst%3DT.%26aulast%3DFurutsuka%26aufirst%3DK.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DOno%26aufirst%3DM.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DNemoto%26aufirst%3DK.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DM.-R.%26atitle%3DRadiosynthesis%252C%2520photoisomerization%252C%2520biodistribution%252C%2520and%2520metabolite%2520analysis%2520of%252011C-PBB3%2520as%2520a%2520clinically%2520useful%2520PET%2520probe%2520for%2520imaging%2520of%2520tau%2520pathology%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1532%26epage%3D1538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Lei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, S. H.</span><span> </span><span class="NLM_article-title">Landscapes of four-enantiomer conical intersections for photoisomerization of stilbene: CASSCF calculation</span> <span class="citation_source-journal">J. Phys. Chem. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x">, </span> <span class="NLM_fpage">9021</span><span class="NLM_x">–</span> <span class="NLM_lpage">903</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp5020109" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVOjt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2014&pages=9021-903&author=Y.+Leiauthor=L.+Yuauthor=B.+Zhouauthor=C.+Zhuauthor=Z.+Wenauthor=S.+H.+Lin&title=Landscapes+of+four-enantiomer+conical+intersections+for+photoisomerization+of+stilbene%3A+CASSCF+calculation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Landscapes of Four-Enantiomer Conical Intersections for Photoisomerization of Stilbene: CASSCF Calculation</span></div><div class="casAuthors">Lei, Yibo; Yu, Le; Zhou, Bo; Zhu, Chaoyuan; Wen, Zhenyi; Lin, Sheng Hsien</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">39</span>),
    <span class="NLM_cas:pages">9021-9031</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The photoisomerization of cis- and trans-stilbene through conical intersections (CI) is mainly governed by four dihedral angles around central C=C double bonds.  The two of them are C-C=C-C and H-C=C-H dihedral angles that are found to form a mirror rotation coordinate, and the mirror plane appears at the two dihedral angles equal to zeros with which the middle state is defined through partial optimization.  There exist the first-type of hula-twist-CI enantiomers, the second-type of hula-twist-CI enantiomers, the first-type of one-bond-flip-CI enantiomers, and the second type of one-bond-flip-CI enantiomers as well as cis-enantiomers and trans-enantiomers with respect to this mirror plane.  The complete active space SCF method is employed to calc. min. potential energy profile along the mirror rotation coordinate for each enantiomers, and it is found that the left-hand manifold and the right-hand manifold of potential energy surfaces can be energetically transferred via photoisomerization.  Furthermore, two-dimensional potential energy surfaces in terms of the branching plane g-h coordinates are constructed at vicinity of each conical intersection, and the landscapes of conical intersections show distinct feature, and in excited-state four potential wells sepd. in different section of g-h plane related to different conical intersections which indicate different photoisomerization pathways.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqiZ-bTti1MbVg90H21EOLACvtfcHk0lg5cwAYJ1VcAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVOjt7vM&md5=384c7477e3011ed14a4313abb88e6439</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjp5020109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp5020109%26sid%3Dliteratum%253Aachs%26aulast%3DLei%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DS.%2BH.%26atitle%3DLandscapes%2520of%2520four-enantiomer%2520conical%2520intersections%2520for%2520photoisomerization%2520of%2520stilbene%253A%2520CASSCF%2520calculation%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D2014%26volume%3D118%26spage%3D9021%26epage%3D903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Waldeck, D. H.</span><span> </span><span class="NLM_article-title">Photoisomerization dynamics of stilbene</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">436</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00003a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1991&pages=415-436&author=D.+H.+Waldeck&title=Photoisomerization+dynamics+of+stilbene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fcr00003a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00003a007%26sid%3Dliteratum%253Aachs%26aulast%3DWaldeck%26aufirst%3DD.%2BH.%26atitle%3DPhotoisomerization%2520dynamics%2520of%2520stilbene%26jtitle%3DChem.%2520Rev.%26date%3D1991%26volume%3D91%26spage%3D415%26epage%3D436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Szardenings, A. K.; Kolb, H. C.; Walsh, J. C.; Chen, G.; Gangadharmath, U. B.; Kasi, D.; Liu, C.; Sinha, A.; Wang, E.; Yu, C.; Zhang, W.; Chen, K.; Mocharla, V. P.; Scott, P. J. H.</span><span> </span><span class="NLM_article-title">Imaging agents for detecting neurological dysfunction</span>. International Patent US 2012/0302755 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+K.+Szardenings&author=H.+C.+Kolb&author=J.+C.+Walsh&author=G.+Chen&author=U.+B.+Gangadharmath&author=D.+Kasi&author=C.+Liu&author=A.+Sinha&author=E.+Wang&author=C.+Yu&author=W.+Zhang&author=K.+Chen&author=V.+P.+Mocharla&author=P.+J.+H.+Scott&title=Imaging+agents+for+detecting+neurological+dysfunction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26atitle%3DImaging%2520agents%2520for%2520detecting%2520neurological%2520dysfunction%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Cashion, D. K.; Cheng, G.; Kasi, D.; Kolb, H. C.</span><span> </span><span class="NLM_article-title">Imaging agents for detecting neurological disorders</span>. International Patent WO 2011/119565 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=D.+K.+Cashion&author=G.+Cheng&author=D.+Kasi&author=H.+C.+Kolb&title=Imaging+agents+for+detecting+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCashion%26aufirst%3DD.%2BK.%26atitle%3DImaging%2520agents%2520for%2520detecting%2520neurological%2520disorders%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cashion, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">A highly selective and specific PET tracer for imaging of tau pathologies</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">601</span><span class="NLM_x">–</span> <span class="NLM_lpage">612</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.3233%2FJAD-2012-120712" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=22683529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1GhurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2012&pages=601-612&author=W.+Zhangauthor=J.+Arteagaauthor=D.+K.+Cashionauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=A.+K.+Szardeningsauthor=E.+Wangauthor=J.+C.+Walshauthor=C.+Xiaauthor=C.+Yuauthor=T.+Zhaoauthor=H.+C.+Kolb&title=A+highly+selective+and+specific+PET+tracer+for+imaging+of+tau+pathologies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">A Highly Selective and Specific PET Tracer for Imaging of Tau Pathologies</span></div><div class="casAuthors">Zhang, Wei; Arteaga, Janna; Cashion, Daniel K.; Chen, Gang; Gangadharmath, Umesh; Gomez, Luis F.; Kasi, Dhanalakshmi; Lam, Chung; Liang, Qianwa; Liu, Changhui; Mocharla, Vani P.; Mu, Fanrong; Sinha, Anjana; Szardenings, A. Katrin; Wang, Eric; Walsh, Joseph C.; Xia, Chunfang; Yu, Chul; Zhao, Tieming; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">601-612</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Senile plaques and neurofibrillary tangles are prominent neuropathol. hallmarks in Alzheimer's disease and are considered to be targets for therapeutic intervention as well as biomarkers for diagnostic in vivo imaging agents.  While there are a no. of amyloid-β positron emission tomog. (PET) tracers currently in different stages of clin. development and commercialization, there have been very few reports on imaging agents selectively targeting tau aggregates.  In search of [18F]-PET tracers that possess great binding affinity and selectivity toward tau tangles, we tested more than 900 compds. utilizing a unique screening process.  A competitive autoradiog. assay was set up to test compds. for binding to native tau tangles and amyloid-β plaques on human brain tissue sections.  In our in vitro assays, the 18F labeled compd. [18F]-T808 displayed a high level of binding affinity and good selectivity for tau aggregates over amyloid-β plaques. [18F]-T808 showed rapid uptake and washout in rodent brains.  Our in vitro and preclin. in vivo studies suggest that [18F]-T808 possesses suitable properties and characteristics to be a specific and selective PET probe for imaging of paired helical filament tau in human brains.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCPcTCD2ucRLVg90H21EOLACvtfcHk0lise17Eg1boYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1GhurbI&md5=f9b40fa67928e2cbaa876fbaef62ff70</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.3233%2FJAD-2012-120712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-2012-120712%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DCashion%26aufirst%3DD.%2BK.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DA%2520highly%2520selective%2520and%2520specific%2520PET%2520tracer%2520for%2520imaging%2520of%2520tau%2520pathologies%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2012%26volume%3D31%26spage%3D601%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Xia, C.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arteaga, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gangadharmath, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomez, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kasi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mocharla, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]T807, a novel tau positron emission tomography imaging agent for Alzheimer’s disease</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1016%2Fj.jalz.2012.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23411393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=666-676&author=C.-F.+Xiaauthor=J.+Arteagaauthor=G.+Chenauthor=U.+Gangadharmathauthor=L.+F.+Gomezauthor=D.+Kasiauthor=C.+Lamauthor=Q.+Liangauthor=C.+Liuauthor=V.+P.+Mocharlaauthor=F.+Muauthor=A.+Sinhaauthor=H.+Suauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=E.+Wangauthor=C.+Yuauthor=W.+Zhangauthor=T.+Zhaoauthor=H.+C.+Kolb&title=%5B18F%5DT807%2C+a+novel+tau+positron+emission+tomography+imaging+agent+for+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease</span></div><div class="casAuthors">Xia Chun-Fang; Arteaga Janna; Chen Gang; Gangadharmath Umesh; Gomez Luis F; Kasi Dhanalakshmi; Lam Chung; Liang Qianwa; Liu Changhui; Mocharla Vani P; Mu Fanrong; Sinha Anjana; Su Helen; Szardenings A Katrin; Walsh Joseph C; Wang Eric; Yu Chul; Zhang Wei; Zhao Tieming; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & dementia : the journal of the Alzheimer's Association</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">666-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  We wished to develop a highly selective positron emission tomography (PET) imaging agent targeting PHF-tau in human Alzheimer's disease (AD) brains.  METHODS:  To screen potential tau binders, human AD brain sections were used as a source of native paired helical filament (PHF)-tau and Aβ rather than synthetic tau aggregates or Aβ fibrils generated in vitro to measure the affinity and selectivity of [(18)F]T807 to tau and Aβ.  Brain uptake and biodistribution of [(18)F]T807 in mice were also tested.  RESULTS:  In vitro autoradiography results show that [(18)F]T807 exhibits strong binding to PHF-tau-positive human brain sections.  A dissociation constant (Kd) of [(18)F]T807 (14.6 nM) was measured using brain sections from the frontal lobe of AD patients.  A comparison of autoradiography and double immunohistochemical staining of PHF-tau and Aβ on adjacent sections demonstrated that [(18)F]T807 binding colocalized with immunoreactive PHF-tau pathology, but did not highlight Aβ plaques.  In vivo studies in mice demonstrated that [(18)F]T807 was able to cross the blood-brain barrier and washed out quickly.  CONCLUSIONS:  [(18)F]T807 demonstrates high affinity and selectivity to PHF-tau as well as favorable in vivo properties, making this a promising candidate as an imaging agent for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ2ZgjLtot9A50d-O_J5C0AfW6udTcc2ebIbUpaL0qF0Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3szosFehsg%253D%253D&md5=1fccbc6c3ffe8e57fdd6f64ec450b1d7</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2012.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2012.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DC.-F.%26aulast%3DArteaga%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DGangadharmath%26aufirst%3DU.%26aulast%3DGomez%26aufirst%3DL.%2BF.%26aulast%3DKasi%26aufirst%3DD.%26aulast%3DLam%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DMocharla%26aufirst%3DV.%2BP.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSinha%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DH.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DWang%26aufirst%3DE.%26aulast%3DYu%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3D%255B18F%255DT807%252C%2520a%2520novel%2520tau%2520positron%2520emission%2520tomography%2520imaging%2520agent%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3D666%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Radde, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolmont, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaeser, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coomaraswamy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoltze, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calhoun, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaeggi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolburg, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gengler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghetti, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czech, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelscher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathews, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jucker, M.</span><span> </span><span class="NLM_article-title">Aβ42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology</span> <span class="citation_source-journal">EMBO Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">940</span><span class="NLM_x">–</span> <span class="NLM_lpage">946</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=940-946&author=R.+Raddeauthor=T.+Bolmontauthor=S.+A.+Kaeserauthor=J.+Coomaraswamyauthor=D.+Lindauauthor=L.+Stoltzeauthor=M.+E.+Calhounauthor=F.+Jaeggiauthor=H.+Wolburgauthor=S.+Genglerauthor=C.+Haassauthor=B.+Ghettiauthor=C.+Czechauthor=C.+Hoelscherauthor=P.+M.+Mathewsauthor=M.+Jucker&title=A%CE%B242-driven+cerebral+amyloidosis+in+transgenic+mice+reveals+early+and+robust+pathology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRadde%26aufirst%3DR.%26aulast%3DBolmont%26aufirst%3DT.%26aulast%3DKaeser%26aufirst%3DS.%2BA.%26aulast%3DCoomaraswamy%26aufirst%3DJ.%26aulast%3DLindau%26aufirst%3DD.%26aulast%3DStoltze%26aufirst%3DL.%26aulast%3DCalhoun%26aufirst%3DM.%2BE.%26aulast%3DJaeggi%26aufirst%3DF.%26aulast%3DWolburg%26aufirst%3DH.%26aulast%3DGengler%26aufirst%3DS.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DGhetti%26aufirst%3DB.%26aulast%3DCzech%26aufirst%3DC.%26aulast%3DHoelscher%26aufirst%3DC.%26aulast%3DMathews%26aufirst%3DP.%2BM.%26aulast%3DJucker%26aufirst%3DM.%26atitle%3DA%25CE%25B242-driven%2520cerebral%2520amyloidosis%2520in%2520transgenic%2520mice%2520reveals%2520early%2520and%2520robust%2520pathology%26jtitle%3DEMBO%2520Rep.%26date%3D2006%26volume%3D7%26spage%3D940%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szardenings, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">457</span><span class="NLM_x">–</span> <span class="NLM_lpage">468</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23234879" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2013&pages=457-468&author=D.+T.+Chienauthor=S.+Bahriauthor=A.+K.+Szardeningsauthor=J.+C.+Walshauthor=F.+Muauthor=M.-Y.+Suauthor=W.+R.+Shankleauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF-18%5D-T807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807</span></div><div class="casAuthors">Chien, David T.; Bahri, Shadfar; Szardenings, A. Katrin; Walsh, Joseph C.; Mu, Fanrong; Su, Min-Ying; Shankle, William R.; Elizarov, Arkadij; Kolb, Hartmuth C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">457-468</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have developed a novel PHF-tau targeting positron emission tomog. imaging agent, [F-18]-T807, which may be useful for imaging Alzheimer's disease and other tauopathies.  Here in, we describe the first human brain images with [F-18]-T807.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofLFkBPeoi47Vg90H21EOLACvtfcHk0li3D1jWvec48Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWlsbk%253D&md5=578173de3104c8e470381f0812ce6356</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DSzardenings%26aufirst%3DA.%2BK.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF-18%255D-T807%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2013%26volume%3D34%26spage%3D457%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shcherbinin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tauscher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Exploratory analyses of regional human brain distribution of the PET tau tracer F18-labeled T807 (AV-1541) in subjects with normal cognitive function or cognitive impairment thought to be due to AD</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">P842</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P842&author=M.+Mintunauthor=A.+Schwarzauthor=A.+Joshiauthor=S.+Shcherbininauthor=D.+Chienauthor=A.+Elizarovauthor=M.-Y.+Suauthor=W.+Shankleauthor=M.+Pontecorvoauthor=J.+Tauscherauthor=D.+Skovronskyauthor=H.+C.+Kolb&title=Exploratory+analyses+of+regional+human+brain+distribution+of+the+PET+tau+tracer+F18-labeled+T807+%28AV-1541%29+in+subjects+with+normal+cognitive+function+or+cognitive+impairment+thought+to+be+due+to+AD"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DSchwarz%26aufirst%3DA.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DShcherbinin%26aufirst%3DS.%26aulast%3DChien%26aufirst%3DD.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DShankle%26aufirst%3DW.%26aulast%3DPontecorvo%26aufirst%3DM.%26aulast%3DTauscher%26aufirst%3DJ.%26aulast%3DSkovronsky%26aufirst%3DD.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DExploratory%2520analyses%2520of%2520regional%2520human%2520brain%2520distribution%2520of%2520the%2520PET%2520tau%2520tracer%2520F18-labeled%2520T807%2520%2528AV-1541%2529%2520in%2520subjects%2520with%2520normal%2520cognitive%2520function%2520or%2520cognitive%2520impairment%2520thought%2520to%2520be%2520due%2520to%2520AD%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3DP842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Kolb, H. C.</span> Human amyloid imaging conference,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">, </span><a href="http://www.alzforum.org/news/conference-coverage/hai-spotlight-tau-tracers-human-amyloid-imaging-meeting" class="extLink">www.alzforum.org/news/conference-coverage/hai-spotlight-tau-tracers-human-amyloid-imaging-meeting</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kolb%2C+H.+C.+Human+amyloid+imaging+conference%2C+2013%2C+www.alzforum.org%2Fnews%2Fconference-coverage%2Fhai-spotlight-tau-tracers-human-amyloid-imaging-meeting."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Chien, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katrin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bahri, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shankle, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolb, H. C.</span><span> </span><span class="NLM_article-title">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">171</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=23948934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2014&pages=171-184&author=D.+T.+Chienauthor=A.+Katrinauthor=S.+Bahriauthor=J.+C.+Walshauthor=F.+Muauthor=C.+Xiaauthor=W.+R.+Shankleauthor=A.+J.+Lernerauthor=M.-Y.+Suauthor=A.+Elizarovauthor=H.+C.+Kolb&title=Early+clinical+PET+imaging+results+with+the+novel+PHF-tau+radioligand+%5BF18%5D-T808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808</span></div><div class="casAuthors">Chien David T; Szardenings A Katrin; Bahri Shadfar; Walsh Joseph C; Mu Fanrong; Xia Chunfang; Shankle William R; Lerner Alan J; Su Min-Ying; Elizarov Arkadij; Kolb Hartmuth C</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">171-84</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Aggregates of hyperphosphorylated tau (PHF-tau), such as neurofibrillary tangles, are linked to the degree of cognitive impairment in Alzheimer's disease.  We have recently reported early clinical results of a novel PHF-tau targeting PET imaging agent, [F18]-T807.  Since then, we have investigated a second novel PHF-tau targeting PET imaging agent, [F18]-T808, with different pharmacokinetic characteristics, which may be favorable for imaging Alzheimer's disease and other tauopathies.  Here, we describe the first human brain images with [F18]-T808.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSvVIddGtbpMLqxQ2mb9Pu8fW6udTcc2eZu-2oT892477ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sbgsVyjtQ%253D%253D&md5=757aaefcfe18524fdd4404c0cb351850</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChien%26aufirst%3DD.%2BT.%26aulast%3DKatrin%26aufirst%3DA.%26aulast%3DBahri%26aufirst%3DS.%26aulast%3DWalsh%26aufirst%3DJ.%2BC.%26aulast%3DMu%26aufirst%3DF.%26aulast%3DXia%26aufirst%3DC.%26aulast%3DShankle%26aufirst%3DW.%2BR.%26aulast%3DLerner%26aufirst%3DA.%2BJ.%26aulast%3DSu%26aufirst%3DM.-Y.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DKolb%26aufirst%3DH.%2BC.%26atitle%3DEarly%2520clinical%2520PET%2520imaging%2520results%2520with%2520the%2520novel%2520PHF-tau%2520radioligand%2520%255BF18%255D-T808%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2014%26volume%3D38%26spage%3D171%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Kolb, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Attardo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elizarov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D.</span><span> </span><span class="NLM_article-title">First case report: image to autopsy correlation for tau imaging with [18F]-T808 (AV-680)</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">P844</span><span class="NLM_x">–</span> <span class="NLM_lpage">845</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=P844-845&author=H.+C.+Kolbauthor=G.+Attardoauthor=M.+Mintunauthor=D.+Chienauthor=A.+Elizarovauthor=P.+Contiauthor=C.+Millerauthor=A.+Joshiauthor=D.+Skovronsky&title=First+case+report%3A+image+to+autopsy+correlation+for+tau+imaging+with+%5B18F%5D-T808+%28AV-680%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKolb%26aufirst%3DH.%2BC.%26aulast%3DAttardo%26aufirst%3DG.%26aulast%3DMintun%26aufirst%3DM.%26aulast%3DChien%26aufirst%3DD.%26aulast%3DElizarov%26aufirst%3DA.%26aulast%3DConti%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DC.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DSkovronsky%26aufirst%3DD.%26atitle%3DFirst%2520case%2520report%253A%2520image%2520to%2520autopsy%2520correlation%2520for%2520tau%2520imaging%2520with%2520%255B18F%255D-T808%2520%2528AV-680%2529%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2013%26volume%3D9%26spage%3DP844%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Landau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawaya, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laganowsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sievers, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrio, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenberg, D.</span><span> </span><span class="NLM_article-title">Towards a pharmacophore for amyloid</span> <span class="citation_source-journal">PLoS Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1001080</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm5017544&amp;key=10.1371%2Fjournal.pbio.1001080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm5017544&amp;key=21695112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm5017544&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=e1001080&author=M.+Landauauthor=M.+R.+Sawayaauthor=K.+F.+Faullauthor=A.+Laganowskyauthor=L.+Jiangauthor=S.+A.+Sieversauthor=J.+Liuauthor=J.+R.+Barrioauthor=D.+Eisenberg&title=Towards+a+pharmacophore+for+amyloid"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a pharmacophore for amyloid</span></div><div class="casAuthors">Landau, Meytal; Sawaya, Michael R.; Faull, Kym F.; Laganowsky, Arthur; Jiang, Lin; Sievers, Stuart A.; Liu, Jie; Barrio, Jorge R.; Eisenberg, David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1001080</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Diagnosing and treating Alzheimer's and other diseases assocd. with amyloid fibers remains a great challenge despite intensive research.  To aid in this effort, we present at. structures of fiber-forming segments of proteins involved in Alzheimer's disease in complex with small mol. binders, detd. by X-ray microcrystallog.  The fiber-like complexes consist of pairs of β-sheets, with small mols. binding between the sheets, roughly parallel to the fiber axis.  The structures suggest that apolar mols. drift along the fiber, consistent with the observation of nonspecific binding to a variety of amyloid proteins.  In contrast, neg. charged orange-G binds specifically to lysine side chains of adjacent sheets.  These structures provide mol. frameworks for the design of diagnostics and drugs for protein aggregation diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHJDf_wPbESrVg90H21EOLACvtfcHk0li8IcLwYOYsZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnvFegtbs%253D&md5=6fedd1729b59ee89733ea5f127fc0b1d</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.1001080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.1001080%26sid%3Dliteratum%253Aachs%26aulast%3DLandau%26aufirst%3DM.%26aulast%3DSawaya%26aufirst%3DM.%2BR.%26aulast%3DFaull%26aufirst%3DK.%2BF.%26aulast%3DLaganowsky%26aufirst%3DA.%26aulast%3DJiang%26aufirst%3DL.%26aulast%3DSievers%26aufirst%3DS.%2BA.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DBarrio%26aufirst%3DJ.%2BR.%26aulast%3DEisenberg%26aufirst%3DD.%26atitle%3DTowards%2520a%2520pharmacophore%2520for%2520amyloid%26jtitle%3DPLoS%2520Biol.%26date%3D2011%26volume%3D9%26spage%3De1001080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5017544&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-11%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm5017544%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5017544" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a5399a443d54","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
